id	sid	tid	token	lemma	pos
cord-029547-9ei1ram3	1	1	key	key	JJ
cord-029547-9ei1ram3	1	2	:	:	:
cord-029547-9ei1ram3	1	3	cord-029547	cord-029547	NNP
cord-029547-9ei1ram3	1	4	-	-	HYPH
cord-029547-9ei1ram3	1	5	9ei1ram3	9ei1ram3	CD
cord-029547-9ei1ram3	1	6	authors	author	NNS
cord-029547-9ei1ram3	1	7	:	:	:
cord-029547-9ei1ram3	1	8	Li	Li	NNP
cord-029547-9ei1ram3	1	9	,	,	,
cord-029547-9ei1ram3	1	10	Jingwei	Jingwei	NNP
cord-029547-9ei1ram3	1	11	;	;	:
cord-029547-9ei1ram3	1	12	Shao	Shao	NNP
cord-029547-9ei1ram3	1	13	,	,	,
cord-029547-9ei1ram3	1	14	Jun	Jun	NNP
cord-029547-9ei1ram3	1	15	;	;	:
cord-029547-9ei1ram3	1	16	Wang	Wang	NNP
cord-029547-9ei1ram3	1	17	,	,	,
cord-029547-9ei1ram3	1	18	Chengdi	Chengdi	NNP
cord-029547-9ei1ram3	1	19	;	;	:
cord-029547-9ei1ram3	1	20	Li	Li	NNP
cord-029547-9ei1ram3	1	21	,	,	,
cord-029547-9ei1ram3	1	22	Weimin	Weimin	NNP
cord-029547-9ei1ram3	1	23	title	title	NN
cord-029547-9ei1ram3	1	24	:	:	:
cord-029547-9ei1ram3	1	25	The	the	DT
cord-029547-9ei1ram3	1	26	epidemiology	epidemiology	NN
cord-029547-9ei1ram3	1	27	and	and	CC
cord-029547-9ei1ram3	1	28	therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	1	29	options	option	NNS
cord-029547-9ei1ram3	1	30	for	for	IN
cord-029547-9ei1ram3	1	31	the	the	DT
cord-029547-9ei1ram3	1	32	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	1	33	date	date	NN
cord-029547-9ei1ram3	1	34	:	:	:
cord-029547-9ei1ram3	1	35	2020	2020	CD
cord-029547-9ei1ram3	1	36	-	-	HYPH
cord-029547-9ei1ram3	1	37	05	05	CD
cord-029547-9ei1ram3	1	38	-	-	HYPH
cord-029547-9ei1ram3	1	39	28	28	CD
cord-029547-9ei1ram3	1	40	journal	journal	NN
cord-029547-9ei1ram3	1	41	:	:	:
cord-029547-9ei1ram3	2	1	Precis	Precis	NNP
cord-029547-9ei1ram3	2	2	Clin	Clin	NNP
cord-029547-9ei1ram3	2	3	Med	Med	NNP
cord-029547-9ei1ram3	2	4	DOI	doi	NN
cord-029547-9ei1ram3	2	5	:	:	:
cord-029547-9ei1ram3	2	6	10.1093	10.1093	CD
cord-029547-9ei1ram3	2	7	/	/	SYM
cord-029547-9ei1ram3	2	8	pcmedi	pcmedi	NNP
cord-029547-9ei1ram3	2	9	/	/	SYM
cord-029547-9ei1ram3	2	10	pbaa017	pbaa017	NNP
cord-029547-9ei1ram3	2	11	sha	sha	NNP
cord-029547-9ei1ram3	2	12	:	:	:
cord-029547-9ei1ram3	2	13	ebc7ff0033a4064852d60670c095d6196d84b32e	ebc7ff0033a4064852d60670c095d6196d84b32e	NNP
cord-029547-9ei1ram3	2	14	doc_id	doc_id	CD
cord-029547-9ei1ram3	2	15	:	:	:
cord-029547-9ei1ram3	2	16	29547	29547	CD
cord-029547-9ei1ram3	2	17	cord_uid	cord_uid	NNS
cord-029547-9ei1ram3	2	18	:	:	:
cord-029547-9ei1ram3	3	1	9ei1ram3	9ei1ram3	CD
cord-029547-9ei1ram3	4	1	An	an	DT
cord-029547-9ei1ram3	4	2	outbreak	outbreak	NN
cord-029547-9ei1ram3	4	3	of	of	IN
cord-029547-9ei1ram3	4	4	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	4	5	disease	disease	NN
cord-029547-9ei1ram3	4	6	2019	2019	CD
cord-029547-9ei1ram3	4	7	(	(	-LRB-
cord-029547-9ei1ram3	4	8	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	4	9	)	)	-RRB-
cord-029547-9ei1ram3	4	10	,	,	,
cord-029547-9ei1ram3	4	11	a	a	DT
cord-029547-9ei1ram3	4	12	disease	disease	NN
cord-029547-9ei1ram3	4	13	caused	cause	VBN
cord-029547-9ei1ram3	4	14	by	by	IN
cord-029547-9ei1ram3	4	15	a	a	DT
cord-029547-9ei1ram3	4	16	novel	novel	JJ
cord-029547-9ei1ram3	4	17	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	4	18	virus	virus	NN
cord-029547-9ei1ram3	4	19	,	,	,
cord-029547-9ei1ram3	4	20	has	have	VBZ
cord-029547-9ei1ram3	4	21	affected	affect	VBN
cord-029547-9ei1ram3	4	22	over	over	IN
cord-029547-9ei1ram3	4	23	200	200	CD
cord-029547-9ei1ram3	4	24	countries	country	NNS
cord-029547-9ei1ram3	4	25	and	and	CC
cord-029547-9ei1ram3	4	26	regions	region	NNS
cord-029547-9ei1ram3	4	27	worldwide	worldwide	RB
cord-029547-9ei1ram3	4	28	.	.	.
cord-029547-9ei1ram3	5	1	With	with	IN
cord-029547-9ei1ram3	5	2	the	the	DT
cord-029547-9ei1ram3	5	3	increasing	increase	VBG
cord-029547-9ei1ram3	5	4	number	number	NN
cord-029547-9ei1ram3	5	5	of	of	IN
cord-029547-9ei1ram3	5	6	patients	patient	NNS
cord-029547-9ei1ram3	5	7	and	and	CC
cord-029547-9ei1ram3	5	8	deaths	death	NNS
cord-029547-9ei1ram3	5	9	,	,	,
cord-029547-9ei1ram3	5	10	WHO	who	WP
cord-029547-9ei1ram3	5	11	have	have	VBP
cord-029547-9ei1ram3	5	12	declared	declare	VBN
cord-029547-9ei1ram3	5	13	it	-PRON-	PRP
cord-029547-9ei1ram3	5	14	as	as	IN
cord-029547-9ei1ram3	5	15	a	a	DT
cord-029547-9ei1ram3	5	16	global	global	JJ
cord-029547-9ei1ram3	5	17	pandemic	pandemic	NN
cord-029547-9ei1ram3	5	18	currently	currently	RB
cord-029547-9ei1ram3	5	19	,	,	,
cord-029547-9ei1ram3	5	20	indicating	indicate	VBG
cord-029547-9ei1ram3	5	21	a	a	DT
cord-029547-9ei1ram3	5	22	third	third	JJ
cord-029547-9ei1ram3	5	23	large	large	JJ
cord-029547-9ei1ram3	5	24	-	-	HYPH
cord-029547-9ei1ram3	5	25	scale	scale	NN
cord-029547-9ei1ram3	5	26	epidemic	epidemic	NN
cord-029547-9ei1ram3	5	27	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	5	28	has	have	VBZ
cord-029547-9ei1ram3	5	29	appeared	appear	VBN
cord-029547-9ei1ram3	5	30	since	since	IN
cord-029547-9ei1ram3	5	31	the	the	DT
cord-029547-9ei1ram3	5	32	emergence	emergence	NN
cord-029547-9ei1ram3	5	33	of	of	IN
cord-029547-9ei1ram3	5	34	severe	severe	JJ
cord-029547-9ei1ram3	5	35	acute	acute	JJ
cord-029547-9ei1ram3	5	36	respiratory	respiratory	JJ
cord-029547-9ei1ram3	5	37	syndrome	syndrome	NN
cord-029547-9ei1ram3	5	38	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	5	39	(	(	-LRB-
cord-029547-9ei1ram3	5	40	SARS	SARS	NNP
cord-029547-9ei1ram3	5	41	)	)	-RRB-
cord-029547-9ei1ram3	5	42	and	and	CC
cord-029547-9ei1ram3	5	43	Middle	Middle	NNP
cord-029547-9ei1ram3	5	44	-	-	HYPH
cord-029547-9ei1ram3	5	45	East	East	NNP
cord-029547-9ei1ram3	5	46	respiratory	respiratory	JJ
cord-029547-9ei1ram3	5	47	syndrome	syndrome	NN
cord-029547-9ei1ram3	5	48	(	(	-LRB-
cord-029547-9ei1ram3	5	49	MERS	MERS	NNP
cord-029547-9ei1ram3	5	50	)	)	-RRB-
cord-029547-9ei1ram3	5	51	in	in	IN
cord-029547-9ei1ram3	5	52	the	the	DT
cord-029547-9ei1ram3	5	53	twenty	twenty	CD
cord-029547-9ei1ram3	5	54	-	-	HYPH
cord-029547-9ei1ram3	5	55	first	first	JJ
cord-029547-9ei1ram3	5	56	century	century	NN
cord-029547-9ei1ram3	5	57	.	.	.
cord-029547-9ei1ram3	6	1	Considering	consider	VBG
cord-029547-9ei1ram3	6	2	the	the	DT
cord-029547-9ei1ram3	6	3	great	great	JJ
cord-029547-9ei1ram3	6	4	harm	harm	NN
cord-029547-9ei1ram3	6	5	it	-PRON-	PRP
cord-029547-9ei1ram3	6	6	has	have	VBZ
cord-029547-9ei1ram3	6	7	caused	cause	VBN
cord-029547-9ei1ram3	6	8	,	,	,
cord-029547-9ei1ram3	6	9	researchers	researcher	NNS
cord-029547-9ei1ram3	6	10	throughout	throughout	IN
cord-029547-9ei1ram3	6	11	the	the	DT
cord-029547-9ei1ram3	6	12	world	world	NN
cord-029547-9ei1ram3	6	13	have	have	VBP
cord-029547-9ei1ram3	6	14	been	be	VBN
cord-029547-9ei1ram3	6	15	chasing	chase	VBG
cord-029547-9ei1ram3	6	16	to	to	TO
cord-029547-9ei1ram3	6	17	exploit	exploit	VB
cord-029547-9ei1ram3	6	18	the	the	DT
cord-029547-9ei1ram3	6	19	pathophysiology	pathophysiology	NN
cord-029547-9ei1ram3	6	20	,	,	,
cord-029547-9ei1ram3	6	21	characteristics	characteristic	NNS
cord-029547-9ei1ram3	6	22	,	,	,
cord-029547-9ei1ram3	6	23	and	and	CC
cord-029547-9ei1ram3	6	24	potential	potential	JJ
cord-029547-9ei1ram3	6	25	remedies	remedy	NNS
cord-029547-9ei1ram3	6	26	for	for	IN
cord-029547-9ei1ram3	6	27	COVID-19	covid-19	CD
cord-029547-9ei1ram3	6	28	to	to	TO
cord-029547-9ei1ram3	6	29	better	well	JJR
cord-029547-9ei1ram3	6	30	battle	battle	VB
cord-029547-9ei1ram3	6	31	the	the	DT
cord-029547-9ei1ram3	6	32	outbreak	outbreak	NN
cord-029547-9ei1ram3	6	33	.	.	.
cord-029547-9ei1ram3	7	1	Therefore	therefore	RB
cord-029547-9ei1ram3	7	2	,	,	,
cord-029547-9ei1ram3	7	3	the	the	DT
cord-029547-9ei1ram3	7	4	current	current	JJ
cord-029547-9ei1ram3	7	5	study	study	NN
cord-029547-9ei1ram3	7	6	revisits	revisit	VBZ
cord-029547-9ei1ram3	7	7	advances	advance	NNS
cord-029547-9ei1ram3	7	8	of	of	IN
cord-029547-9ei1ram3	7	9	the	the	DT
cord-029547-9ei1ram3	7	10	virology	virology	NN
cord-029547-9ei1ram3	7	11	,	,	,
cord-029547-9ei1ram3	7	12	epidemiology	epidemiology	NN
cord-029547-9ei1ram3	7	13	,	,	,
cord-029547-9ei1ram3	7	14	clinical	clinical	JJ
cord-029547-9ei1ram3	7	15	features	feature	NNS
cord-029547-9ei1ram3	7	16	,	,	,
cord-029547-9ei1ram3	7	17	therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	7	18	options	option	NNS
cord-029547-9ei1ram3	7	19	,	,	,
cord-029547-9ei1ram3	7	20	and	and	CC
cord-029547-9ei1ram3	7	21	prevention	prevention	NN
cord-029547-9ei1ram3	7	22	of	of	IN
cord-029547-9ei1ram3	7	23	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	7	24	.	.	.
cord-029547-9ei1ram3	8	1	The	the	DT
cord-029547-9ei1ram3	8	2	features	feature	NNS
cord-029547-9ei1ram3	8	3	of	of	IN
cord-029547-9ei1ram3	8	4	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	8	5	carriers	carrier	NNS
cord-029547-9ei1ram3	8	6	are	be	VBP
cord-029547-9ei1ram3	8	7	also	also	RB
cord-029547-9ei1ram3	8	8	been	be	VBN
cord-029547-9ei1ram3	8	9	explored	explore	VBN
cord-029547-9ei1ram3	8	10	.	.	.
cord-029547-9ei1ram3	9	1	At	at	IN
cord-029547-9ei1ram3	9	2	the	the	DT
cord-029547-9ei1ram3	9	3	end	end	NN
cord-029547-9ei1ram3	9	4	of	of	IN
cord-029547-9ei1ram3	9	5	2019	2019	CD
cord-029547-9ei1ram3	9	6	,	,	,
cord-029547-9ei1ram3	9	7	a	a	DT
cord-029547-9ei1ram3	9	8	sudden	sudden	JJ
cord-029547-9ei1ram3	9	9	outbreak	outbreak	NN
cord-029547-9ei1ram3	9	10	of	of	IN
cord-029547-9ei1ram3	9	11	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	9	12	occurred	occur	VBD
cord-029547-9ei1ram3	9	13	in	in	IN
cord-029547-9ei1ram3	9	14	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	9	15	,	,	,
cord-029547-9ei1ram3	9	16	China	China	NNP
cord-029547-9ei1ram3	9	17	,	,	,
cord-029547-9ei1ram3	9	18	which	which	WDT
cord-029547-9ei1ram3	9	19	was	be	VBD
cord-029547-9ei1ram3	9	20	later	later	RB
cord-029547-9ei1ram3	9	21	confirmed	confirm	VBN
cord-029547-9ei1ram3	9	22	to	to	TO
cord-029547-9ei1ram3	9	23	be	be	VB
cord-029547-9ei1ram3	9	24	caused	cause	VBN
cord-029547-9ei1ram3	9	25	by	by	IN
cord-029547-9ei1ram3	9	26	a	a	DT
cord-029547-9ei1ram3	9	27	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	9	28	,	,	,
cord-029547-9ei1ram3	9	29	severe	severe	JJ
cord-029547-9ei1ram3	9	30	acute	acute	JJ
cord-029547-9ei1ram3	9	31	respiratory	respiratory	JJ
cord-029547-9ei1ram3	9	32	syndrome	syndrome	NN
cord-029547-9ei1ram3	9	33	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	9	34	2	2	CD
cord-029547-9ei1ram3	9	35	(	(	-LRB-
cord-029547-9ei1ram3	9	36	SARS	SARS	NNP
cord-029547-9ei1ram3	9	37	-	-	HYPH
cord-029547-9ei1ram3	9	38	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	9	39	)	)	-RRB-
cord-029547-9ei1ram3	9	40	.	.	.
cord-029547-9ei1ram3	10	1	1,2	1,2	LS
cord-029547-9ei1ram3	11	1	Soon	soon	RB
cord-029547-9ei1ram3	11	2	after	after	RB
cord-029547-9ei1ram3	11	3	,	,	,
cord-029547-9ei1ram3	11	4	the	the	DT
cord-029547-9ei1ram3	11	5	virus	virus	NN
cord-029547-9ei1ram3	11	6	spread	spread	VBD
cord-029547-9ei1ram3	11	7	rapidly	rapidly	RB
cord-029547-9ei1ram3	11	8	around	around	IN
cord-029547-9ei1ram3	11	9	the	the	DT
cord-029547-9ei1ram3	11	10	world	world	NN
cord-029547-9ei1ram3	11	11	and	and	CC
cord-029547-9ei1ram3	11	12	affected	affect	VBN
cord-029547-9ei1ram3	11	13	human	human	JJ
cord-029547-9ei1ram3	11	14	health	health	NN
cord-029547-9ei1ram3	11	15	as	as	RB
cord-029547-9ei1ram3	11	16	well	well	RB
cord-029547-9ei1ram3	11	17	as	as	IN
cord-029547-9ei1ram3	11	18	causing	cause	VBG
cord-029547-9ei1ram3	11	19	huge	huge	JJ
cord-029547-9ei1ram3	11	20	economic	economic	JJ
cord-029547-9ei1ram3	11	21	losses	loss	NNS
cord-029547-9ei1ram3	11	22	to	to	IN
cord-029547-9ei1ram3	11	23	society	society	NN
cord-029547-9ei1ram3	11	24	.	.	.
cord-029547-9ei1ram3	12	1	[	[	-LRB-
cord-029547-9ei1ram3	12	2	3	3	CD
cord-029547-9ei1ram3	12	3	]	]	-RRB-
cord-029547-9ei1ram3	12	4	[	[	-LRB-
cord-029547-9ei1ram3	12	5	4	4	CD
cord-029547-9ei1ram3	12	6	]	]	-RRB-
cord-029547-9ei1ram3	12	7	[	[	-LRB-
cord-029547-9ei1ram3	12	8	5	5	CD
cord-029547-9ei1ram3	12	9	]	]	-RRB-
cord-029547-9ei1ram3	13	1	On	on	IN
cord-029547-9ei1ram3	13	2	12	12	CD
cord-029547-9ei1ram3	13	3	February	February	NNP
cord-029547-9ei1ram3	13	4	2020	2020	CD
cord-029547-9ei1ram3	13	5	,	,	,
cord-029547-9ei1ram3	13	6	this	this	DT
cord-029547-9ei1ram3	13	7	novel	novel	JJ
cord-029547-9ei1ram3	13	8	disease	disease	NN
cord-029547-9ei1ram3	13	9	was	be	VBD
cord-029547-9ei1ram3	13	10	named	name	VBN
cord-029547-9ei1ram3	13	11	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	13	12	disease	disease	NN
cord-029547-9ei1ram3	13	13	2019	2019	CD
cord-029547-9ei1ram3	13	14	(	(	-LRB-
cord-029547-9ei1ram3	13	15	COVID-19	covid-19	VB
cord-029547-9ei1ram3	13	16	)	)	-RRB-
cord-029547-9ei1ram3	13	17	by	by	IN
cord-029547-9ei1ram3	13	18	WHO	WHO	NNP
cord-029547-9ei1ram3	13	19	.	.	.
cord-029547-9ei1ram3	14	1	6	6	CD
cord-029547-9ei1ram3	15	1	Since	since	IN
cord-029547-9ei1ram3	15	2	then	then	RB
cord-029547-9ei1ram3	15	3	,	,	,
cord-029547-9ei1ram3	15	4	medical	medical	JJ
cord-029547-9ei1ram3	15	5	experts	expert	NNS
cord-029547-9ei1ram3	15	6	around	around	IN
cord-029547-9ei1ram3	15	7	the	the	DT
cord-029547-9ei1ram3	15	8	world	world	NN
cord-029547-9ei1ram3	15	9	have	have	VBP
cord-029547-9ei1ram3	15	10	been	be	VBN
cord-029547-9ei1ram3	15	11	trying	try	VBG
cord-029547-9ei1ram3	15	12	to	to	TO
cord-029547-9ei1ram3	15	13	find	find	VB
cord-029547-9ei1ram3	15	14	the	the	DT
cord-029547-9ei1ram3	15	15	control	control	NN
cord-029547-9ei1ram3	15	16	measures	measure	NNS
cord-029547-9ei1ram3	15	17	and	and	CC
cord-029547-9ei1ram3	15	18	treatment	treatment	NN
cord-029547-9ei1ram3	15	19	for	for	IN
cord-029547-9ei1ram3	15	20	it	-PRON-	PRP
cord-029547-9ei1ram3	15	21	.	.	.
cord-029547-9ei1ram3	16	1	Because	because	IN
cord-029547-9ei1ram3	16	2	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	16	3	is	be	VBZ
cord-029547-9ei1ram3	16	4	highly	highly	RB
cord-029547-9ei1ram3	16	5	contagious	contagious	JJ
cord-029547-9ei1ram3	16	6	,	,	,
cord-029547-9ei1ram3	16	7	the	the	DT
cord-029547-9ei1ram3	16	8	number	number	NN
cord-029547-9ei1ram3	16	9	of	of	IN
cord-029547-9ei1ram3	16	10	patients	patient	NNS
cord-029547-9ei1ram3	16	11	has	have	VBZ
cord-029547-9ei1ram3	16	12	increased	increase	VBN
cord-029547-9ei1ram3	16	13	rapidly	rapidly	RB
cord-029547-9ei1ram3	16	14	.	.	.
cord-029547-9ei1ram3	17	1	Thus	thus	RB
cord-029547-9ei1ram3	17	2	,	,	,
cord-029547-9ei1ram3	17	3	realizing	realize	VBG
cord-029547-9ei1ram3	17	4	its	-PRON-	PRP$
cord-029547-9ei1ram3	17	5	basic	basic	JJ
cord-029547-9ei1ram3	17	6	characteristics	characteristic	NNS
cord-029547-9ei1ram3	17	7	and	and	CC
cord-029547-9ei1ram3	17	8	finding	find	VBG
cord-029547-9ei1ram3	17	9	appropriate	appropriate	JJ
cord-029547-9ei1ram3	17	10	methods	method	NNS
cord-029547-9ei1ram3	17	11	to	to	TO
cord-029547-9ei1ram3	17	12	detect	detect	VB
cord-029547-9ei1ram3	17	13	and	and	CC
cord-029547-9ei1ram3	17	14	cure	cure	VB
cord-029547-9ei1ram3	17	15	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	17	16	is	be	VBZ
cord-029547-9ei1ram3	17	17	necessary	necessary	JJ
cord-029547-9ei1ram3	17	18	for	for	IN
cord-029547-9ei1ram3	17	19	outbreak	outbreak	NN
cord-029547-9ei1ram3	17	20	control	control	NN
cord-029547-9ei1ram3	17	21	.	.	.
cord-029547-9ei1ram3	18	1	The	the	DT
cord-029547-9ei1ram3	18	2	detection	detection	NN
cord-029547-9ei1ram3	18	3	and	and	CC
cord-029547-9ei1ram3	18	4	rehabilitation	rehabilitation	NN
cord-029547-9ei1ram3	18	5	judgment	judgment	NN
cord-029547-9ei1ram3	18	6	of	of	IN
cord-029547-9ei1ram3	18	7	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	18	8	are	be	VBP
cord-029547-9ei1ram3	18	9	mainly	mainly	RB
cord-029547-9ei1ram3	18	10	through	through	IN
cord-029547-9ei1ram3	18	11	reverse	reverse	JJ
cord-029547-9ei1ram3	18	12	transcriptionpolymerase	transcriptionpolymerase	NN
cord-029547-9ei1ram3	18	13	chain	chain	NN
cord-029547-9ei1ram3	18	14	reaction	reaction	NN
cord-029547-9ei1ram3	18	15	(	(	-LRB-
cord-029547-9ei1ram3	18	16	RT	RT	NNP
cord-029547-9ei1ram3	18	17	-	-	HYPH
cord-029547-9ei1ram3	18	18	PCR	PCR	NNP
cord-029547-9ei1ram3	18	19	)	)	-RRB-
cord-029547-9ei1ram3	18	20	,	,	,
cord-029547-9ei1ram3	18	21	7	7	CD
cord-029547-9ei1ram3	18	22	but	but	CC
cord-029547-9ei1ram3	18	23	experts	expert	NNS
cord-029547-9ei1ram3	18	24	have	have	VBP
cord-029547-9ei1ram3	18	25	pointed	point	VBN
cord-029547-9ei1ram3	18	26	out	out	RP
cord-029547-9ei1ram3	18	27	the	the	DT
cord-029547-9ei1ram3	18	28	low	low	JJ
cord-029547-9ei1ram3	18	29	sensitivity	sensitivity	NN
cord-029547-9ei1ram3	18	30	will	will	MD
cord-029547-9ei1ram3	18	31	lead	lead	VB
cord-029547-9ei1ram3	18	32	to	to	IN
cord-029547-9ei1ram3	18	33	missed	miss	VBN
cord-029547-9ei1ram3	18	34	diagnosis	diagnosis	NN
cord-029547-9ei1ram3	18	35	.	.	.
cord-029547-9ei1ram3	19	1	So	so	RB
cord-029547-9ei1ram3	19	2	a	a	DT
cord-029547-9ei1ram3	19	3	combination	combination	NN
cord-029547-9ei1ram3	19	4	of	of	IN
cord-029547-9ei1ram3	19	5	RT	RT	NNP
cord-029547-9ei1ram3	19	6	-	-	HYPH
cord-029547-9ei1ram3	19	7	PCR	PCR	NNP
cord-029547-9ei1ram3	19	8	and	and	CC
cord-029547-9ei1ram3	19	9	other	other	JJ
cord-029547-9ei1ram3	19	10	clinical	clinical	JJ
cord-029547-9ei1ram3	19	11	features	feature	NNS
cord-029547-9ei1ram3	19	12	of	of	IN
cord-029547-9ei1ram3	19	13	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	19	14	is	be	VBZ
cord-029547-9ei1ram3	19	15	important	important	JJ
cord-029547-9ei1ram3	19	16	for	for	IN
cord-029547-9ei1ram3	19	17	diagnosis	diagnosis	NN
cord-029547-9ei1ram3	19	18	.	.	.
cord-029547-9ei1ram3	20	1	8	8	CD
cord-029547-9ei1ram3	21	1	The	the	DT
cord-029547-9ei1ram3	21	2	treatments	treatment	NNS
cord-029547-9ei1ram3	21	3	for	for	IN
cord-029547-9ei1ram3	21	4	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	21	5	are	be	VBP
cord-029547-9ei1ram3	21	6	still	still	RB
cord-029547-9ei1ram3	21	7	unclear	unclear	JJ
cord-029547-9ei1ram3	21	8	and	and	CC
cord-029547-9ei1ram3	21	9	mainly	mainly	RB
cord-029547-9ei1ram3	21	10	contain	contain	VBP
cord-029547-9ei1ram3	21	11	administration	administration	NN
cord-029547-9ei1ram3	21	12	of	of	IN
cord-029547-9ei1ram3	21	13	oxygen	oxygen	NN
cord-029547-9ei1ram3	21	14	,	,	,
cord-029547-9ei1ram3	21	15	drug	drug	NN
cord-029547-9ei1ram3	21	16	therapy	therapy	NN
cord-029547-9ei1ram3	21	17	,	,	,
cord-029547-9ei1ram3	21	18	and	and	CC
cord-029547-9ei1ram3	21	19	emergency	emergency	NN
cord-029547-9ei1ram3	21	20	treatments	treatment	NNS
cord-029547-9ei1ram3	21	21	such	such	JJ
cord-029547-9ei1ram3	21	22	as	as	IN
cord-029547-9ei1ram3	21	23	ECMO	ECMO	NNP
cord-029547-9ei1ram3	21	24	.	.	.
cord-029547-9ei1ram3	22	1	9	9	CD
cord-029547-9ei1ram3	22	2	,	,	,
cord-029547-9ei1ram3	22	3	10	10	CD
cord-029547-9ei1ram3	23	1	As	as	IN
cord-029547-9ei1ram3	23	2	we	-PRON-	PRP
cord-029547-9ei1ram3	23	3	know	know	VBP
cord-029547-9ei1ram3	23	4	,	,	,
cord-029547-9ei1ram3	23	5	few	few	JJ
cord-029547-9ei1ram3	23	6	studies	study	NNS
cord-029547-9ei1ram3	23	7	have	have	VBP
cord-029547-9ei1ram3	23	8	summarized	summarize	VBN
cord-029547-9ei1ram3	23	9	and	and	CC
cord-029547-9ei1ram3	23	10	classified	classified	JJ
cord-029547-9ei1ram3	23	11	therapies	therapy	NNS
cord-029547-9ei1ram3	23	12	for	for	IN
cord-029547-9ei1ram3	23	13	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	23	14	systematically	systematically	RB
cord-029547-9ei1ram3	23	15	.	.	.
cord-029547-9ei1ram3	24	1	Therefore	therefore	RB
cord-029547-9ei1ram3	24	2	,	,	,
cord-029547-9ei1ram3	24	3	we	-PRON-	PRP
cord-029547-9ei1ram3	24	4	review	review	VBP
cord-029547-9ei1ram3	24	5	basic	basic	JJ
cord-029547-9ei1ram3	24	6	characteristics	characteristic	NNS
cord-029547-9ei1ram3	24	7	such	such	JJ
cord-029547-9ei1ram3	24	8	as	as	IN
cord-029547-9ei1ram3	24	9	virology	virology	NN
cord-029547-9ei1ram3	24	10	and	and	CC
cord-029547-9ei1ram3	24	11	epidemiology	epidemiology	NN
cord-029547-9ei1ram3	24	12	of	of	IN
cord-029547-9ei1ram3	24	13	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	24	14	and	and	CC
cord-029547-9ei1ram3	24	15	classified	classify	VBN
cord-029547-9ei1ram3	24	16	explore	explore	VB
cord-029547-9ei1ram3	24	17	antiviral	antiviral	JJ
cord-029547-9ei1ram3	24	18	therapy	therapy	NN
cord-029547-9ei1ram3	24	19	,	,	,
cord-029547-9ei1ram3	24	20	symptomatic	symptomatic	JJ
cord-029547-9ei1ram3	24	21	treatment	treatment	NN
cord-029547-9ei1ram3	24	22	,	,	,
cord-029547-9ei1ram3	24	23	and	and	CC
cord-029547-9ei1ram3	24	24	traditional	traditional	JJ
cord-029547-9ei1ram3	24	25	Chinese	chinese	JJ
cord-029547-9ei1ram3	24	26	medicines	medicine	NNS
cord-029547-9ei1ram3	24	27	for	for	IN
cord-029547-9ei1ram3	24	28	curing	cure	VBG
cord-029547-9ei1ram3	24	29	COVID-19	covid-19	CD
cord-029547-9ei1ram3	24	30	.	.	.
cord-029547-9ei1ram3	25	1	Considering	consider	VBG
cord-029547-9ei1ram3	25	2	no	no	DT
cord-029547-9ei1ram3	25	3	licensed	licensed	JJ
cord-029547-9ei1ram3	25	4	vaccine	vaccine	NN
cord-029547-9ei1ram3	25	5	exists	exist	VBZ
cord-029547-9ei1ram3	25	6	for	for	IN
cord-029547-9ei1ram3	25	7	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	25	8	,	,	,
cord-029547-9ei1ram3	25	9	we	-PRON-	PRP
cord-029547-9ei1ram3	25	10	also	also	RB
cord-029547-9ei1ram3	25	11	summarize	summarize	VBP
cord-029547-9ei1ram3	25	12	the	the	DT
cord-029547-9ei1ram3	25	13	research	research	NN
cord-029547-9ei1ram3	25	14	and	and	CC
cord-029547-9ei1ram3	25	15	development	development	NN
cord-029547-9ei1ram3	25	16	of	of	IN
cord-029547-9ei1ram3	25	17	its	-PRON-	PRP$
cord-029547-9ei1ram3	25	18	vaccine	vaccine	NN
cord-029547-9ei1ram3	25	19	.	.	.
cord-029547-9ei1ram3	26	1	Notice	notice	VB
cord-029547-9ei1ram3	26	2	that	that	IN
cord-029547-9ei1ram3	26	3	the	the	DT
cord-029547-9ei1ram3	26	4	recent	recent	JJ
cord-029547-9ei1ram3	26	5	emergence	emergence	NN
cord-029547-9ei1ram3	26	6	of	of	IN
cord-029547-9ei1ram3	26	7	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	26	8	carriers	carrier	NNS
cord-029547-9ei1ram3	26	9	has	have	VBZ
cord-029547-9ei1ram3	26	10	brought	bring	VBN
cord-029547-9ei1ram3	26	11	great	great	JJ
cord-029547-9ei1ram3	26	12	difficulties	difficulty	NNS
cord-029547-9ei1ram3	26	13	for	for	IN
cord-029547-9ei1ram3	26	14	prevention	prevention	NN
cord-029547-9ei1ram3	26	15	and	and	CC
cord-029547-9ei1ram3	26	16	control	control	NN
cord-029547-9ei1ram3	26	17	of	of	IN
cord-029547-9ei1ram3	26	18	this	this	DT
cord-029547-9ei1ram3	26	19	disease	disease	NN
cord-029547-9ei1ram3	26	20	,	,	,
cord-029547-9ei1ram3	26	21	11	11	CD
cord-029547-9ei1ram3	26	22	we	-PRON-	PRP
cord-029547-9ei1ram3	26	23	highlight	highlight	VBP
cord-029547-9ei1ram3	26	24	the	the	DT
cord-029547-9ei1ram3	26	25	characteristics	characteristic	NNS
cord-029547-9ei1ram3	26	26	of	of	IN
cord-029547-9ei1ram3	26	27	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	26	28	carriers	carrier	NNS
cord-029547-9ei1ram3	26	29	and	and	CC
cord-029547-9ei1ram3	26	30	how	how	WRB
cord-029547-9ei1ram3	26	31	to	to	TO
cord-029547-9ei1ram3	26	32	reduce	reduce	VB
cord-029547-9ei1ram3	26	33	their	-PRON-	PRP$
cord-029547-9ei1ram3	26	34	impact	impact	NN
cord-029547-9ei1ram3	26	35	on	on	IN
cord-029547-9ei1ram3	26	36	the	the	DT
cord-029547-9ei1ram3	26	37	development	development	NN
cord-029547-9ei1ram3	26	38	of	of	IN
cord-029547-9ei1ram3	26	39	the	the	DT
cord-029547-9ei1ram3	26	40	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	26	41	pandemic	pandemic	NN
cord-029547-9ei1ram3	26	42	.	.	.
cord-029547-9ei1ram3	27	1	In	in	IN
cord-029547-9ei1ram3	27	2	January	January	NNP
cord-029547-9ei1ram3	27	3	2020	2020	CD
cord-029547-9ei1ram3	27	4	,	,	,
cord-029547-9ei1ram3	27	5	after	after	IN
cord-029547-9ei1ram3	27	6	the	the	DT
cord-029547-9ei1ram3	27	7	outbreak	outbreak	NN
cord-029547-9ei1ram3	27	8	of	of	IN
cord-029547-9ei1ram3	27	9	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	27	10	,	,	,
cord-029547-9ei1ram3	27	11	scientists	scientist	NNS
cord-029547-9ei1ram3	27	12	identified	identify	VBD
cord-029547-9ei1ram3	27	13	its	-PRON-	PRP$
cord-029547-9ei1ram3	27	14	pathogen	pathogen	NN
cord-029547-9ei1ram3	27	15	and	and	CC
cord-029547-9ei1ram3	27	16	immediately	immediately	RB
cord-029547-9ei1ram3	27	17	confirmed	confirm	VBD
cord-029547-9ei1ram3	27	18	it	-PRON-	PRP
cord-029547-9ei1ram3	27	19	to	to	TO
cord-029547-9ei1ram3	27	20	be	be	VB
cord-029547-9ei1ram3	27	21	a	a	DT
cord-029547-9ei1ram3	27	22	novel	novel	JJ
cord-029547-9ei1ram3	27	23	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	27	24	,	,	,
cord-029547-9ei1ram3	27	25	which	which	WDT
cord-029547-9ei1ram3	27	26	is	be	VBZ
cord-029547-9ei1ram3	27	27	found	find	VBN
cord-029547-9ei1ram3	27	28	to	to	TO
cord-029547-9ei1ram3	27	29	be	be	VB
cord-029547-9ei1ram3	27	30	a	a	DT
cord-029547-9ei1ram3	27	31	β	β	NN
cord-029547-9ei1ram3	27	32	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	27	33	of	of	IN
cord-029547-9ei1ram3	27	34	group	group	NN
cord-029547-9ei1ram3	27	35	2B	2b	CD
cord-029547-9ei1ram3	27	36	and	and	CC
cord-029547-9ei1ram3	27	37	was	be	VBD
cord-029547-9ei1ram3	27	38	named	name	VBN
cord-029547-9ei1ram3	27	39	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	27	40	by	by	IN
cord-029547-9ei1ram3	27	41	WHO	who	WP
cord-029547-9ei1ram3	27	42	initially	initially	RB
cord-029547-9ei1ram3	27	43	.	.	.
cord-029547-9ei1ram3	28	1	2	2	LS
cord-029547-9ei1ram3	28	2	Because	because	IN
cord-029547-9ei1ram3	28	3	70	70	CD
cord-029547-9ei1ram3	28	4	%	%	NN
cord-029547-9ei1ram3	28	5	of	of	IN
cord-029547-9ei1ram3	28	6	its	-PRON-	PRP$
cord-029547-9ei1ram3	28	7	genetic	genetic	JJ
cord-029547-9ei1ram3	28	8	sequences	sequence	NNS
cord-029547-9ei1ram3	28	9	are	be	VBP
cord-029547-9ei1ram3	28	10	similar	similar	JJ
cord-029547-9ei1ram3	28	11	to	to	IN
cord-029547-9ei1ram3	28	12	the	the	DT
cord-029547-9ei1ram3	28	13	SARS	SARS	NNP
cord-029547-9ei1ram3	28	14	-	-	HYPH
cord-029547-9ei1ram3	28	15	CoV	CoV	NNP
cord-029547-9ei1ram3	28	16	,	,	,
cord-029547-9ei1ram3	28	17	it	-PRON-	PRP
cord-029547-9ei1ram3	28	18	was	be	VBD
cord-029547-9ei1ram3	28	19	later	later	RB
cord-029547-9ei1ram3	28	20	renamed	rename	VBN
cord-029547-9ei1ram3	28	21	SARS	SARS	NNP
cord-029547-9ei1ram3	28	22	-	-	HYPH
cord-029547-9ei1ram3	28	23	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	28	24	.	.	.
cord-029547-9ei1ram3	29	1	12	12	CD
cord-029547-9ei1ram3	30	1	The	the	DT
cord-029547-9ei1ram3	30	2	origin	origin	NN
cord-029547-9ei1ram3	30	3	of	of	IN
cord-029547-9ei1ram3	30	4	SARS	SARS	NNP
cord-029547-9ei1ram3	30	5	-	-	HYPH
cord-029547-9ei1ram3	30	6	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	30	7	is	be	VBZ
cord-029547-9ei1ram3	30	8	unclear	unclear	JJ
cord-029547-9ei1ram3	30	9	and	and	CC
cord-029547-9ei1ram3	30	10	is	be	VBZ
cord-029547-9ei1ram3	30	11	thought	think	VBN
cord-029547-9ei1ram3	30	12	to	to	TO
cord-029547-9ei1ram3	30	13	be	be	VB
cord-029547-9ei1ram3	30	14	related	relate	VBN
cord-029547-9ei1ram3	30	15	to	to	IN
cord-029547-9ei1ram3	30	16	bat	bat	NN
cord-029547-9ei1ram3	30	17	coronaviruses	coronaviruse	NNS
cord-029547-9ei1ram3	30	18	.	.	.
cord-029547-9ei1ram3	31	1	Zhou	Zhou	NNP
cord-029547-9ei1ram3	31	2	et	et	NNP
cord-029547-9ei1ram3	31	3	al	al	NNP
cord-029547-9ei1ram3	31	4	.	.	.
cord-029547-9ei1ram3	32	1	compared	compare	VBN
cord-029547-9ei1ram3	32	2	gene	gene	NN
cord-029547-9ei1ram3	32	3	sequence	sequence	NN
cord-029547-9ei1ram3	32	4	of	of	IN
cord-029547-9ei1ram3	32	5	SARS	SARS	NNP
cord-029547-9ei1ram3	32	6	-	-	HYPH
cord-029547-9ei1ram3	32	7	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	32	8	with	with	IN
cord-029547-9ei1ram3	32	9	RaTG13	RaTG13	NNP
cord-029547-9ei1ram3	32	10	,	,	,
cord-029547-9ei1ram3	32	11	a	a	DT
cord-029547-9ei1ram3	32	12	bat	bat	NN
cord-029547-9ei1ram3	32	13	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	32	14	,	,	,
cord-029547-9ei1ram3	32	15	and	and	CC
cord-029547-9ei1ram3	32	16	found	find	VBD
cord-029547-9ei1ram3	32	17	the	the	DT
cord-029547-9ei1ram3	32	18	whole	whole	JJ
cord-029547-9ei1ram3	32	19	-	-	HYPH
cord-029547-9ei1ram3	32	20	genome	genome	NN
cord-029547-9ei1ram3	32	21	sequence	sequence	NN
cord-029547-9ei1ram3	32	22	of	of	IN
cord-029547-9ei1ram3	32	23	SARS	SARS	NNP
cord-029547-9ei1ram3	32	24	-	-	HYPH
cord-029547-9ei1ram3	32	25	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	32	26	is	be	VBZ
cord-029547-9ei1ram3	32	27	96.2	96.2	CD
cord-029547-9ei1ram3	32	28	%	%	NN
cord-029547-9ei1ram3	32	29	similar	similar	JJ
cord-029547-9ei1ram3	32	30	to	to	IN
cord-029547-9ei1ram3	32	31	RaTG13	RaTG13	NNP
cord-029547-9ei1ram3	32	32	,	,	,
cord-029547-9ei1ram3	32	33	indicating	indicate	VBG
cord-029547-9ei1ram3	32	34	that	that	IN
cord-029547-9ei1ram3	32	35	SARS	SARS	NNP
cord-029547-9ei1ram3	32	36	-	-	HYPH
cord-029547-9ei1ram3	32	37	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	32	38	may	may	MD
cord-029547-9ei1ram3	32	39	originate	originate	VB
cord-029547-9ei1ram3	32	40	from	from	IN
cord-029547-9ei1ram3	32	41	a	a	DT
cord-029547-9ei1ram3	32	42	bat	bat	NN
cord-029547-9ei1ram3	32	43	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	32	44	.	.	.
cord-029547-9ei1ram3	33	1	13	13	CD
cord-029547-9ei1ram3	34	1	At	at	IN
cord-029547-9ei1ram3	34	2	the	the	DT
cord-029547-9ei1ram3	34	3	same	same	JJ
cord-029547-9ei1ram3	34	4	time	time	NN
cord-029547-9ei1ram3	34	5	,	,	,
cord-029547-9ei1ram3	34	6	Wu	Wu	NNP
cord-029547-9ei1ram3	34	7	and	and	CC
cord-029547-9ei1ram3	34	8	colleagues	colleague	NNS
cord-029547-9ei1ram3	34	9	reported	report	VBD
cord-029547-9ei1ram3	34	10	that	that	IN
cord-029547-9ei1ram3	34	11	the	the	DT
cord-029547-9ei1ram3	34	12	genome	genome	NN
cord-029547-9ei1ram3	34	13	sequence	sequence	NN
cord-029547-9ei1ram3	34	14	of	of	IN
cord-029547-9ei1ram3	34	15	SARS	SARS	NNP
cord-029547-9ei1ram3	34	16	-	-	HYPH
cord-029547-9ei1ram3	34	17	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	34	18	was	be	VBD
cord-029547-9ei1ram3	34	19	closely	closely	RB
cord-029547-9ei1ram3	34	20	linked	link	VBN
cord-029547-9ei1ram3	34	21	with	with	IN
cord-029547-9ei1ram3	34	22	SL	SL	NNP
cord-029547-9ei1ram3	34	23	-	-	HYPH
cord-029547-9ei1ram3	34	24	CoVZC45	CoVZC45	NNP
cord-029547-9ei1ram3	34	25	,	,	,
cord-029547-9ei1ram3	34	26	another	another	DT
cord-029547-9ei1ram3	34	27	bat	bat	NN
cord-029547-9ei1ram3	34	28	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	34	29	,	,	,
cord-029547-9ei1ram3	34	30	with	with	IN
cord-029547-9ei1ram3	34	31	82.3	82.3	CD
cord-029547-9ei1ram3	34	32	%	%	NN
cord-029547-9ei1ram3	34	33	similarity	similarity	NN
cord-029547-9ei1ram3	34	34	.	.	.
cord-029547-9ei1ram3	35	1	14	14	CD
cord-029547-9ei1ram3	36	1	However	however	RB
cord-029547-9ei1ram3	36	2	,	,	,
cord-029547-9ei1ram3	36	3	despite	despite	IN
cord-029547-9ei1ram3	36	4	the	the	DT
cord-029547-9ei1ram3	36	5	high	high	JJ
cord-029547-9ei1ram3	36	6	similarity	similarity	NN
cord-029547-9ei1ram3	36	7	of	of	IN
cord-029547-9ei1ram3	36	8	SARS	SARS	NNP
cord-029547-9ei1ram3	36	9	-	-	HYPH
cord-029547-9ei1ram3	36	10	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	36	11	to	to	IN
cord-029547-9ei1ram3	36	12	the	the	DT
cord-029547-9ei1ram3	36	13	virus	virus	NN
cord-029547-9ei1ram3	36	14	from	from	IN
cord-029547-9ei1ram3	36	15	bats	bat	NNS
cord-029547-9ei1ram3	36	16	,	,	,
cord-029547-9ei1ram3	36	17	the	the	DT
cord-029547-9ei1ram3	36	18	genetic	genetic	JJ
cord-029547-9ei1ram3	36	19	differences	difference	NNS
cord-029547-9ei1ram3	36	20	will	will	MD
cord-029547-9ei1ram3	36	21	take	take	VB
cord-029547-9ei1ram3	36	22	at	at	RB
cord-029547-9ei1ram3	36	23	least	least	JJS
cord-029547-9ei1ram3	36	24	a	a	DT
cord-029547-9ei1ram3	36	25	few	few	JJ
cord-029547-9ei1ram3	36	26	decades	decade	NNS
cord-029547-9ei1ram3	36	27	of	of	IN
cord-029547-9ei1ram3	36	28	evolution	evolution	NN
cord-029547-9ei1ram3	36	29	to	to	TO
cord-029547-9ei1ram3	36	30	make	make	VB
cord-029547-9ei1ram3	36	31	up	up	RP
cord-029547-9ei1ram3	36	32	.	.	.
cord-029547-9ei1ram3	37	1	15	15	CD
cord-029547-9ei1ram3	38	1	Thus	thus	RB
cord-029547-9ei1ram3	38	2	,	,	,
cord-029547-9ei1ram3	38	3	bats	bat	NNS
cord-029547-9ei1ram3	38	4	are	be	VBP
cord-029547-9ei1ram3	38	5	unlikely	unlikely	JJ
cord-029547-9ei1ram3	38	6	to	to	TO
cord-029547-9ei1ram3	38	7	be	be	VB
cord-029547-9ei1ram3	38	8	the	the	DT
cord-029547-9ei1ram3	38	9	definitive	definitive	JJ
cord-029547-9ei1ram3	38	10	hosts	host	NNS
cord-029547-9ei1ram3	38	11	of	of	IN
cord-029547-9ei1ram3	38	12	it	-PRON-	PRP
cord-029547-9ei1ram3	38	13	,	,	,
cord-029547-9ei1ram3	38	14	and	and	CC
cord-029547-9ei1ram3	38	15	there	there	EX
cord-029547-9ei1ram3	38	16	may	may	MD
cord-029547-9ei1ram3	38	17	exist	exist	VB
cord-029547-9ei1ram3	38	18	other	other	JJ
cord-029547-9ei1ram3	38	19	intermediate	intermediate	JJ
cord-029547-9ei1ram3	38	20	hosts	host	NNS
cord-029547-9ei1ram3	38	21	which	which	WDT
cord-029547-9ei1ram3	38	22	brought	bring	VBD
cord-029547-9ei1ram3	38	23	the	the	DT
cord-029547-9ei1ram3	38	24	virus	virus	NN
cord-029547-9ei1ram3	38	25	into	into	IN
cord-029547-9ei1ram3	38	26	humans	human	NNS
cord-029547-9ei1ram3	38	27	.	.	.
cord-029547-9ei1ram3	39	1	16	16	CD
cord-029547-9ei1ram3	40	1	The	the	DT
cord-029547-9ei1ram3	40	2	relative	relative	JJ
cord-029547-9ei1ram3	40	3	synonymous	synonymous	JJ
cord-029547-9ei1ram3	40	4	codon	codon	NN
cord-029547-9ei1ram3	40	5	usage	usage	NN
cord-029547-9ei1ram3	40	6	analysis	analysis	NN
cord-029547-9ei1ram3	40	7	of	of	IN
cord-029547-9ei1ram3	40	8	viruses	virus	NNS
cord-029547-9ei1ram3	40	9	found	find	VBD
cord-029547-9ei1ram3	40	10	SARS	SARS	NNP
cord-029547-9ei1ram3	40	11	-	-	HYPH
cord-029547-9ei1ram3	40	12	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	40	13	used	use	VBD
cord-029547-9ei1ram3	40	14	the	the	DT
cord-029547-9ei1ram3	40	15	translation	translation	NN
cord-029547-9ei1ram3	40	16	machinery	machinery	NN
cord-029547-9ei1ram3	40	17	of	of	IN
cord-029547-9ei1ram3	40	18	several	several	JJ
cord-029547-9ei1ram3	40	19	snakes	snake	NNS
cord-029547-9ei1ram3	40	20	effectively	effectively	RB
cord-029547-9ei1ram3	40	21	.	.	.
cord-029547-9ei1ram3	41	1	Therefore	therefore	RB
cord-029547-9ei1ram3	41	2	,	,	,
cord-029547-9ei1ram3	41	3	snakes	snake	NNS
cord-029547-9ei1ram3	41	4	are	be	VBP
cord-029547-9ei1ram3	41	5	a	a	DT
cord-029547-9ei1ram3	41	6	potential	potential	JJ
cord-029547-9ei1ram3	41	7	reservoir	reservoir	NN
cord-029547-9ei1ram3	41	8	of	of	IN
cord-029547-9ei1ram3	41	9	the	the	DT
cord-029547-9ei1ram3	41	10	novel	novel	JJ
cord-029547-9ei1ram3	41	11	virus	virus	NN
cord-029547-9ei1ram3	41	12	.	.	.
cord-029547-9ei1ram3	42	1	17	17	CD
cord-029547-9ei1ram3	43	1	Apart	apart	RB
cord-029547-9ei1ram3	43	2	from	from	IN
cord-029547-9ei1ram3	43	3	this	this	DT
cord-029547-9ei1ram3	43	4	,	,	,
cord-029547-9ei1ram3	43	5	pangolins	pangolin	NNS
cord-029547-9ei1ram3	43	6	are	be	VBP
cord-029547-9ei1ram3	43	7	thought	think	VBN
cord-029547-9ei1ram3	43	8	to	to	TO
cord-029547-9ei1ram3	43	9	be	be	VB
cord-029547-9ei1ram3	43	10	the	the	DT
cord-029547-9ei1ram3	43	11	potential	potential	JJ
cord-029547-9ei1ram3	43	12	intermediate	intermediate	JJ
cord-029547-9ei1ram3	43	13	host	host	NN
cord-029547-9ei1ram3	43	14	of	of	IN
cord-029547-9ei1ram3	43	15	SARS	SARS	NNP
cord-029547-9ei1ram3	43	16	-	-	HYPH
cord-029547-9ei1ram3	43	17	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	43	18	due	due	IN
cord-029547-9ei1ram3	43	19	to	to	IN
cord-029547-9ei1ram3	43	20	the	the	DT
cord-029547-9ei1ram3	43	21	sequence	sequence	NN
cord-029547-9ei1ram3	43	22	similarity	similarity	NN
cord-029547-9ei1ram3	43	23	of	of	IN
cord-029547-9ei1ram3	43	24	their	-PRON-	PRP$
cord-029547-9ei1ram3	43	25	spike	spike	NN
cord-029547-9ei1ram3	43	26	receptor	receptor	NN
cord-029547-9ei1ram3	43	27	binding	bind	VBG
cord-029547-9ei1ram3	43	28	domains	domain	NNS
cord-029547-9ei1ram3	43	29	.	.	.
cord-029547-9ei1ram3	44	1	18	18	CD
cord-029547-9ei1ram3	45	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	45	2	,	,	,
cord-029547-9ei1ram3	45	3	Liu	Liu	NNP
cord-029547-9ei1ram3	45	4	et	et	NNP
cord-029547-9ei1ram3	45	5	al	al	NNP
cord-029547-9ei1ram3	45	6	.	.	NNP
cord-029547-9ei1ram3	45	7	declared	declare	VBD
cord-029547-9ei1ram3	45	8	that	that	IN
cord-029547-9ei1ram3	45	9	turtles	turtle	NNS
cord-029547-9ei1ram3	45	10	were	be	VBD
cord-029547-9ei1ram3	45	11	another	another	DT
cord-029547-9ei1ram3	45	12	possible	possible	JJ
cord-029547-9ei1ram3	45	13	host	host	NN
cord-029547-9ei1ram3	45	14	of	of	IN
cord-029547-9ei1ram3	45	15	SARS	SARS	NNP
cord-029547-9ei1ram3	45	16	-	-	HYPH
cord-029547-9ei1ram3	45	17	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	45	18	.	.	.
cord-029547-9ei1ram3	46	1	19	19	CD
cord-029547-9ei1ram3	47	1	Thus	thus	RB
cord-029547-9ei1ram3	47	2	,	,	,
cord-029547-9ei1ram3	47	3	more	more	JJR
cord-029547-9ei1ram3	47	4	studies	study	NNS
cord-029547-9ei1ram3	47	5	are	be	VBP
cord-029547-9ei1ram3	47	6	necessary	necessary	JJ
cord-029547-9ei1ram3	47	7	for	for	IN
cord-029547-9ei1ram3	47	8	confirming	confirm	VBG
cord-029547-9ei1ram3	47	9	the	the	DT
cord-029547-9ei1ram3	47	10	intermediate	intermediate	JJ
cord-029547-9ei1ram3	47	11	host	host	NN
cord-029547-9ei1ram3	47	12	of	of	IN
cord-029547-9ei1ram3	47	13	SARS	SARS	NNP
cord-029547-9ei1ram3	47	14	-	-	HYPH
cord-029547-9ei1ram3	47	15	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	47	16	.	.	.
cord-029547-9ei1ram3	48	1	The	the	DT
cord-029547-9ei1ram3	48	2	pathogenic	pathogenic	JJ
cord-029547-9ei1ram3	48	3	mechanism	mechanism	NN
cord-029547-9ei1ram3	48	4	of	of	IN
cord-029547-9ei1ram3	48	5	SARS	SARS	NNP
cord-029547-9ei1ram3	48	6	-	-	HYPH
cord-029547-9ei1ram3	48	7	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	48	8	is	be	VBZ
cord-029547-9ei1ram3	48	9	still	still	RB
cord-029547-9ei1ram3	48	10	unclear	unclear	JJ
cord-029547-9ei1ram3	48	11	and	and	CC
cord-029547-9ei1ram3	48	12	thought	think	VBD
cord-029547-9ei1ram3	48	13	to	to	TO
cord-029547-9ei1ram3	48	14	be	be	VB
cord-029547-9ei1ram3	48	15	closely	closely	RB
cord-029547-9ei1ram3	48	16	related	relate	VBN
cord-029547-9ei1ram3	48	17	to	to	IN
cord-029547-9ei1ram3	48	18	viral	viral	JJ
cord-029547-9ei1ram3	48	19	sepsis	sepsis	NN
cord-029547-9ei1ram3	48	20	,	,	,
cord-029547-9ei1ram3	48	21	20	20	CD
cord-029547-9ei1ram3	48	22	but	but	CC
cord-029547-9ei1ram3	48	23	structural	structural	JJ
cord-029547-9ei1ram3	48	24	biology	biology	NN
cord-029547-9ei1ram3	48	25	has	have	VBZ
cord-029547-9ei1ram3	48	26	explained	explain	VBN
cord-029547-9ei1ram3	48	27	how	how	WRB
cord-029547-9ei1ram3	48	28	viruses	virus	NNS
cord-029547-9ei1ram3	48	29	enter	enter	VBP
cord-029547-9ei1ram3	48	30	cells	cell	NNS
cord-029547-9ei1ram3	48	31	.	.	.
cord-029547-9ei1ram3	49	1	Angiotensin	angiotensin	NN
cord-029547-9ei1ram3	49	2	converting	convert	VBG
cord-029547-9ei1ram3	49	3	enzyme	enzyme	NN
cord-029547-9ei1ram3	49	4	II	II	NNP
cord-029547-9ei1ram3	49	5	(	(	-LRB-
cord-029547-9ei1ram3	49	6	ACE2	ACE2	NNP
cord-029547-9ei1ram3	49	7	)	)	-RRB-
cord-029547-9ei1ram3	49	8	has	have	VBZ
cord-029547-9ei1ram3	49	9	been	be	VBN
cord-029547-9ei1ram3	49	10	demonstrated	demonstrate	VBN
cord-029547-9ei1ram3	49	11	to	to	TO
cord-029547-9ei1ram3	49	12	be	be	VB
cord-029547-9ei1ram3	49	13	the	the	DT
cord-029547-9ei1ram3	49	14	only	only	JJ
cord-029547-9ei1ram3	49	15	receptor	receptor	NN
cord-029547-9ei1ram3	49	16	for	for	IN
cord-029547-9ei1ram3	49	17	SARS	SARS	NNP
cord-029547-9ei1ram3	49	18	-	-	HYPH
cord-029547-9ei1ram3	49	19	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	49	20	.	.	.
cord-029547-9ei1ram3	50	1	13	13	CD
cord-029547-9ei1ram3	51	1	The	the	DT
cord-029547-9ei1ram3	51	2	S	S	NNP
cord-029547-9ei1ram3	51	3	protein	protein	NN
cord-029547-9ei1ram3	51	4	on	on	IN
cord-029547-9ei1ram3	51	5	the	the	DT
cord-029547-9ei1ram3	51	6	surface	surface	NN
cord-029547-9ei1ram3	51	7	of	of	IN
cord-029547-9ei1ram3	51	8	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	51	9	was	be	VBD
cord-029547-9ei1ram3	51	10	confirmed	confirm	VBN
cord-029547-9ei1ram3	51	11	to	to	TO
cord-029547-9ei1ram3	51	12	mediate	mediate	VB
cord-029547-9ei1ram3	51	13	virus	virus	NN
cord-029547-9ei1ram3	51	14	entry	entry	NN
cord-029547-9ei1ram3	51	15	,	,	,
cord-029547-9ei1ram3	51	16	21	21	CD
cord-029547-9ei1ram3	51	17	which	which	WDT
cord-029547-9ei1ram3	51	18	contains	contain	VBZ
cord-029547-9ei1ram3	51	19	proteins	protein	NNS
cord-029547-9ei1ram3	51	20	S1	S1	NNP
cord-029547-9ei1ram3	51	21	and	and	CC
cord-029547-9ei1ram3	51	22	S2	S2	NNP
cord-029547-9ei1ram3	51	23	subunits	subunit	NNS
cord-029547-9ei1ram3	51	24	.	.	.
cord-029547-9ei1ram3	52	1	The	the	DT
cord-029547-9ei1ram3	52	2	receptor	receptor	NN
cord-029547-9ei1ram3	52	3	-	-	HYPH
cord-029547-9ei1ram3	52	4	binding	bind	VBG
cord-029547-9ei1ram3	52	5	domain	domain	NN
cord-029547-9ei1ram3	52	6	(	(	-LRB-
cord-029547-9ei1ram3	52	7	RBD	RBD	NNP
cord-029547-9ei1ram3	52	8	)	)	-RRB-
cord-029547-9ei1ram3	52	9	of	of	IN
cord-029547-9ei1ram3	52	10	S1	S1	NNP
cord-029547-9ei1ram3	52	11	is	be	VBZ
cord-029547-9ei1ram3	52	12	responsible	responsible	JJ
cord-029547-9ei1ram3	52	13	for	for	IN
cord-029547-9ei1ram3	52	14	the	the	DT
cord-029547-9ei1ram3	52	15	recognition	recognition	NN
cord-029547-9ei1ram3	52	16	of	of	IN
cord-029547-9ei1ram3	52	17	ACE2	ACE2	NNP
cord-029547-9ei1ram3	52	18	on	on	IN
cord-029547-9ei1ram3	52	19	the	the	DT
cord-029547-9ei1ram3	52	20	surface	surface	NN
cord-029547-9ei1ram3	52	21	of	of	IN
cord-029547-9ei1ram3	52	22	human	human	JJ
cord-029547-9ei1ram3	52	23	cells	cell	NNS
cord-029547-9ei1ram3	52	24	to	to	TO
cord-029547-9ei1ram3	52	25	complete	complete	VB
cord-029547-9ei1ram3	52	26	the	the	DT
cord-029547-9ei1ram3	52	27	binding	binding	NN
cord-029547-9ei1ram3	52	28	of	of	IN
cord-029547-9ei1ram3	52	29	viruses	virus	NNS
cord-029547-9ei1ram3	52	30	to	to	IN
cord-029547-9ei1ram3	52	31	cells	cell	NNS
cord-029547-9ei1ram3	52	32	.	.	.
cord-029547-9ei1ram3	53	1	The	the	DT
cord-029547-9ei1ram3	53	2	S2	S2	NNP
cord-029547-9ei1ram3	53	3	subunit	subunit	NN
cord-029547-9ei1ram3	53	4	mediates	mediate	VBZ
cord-029547-9ei1ram3	53	5	the	the	DT
cord-029547-9ei1ram3	53	6	fusion	fusion	NN
cord-029547-9ei1ram3	53	7	of	of	IN
cord-029547-9ei1ram3	53	8	the	the	DT
cord-029547-9ei1ram3	53	9	virus	virus	NN
cord-029547-9ei1ram3	53	10	envelope	envelope	NN
cord-029547-9ei1ram3	53	11	and	and	CC
cord-029547-9ei1ram3	53	12	human	human	JJ
cord-029547-9ei1ram3	53	13	cell	cell	NN
cord-029547-9ei1ram3	53	14	membrane	membrane	NN
cord-029547-9ei1ram3	53	15	to	to	TO
cord-029547-9ei1ram3	53	16	complete	complete	VB
cord-029547-9ei1ram3	53	17	the	the	DT
cord-029547-9ei1ram3	53	18	invasion	invasion	NN
cord-029547-9ei1ram3	53	19	process	process	NN
cord-029547-9ei1ram3	53	20	.	.	.
cord-029547-9ei1ram3	54	1	There	there	EX
cord-029547-9ei1ram3	54	2	are	be	VBP
cord-029547-9ei1ram3	54	3	two	two	CD
cord-029547-9ei1ram3	54	4	important	important	JJ
cord-029547-9ei1ram3	54	5	conserved	conserve	VBN
cord-029547-9ei1ram3	54	6	repeated	repeat	VBN
cord-029547-9ei1ram3	54	7	amino	amino	NN
cord-029547-9ei1ram3	54	8	acid	acid	NN
cord-029547-9ei1ram3	54	9	sequences	sequence	NNS
cord-029547-9ei1ram3	54	10	,	,	,
cord-029547-9ei1ram3	54	11	HR1	HR1	NNP
cord-029547-9ei1ram3	54	12	and	and	CC
cord-029547-9ei1ram3	54	13	HR2	HR2	NNP
cord-029547-9ei1ram3	54	14	,	,	,
cord-029547-9ei1ram3	54	15	in	in	IN
cord-029547-9ei1ram3	54	16	the	the	DT
cord-029547-9ei1ram3	54	17	S2	S2	NNP
cord-029547-9ei1ram3	54	18	subunit	subunit	NN
cord-029547-9ei1ram3	54	19	of	of	IN
cord-029547-9ei1ram3	54	20	SARS	SARS	NNP
cord-029547-9ei1ram3	54	21	-	-	HYPH
cord-029547-9ei1ram3	54	22	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	54	23	.	.	.
cord-029547-9ei1ram3	55	1	Together	together	RB
cord-029547-9ei1ram3	55	2	,	,	,
cord-029547-9ei1ram3	55	3	they	-PRON-	PRP
cord-029547-9ei1ram3	55	4	form	form	VBP
cord-029547-9ei1ram3	55	5	a	a	DT
cord-029547-9ei1ram3	55	6	spiral	spiral	JJ
cord-029547-9ei1ram3	55	7	structure	structure	NN
cord-029547-9ei1ram3	55	8	called	call	VBN
cord-029547-9ei1ram3	55	9	6-HB	6-hb	CD
cord-029547-9ei1ram3	55	10	,	,	,
cord-029547-9ei1ram3	55	11	which	which	WDT
cord-029547-9ei1ram3	55	12	is	be	VBZ
cord-029547-9ei1ram3	55	13	the	the	DT
cord-029547-9ei1ram3	55	14	key	key	NN
cord-029547-9ei1ram3	55	15	for	for	IN
cord-029547-9ei1ram3	55	16	the	the	DT
cord-029547-9ei1ram3	55	17	fusion	fusion	NN
cord-029547-9ei1ram3	55	18	of	of	IN
cord-029547-9ei1ram3	55	19	a	a	DT
cord-029547-9ei1ram3	55	20	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	55	21	envelope	envelope	NN
cord-029547-9ei1ram3	55	22	with	with	IN
cord-029547-9ei1ram3	55	23	cell	cell	NN
cord-029547-9ei1ram3	55	24	membrane	membrane	NN
cord-029547-9ei1ram3	55	25	.	.	.
cord-029547-9ei1ram3	56	1	22	22	CD
cord-029547-9ei1ram3	57	1	The	the	DT
cord-029547-9ei1ram3	57	2	serine	serine	NN
cord-029547-9ei1ram3	57	3	protease	protease	NN
cord-029547-9ei1ram3	57	4	TMPRSS2	TMPRSS2	NNP
cord-029547-9ei1ram3	57	5	triggers	trigger	VBZ
cord-029547-9ei1ram3	57	6	the	the	DT
cord-029547-9ei1ram3	57	7	S	S	NNP
cord-029547-9ei1ram3	57	8	protein	protein	NN
cord-029547-9ei1ram3	57	9	and	and	CC
cord-029547-9ei1ram3	57	10	promotes	promote	VBZ
cord-029547-9ei1ram3	57	11	its	-PRON-	PRP$
cord-029547-9ei1ram3	57	12	fusion	fusion	NN
cord-029547-9ei1ram3	57	13	with	with	IN
cord-029547-9ei1ram3	57	14	the	the	DT
cord-029547-9ei1ram3	57	15	cell	cell	NN
cord-029547-9ei1ram3	57	16	membrane	membrane	NN
cord-029547-9ei1ram3	57	17	.	.	.
cord-029547-9ei1ram3	58	1	23	23	CD
cord-029547-9ei1ram3	59	1	After	after	IN
cord-029547-9ei1ram3	59	2	that	that	DT
cord-029547-9ei1ram3	59	3	,	,	,
cord-029547-9ei1ram3	59	4	the	the	DT
cord-029547-9ei1ram3	59	5	RNA	RNA	NNP
cord-029547-9ei1ram3	59	6	of	of	IN
cord-029547-9ei1ram3	59	7	the	the	DT
cord-029547-9ei1ram3	59	8	virus	virus	NN
cord-029547-9ei1ram3	59	9	is	be	VBZ
cord-029547-9ei1ram3	59	10	released	release	VBN
cord-029547-9ei1ram3	59	11	into	into	IN
cord-029547-9ei1ram3	59	12	the	the	DT
cord-029547-9ei1ram3	59	13	cytoplasm	cytoplasm	NN
cord-029547-9ei1ram3	59	14	to	to	TO
cord-029547-9ei1ram3	59	15	complete	complete	VB
cord-029547-9ei1ram3	59	16	its	-PRON-	PRP$
cord-029547-9ei1ram3	59	17	biosynthesis	biosynthesis	NN
cord-029547-9ei1ram3	59	18	.	.	.
cord-029547-9ei1ram3	60	1	SARS	SARS	NNP
cord-029547-9ei1ram3	60	2	-	-	HYPH
cord-029547-9ei1ram3	60	3	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	60	4	is	be	VBZ
cord-029547-9ei1ram3	60	5	more	more	RBR
cord-029547-9ei1ram3	60	6	contagious	contagious	JJ
cord-029547-9ei1ram3	60	7	,	,	,
cord-029547-9ei1ram3	60	8	although	although	IN
cord-029547-9ei1ram3	60	9	it	-PRON-	PRP
cord-029547-9ei1ram3	60	10	has	have	VBZ
cord-029547-9ei1ram3	60	11	a	a	DT
cord-029547-9ei1ram3	60	12	similar	similar	JJ
cord-029547-9ei1ram3	60	13	structure	structure	NN
cord-029547-9ei1ram3	60	14	of	of	IN
cord-029547-9ei1ram3	60	15	S	s	NN
cord-029547-9ei1ram3	60	16	protein	protein	NN
cord-029547-9ei1ram3	60	17	to	to	IN
cord-029547-9ei1ram3	60	18	SARS	SARS	NNP
cord-029547-9ei1ram3	60	19	-	-	HYPH
cord-029547-9ei1ram3	60	20	CoV	CoV	NNP
cord-029547-9ei1ram3	60	21	,	,	,
cord-029547-9ei1ram3	60	22	so	so	IN
cord-029547-9ei1ram3	60	23	virus	virus	NN
cord-029547-9ei1ram3	60	24	-	-	HYPH
cord-029547-9ei1ram3	60	25	receptor	receptor	NN
cord-029547-9ei1ram3	60	26	-	-	HYPH
cord-029547-9ei1ram3	60	27	binding	bind	VBG
cord-029547-9ei1ram3	60	28	affinity	affinity	NN
cord-029547-9ei1ram3	60	29	is	be	VBZ
cord-029547-9ei1ram3	60	30	now	now	RB
cord-029547-9ei1ram3	60	31	being	be	VBG
cord-029547-9ei1ram3	60	32	conducted	conduct	VBN
cord-029547-9ei1ram3	60	33	in	in	IN
cord-029547-9ei1ram3	60	34	further	further	JJ
cord-029547-9ei1ram3	60	35	studies	study	NNS
cord-029547-9ei1ram3	60	36	.	.	.
cord-029547-9ei1ram3	61	1	Goh	Goh	NNP
cord-029547-9ei1ram3	61	2	et	et	NNP
cord-029547-9ei1ram3	61	3	al	al	NNP
cord-029547-9ei1ram3	61	4	.	.	.
cord-029547-9ei1ram3	62	1	found	find	VBD
cord-029547-9ei1ram3	62	2	the	the	DT
cord-029547-9ei1ram3	62	3	rigidity	rigidity	NN
cord-029547-9ei1ram3	62	4	and	and	CC
cord-029547-9ei1ram3	62	5	stability	stability	NN
cord-029547-9ei1ram3	62	6	of	of	IN
cord-029547-9ei1ram3	62	7	SARS	SARS	NNP
cord-029547-9ei1ram3	62	8	-	-	HYPH
cord-029547-9ei1ram3	62	9	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	62	10	shell	shell	NN
cord-029547-9ei1ram3	62	11	are	be	VBP
cord-029547-9ei1ram3	62	12	apparently	apparently	RB
cord-029547-9ei1ram3	62	13	higher	high	JJR
cord-029547-9ei1ram3	62	14	than	than	IN
cord-029547-9ei1ram3	62	15	SARS	SARS	NNP
cord-029547-9ei1ram3	62	16	-	-	HYPH
cord-029547-9ei1ram3	62	17	CoV	CoV	NNP
cord-029547-9ei1ram3	62	18	,	,	,
cord-029547-9ei1ram3	62	19	24	24	CD
cord-029547-9ei1ram3	62	20	which	which	WDT
cord-029547-9ei1ram3	62	21	increase	increase	VBP
cord-029547-9ei1ram3	62	22	its	-PRON-	PRP$
cord-029547-9ei1ram3	62	23	adaption	adaption	NN
cord-029547-9ei1ram3	62	24	to	to	IN
cord-029547-9ei1ram3	62	25	the	the	DT
cord-029547-9ei1ram3	62	26	environment	environment	NN
cord-029547-9ei1ram3	62	27	.	.	.
cord-029547-9ei1ram3	63	1	Moreover	moreover	RB
cord-029547-9ei1ram3	63	2	,	,	,
cord-029547-9ei1ram3	63	3	the	the	DT
cord-029547-9ei1ram3	63	4	structural	structural	JJ
cord-029547-9ei1ram3	63	5	difference	difference	NN
cord-029547-9ei1ram3	63	6	of	of	IN
cord-029547-9ei1ram3	63	7	HR1	HR1	NNP
cord-029547-9ei1ram3	63	8	contributes	contribute	VBZ
cord-029547-9ei1ram3	63	9	to	to	IN
cord-029547-9ei1ram3	63	10	the	the	DT
cord-029547-9ei1ram3	63	11	higher	high	JJR
cord-029547-9ei1ram3	63	12	structural	structural	JJ
cord-029547-9ei1ram3	63	13	stability	stability	NN
cord-029547-9ei1ram3	63	14	for	for	IN
cord-029547-9ei1ram3	63	15	the	the	DT
cord-029547-9ei1ram3	63	16	6-HB	6-hb	CD
cord-029547-9ei1ram3	63	17	of	of	IN
cord-029547-9ei1ram3	63	18	SARS	SARS	NNP
cord-029547-9ei1ram3	63	19	-	-	HYPH
cord-029547-9ei1ram3	63	20	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	63	21	,	,	,
cord-029547-9ei1ram3	63	22	which	which	WDT
cord-029547-9ei1ram3	63	23	has	have	VBZ
cord-029547-9ei1ram3	63	24	caused	cause	VBN
cord-029547-9ei1ram3	63	25	the	the	DT
cord-029547-9ei1ram3	63	26	better	well	JJR
cord-029547-9ei1ram3	63	27	membrane	membrane	NN
cord-029547-9ei1ram3	63	28	fusion	fusion	NN
cord-029547-9ei1ram3	63	29	capacity	capacity	NN
cord-029547-9ei1ram3	63	30	of	of	IN
cord-029547-9ei1ram3	63	31	SARS	SARS	NNP
cord-029547-9ei1ram3	63	32	-	-	HYPH
cord-029547-9ei1ram3	63	33	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	63	34	.	.	.
cord-029547-9ei1ram3	64	1	22	22	CD
cord-029547-9ei1ram3	65	1	Thus	thus	RB
cord-029547-9ei1ram3	65	2	,	,	,
cord-029547-9ei1ram3	65	3	SARS	SARS	NNP
cord-029547-9ei1ram3	65	4	-	-	HYPH
cord-029547-9ei1ram3	65	5	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	65	6	has	have	VBZ
cord-029547-9ei1ram3	65	7	a	a	DT
cord-029547-9ei1ram3	65	8	stronger	strong	JJR
cord-029547-9ei1ram3	65	9	infectious	infectious	JJ
cord-029547-9ei1ram3	65	10	ability	ability	NN
cord-029547-9ei1ram3	65	11	.	.	.
cord-029547-9ei1ram3	66	1	It	-PRON-	PRP
cord-029547-9ei1ram3	66	2	is	be	VBZ
cord-029547-9ei1ram3	66	3	worth	worth	JJ
cord-029547-9ei1ram3	66	4	noting	note	VBG
cord-029547-9ei1ram3	66	5	that	that	IN
cord-029547-9ei1ram3	66	6	the	the	DT
cord-029547-9ei1ram3	66	7	expressions	expression	NNS
cord-029547-9ei1ram3	66	8	of	of	IN
cord-029547-9ei1ram3	66	9	ACE2	ACE2	NNP
cord-029547-9ei1ram3	66	10	in	in	IN
cord-029547-9ei1ram3	66	11	patients	patient	NNS
cord-029547-9ei1ram3	66	12	with	with	IN
cord-029547-9ei1ram3	66	13	some	some	DT
cord-029547-9ei1ram3	66	14	diseases	disease	NNS
cord-029547-9ei1ram3	66	15	such	such	JJ
cord-029547-9ei1ram3	66	16	as	as	IN
cord-029547-9ei1ram3	66	17	diabetes	diabete	NNS
cord-029547-9ei1ram3	66	18	are	be	VBP
cord-029547-9ei1ram3	66	19	notably	notably	RB
cord-029547-9ei1ram3	66	20	higher	high	JJR
cord-029547-9ei1ram3	66	21	than	than	IN
cord-029547-9ei1ram3	66	22	those	those	DT
cord-029547-9ei1ram3	66	23	in	in	IN
cord-029547-9ei1ram3	66	24	healthy	healthy	JJ
cord-029547-9ei1ram3	66	25	people	people	NNS
cord-029547-9ei1ram3	66	26	,	,	,
cord-029547-9ei1ram3	66	27	25	25	CD
cord-029547-9ei1ram3	66	28	indicating	indicate	VBG
cord-029547-9ei1ram3	66	29	that	that	IN
cord-029547-9ei1ram3	66	30	people	people	NNS
cord-029547-9ei1ram3	66	31	with	with	IN
cord-029547-9ei1ram3	66	32	underlying	underlie	VBG
cord-029547-9ei1ram3	66	33	diseases	disease	NNS
cord-029547-9ei1ram3	66	34	are	be	VBP
cord-029547-9ei1ram3	66	35	more	more	RBR
cord-029547-9ei1ram3	66	36	likely	likely	JJ
cord-029547-9ei1ram3	66	37	to	to	TO
cord-029547-9ei1ram3	66	38	be	be	VB
cord-029547-9ei1ram3	66	39	infected	infect	VBN
cord-029547-9ei1ram3	66	40	.	.	.
cord-029547-9ei1ram3	67	1	On	on	IN
cord-029547-9ei1ram3	67	2	31	31	CD
cord-029547-9ei1ram3	67	3	December	December	NNP
cord-029547-9ei1ram3	67	4	2019	2019	CD
cord-029547-9ei1ram3	67	5	,	,	,
cord-029547-9ei1ram3	67	6	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	67	7	Municipal	Municipal	NNP
cord-029547-9ei1ram3	67	8	Health	Health	NNP
cord-029547-9ei1ram3	67	9	Commission	Commission	NNP
cord-029547-9ei1ram3	67	10	reported	report	VBD
cord-029547-9ei1ram3	67	11	that	that	IN
cord-029547-9ei1ram3	67	12	27	27	CD
cord-029547-9ei1ram3	67	13	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	67	14	patients	patient	NNS
cord-029547-9ei1ram3	67	15	were	be	VBD
cord-029547-9ei1ram3	67	16	associated	associate	VBN
cord-029547-9ei1ram3	67	17	with	with	IN
cord-029547-9ei1ram3	67	18	a	a	DT
cord-029547-9ei1ram3	67	19	South	South	NNP
cord-029547-9ei1ram3	67	20	China	China	NNP
cord-029547-9ei1ram3	67	21	seafood	seafood	NN
cord-029547-9ei1ram3	67	22	market	market	NN
cord-029547-9ei1ram3	67	23	,	,	,
cord-029547-9ei1ram3	67	24	which	which	WDT
cord-029547-9ei1ram3	67	25	was	be	VBD
cord-029547-9ei1ram3	67	26	the	the	DT
cord-029547-9ei1ram3	67	27	earliest	early	JJS
cord-029547-9ei1ram3	67	28	discovery	discovery	NN
cord-029547-9ei1ram3	67	29	of	of	IN
cord-029547-9ei1ram3	67	30	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	67	31	.	.	.
cord-029547-9ei1ram3	67	32	26	26	CD
cord-029547-9ei1ram3	68	1	Then	then	RB
cord-029547-9ei1ram3	68	2	,	,	,
cord-029547-9ei1ram3	68	3	the	the	DT
cord-029547-9ei1ram3	68	4	quantity	quantity	NN
cord-029547-9ei1ram3	68	5	of	of	IN
cord-029547-9ei1ram3	68	6	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	68	7	patients	patient	NNS
cord-029547-9ei1ram3	68	8	increased	increase	VBD
cord-029547-9ei1ram3	68	9	rapidly	rapidly	RB
cord-029547-9ei1ram3	68	10	after	after	IN
cord-029547-9ei1ram3	68	11	Chinese	Chinese	NNP
cord-029547-9ei1ram3	68	12	New	New	NNP
cord-029547-9ei1ram3	68	13	Year	Year	NNP
cord-029547-9ei1ram3	68	14	.	.	.
cord-029547-9ei1ram3	69	1	Up	up	IN
cord-029547-9ei1ram3	69	2	to	to	TO
cord-029547-9ei1ram3	69	3	16	16	CD
cord-029547-9ei1ram3	69	4	May	May	NNP
cord-029547-9ei1ram3	69	5	2020	2020	CD
cord-029547-9ei1ram3	69	6	,	,	,
cord-029547-9ei1ram3	69	7	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	69	8	had	have	VBD
cord-029547-9ei1ram3	69	9	affected	affect	VBN
cord-029547-9ei1ram3	69	10	more	more	JJR
cord-029547-9ei1ram3	69	11	than	than	IN
cord-029547-9ei1ram3	69	12	200	200	CD
cord-029547-9ei1ram3	69	13	countries	country	NNS
cord-029547-9ei1ram3	69	14	and	and	CC
cord-029547-9ei1ram3	69	15	regions	region	NNS
cord-029547-9ei1ram3	69	16	,	,	,
cord-029547-9ei1ram3	69	17	and	and	CC
cord-029547-9ei1ram3	69	18	the	the	DT
cord-029547-9ei1ram3	69	19	quantity	quantity	NN
cord-029547-9ei1ram3	69	20	of	of	IN
cord-029547-9ei1ram3	69	21	confirmed	confirm	VBN
cord-029547-9ei1ram3	69	22	patients	patient	NNS
cord-029547-9ei1ram3	69	23	had	have	VBD
cord-029547-9ei1ram3	69	24	reached	reach	VBN
cord-029547-9ei1ram3	69	25	4	4	CD
cord-029547-9ei1ram3	69	26	425	425	CD
cord-029547-9ei1ram3	69	27	485	485	CD
cord-029547-9ei1ram3	69	28	globally	globally	RB
cord-029547-9ei1ram3	69	29	.	.	.
cord-029547-9ei1ram3	70	1	27	27	CD
cord-029547-9ei1ram3	71	1	After	after	IN
cord-029547-9ei1ram3	71	2	the	the	DT
cord-029547-9ei1ram3	71	3	breakthrough	breakthrough	NN
cord-029547-9ei1ram3	71	4	of	of	IN
cord-029547-9ei1ram3	71	5	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	71	6	,	,	,
cord-029547-9ei1ram3	71	7	experts	expert	NNS
cord-029547-9ei1ram3	71	8	began	begin	VBD
cord-029547-9ei1ram3	71	9	to	to	TO
cord-029547-9ei1ram3	71	10	predict	predict	VB
cord-029547-9ei1ram3	71	11	the	the	DT
cord-029547-9ei1ram3	71	12	incubation	incubation	NN
cord-029547-9ei1ram3	71	13	stage	stage	NN
cord-029547-9ei1ram3	71	14	of	of	IN
cord-029547-9ei1ram3	71	15	the	the	DT
cord-029547-9ei1ram3	71	16	SARS	SARS	NNP
cord-029547-9ei1ram3	71	17	-	-	HYPH
cord-029547-9ei1ram3	71	18	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	71	19	.	.	.
cord-029547-9ei1ram3	72	1	According	accord	VBG
cord-029547-9ei1ram3	72	2	to	to	IN
cord-029547-9ei1ram3	72	3	the	the	DT
cord-029547-9ei1ram3	72	4	data	datum	NNS
cord-029547-9ei1ram3	72	5	collected	collect	VBN
cord-029547-9ei1ram3	72	6	in	in	IN
cord-029547-9ei1ram3	72	7	January	January	NNP
cord-029547-9ei1ram3	72	8	2020	2020	CD
cord-029547-9ei1ram3	72	9	,	,	,
cord-029547-9ei1ram3	72	10	the	the	DT
cord-029547-9ei1ram3	72	11	incubation	incubation	NN
cord-029547-9ei1ram3	72	12	stage	stage	NN
cord-029547-9ei1ram3	72	13	of	of	IN
cord-029547-9ei1ram3	72	14	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	72	15	patients	patient	NNS
cord-029547-9ei1ram3	72	16	ranges	range	VBZ
cord-029547-9ei1ram3	72	17	between	between	IN
cord-029547-9ei1ram3	72	18	2	2	CD
cord-029547-9ei1ram3	72	19	and	and	CC
cord-029547-9ei1ram3	72	20	14	14	CD
cord-029547-9ei1ram3	72	21	days	day	NNS
cord-029547-9ei1ram3	72	22	,	,	,
cord-029547-9ei1ram3	72	23	and	and	CC
cord-029547-9ei1ram3	72	24	its	-PRON-	PRP$
cord-029547-9ei1ram3	72	25	average	average	NN
cord-029547-9ei1ram3	72	26	is	be	VBZ
cord-029547-9ei1ram3	72	27	about	about	RB
cord-029547-9ei1ram3	72	28	5	5	CD
cord-029547-9ei1ram3	72	29	days	day	NNS
cord-029547-9ei1ram3	72	30	(	(	-LRB-
cord-029547-9ei1ram3	72	31	95	95	CD
cord-029547-9ei1ram3	72	32	%	%	NN
cord-029547-9ei1ram3	72	33	credible	credible	JJ
cord-029547-9ei1ram3	72	34	interval	interval	NN
cord-029547-9ei1ram3	72	35	:	:	:
cord-029547-9ei1ram3	72	36	4.2	4.2	CD
cord-029547-9ei1ram3	72	37	-	-	HYPH
cord-029547-9ei1ram3	72	38	6.0	6.0	CD
cord-029547-9ei1ram3	72	39	)	)	-RRB-
cord-029547-9ei1ram3	72	40	when	when	WRB
cord-029547-9ei1ram3	72	41	implementing	implement	VBG
cord-029547-9ei1ram3	72	42	the	the	DT
cord-029547-9ei1ram3	72	43	best	well	RBS
cord-029547-9ei1ram3	72	44	-	-	HYPH
cord-029547-9ei1ram3	72	45	fit	fit	JJ
cord-029547-9ei1ram3	72	46	lognormal	lognormal	JJ
cord-029547-9ei1ram3	72	47	distribution	distribution	NN
cord-029547-9ei1ram3	72	48	.	.	.
cord-029547-9ei1ram3	73	1	Thus	thus	RB
cord-029547-9ei1ram3	73	2	,	,	,
cord-029547-9ei1ram3	73	3	experts	expert	NNS
cord-029547-9ei1ram3	73	4	recommended	recommend	VBD
cord-029547-9ei1ram3	73	5	that	that	IN
cord-029547-9ei1ram3	73	6	suspected	suspect	VBN
cord-029547-9ei1ram3	73	7	patients	patient	NNS
cord-029547-9ei1ram3	73	8	are	be	VBP
cord-029547-9ei1ram3	73	9	quarantined	quarantine	VBN
cord-029547-9ei1ram3	73	10	for	for	IN
cord-029547-9ei1ram3	73	11	at	at	RB
cord-029547-9ei1ram3	73	12	least	least	RBS
cord-029547-9ei1ram3	73	13	14	14	CD
cord-029547-9ei1ram3	73	14	days	day	NNS
cord-029547-9ei1ram3	73	15	.	.	.
cord-029547-9ei1ram3	74	1	28	28	CD
cord-029547-9ei1ram3	75	1	The	the	DT
cord-029547-9ei1ram3	75	2	mode	mode	NN
cord-029547-9ei1ram3	75	3	of	of	IN
cord-029547-9ei1ram3	75	4	SARS	SARS	NNP
cord-029547-9ei1ram3	75	5	-	-	HYPH
cord-029547-9ei1ram3	75	6	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	75	7	transmission	transmission	NN
cord-029547-9ei1ram3	75	8	is	be	VBZ
cord-029547-9ei1ram3	75	9	also	also	RB
cord-029547-9ei1ram3	75	10	an	an	DT
cord-029547-9ei1ram3	75	11	important	important	JJ
cord-029547-9ei1ram3	75	12	part	part	NN
cord-029547-9ei1ram3	75	13	of	of	IN
cord-029547-9ei1ram3	75	14	epidemiological	epidemiological	JJ
cord-029547-9ei1ram3	75	15	investigation	investigation	NN
cord-029547-9ei1ram3	75	16	.	.	.
cord-029547-9ei1ram3	76	1	It	-PRON-	PRP
cord-029547-9ei1ram3	76	2	is	be	VBZ
cord-029547-9ei1ram3	76	3	clear	clear	JJ
cord-029547-9ei1ram3	76	4	that	that	IN
cord-029547-9ei1ram3	76	5	humanto	humanto	JJ
cord-029547-9ei1ram3	76	6	-	-	HYPH
cord-029547-9ei1ram3	76	7	human	human	JJ
cord-029547-9ei1ram3	76	8	transmission	transmission	NN
cord-029547-9ei1ram3	76	9	of	of	IN
cord-029547-9ei1ram3	76	10	COVID-19	covid-19	NN
cord-029547-9ei1ram3	76	11	occurs	occur	VBZ
cord-029547-9ei1ram3	76	12	mainly	mainly	RB
cord-029547-9ei1ram3	76	13	via	via	IN
cord-029547-9ei1ram3	76	14	droplet	droplet	NN
cord-029547-9ei1ram3	76	15	respiratory	respiratory	JJ
cord-029547-9ei1ram3	76	16	particles	particle	NNS
cord-029547-9ei1ram3	76	17	,	,	,
cord-029547-9ei1ram3	76	18	29	29	CD
cord-029547-9ei1ram3	76	19	but	but	CC
cord-029547-9ei1ram3	76	20	whether	whether	IN
cord-029547-9ei1ram3	76	21	SARS	SARS	NNP
cord-029547-9ei1ram3	76	22	-	-	HYPH
cord-029547-9ei1ram3	76	23	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	76	24	can	can	MD
cord-029547-9ei1ram3	76	25	be	be	VB
cord-029547-9ei1ram3	76	26	transmitted	transmit	VBN
cord-029547-9ei1ram3	76	27	via	via	IN
cord-029547-9ei1ram3	76	28	the	the	DT
cord-029547-9ei1ram3	76	29	eyes	eye	NNS
cord-029547-9ei1ram3	76	30	is	be	VBZ
cord-029547-9ei1ram3	76	31	still	still	RB
cord-029547-9ei1ram3	76	32	unclear	unclear	JJ
cord-029547-9ei1ram3	76	33	.	.	.
cord-029547-9ei1ram3	77	1	30	30	CD
cord-029547-9ei1ram3	78	1	It	-PRON-	PRP
cord-029547-9ei1ram3	78	2	should	should	MD
cord-029547-9ei1ram3	78	3	be	be	VB
cord-029547-9ei1ram3	78	4	noted	note	VBN
cord-029547-9ei1ram3	78	5	that	that	IN
cord-029547-9ei1ram3	78	6	several	several	JJ
cord-029547-9ei1ram3	78	7	studies	study	NNS
cord-029547-9ei1ram3	78	8	have	have	VBP
cord-029547-9ei1ram3	78	9	showed	show	VBN
cord-029547-9ei1ram3	78	10	that	that	IN
cord-029547-9ei1ram3	78	11	chief	chief	JJ
cord-029547-9ei1ram3	78	12	complaint	complaint	NN
cord-029547-9ei1ram3	78	13	of	of	IN
cord-029547-9ei1ram3	78	14	some	some	DT
cord-029547-9ei1ram3	78	15	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	78	16	patients	patient	NNS
cord-029547-9ei1ram3	78	17	were	be	VBD
cord-029547-9ei1ram3	78	18	digestive	digestive	JJ
cord-029547-9ei1ram3	78	19	symptoms	symptom	NNS
cord-029547-9ei1ram3	78	20	,	,	,
cord-029547-9ei1ram3	78	21	and	and	CC
cord-029547-9ei1ram3	78	22	nucleic	nucleic	JJ
cord-029547-9ei1ram3	78	23	acids	acid	NNS
cord-029547-9ei1ram3	78	24	of	of	IN
cord-029547-9ei1ram3	78	25	SARS	SARS	NNP
cord-029547-9ei1ram3	78	26	-	-	HYPH
cord-029547-9ei1ram3	78	27	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	78	28	were	be	VBD
cord-029547-9ei1ram3	78	29	even	even	RB
cord-029547-9ei1ram3	78	30	found	find	VBN
cord-029547-9ei1ram3	78	31	in	in	IN
cord-029547-9ei1ram3	78	32	fecal	fecal	JJ
cord-029547-9ei1ram3	78	33	samples	sample	NNS
cord-029547-9ei1ram3	78	34	or	or	CC
cord-029547-9ei1ram3	78	35	anal	anal	JJ
cord-029547-9ei1ram3	78	36	swabs	swab	NNS
cord-029547-9ei1ram3	78	37	of	of	IN
cord-029547-9ei1ram3	78	38	some	some	DT
cord-029547-9ei1ram3	78	39	patients	patient	NNS
cord-029547-9ei1ram3	78	40	,	,	,
cord-029547-9ei1ram3	78	41	demonstrating	demonstrate	VBG
cord-029547-9ei1ram3	78	42	the	the	DT
cord-029547-9ei1ram3	78	43	possibility	possibility	NN
cord-029547-9ei1ram3	78	44	of	of	IN
cord-029547-9ei1ram3	78	45	an	an	DT
cord-029547-9ei1ram3	78	46	oralfecal	oralfecal	JJ
cord-029547-9ei1ram3	78	47	route	route	NN
cord-029547-9ei1ram3	78	48	.	.	.
cord-029547-9ei1ram3	79	1	[	[	-LRB-
cord-029547-9ei1ram3	79	2	31	31	CD
cord-029547-9ei1ram3	79	3	]	]	-RRB-
cord-029547-9ei1ram3	79	4	[	[	-LRB-
cord-029547-9ei1ram3	79	5	32	32	CD
cord-029547-9ei1ram3	79	6	]	]	-RRB-
cord-029547-9ei1ram3	79	7	[	[	-LRB-
cord-029547-9ei1ram3	79	8	33	33	CD
cord-029547-9ei1ram3	79	9	]	]	-RRB-
cord-029547-9ei1ram3	80	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	80	2	,	,	,
cord-029547-9ei1ram3	80	3	mother	mother	NN
cord-029547-9ei1ram3	80	4	-	-	HYPH
cord-029547-9ei1ram3	80	5	to	to	IN
cord-029547-9ei1ram3	80	6	-	-	HYPH
cord-029547-9ei1ram3	80	7	child	child	NN
cord-029547-9ei1ram3	80	8	transmission	transmission	NN
cord-029547-9ei1ram3	80	9	is	be	VBZ
cord-029547-9ei1ram3	80	10	also	also	RB
cord-029547-9ei1ram3	80	11	a	a	DT
cord-029547-9ei1ram3	80	12	potential	potential	JJ
cord-029547-9ei1ram3	80	13	route	route	NN
cord-029547-9ei1ram3	80	14	of	of	IN
cord-029547-9ei1ram3	80	15	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	80	16	.	.	.
cord-029547-9ei1ram3	81	1	34	34	CD
cord-029547-9ei1ram3	81	2	,	,	,
cord-029547-9ei1ram3	81	3	35	35	CD
cord-029547-9ei1ram3	81	4	Luckily	luckily	RB
cord-029547-9ei1ram3	81	5	,	,	,
cord-029547-9ei1ram3	81	6	infection	infection	NN
cord-029547-9ei1ram3	81	7	rates	rate	NNS
cord-029547-9ei1ram3	81	8	of	of	IN
cord-029547-9ei1ram3	81	9	children	child	NNS
cord-029547-9ei1ram3	81	10	are	be	VBP
cord-029547-9ei1ram3	81	11	relatively	relatively	RB
cord-029547-9ei1ram3	81	12	low	low	JJ
cord-029547-9ei1ram3	81	13	,	,	,
cord-029547-9ei1ram3	81	14	and	and	CC
cord-029547-9ei1ram3	81	15	most	most	RBS
cord-029547-9ei1ram3	81	16	inpatient	inpatient	JJ
cord-029547-9ei1ram3	81	17	children	child	NNS
cord-029547-9ei1ram3	81	18	only	only	RB
cord-029547-9ei1ram3	81	19	have	have	VBP
cord-029547-9ei1ram3	81	20	mild	mild	JJ
cord-029547-9ei1ram3	81	21	symptoms	symptom	NNS
cord-029547-9ei1ram3	81	22	even	even	RB
cord-029547-9ei1ram3	81	23	if	if	IN
cord-029547-9ei1ram3	81	24	they	-PRON-	PRP
cord-029547-9ei1ram3	81	25	are	be	VBP
cord-029547-9ei1ram3	81	26	infected	infect	VBN
cord-029547-9ei1ram3	81	27	,	,	,
cord-029547-9ei1ram3	81	28	[	[	-LRB-
cord-029547-9ei1ram3	81	29	36	36	CD
cord-029547-9ei1ram3	81	30	]	]	-RRB-
cord-029547-9ei1ram3	81	31	[	[	-LRB-
cord-029547-9ei1ram3	81	32	37	37	CD
cord-029547-9ei1ram3	81	33	]	]	-RRB-
cord-029547-9ei1ram3	81	34	[	[	-LRB-
cord-029547-9ei1ram3	81	35	38	38	CD
cord-029547-9ei1ram3	81	36	]	]	-RRB-
cord-029547-9ei1ram3	81	37	thus	thus	RB
cord-029547-9ei1ram3	81	38	less	less	JJR
cord-029547-9ei1ram3	81	39	damage	damage	NN
cord-029547-9ei1ram3	81	40	would	would	MD
cord-029547-9ei1ram3	81	41	occur	occur	VB
cord-029547-9ei1ram3	81	42	to	to	IN
cord-029547-9ei1ram3	81	43	them	-PRON-	PRP
cord-029547-9ei1ram3	81	44	.	.	.
cord-029547-9ei1ram3	82	1	Up	up	IN
cord-029547-9ei1ram3	82	2	until	until	IN
cord-029547-9ei1ram3	82	3	now	now	RB
cord-029547-9ei1ram3	82	4	,	,	,
cord-029547-9ei1ram3	82	5	the	the	DT
cord-029547-9ei1ram3	82	6	largest	large	JJS
cord-029547-9ei1ram3	82	7	case	case	NN
cord-029547-9ei1ram3	82	8	series	series	NN
cord-029547-9ei1ram3	82	9	data	datum	NNS
cord-029547-9ei1ram3	82	10	of	of	IN
cord-029547-9ei1ram3	82	11	China	China	NNP
cord-029547-9ei1ram3	82	12	has	have	VBZ
cord-029547-9ei1ram3	82	13	shown	show	VBN
cord-029547-9ei1ram3	82	14	that	that	IN
cord-029547-9ei1ram3	82	15	86.6	86.6	CD
cord-029547-9ei1ram3	82	16	%	%	NN
cord-029547-9ei1ram3	82	17	of	of	IN
cord-029547-9ei1ram3	82	18	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	82	19	patients	patient	NNS
cord-029547-9ei1ram3	82	20	were	be	VBD
cord-029547-9ei1ram3	82	21	aged	aged	JJ
cord-029547-9ei1ram3	82	22	30	30	CD
cord-029547-9ei1ram3	82	23	-	-	SYM
cord-029547-9ei1ram3	82	24	79	79	CD
cord-029547-9ei1ram3	82	25	years	year	NNS
cord-029547-9ei1ram3	82	26	,	,	,
cord-029547-9ei1ram3	82	27	1	1	CD
cord-029547-9ei1ram3	82	28	%	%	NN
cord-029547-9ei1ram3	82	29	were	be	VBD
cord-029547-9ei1ram3	82	30	aged	age	VBN
cord-029547-9ei1ram3	82	31	under	under	IN
cord-029547-9ei1ram3	82	32	1	1	CD
cord-029547-9ei1ram3	82	33	year	year	NN
cord-029547-9ei1ram3	82	34	old	old	JJ
cord-029547-9ei1ram3	82	35	,	,	,
cord-029547-9ei1ram3	82	36	1	1	CD
cord-029547-9ei1ram3	82	37	%	%	NN
cord-029547-9ei1ram3	82	38	aged	age	VBN
cord-029547-9ei1ram3	82	39	10	10	CD
cord-029547-9ei1ram3	82	40	-	-	SYM
cord-029547-9ei1ram3	82	41	19	19	CD
cord-029547-9ei1ram3	82	42	years	year	NNS
cord-029547-9ei1ram3	82	43	,	,	,
cord-029547-9ei1ram3	82	44	and	and	CC
cord-029547-9ei1ram3	82	45	3	3	CD
cord-029547-9ei1ram3	82	46	%	%	NN
cord-029547-9ei1ram3	82	47	were	be	VBD
cord-029547-9ei1ram3	82	48	aged	age	VBN
cord-029547-9ei1ram3	82	49	above	above	IN
cord-029547-9ei1ram3	82	50	80	80	CD
cord-029547-9ei1ram3	82	51	years	year	NNS
cord-029547-9ei1ram3	82	52	.	.	.
cord-029547-9ei1ram3	83	1	Among	among	IN
cord-029547-9ei1ram3	83	2	all	all	DT
cord-029547-9ei1ram3	83	3	patients	patient	NNS
cord-029547-9ei1ram3	83	4	,	,	,
cord-029547-9ei1ram3	83	5	males	male	NNS
cord-029547-9ei1ram3	83	6	account	account	VBP
cord-029547-9ei1ram3	83	7	for	for	IN
cord-029547-9ei1ram3	83	8	51	51	CD
cord-029547-9ei1ram3	83	9	%	%	NN
cord-029547-9ei1ram3	83	10	,	,	,
cord-029547-9ei1ram3	83	11	and	and	CC
cord-029547-9ei1ram3	83	12	females	female	NNS
cord-029547-9ei1ram3	83	13	account	account	VBP
cord-029547-9ei1ram3	83	14	for	for	IN
cord-029547-9ei1ram3	83	15	49	49	CD
cord-029547-9ei1ram3	83	16	%	%	NN
cord-029547-9ei1ram3	83	17	.	.	.
cord-029547-9ei1ram3	84	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	84	2	,	,	,
cord-029547-9ei1ram3	84	3	4	4	CD
cord-029547-9ei1ram3	84	4	%	%	NN
cord-029547-9ei1ram3	84	5	of	of	IN
cord-029547-9ei1ram3	84	6	them	-PRON-	PRP
cord-029547-9ei1ram3	84	7	are	be	VBP
cord-029547-9ei1ram3	84	8	medical	medical	JJ
cord-029547-9ei1ram3	84	9	workers	worker	NNS
cord-029547-9ei1ram3	84	10	.	.	.
cord-029547-9ei1ram3	85	1	39	39	CD
cord-029547-9ei1ram3	86	1	In	in	IN
cord-029547-9ei1ram3	86	2	the	the	DT
cord-029547-9ei1ram3	86	3	United	United	NNP
cord-029547-9ei1ram3	86	4	States	States	NNP
cord-029547-9ei1ram3	86	5	,	,	,
cord-029547-9ei1ram3	86	6	the	the	DT
cord-029547-9ei1ram3	86	7	elderly	elderly	JJ
cord-029547-9ei1ram3	86	8	(	(	-LRB-
cord-029547-9ei1ram3	86	9	aged	age	VBN
cord-029547-9ei1ram3	86	10	over	over	IN
cord-029547-9ei1ram3	86	11	65	65	CD
cord-029547-9ei1ram3	86	12	)	)	-RRB-
cord-029547-9ei1ram3	86	13	account	account	VBP
cord-029547-9ei1ram3	86	14	for	for	IN
cord-029547-9ei1ram3	86	15	31	31	CD
cord-029547-9ei1ram3	86	16	%	%	NN
cord-029547-9ei1ram3	86	17	of	of	IN
cord-029547-9ei1ram3	86	18	total	total	JJ
cord-029547-9ei1ram3	86	19	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	86	20	cases	case	NNS
cord-029547-9ei1ram3	86	21	,	,	,
cord-029547-9ei1ram3	86	22	45	45	CD
cord-029547-9ei1ram3	86	23	%	%	NN
cord-029547-9ei1ram3	86	24	of	of	IN
cord-029547-9ei1ram3	86	25	inpatients	inpatient	NNS
cord-029547-9ei1ram3	86	26	,	,	,
cord-029547-9ei1ram3	86	27	53	53	CD
cord-029547-9ei1ram3	86	28	%	%	NN
cord-029547-9ei1ram3	86	29	of	of	IN
cord-029547-9ei1ram3	86	30	ICU	ICU	NNP
cord-029547-9ei1ram3	86	31	patients	patient	NNS
cord-029547-9ei1ram3	86	32	,	,	,
cord-029547-9ei1ram3	86	33	and	and	CC
cord-029547-9ei1ram3	86	34	80	80	CD
cord-029547-9ei1ram3	86	35	%	%	NN
cord-029547-9ei1ram3	86	36	of	of	IN
cord-029547-9ei1ram3	86	37	death	death	NN
cord-029547-9ei1ram3	86	38	cases	case	NNS
cord-029547-9ei1ram3	86	39	.	.	.
cord-029547-9ei1ram3	87	1	40	40	CD
cord-029547-9ei1ram3	88	1	In	in	IN
cord-029547-9ei1ram3	88	2	terms	term	NNS
cord-029547-9ei1ram3	88	3	of	of	IN
cord-029547-9ei1ram3	88	4	epidemiology	epidemiology	NN
cord-029547-9ei1ram3	88	5	,	,	,
cord-029547-9ei1ram3	88	6	the	the	DT
cord-029547-9ei1ram3	88	7	basic	basic	JJ
cord-029547-9ei1ram3	88	8	reproductive	reproductive	JJ
cord-029547-9ei1ram3	88	9	number	number	NN
cord-029547-9ei1ram3	88	10	and	and	CC
cord-029547-9ei1ram3	88	11	mortality	mortality	NN
cord-029547-9ei1ram3	88	12	rate	rate	NN
cord-029547-9ei1ram3	88	13	are	be	VBP
cord-029547-9ei1ram3	88	14	indispensable	indispensable	JJ
cord-029547-9ei1ram3	88	15	.	.	.
cord-029547-9ei1ram3	89	1	Basic	basic	JJ
cord-029547-9ei1ram3	89	2	reproductive	reproductive	JJ
cord-029547-9ei1ram3	89	3	number	number	NN
cord-029547-9ei1ram3	89	4	(	(	-LRB-
cord-029547-9ei1ram3	89	5	R0	R0	NNP
cord-029547-9ei1ram3	89	6	)	)	-RRB-
cord-029547-9ei1ram3	89	7	is	be	VBZ
cord-029547-9ei1ram3	89	8	thought	think	VBN
cord-029547-9ei1ram3	89	9	to	to	TO
cord-029547-9ei1ram3	89	10	be	be	VB
cord-029547-9ei1ram3	89	11	an	an	DT
cord-029547-9ei1ram3	89	12	important	important	JJ
cord-029547-9ei1ram3	89	13	index	index	NN
cord-029547-9ei1ram3	89	14	for	for	IN
cord-029547-9ei1ram3	89	15	predicting	predict	VBG
cord-029547-9ei1ram3	89	16	the	the	DT
cord-029547-9ei1ram3	89	17	development	development	NN
cord-029547-9ei1ram3	89	18	of	of	IN
cord-029547-9ei1ram3	89	19	an	an	DT
cord-029547-9ei1ram3	89	20	outbreak	outbreak	NN
cord-029547-9ei1ram3	89	21	.	.	.
cord-029547-9ei1ram3	90	1	The	the	DT
cord-029547-9ei1ram3	90	2	main	main	JJ
cord-029547-9ei1ram3	90	3	method	method	NN
cord-029547-9ei1ram3	90	4	of	of	IN
cord-029547-9ei1ram3	90	5	calculating	calculate	VBG
cord-029547-9ei1ram3	90	6	R0	R0	NNP
cord-029547-9ei1ram3	90	7	is	be	VBZ
cord-029547-9ei1ram3	90	8	using	use	VBG
cord-029547-9ei1ram3	90	9	the	the	DT
cord-029547-9ei1ram3	90	10	data	datum	NNS
cord-029547-9ei1ram3	90	11	of	of	IN
cord-029547-9ei1ram3	90	12	infected	infected	JJ
cord-029547-9ei1ram3	90	13	people	people	NNS
cord-029547-9ei1ram3	90	14	,	,	,
cord-029547-9ei1ram3	90	15	such	such	JJ
cord-029547-9ei1ram3	90	16	as	as	IN
cord-029547-9ei1ram3	90	17	serial	serial	JJ
cord-029547-9ei1ram3	90	18	interval	interval	NN
cord-029547-9ei1ram3	90	19	distribution	distribution	NN
cord-029547-9ei1ram3	90	20	and	and	CC
cord-029547-9ei1ram3	90	21	latent	latent	JJ
cord-029547-9ei1ram3	90	22	period	period	NN
cord-029547-9ei1ram3	90	23	,	,	,
cord-029547-9ei1ram3	90	24	to	to	TO
cord-029547-9ei1ram3	90	25	build	build	VB
cord-029547-9ei1ram3	90	26	a	a	DT
cord-029547-9ei1ram3	90	27	proper	proper	JJ
cord-029547-9ei1ram3	90	28	mathematical	mathematical	JJ
cord-029547-9ei1ram3	90	29	model	model	NN
cord-029547-9ei1ram3	90	30	for	for	IN
cord-029547-9ei1ram3	90	31	predicting	predict	VBG
cord-029547-9ei1ram3	90	32	the	the	DT
cord-029547-9ei1ram3	90	33	trend	trend	NN
cord-029547-9ei1ram3	90	34	of	of	IN
cord-029547-9ei1ram3	90	35	the	the	DT
cord-029547-9ei1ram3	90	36	epidemic	epidemic	NN
cord-029547-9ei1ram3	90	37	.	.	.
cord-029547-9ei1ram3	91	1	A	a	DT
cord-029547-9ei1ram3	91	2	big	big	JJ
cord-029547-9ei1ram3	91	3	epidemiological	epidemiological	JJ
cord-029547-9ei1ram3	91	4	data	datum	NNS
cord-029547-9ei1ram3	91	5	of	of	IN
cord-029547-9ei1ram3	91	6	425	425	CD
cord-029547-9ei1ram3	91	7	confirmed	confirm	VBD
cord-029547-9ei1ram3	91	8	COVID-19	covid-19	CD
cord-029547-9ei1ram3	91	9	patients	patient	NNS
cord-029547-9ei1ram3	91	10	reported	report	VBD
cord-029547-9ei1ram3	91	11	that	that	IN
cord-029547-9ei1ram3	91	12	the	the	DT
cord-029547-9ei1ram3	91	13	basic	basic	JJ
cord-029547-9ei1ram3	91	14	reproductive	reproductive	JJ
cord-029547-9ei1ram3	91	15	number	number	NN
cord-029547-9ei1ram3	91	16	of	of	IN
cord-029547-9ei1ram3	91	17	SARS	SARS	NNP
cord-029547-9ei1ram3	91	18	-	-	HYPH
cord-029547-9ei1ram3	91	19	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	91	20	was	be	VBD
cord-029547-9ei1ram3	91	21	2.2	2.2	CD
cord-029547-9ei1ram3	91	22	,	,	,
cord-029547-9ei1ram3	91	23	which	which	WDT
cord-029547-9ei1ram3	91	24	means	mean	VBZ
cord-029547-9ei1ram3	91	25	each	each	DT
cord-029547-9ei1ram3	91	26	patient	patient	NN
cord-029547-9ei1ram3	91	27	could	could	MD
cord-029547-9ei1ram3	91	28	infect	infect	VB
cord-029547-9ei1ram3	91	29	2.2	2.2	CD
cord-029547-9ei1ram3	91	30	other	other	JJ
cord-029547-9ei1ram3	91	31	people	people	NNS
cord-029547-9ei1ram3	91	32	.	.	.
cord-029547-9ei1ram3	92	1	1	1	LS
cord-029547-9ei1ram3	93	1	However	however	RB
cord-029547-9ei1ram3	93	2	,	,	,
cord-029547-9ei1ram3	93	3	more	more	RBR
cord-029547-9ei1ram3	93	4	recent	recent	JJ
cord-029547-9ei1ram3	93	5	research	research	NN
cord-029547-9ei1ram3	93	6	estimated	estimate	VBD
cord-029547-9ei1ram3	93	7	that	that	IN
cord-029547-9ei1ram3	93	8	basic	basic	JJ
cord-029547-9ei1ram3	93	9	reproductive	reproductive	JJ
cord-029547-9ei1ram3	93	10	number	number	NN
cord-029547-9ei1ram3	93	11	was	be	VBD
cord-029547-9ei1ram3	93	12	5.8	5.8	CD
cord-029547-9ei1ram3	93	13	.	.	.
cord-029547-9ei1ram3	94	1	41	41	CD
cord-029547-9ei1ram3	95	1	It	-PRON-	PRP
cord-029547-9ei1ram3	95	2	is	be	VBZ
cord-029547-9ei1ram3	95	3	obvious	obvious	JJ
cord-029547-9ei1ram3	95	4	that	that	IN
cord-029547-9ei1ram3	95	5	distinctions	distinction	NNS
cord-029547-9ei1ram3	95	6	of	of	IN
cord-029547-9ei1ram3	95	7	R0	R0	NNP
cord-029547-9ei1ram3	95	8	exist	exist	VBP
cord-029547-9ei1ram3	95	9	in	in	IN
cord-029547-9ei1ram3	95	10	these	these	DT
cord-029547-9ei1ram3	95	11	studies	study	NNS
cord-029547-9ei1ram3	95	12	,	,	,
cord-029547-9ei1ram3	95	13	and	and	CC
cord-029547-9ei1ram3	95	14	they	-PRON-	PRP
cord-029547-9ei1ram3	95	15	result	result	VBP
cord-029547-9ei1ram3	95	16	in	in	IN
cord-029547-9ei1ram3	95	17	data	datum	NNS
cord-029547-9ei1ram3	95	18	and	and	CC
cord-029547-9ei1ram3	95	19	model	model	NN
cord-029547-9ei1ram3	95	20	differences	difference	NNS
cord-029547-9ei1ram3	95	21	.	.	.
cord-029547-9ei1ram3	96	1	The	the	DT
cord-029547-9ei1ram3	96	2	incubation	incubation	NN
cord-029547-9ei1ram3	96	3	period	period	NN
cord-029547-9ei1ram3	96	4	and	and	CC
cord-029547-9ei1ram3	96	5	serial	serial	JJ
cord-029547-9ei1ram3	96	6	interval	interval	NN
cord-029547-9ei1ram3	96	7	distribution	distribution	NN
cord-029547-9ei1ram3	96	8	of	of	IN
cord-029547-9ei1ram3	96	9	former	former	JJ
cord-029547-9ei1ram3	96	10	research	research	NN
cord-029547-9ei1ram3	96	11	are	be	VBP
cord-029547-9ei1ram3	96	12	calculated	calculate	VBN
cord-029547-9ei1ram3	96	13	only	only	RB
cord-029547-9ei1ram3	96	14	through	through	IN
cord-029547-9ei1ram3	96	15	10	10	CD
cord-029547-9ei1ram3	96	16	confirmed	confirm	VBN
cord-029547-9ei1ram3	96	17	cases	case	NNS
cord-029547-9ei1ram3	96	18	and	and	CC
cord-029547-9ei1ram3	96	19	six	six	CD
cord-029547-9ei1ram3	96	20	pairs	pair	NNS
cord-029547-9ei1ram3	96	21	of	of	IN
cord-029547-9ei1ram3	96	22	cases	case	NNS
cord-029547-9ei1ram3	96	23	in	in	IN
cord-029547-9ei1ram3	96	24	clusters	cluster	NNS
cord-029547-9ei1ram3	96	25	,	,	,
cord-029547-9ei1ram3	96	26	respectively	respectively	RB
cord-029547-9ei1ram3	96	27	.	.	.
cord-029547-9ei1ram3	97	1	1	1	LS
cord-029547-9ei1ram3	98	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	98	2	,	,	,
cord-029547-9ei1ram3	98	3	the	the	DT
cord-029547-9ei1ram3	98	4	model	model	NN
cord-029547-9ei1ram3	98	5	of	of	IN
cord-029547-9ei1ram3	98	6	the	the	DT
cord-029547-9ei1ram3	98	7	former	former	JJ
cord-029547-9ei1ram3	98	8	research	research	NN
cord-029547-9ei1ram3	98	9	is	be	VBZ
cord-029547-9ei1ram3	98	10	made	make	VBN
cord-029547-9ei1ram3	98	11	merely	merely	RB
cord-029547-9ei1ram3	98	12	on	on	IN
cord-029547-9ei1ram3	98	13	the	the	DT
cord-029547-9ei1ram3	98	14	basis	basis	NN
cord-029547-9ei1ram3	98	15	of	of	IN
cord-029547-9ei1ram3	98	16	one	one	CD
cord-029547-9ei1ram3	98	17	region	region	NN
cord-029547-9ei1ram3	98	18	,	,	,
cord-029547-9ei1ram3	98	19	1	1	CD
cord-029547-9ei1ram3	98	20	thus	thus	RB
cord-029547-9ei1ram3	98	21	its	-PRON-	PRP$
cord-029547-9ei1ram3	98	22	R0	R0	NNP
cord-029547-9ei1ram3	98	23	distinctly	distinctly	RB
cord-029547-9ei1ram3	98	24	lacks	lack	VBZ
cord-029547-9ei1ram3	98	25	universality	universality	NN
cord-029547-9ei1ram3	98	26	.	.	.
cord-029547-9ei1ram3	99	1	By	by	IN
cord-029547-9ei1ram3	99	2	contrast	contrast	NN
cord-029547-9ei1ram3	99	3	,	,	,
cord-029547-9ei1ram3	99	4	the	the	DT
cord-029547-9ei1ram3	99	5	latter	latter	JJ
cord-029547-9ei1ram3	99	6	study	study	NN
cord-029547-9ei1ram3	99	7	gathered	gather	VBD
cord-029547-9ei1ram3	99	8	the	the	DT
cord-029547-9ei1ram3	99	9	information	information	NN
cord-029547-9ei1ram3	99	10	of	of	IN
cord-029547-9ei1ram3	99	11	incubation	incubation	NN
cord-029547-9ei1ram3	99	12	period	period	NN
cord-029547-9ei1ram3	99	13	,	,	,
cord-029547-9ei1ram3	99	14	serial	serial	JJ
cord-029547-9ei1ram3	99	15	interval	interval	NN
cord-029547-9ei1ram3	99	16	,	,	,
cord-029547-9ei1ram3	99	17	and	and	CC
cord-029547-9ei1ram3	99	18	infectious	infectious	JJ
cord-029547-9ei1ram3	99	19	period	period	NN
cord-029547-9ei1ram3	99	20	from	from	IN
cord-029547-9ei1ram3	99	21	the	the	DT
cord-029547-9ei1ram3	99	22	individual	individual	JJ
cord-029547-9ei1ram3	99	23	cases	case	NNS
cord-029547-9ei1ram3	99	24	reported	report	VBN
cord-029547-9ei1ram3	99	25	throughout	throughout	IN
cord-029547-9ei1ram3	99	26	China	China	NNP
cord-029547-9ei1ram3	99	27	and	and	CC
cord-029547-9ei1ram3	99	28	designed	design	VBD
cord-029547-9ei1ram3	99	29	two	two	CD
cord-029547-9ei1ram3	99	30	models	model	NNS
cord-029547-9ei1ram3	99	31	to	to	TO
cord-029547-9ei1ram3	99	32	infer	infer	VB
cord-029547-9ei1ram3	99	33	the	the	DT
cord-029547-9ei1ram3	99	34	growth	growth	NN
cord-029547-9ei1ram3	99	35	rate	rate	NN
cord-029547-9ei1ram3	99	36	of	of	IN
cord-029547-9ei1ram3	99	37	the	the	DT
cord-029547-9ei1ram3	99	38	outbreak	outbreak	NN
cord-029547-9ei1ram3	99	39	in	in	IN
cord-029547-9ei1ram3	99	40	different	different	JJ
cord-029547-9ei1ram3	99	41	perspectives	perspective	NNS
cord-029547-9ei1ram3	99	42	.	.	.
cord-029547-9ei1ram3	100	1	41	41	CD
cord-029547-9ei1ram3	101	1	So	so	RB
cord-029547-9ei1ram3	101	2	,	,	,
cord-029547-9ei1ram3	101	3	its	-PRON-	PRP$
cord-029547-9ei1ram3	101	4	R0	R0	NNP
cord-029547-9ei1ram3	101	5	better	well	RBR
cord-029547-9ei1ram3	101	6	reflects	reflect	VBZ
cord-029547-9ei1ram3	101	7	the	the	DT
cord-029547-9ei1ram3	101	8	epidemic	epidemic	NN
cord-029547-9ei1ram3	101	9	situation	situation	NN
cord-029547-9ei1ram3	101	10	of	of	IN
cord-029547-9ei1ram3	101	11	China	China	NNP
cord-029547-9ei1ram3	101	12	.	.	.
cord-029547-9ei1ram3	102	1	Similarly	similarly	RB
cord-029547-9ei1ram3	102	2	,	,	,
cord-029547-9ei1ram3	102	3	the	the	DT
cord-029547-9ei1ram3	102	4	R0	R0	NNP
cord-029547-9ei1ram3	102	5	of	of	IN
cord-029547-9ei1ram3	102	6	around	around	RB
cord-029547-9ei1ram3	102	7	3.87	3.87	CD
cord-029547-9ei1ram3	102	8	reported	report	VBN
cord-029547-9ei1ram3	102	9	by	by	IN
cord-029547-9ei1ram3	102	10	Imperial	Imperial	NNP
cord-029547-9ei1ram3	102	11	College	College	NNP
cord-029547-9ei1ram3	102	12	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	102	13	Response	Response	NNP
cord-029547-9ei1ram3	102	14	Team	Team	NNP
cord-029547-9ei1ram3	102	15	only	only	RB
cord-029547-9ei1ram3	102	16	represented	represent	VBD
cord-029547-9ei1ram3	102	17	the	the	DT
cord-029547-9ei1ram3	102	18	situation	situation	NN
cord-029547-9ei1ram3	102	19	in	in	IN
cord-029547-9ei1ram3	102	20	Europe	Europe	NNP
cord-029547-9ei1ram3	102	21	.	.	.
cord-029547-9ei1ram3	103	1	42	42	CD
cord-029547-9ei1ram3	104	1	According	accord	VBG
cord-029547-9ei1ram3	104	2	to	to	IN
cord-029547-9ei1ram3	104	3	the	the	DT
cord-029547-9ei1ram3	104	4	data	data	NN
cord-029547-9ei1ram3	104	5	analysis	analysis	NN
cord-029547-9ei1ram3	104	6	of	of	IN
cord-029547-9ei1ram3	104	7	the	the	DT
cord-029547-9ei1ram3	104	8	Chinese	Chinese	NNP
cord-029547-9ei1ram3	104	9	Center	Center	NNP
cord-029547-9ei1ram3	104	10	for	for	IN
cord-029547-9ei1ram3	104	11	Disease	Disease	NNP
cord-029547-9ei1ram3	104	12	Control	Control	NNP
cord-029547-9ei1ram3	104	13	and	and	CC
cord-029547-9ei1ram3	104	14	Prevention	Prevention	NNP
cord-029547-9ei1ram3	104	15	,	,	,
cord-029547-9ei1ram3	104	16	the	the	DT
cord-029547-9ei1ram3	104	17	overall	overall	JJ
cord-029547-9ei1ram3	104	18	mortality	mortality	NN
cord-029547-9ei1ram3	104	19	of	of	IN
cord-029547-9ei1ram3	104	20	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	104	21	patients	patient	NNS
cord-029547-9ei1ram3	104	22	was	be	VBD
cord-029547-9ei1ram3	104	23	approximately	approximately	RB
cord-029547-9ei1ram3	104	24	2.3	2.3	CD
cord-029547-9ei1ram3	104	25	%	%	NN
cord-029547-9ei1ram3	104	26	,	,	,
cord-029547-9ei1ram3	104	27	43	43	CD
cord-029547-9ei1ram3	104	28	which	which	WDT
cord-029547-9ei1ram3	104	29	is	be	VBZ
cord-029547-9ei1ram3	104	30	obviously	obviously	RB
cord-029547-9ei1ram3	104	31	lower	low	JJR
cord-029547-9ei1ram3	104	32	than	than	IN
cord-029547-9ei1ram3	104	33	Severe	severe	JJ
cord-029547-9ei1ram3	104	34	Acute	acute	JJ
cord-029547-9ei1ram3	104	35	Respiratory	Respiratory	NNP
cord-029547-9ei1ram3	104	36	Syndrome	Syndrome	NNP
cord-029547-9ei1ram3	104	37	(	(	-LRB-
cord-029547-9ei1ram3	104	38	SARS	SARS	NNP
cord-029547-9ei1ram3	104	39	)	)	-RRB-
cord-029547-9ei1ram3	104	40	and	and	CC
cord-029547-9ei1ram3	104	41	Middle	Middle	NNP
cord-029547-9ei1ram3	104	42	East	East	NNP
cord-029547-9ei1ram3	104	43	Respiratory	Respiratory	NNP
cord-029547-9ei1ram3	104	44	Syndrome	Syndrome	NNP
cord-029547-9ei1ram3	104	45	(	(	-LRB-
cord-029547-9ei1ram3	104	46	MERS	MERS	NNP
cord-029547-9ei1ram3	104	47	)	)	-RRB-
cord-029547-9ei1ram3	104	48	.	.	.
cord-029547-9ei1ram3	105	1	44	44	CD
cord-029547-9ei1ram3	106	1	However	however	RB
cord-029547-9ei1ram3	106	2	,	,	,
cord-029547-9ei1ram3	106	3	because	because	IN
cord-029547-9ei1ram3	106	4	of	of	IN
cord-029547-9ei1ram3	106	5	the	the	DT
cord-029547-9ei1ram3	106	6	lager	lager	NN
cord-029547-9ei1ram3	106	7	quantity	quantity	NN
cord-029547-9ei1ram3	106	8	of	of	IN
cord-029547-9ei1ram3	106	9	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	106	10	patients	patient	NNS
cord-029547-9ei1ram3	106	11	,	,	,
cord-029547-9ei1ram3	106	12	the	the	DT
cord-029547-9ei1ram3	106	13	number	number	NN
cord-029547-9ei1ram3	106	14	of	of	IN
cord-029547-9ei1ram3	106	15	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	106	16	deaths	death	NNS
cord-029547-9ei1ram3	106	17	is	be	VBZ
cord-029547-9ei1ram3	106	18	still	still	RB
cord-029547-9ei1ram3	106	19	high	high	JJ
cord-029547-9ei1ram3	106	20	.	.	.
cord-029547-9ei1ram3	107	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	107	2	,	,	,
cord-029547-9ei1ram3	107	3	the	the	DT
cord-029547-9ei1ram3	107	4	data	datum	NNS
cord-029547-9ei1ram3	107	5	from	from	IN
cord-029547-9ei1ram3	107	6	the	the	DT
cord-029547-9ei1ram3	107	7	epidemic	epidemic	NN
cord-029547-9ei1ram3	107	8	area	area	NN
cord-029547-9ei1ram3	107	9	indicated	indicate	VBD
cord-029547-9ei1ram3	107	10	that	that	IN
cord-029547-9ei1ram3	107	11	people	people	NNS
cord-029547-9ei1ram3	107	12	aged	aged	JJ
cord-029547-9ei1ram3	107	13	30	30	CD
cord-029547-9ei1ram3	107	14	-	-	SYM
cord-029547-9ei1ram3	107	15	59	59	CD
cord-029547-9ei1ram3	107	16	years	year	NNS
cord-029547-9ei1ram3	107	17	had	have	VBD
cord-029547-9ei1ram3	107	18	the	the	DT
cord-029547-9ei1ram3	107	19	highest	high	JJS
cord-029547-9ei1ram3	107	20	death	death	NN
cord-029547-9ei1ram3	107	21	rate	rate	NN
cord-029547-9ei1ram3	107	22	of	of	IN
cord-029547-9ei1ram3	107	23	any	any	DT
cord-029547-9ei1ram3	107	24	age	age	NN
cord-029547-9ei1ram3	107	25	group	group	NN
cord-029547-9ei1ram3	107	26	,	,	,
cord-029547-9ei1ram3	107	27	and	and	CC
cord-029547-9ei1ram3	107	28	the	the	DT
cord-029547-9ei1ram3	107	29	risk	risk	NN
cord-029547-9ei1ram3	107	30	of	of	IN
cord-029547-9ei1ram3	107	31	symptomatic	symptomatic	JJ
cord-029547-9ei1ram3	107	32	infection	infection	NN
cord-029547-9ei1ram3	107	33	increased	increase	VBN
cord-029547-9ei1ram3	107	34	year	year	NN
cord-029547-9ei1ram3	107	35	by	by	IN
cord-029547-9ei1ram3	107	36	year	year	NN
cord-029547-9ei1ram3	107	37	.	.	.
cord-029547-9ei1ram3	108	1	45	45	CD
cord-029547-9ei1ram3	108	2	 	 	_SP
cord-029547-9ei1ram3	109	1	Like	like	IN
cord-029547-9ei1ram3	109	2	most	most	JJS
cord-029547-9ei1ram3	109	3	respiratory	respiratory	JJ
cord-029547-9ei1ram3	109	4	illnesses	illness	NNS
cord-029547-9ei1ram3	109	5	,	,	,
cord-029547-9ei1ram3	109	6	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	109	7	has	have	VBZ
cord-029547-9ei1ram3	109	8	many	many	JJ
cord-029547-9ei1ram3	109	9	typical	typical	JJ
cord-029547-9ei1ram3	109	10	respiratory	respiratory	JJ
cord-029547-9ei1ram3	109	11	clinical	clinical	JJ
cord-029547-9ei1ram3	109	12	symptoms	symptom	NNS
cord-029547-9ei1ram3	109	13	.	.	.
cord-029547-9ei1ram3	110	1	Data	datum	NNS
cord-029547-9ei1ram3	110	2	from	from	IN
cord-029547-9ei1ram3	110	3	1099	1099	CD
cord-029547-9ei1ram3	110	4	confirmed	confirm	VBN
cord-029547-9ei1ram3	111	1	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	111	2	patients	patient	NNS
cord-029547-9ei1ram3	111	3	have	have	VBP
cord-029547-9ei1ram3	111	4	shown	show	VBN
cord-029547-9ei1ram3	111	5	that	that	IN
cord-029547-9ei1ram3	111	6	88.7	88.7	CD
cord-029547-9ei1ram3	111	7	%	%	NN
cord-029547-9ei1ram3	111	8	had	have	VBD
cord-029547-9ei1ram3	111	9	a	a	DT
cord-029547-9ei1ram3	111	10	fever	fever	NN
cord-029547-9ei1ram3	111	11	,	,	,
cord-029547-9ei1ram3	111	12	67.8	67.8	CD
cord-029547-9ei1ram3	111	13	%	%	NN
cord-029547-9ei1ram3	111	14	developed	develop	VBD
cord-029547-9ei1ram3	111	15	a	a	DT
cord-029547-9ei1ram3	111	16	cough	cough	NN
cord-029547-9ei1ram3	111	17	,	,	,
cord-029547-9ei1ram3	111	18	and	and	CC
cord-029547-9ei1ram3	111	19	2.3	2.3	CD
cord-029547-9ei1ram3	111	20	%	%	NN
cord-029547-9ei1ram3	111	21	received	receive	VBD
cord-029547-9ei1ram3	111	22	invasive	invasive	JJ
cord-029547-9ei1ram3	111	23	mechanical	mechanical	JJ
cord-029547-9ei1ram3	111	24	ventilation	ventilation	NN
cord-029547-9ei1ram3	111	25	,	,	,
cord-029547-9ei1ram3	111	26	46	46	CD
cord-029547-9ei1ram3	111	27	which	which	WDT
cord-029547-9ei1ram3	111	28	is	be	VBZ
cord-029547-9ei1ram3	111	29	consistent	consistent	JJ
cord-029547-9ei1ram3	111	30	with	with	IN
cord-029547-9ei1ram3	111	31	other	other	JJ
cord-029547-9ei1ram3	111	32	studies	study	NNS
cord-029547-9ei1ram3	111	33	.	.	.
cord-029547-9ei1ram3	112	1	47	47	CD
cord-029547-9ei1ram3	113	1	For	for	IN
cord-029547-9ei1ram3	113	2	some	some	DT
cord-029547-9ei1ram3	113	3	severe	severe	JJ
cord-029547-9ei1ram3	113	4	patients	patient	NNS
cord-029547-9ei1ram3	113	5	,	,	,
cord-029547-9ei1ram3	113	6	acute	acute	JJ
cord-029547-9ei1ram3	113	7	respiratory	respiratory	JJ
cord-029547-9ei1ram3	113	8	distress	distress	NN
cord-029547-9ei1ram3	113	9	syndrome	syndrome	NN
cord-029547-9ei1ram3	113	10	(	(	-LRB-
cord-029547-9ei1ram3	113	11	ARDS	ARDS	NNP
cord-029547-9ei1ram3	113	12	)	)	-RRB-
cord-029547-9ei1ram3	113	13	,	,	,
cord-029547-9ei1ram3	113	14	shock	shock	NN
cord-029547-9ei1ram3	113	15	,	,	,
cord-029547-9ei1ram3	113	16	and	and	CC
cord-029547-9ei1ram3	113	17	arrhythmia	arrhythmia	NN
cord-029547-9ei1ram3	113	18	are	be	VBP
cord-029547-9ei1ram3	113	19	common	common	JJ
cord-029547-9ei1ram3	113	20	complications	complication	NNS
cord-029547-9ei1ram3	113	21	.	.	.
cord-029547-9ei1ram3	114	1	48	48	CD
cord-029547-9ei1ram3	115	1	,	,	,
cord-029547-9ei1ram3	115	2	49	49	CD
cord-029547-9ei1ram3	115	3	Apart	apart	RB
cord-029547-9ei1ram3	115	4	from	from	IN
cord-029547-9ei1ram3	115	5	these	these	DT
cord-029547-9ei1ram3	115	6	symptoms	symptom	NNS
cord-029547-9ei1ram3	115	7	,	,	,
cord-029547-9ei1ram3	115	8	COVID-19	covid-19	VBP
cord-029547-9ei1ram3	115	9	patients	patient	NNS
cord-029547-9ei1ram3	115	10	sometimes	sometimes	RB
cord-029547-9ei1ram3	115	11	have	have	VBP
cord-029547-9ei1ram3	115	12	other	other	JJ
cord-029547-9ei1ram3	115	13	non	non	JJ
cord-029547-9ei1ram3	115	14	-	-	JJ
cord-029547-9ei1ram3	115	15	respiratory	respiratory	JJ
cord-029547-9ei1ram3	115	16	symptoms	symptom	NNS
cord-029547-9ei1ram3	115	17	such	such	JJ
cord-029547-9ei1ram3	115	18	as	as	IN
cord-029547-9ei1ram3	115	19	fatigue	fatigue	NN
cord-029547-9ei1ram3	115	20	,	,	,
cord-029547-9ei1ram3	115	21	myalgia	myalgia	NN
cord-029547-9ei1ram3	115	22	,	,	,
cord-029547-9ei1ram3	115	23	headache	headache	NN
cord-029547-9ei1ram3	115	24	,	,	,
cord-029547-9ei1ram3	115	25	and	and	CC
cord-029547-9ei1ram3	115	26	digestive	digestive	JJ
cord-029547-9ei1ram3	115	27	tract	tract	NN
cord-029547-9ei1ram3	115	28	symptoms	symptom	NNS
cord-029547-9ei1ram3	115	29	.	.	.
cord-029547-9ei1ram3	116	1	48	48	CD
cord-029547-9ei1ram3	116	2	,	,	,
cord-029547-9ei1ram3	116	3	50	50	CD
cord-029547-9ei1ram3	117	1	Moreover	moreover	RB
cord-029547-9ei1ram3	117	2	,	,	,
cord-029547-9ei1ram3	117	3	the	the	DT
cord-029547-9ei1ram3	117	4	main	main	JJ
cord-029547-9ei1ram3	117	5	changes	change	NNS
cord-029547-9ei1ram3	117	6	in	in	IN
cord-029547-9ei1ram3	117	7	laboratory	laboratory	NN
cord-029547-9ei1ram3	117	8	results	result	NNS
cord-029547-9ei1ram3	117	9	of	of	IN
cord-029547-9ei1ram3	117	10	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	117	11	are	be	VBP
cord-029547-9ei1ram3	117	12	decreases	decrease	NNS
cord-029547-9ei1ram3	117	13	in	in	IN
cord-029547-9ei1ram3	117	14	lymphocytes	lymphocyte	NNS
cord-029547-9ei1ram3	117	15	and	and	CC
cord-029547-9ei1ram3	117	16	eosinophils	eosinophil	NNS
cord-029547-9ei1ram3	117	17	as	as	RB
cord-029547-9ei1ram3	117	18	well	well	RB
cord-029547-9ei1ram3	117	19	as	as	IN
cord-029547-9ei1ram3	117	20	increases	increase	NNS
cord-029547-9ei1ram3	117	21	in	in	IN
cord-029547-9ei1ram3	117	22	D	d	NN
cord-029547-9ei1ram3	117	23	-	-	HYPH
cord-029547-9ei1ram3	117	24	dimer	dimer	NN
cord-029547-9ei1ram3	117	25	,	,	,
cord-029547-9ei1ram3	117	26	C	C	NNP
cord-029547-9ei1ram3	117	27	-	-	HYPH
cord-029547-9ei1ram3	117	28	reactive	reactive	JJ
cord-029547-9ei1ram3	117	29	protein	protein	NN
cord-029547-9ei1ram3	117	30	,	,	,
cord-029547-9ei1ram3	117	31	prothrombin	prothrombin	JJ
cord-029547-9ei1ram3	117	32	time	time	NN
cord-029547-9ei1ram3	117	33	,	,	,
cord-029547-9ei1ram3	117	34	and	and	CC
cord-029547-9ei1ram3	117	35	procalcitonin	procalcitonin	NNS
cord-029547-9ei1ram3	117	36	.	.	.
cord-029547-9ei1ram3	118	1	48	48	CD
cord-029547-9ei1ram3	118	2	,	,	,
cord-029547-9ei1ram3	118	3	51	51	CD
cord-029547-9ei1ram3	118	4	Computed	compute	VBN
cord-029547-9ei1ram3	118	5	tomography	tomography	NN
cord-029547-9ei1ram3	118	6	(	(	-LRB-
cord-029547-9ei1ram3	118	7	CT	CT	NNP
cord-029547-9ei1ram3	118	8	)	)	-RRB-
cord-029547-9ei1ram3	118	9	is	be	VBZ
cord-029547-9ei1ram3	118	10	one	one	CD
cord-029547-9ei1ram3	118	11	of	of	IN
cord-029547-9ei1ram3	118	12	the	the	DT
cord-029547-9ei1ram3	118	13	most	most	RBS
cord-029547-9ei1ram3	118	14	efficient	efficient	JJ
cord-029547-9ei1ram3	118	15	techniques	technique	NNS
cord-029547-9ei1ram3	118	16	for	for	IN
cord-029547-9ei1ram3	118	17	evaluating	evaluate	VBG
cord-029547-9ei1ram3	118	18	severity	severity	NN
cord-029547-9ei1ram3	118	19	and	and	CC
cord-029547-9ei1ram3	118	20	differential	differential	JJ
cord-029547-9ei1ram3	118	21	diagnosis	diagnosis	NN
cord-029547-9ei1ram3	118	22	of	of	IN
cord-029547-9ei1ram3	118	23	pulmonary	pulmonary	JJ
cord-029547-9ei1ram3	118	24	diseases	disease	NNS
cord-029547-9ei1ram3	118	25	,	,	,
cord-029547-9ei1ram3	118	26	thus	thus	RB
cord-029547-9ei1ram3	118	27	the	the	DT
cord-029547-9ei1ram3	118	28	CT	CT	NNP
cord-029547-9ei1ram3	118	29	characteristics	characteristic	NNS
cord-029547-9ei1ram3	118	30	(	(	-LRB-
cord-029547-9ei1ram3	118	31	Fig	Fig	NNP
cord-029547-9ei1ram3	118	32	.	.	.
cord-029547-9ei1ram3	118	33	1	1	CD
cord-029547-9ei1ram3	118	34	)	)	-RRB-
cord-029547-9ei1ram3	118	35	of	of	IN
cord-029547-9ei1ram3	118	36	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	118	37	are	be	VBP
cord-029547-9ei1ram3	118	38	another	another	DT
cord-029547-9ei1ram3	118	39	important	important	JJ
cord-029547-9ei1ram3	118	40	clinical	clinical	JJ
cord-029547-9ei1ram3	118	41	feature	feature	NN
cord-029547-9ei1ram3	118	42	.	.	.
cord-029547-9ei1ram3	119	1	This	this	DT
cord-029547-9ei1ram3	119	2	clinical	clinical	JJ
cord-029547-9ei1ram3	119	3	evidence	evidence	NN
cord-029547-9ei1ram3	119	4	indicates	indicate	VBZ
cord-029547-9ei1ram3	119	5	that	that	IN
cord-029547-9ei1ram3	119	6	ground	ground	NN
cord-029547-9ei1ram3	119	7	glass	glass	NN
cord-029547-9ei1ram3	119	8	opacity	opacity	NN
cord-029547-9ei1ram3	119	9	(	(	-LRB-
cord-029547-9ei1ram3	119	10	GGO	GGO	NNP
cord-029547-9ei1ram3	119	11	)	)	-RRB-
cord-029547-9ei1ram3	119	12	,	,	,
cord-029547-9ei1ram3	119	13	consolidation	consolidation	NN
cord-029547-9ei1ram3	119	14	,	,	,
cord-029547-9ei1ram3	119	15	and	and	CC
cord-029547-9ei1ram3	119	16	interlobular	interlobular	JJ
cord-029547-9ei1ram3	119	17	septal	septal	JJ
cord-029547-9ei1ram3	119	18	thickening	thickening	NN
cord-029547-9ei1ram3	119	19	are	be	VBP
cord-029547-9ei1ram3	119	20	the	the	DT
cord-029547-9ei1ram3	119	21	most	most	RBS
cord-029547-9ei1ram3	119	22	common	common	JJ
cord-029547-9ei1ram3	119	23	CT	CT	NNP
cord-029547-9ei1ram3	119	24	characteristics	characteristic	NNS
cord-029547-9ei1ram3	119	25	of	of	IN
cord-029547-9ei1ram3	119	26	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	119	27	,	,	,
cord-029547-9ei1ram3	119	28	which	which	WDT
cord-029547-9ei1ram3	119	29	occurs	occur	VBZ
cord-029547-9ei1ram3	119	30	mainly	mainly	RB
cord-029547-9ei1ram3	119	31	in	in	IN
cord-029547-9ei1ram3	119	32	the	the	DT
cord-029547-9ei1ram3	119	33	posterior	posterior	JJ
cord-029547-9ei1ram3	119	34	lung	lung	NN
cord-029547-9ei1ram3	119	35	area	area	NN
cord-029547-9ei1ram3	119	36	and	and	CC
cord-029547-9ei1ram3	119	37	middle	middle	JJ
cord-029547-9ei1ram3	119	38	and	and	CC
cord-029547-9ei1ram3	119	39	lower	low	JJR
cord-029547-9ei1ram3	119	40	lung	lung	NN
cord-029547-9ei1ram3	119	41	regions	region	NNS
cord-029547-9ei1ram3	119	42	.	.	.
cord-029547-9ei1ram3	120	1	52	52	CD
cord-029547-9ei1ram3	120	2	,	,	,
cord-029547-9ei1ram3	120	3	53	53	CD
cord-029547-9ei1ram3	121	1	Compared	compare	VBN
cord-029547-9ei1ram3	121	2	to	to	IN
cord-029547-9ei1ram3	121	3	patients	patient	NNS
cord-029547-9ei1ram3	121	4	with	with	IN
cord-029547-9ei1ram3	121	5	mild	mild	JJ
cord-029547-9ei1ram3	121	6	symptoms	symptom	NNS
cord-029547-9ei1ram3	121	7	,	,	,
cord-029547-9ei1ram3	121	8	signs	sign	NNS
cord-029547-9ei1ram3	121	9	such	such	JJ
cord-029547-9ei1ram3	121	10	as	as	IN
cord-029547-9ei1ram3	121	11	consolidation	consolidation	NN
cord-029547-9ei1ram3	121	12	,	,	,
cord-029547-9ei1ram3	121	13	thickened	thicken	VBD
cord-029547-9ei1ram3	121	14	bronchial	bronchial	JJ
cord-029547-9ei1ram3	121	15	wall	wall	NN
cord-029547-9ei1ram3	121	16	,	,	,
cord-029547-9ei1ram3	121	17	linear	linear	NNP
cord-029547-9ei1ram3	121	18	opacities	opacity	NNS
cord-029547-9ei1ram3	121	19	,	,	,
cord-029547-9ei1ram3	121	20	extrapulmonary	extrapulmonary	JJ
cord-029547-9ei1ram3	121	21	lesions	lesion	NNS
cord-029547-9ei1ram3	121	22	,	,	,
cord-029547-9ei1ram3	121	23	and	and	CC
cord-029547-9ei1ram3	121	24	higher	high	JJR
cord-029547-9ei1ram3	121	25	CT	CT	NNP
cord-029547-9ei1ram3	121	26	scores	score	NNS
cord-029547-9ei1ram3	121	27	are	be	VBP
cord-029547-9ei1ram3	121	28	marked	mark	VBN
cord-029547-9ei1ram3	121	29	CT	CT	NNP
cord-029547-9ei1ram3	121	30	features	feature	NNS
cord-029547-9ei1ram3	121	31	of	of	IN
cord-029547-9ei1ram3	121	32	critically	critically	RB
cord-029547-9ei1ram3	121	33	ill	ill	JJ
cord-029547-9ei1ram3	121	34	patients	patient	NNS
cord-029547-9ei1ram3	121	35	.	.	.
cord-029547-9ei1ram3	122	1	54	54	CD
cord-029547-9ei1ram3	123	1	Therefore	therefore	RB
cord-029547-9ei1ram3	123	2	,	,	,
cord-029547-9ei1ram3	123	3	CT	CT	NNP
cord-029547-9ei1ram3	123	4	is	be	VBZ
cord-029547-9ei1ram3	123	5	potentially	potentially	RB
cord-029547-9ei1ram3	123	6	used	use	VBN
cord-029547-9ei1ram3	123	7	to	to	TO
cord-029547-9ei1ram3	123	8	diagnose	diagnose	VB
cord-029547-9ei1ram3	123	9	and	and	CC
cord-029547-9ei1ram3	123	10	predict	predict	VB
cord-029547-9ei1ram3	123	11	the	the	DT
cord-029547-9ei1ram3	123	12	prognosis	prognosis	NN
cord-029547-9ei1ram3	123	13	of	of	IN
cord-029547-9ei1ram3	123	14	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	123	15	patients	patient	NNS
cord-029547-9ei1ram3	123	16	.	.	.
cord-029547-9ei1ram3	124	1	Clinical	clinical	JJ
cord-029547-9ei1ram3	124	2	symptoms	symptom	NNS
cord-029547-9ei1ram3	124	3	are	be	VBP
cord-029547-9ei1ram3	124	4	often	often	RB
cord-029547-9ei1ram3	124	5	used	use	VBN
cord-029547-9ei1ram3	124	6	as	as	IN
cord-029547-9ei1ram3	124	7	indicators	indicator	NNS
cord-029547-9ei1ram3	124	8	of	of	IN
cord-029547-9ei1ram3	124	9	clinically	clinically	RB
cord-029547-9ei1ram3	124	10	suspected	suspect	VBN
cord-029547-9ei1ram3	124	11	cases	case	NNS
cord-029547-9ei1ram3	124	12	.	.	.
cord-029547-9ei1ram3	125	1	Thus	thus	RB
cord-029547-9ei1ram3	125	2	,	,	,
cord-029547-9ei1ram3	125	3	when	when	WRB
cord-029547-9ei1ram3	125	4	it	-PRON-	PRP
cord-029547-9ei1ram3	125	5	comes	come	VBZ
cord-029547-9ei1ram3	125	6	to	to	IN
cord-029547-9ei1ram3	125	7	the	the	DT
cord-029547-9ei1ram3	125	8	clinical	clinical	JJ
cord-029547-9ei1ram3	125	9	features	feature	NNS
cord-029547-9ei1ram3	125	10	above	above	RB
cord-029547-9ei1ram3	125	11	,	,	,
cord-029547-9ei1ram3	125	12	it	-PRON-	PRP
cord-029547-9ei1ram3	125	13	is	be	VBZ
cord-029547-9ei1ram3	125	14	easy	easy	JJ
cord-029547-9ei1ram3	125	15	to	to	TO
cord-029547-9ei1ram3	125	16	think	think	VB
cord-029547-9ei1ram3	125	17	about	about	IN
cord-029547-9ei1ram3	125	18	clinical	clinical	JJ
cord-029547-9ei1ram3	125	19	diagnosis	diagnosis	NN
cord-029547-9ei1ram3	125	20	of	of	IN
cord-029547-9ei1ram3	125	21	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	125	22	(	(	-LRB-
cord-029547-9ei1ram3	125	23	Table	table	NN
cord-029547-9ei1ram3	125	24	2and	2and	CD
cord-029547-9ei1ram3	125	25	Fig	Fig	NNP
cord-029547-9ei1ram3	125	26	.	.	NNP
cord-029547-9ei1ram3	125	27	2	2	CD
cord-029547-9ei1ram3	125	28	)	)	-RRB-
cord-029547-9ei1ram3	125	29	.	.	.
cord-029547-9ei1ram3	126	1	According	accord	VBG
cord-029547-9ei1ram3	126	2	to	to	IN
cord-029547-9ei1ram3	126	3	the	the	DT
cord-029547-9ei1ram3	126	4	Diagnosis	Diagnosis	NNP
cord-029547-9ei1ram3	126	5	and	and	CC
cord-029547-9ei1ram3	126	6	Treatment	Treatment	NNP
cord-029547-9ei1ram3	126	7	Program	Program	NNP
cord-029547-9ei1ram3	126	8	of	of	IN
cord-029547-9ei1ram3	126	9	Novel	Novel	NNP
cord-029547-9ei1ram3	126	10	Coronavirus	Coronavirus	NNP
cord-029547-9ei1ram3	126	11	Pneumonia	Pneumonia	NNP
cord-029547-9ei1ram3	126	12	,	,	,
cord-029547-9ei1ram3	126	13	only	only	RB
cord-029547-9ei1ram3	126	14	a	a	DT
cord-029547-9ei1ram3	126	15	suspected	suspect	VBN
cord-029547-9ei1ram3	126	16	case	case	NN
cord-029547-9ei1ram3	126	17	has	have	VBZ
cord-029547-9ei1ram3	126	18	one	one	CD
cord-029547-9ei1ram3	126	19	of	of	IN
cord-029547-9ei1ram3	126	20	the	the	DT
cord-029547-9ei1ram3	126	21	pieces	piece	NNS
cord-029547-9ei1ram3	126	22	of	of	IN
cord-029547-9ei1ram3	126	23	evidence	evidence	NN
cord-029547-9ei1ram3	126	24	of	of	IN
cord-029547-9ei1ram3	126	25	etiology	etiology	NN
cord-029547-9ei1ram3	126	26	or	or	CC
cord-029547-9ei1ram3	126	27	serology	serology	NN
cord-029547-9ei1ram3	126	28	,	,	,
cord-029547-9ei1ram3	126	29	such	such	JJ
cord-029547-9ei1ram3	126	30	as	as	IN
cord-029547-9ei1ram3	126	31	positive	positive	JJ
cord-029547-9ei1ram3	126	32	nucleic	nucleic	JJ
cord-029547-9ei1ram3	126	33	acid	acid	NN
cord-029547-9ei1ram3	126	34	,	,	,
cord-029547-9ei1ram3	126	35	confirmation	confirmation	NN
cord-029547-9ei1ram3	126	36	of	of	IN
cord-029547-9ei1ram3	126	37	gene	gene	NN
cord-029547-9ei1ram3	126	38	sequencing	sequencing	NN
cord-029547-9ei1ram3	126	39	,	,	,
cord-029547-9ei1ram3	126	40	and	and	CC
cord-029547-9ei1ram3	126	41	virus	virus	NN
cord-029547-9ei1ram3	126	42	specific	specific	JJ
cord-029547-9ei1ram3	126	43	antibody	antibody	NN
cord-029547-9ei1ram3	126	44	,	,	,
cord-029547-9ei1ram3	126	45	to	to	TO
cord-029547-9ei1ram3	126	46	be	be	VB
cord-029547-9ei1ram3	126	47	confirmed	confirm	VBN
cord-029547-9ei1ram3	126	48	to	to	TO
cord-029547-9ei1ram3	126	49	be	be	VB
cord-029547-9ei1ram3	126	50	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	126	51	patient	patient	NN
cord-029547-9ei1ram3	126	52	,	,	,
cord-029547-9ei1ram3	126	53	55	55	CD
cord-029547-9ei1ram3	126	54	and	and	CC
cord-029547-9ei1ram3	126	55	the	the	DT
cord-029547-9ei1ram3	126	56	suspected	suspect	VBN
cord-029547-9ei1ram3	126	57	cases	case	NNS
cord-029547-9ei1ram3	126	58	were	be	VBD
cord-029547-9ei1ram3	126	59	identified	identify	VBN
cord-029547-9ei1ram3	126	60	by	by	IN
cord-029547-9ei1ram3	126	61	a	a	DT
cord-029547-9ei1ram3	126	62	comprehensive	comprehensive	JJ
cord-029547-9ei1ram3	126	63	analysis	analysis	NN
cord-029547-9ei1ram3	126	64	of	of	IN
cord-029547-9ei1ram3	126	65	epidemiological	epidemiological	JJ
cord-029547-9ei1ram3	126	66	history	history	NN
cord-029547-9ei1ram3	126	67	and	and	CC
cord-029547-9ei1ram3	126	68	clinical	clinical	JJ
cord-029547-9ei1ram3	126	69	manifestations	manifestation	NNS
cord-029547-9ei1ram3	126	70	.	.	.
cord-029547-9ei1ram3	127	1	56	56	CD
cord-029547-9ei1ram3	128	1	However	however	RB
cord-029547-9ei1ram3	128	2	,	,	,
cord-029547-9ei1ram3	128	3	there	there	EX
cord-029547-9ei1ram3	128	4	are	be	VBP
cord-029547-9ei1ram3	128	5	also	also	RB
cord-029547-9ei1ram3	128	6	many	many	JJ
cord-029547-9ei1ram3	128	7	problems	problem	NNS
cord-029547-9ei1ram3	128	8	with	with	IN
cord-029547-9ei1ram3	128	9	this	this	DT
cord-029547-9ei1ram3	128	10	program	program	NN
cord-029547-9ei1ram3	128	11	.	.	.
cord-029547-9ei1ram3	129	1	The	the	DT
cord-029547-9ei1ram3	129	2	most	most	RBS
cord-029547-9ei1ram3	129	3	obvious	obvious	JJ
cord-029547-9ei1ram3	129	4	problem	problem	NN
cord-029547-9ei1ram3	129	5	is	be	VBZ
cord-029547-9ei1ram3	129	6	that	that	IN
cord-029547-9ei1ram3	129	7	RT	RT	NNP
cord-029547-9ei1ram3	129	8	-	-	HYPH
cord-029547-9ei1ram3	129	9	PCR	PCR	NNP
cord-029547-9ei1ram3	129	10	 	 	_SP
cord-029547-9ei1ram3	129	11	Patients	patient	NNS
cord-029547-9ei1ram3	129	12	have	have	VBP
cord-029547-9ei1ram3	129	13	any	any	DT
cord-029547-9ei1ram3	129	14	epidemiological	epidemiological	JJ
cord-029547-9ei1ram3	129	15	history	history	NN
cord-029547-9ei1ram3	129	16	and	and	CC
cord-029547-9ei1ram3	129	17	conform	conform	VB
cord-029547-9ei1ram3	129	18	to	to	IN
cord-029547-9ei1ram3	129	19	at	at	RB
cord-029547-9ei1ram3	129	20	least	least	RBS
cord-029547-9ei1ram3	129	21	two	two	CD
cord-029547-9ei1ram3	129	22	clinical	clinical	JJ
cord-029547-9ei1ram3	129	23	manifestations	manifestation	NNS
cord-029547-9ei1ram3	129	24	,	,	,
cord-029547-9ei1ram3	129	25	or	or	CC
cord-029547-9ei1ram3	129	26	patients	patient	NNS
cord-029547-9ei1ram3	129	27	without	without	IN
cord-029547-9ei1ram3	129	28	clear	clear	JJ
cord-029547-9ei1ram3	129	29	epidemiological	epidemiological	JJ
cord-029547-9ei1ram3	129	30	history	history	NN
cord-029547-9ei1ram3	129	31	conform	conform	VBP
cord-029547-9ei1ram3	129	32	to	to	IN
cord-029547-9ei1ram3	129	33	three	three	CD
cord-029547-9ei1ram3	129	34	clinical	clinical	JJ
cord-029547-9ei1ram3	129	35	manifestations	manifestation	NNS
cord-029547-9ei1ram3	129	36	.	.	.
cord-029547-9ei1ram3	130	1	Epidemiological	epidemiological	JJ
cord-029547-9ei1ram3	130	2	history	history	NN
cord-029547-9ei1ram3	130	3	:	:	:
cord-029547-9ei1ram3	131	1	I.	I.	NNP
cord-029547-9ei1ram3	131	2	Travel	Travel	NNP
cord-029547-9ei1ram3	131	3	or	or	CC
cord-029547-9ei1ram3	131	4	residence	residence	NN
cord-029547-9ei1ram3	131	5	history	history	NN
cord-029547-9ei1ram3	131	6	of	of	IN
cord-029547-9ei1ram3	131	7	an	an	DT
cord-029547-9ei1ram3	131	8	affected	affected	JJ
cord-029547-9ei1ram3	131	9	area	area	NN
cord-029547-9ei1ram3	131	10	or	or	CC
cord-029547-9ei1ram3	131	11	close	close	JJ
cord-029547-9ei1ram3	131	12	contact	contact	NN
cord-029547-9ei1ram3	131	13	with	with	IN
cord-029547-9ei1ram3	131	14	a	a	DT
cord-029547-9ei1ram3	131	15	suspected	suspect	VBN
cord-029547-9ei1ram3	131	16	or	or	CC
cord-029547-9ei1ram3	131	17	confirmed	confirm	VBN
cord-029547-9ei1ram3	131	18	case	case	NN
cord-029547-9ei1ram3	131	19	within	within	IN
cord-029547-9ei1ram3	131	20	14	14	CD
cord-029547-9ei1ram3	131	21	days	day	NNS
cord-029547-9ei1ram3	131	22	before	before	IN
cord-029547-9ei1ram3	131	23	onset	onset	NN
cord-029547-9ei1ram3	131	24	II	II	NNP
cord-029547-9ei1ram3	131	25	.	.	.
cord-029547-9ei1ram3	132	1	Have	have	VBP
cord-029547-9ei1ram3	132	2	contact	contact	NN
cord-029547-9ei1ram3	132	3	with	with	IN
cord-029547-9ei1ram3	132	4	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	132	5	cases	case	NNS
cord-029547-9ei1ram3	132	6	(	(	-LRB-
cord-029547-9ei1ram3	132	7	nucleic	nucleic	JJ
cord-029547-9ei1ram3	132	8	acid	acid	NN
cord-029547-9ei1ram3	132	9	positive	positive	JJ
cord-029547-9ei1ram3	132	10	)	)	-RRB-
cord-029547-9ei1ram3	132	11	within	within	IN
cord-029547-9ei1ram3	132	12	14	14	CD
cord-029547-9ei1ram3	132	13	days	day	NNS
cord-029547-9ei1ram3	132	14	prior	prior	RB
cord-029547-9ei1ram3	132	15	to	to	IN
cord-029547-9ei1ram3	132	16	onset	onset	NN
cord-029547-9ei1ram3	132	17	III	III	NNP
cord-029547-9ei1ram3	132	18	.	.	.
cord-029547-9ei1ram3	133	1	Have	have	VBP
cord-029547-9ei1ram3	133	2	contact	contact	NN
cord-029547-9ei1ram3	133	3	with	with	IN
cord-029547-9ei1ram3	133	4	patients	patient	NNS
cord-029547-9ei1ram3	133	5	with	with	IN
cord-029547-9ei1ram3	133	6	fever	fever	NN
cord-029547-9ei1ram3	133	7	or	or	CC
cord-029547-9ei1ram3	133	8	respiratory	respiratory	JJ
cord-029547-9ei1ram3	133	9	symptoms	symptom	NNS
cord-029547-9ei1ram3	133	10	from	from	IN
cord-029547-9ei1ram3	133	11	an	an	DT
cord-029547-9ei1ram3	133	12	affected	affected	JJ
cord-029547-9ei1ram3	133	13	area	area	NN
cord-029547-9ei1ram3	133	14	,	,	,
cord-029547-9ei1ram3	133	15	or	or	CC
cord-029547-9ei1ram3	133	16	from	from	IN
cord-029547-9ei1ram3	133	17	communities	community	NNS
cord-029547-9ei1ram3	133	18	with	with	IN
cord-029547-9ei1ram3	133	19	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	133	20	cases	case	NNS
cord-029547-9ei1ram3	133	21	IV	IV	NNP
cord-029547-9ei1ram3	133	22	.	.	.
cord-029547-9ei1ram3	134	1	Cluster	cluster	NN
cord-029547-9ei1ram3	134	2	onset	onset	NN
cord-029547-9ei1ram3	134	3	(	(	-LRB-
cord-029547-9ei1ram3	134	4	two	two	CD
cord-029547-9ei1ram3	134	5	or	or	CC
cord-029547-9ei1ram3	134	6	more	more	JJR
cord-029547-9ei1ram3	134	7	cases	case	NNS
cord-029547-9ei1ram3	134	8	of	of	IN
cord-029547-9ei1ram3	134	9	fever	fever	NN
cord-029547-9ei1ram3	134	10	and/or	and/or	CC
cord-029547-9ei1ram3	134	11	respiratory	respiratory	JJ
cord-029547-9ei1ram3	134	12	symptoms	symptom	NNS
cord-029547-9ei1ram3	134	13	within	within	IN
cord-029547-9ei1ram3	134	14	2	2	CD
cord-029547-9ei1ram3	134	15	weeks	week	NNS
cord-029547-9ei1ram3	134	16	in	in	IN
cord-029547-9ei1ram3	134	17	a	a	DT
cord-029547-9ei1ram3	134	18	small	small	JJ
cord-029547-9ei1ram3	134	19	area	area	NN
cord-029547-9ei1ram3	134	20	such	such	JJ
cord-029547-9ei1ram3	134	21	as	as	IN
cord-029547-9ei1ram3	134	22	home	home	NN
cord-029547-9ei1ram3	134	23	,	,	,
cord-029547-9ei1ram3	134	24	office	office	NN
cord-029547-9ei1ram3	134	25	,	,	,
cord-029547-9ei1ram3	134	26	school	school	NN
cord-029547-9ei1ram3	134	27	,	,	,
cord-029547-9ei1ram3	134	28	and	and	CC
cord-029547-9ei1ram3	134	29	class	class	NN
cord-029547-9ei1ram3	134	30	)	)	-RRB-
cord-029547-9ei1ram3	135	1	Clinical	clinical	JJ
cord-029547-9ei1ram3	135	2	manifestations	manifestation	NNS
cord-029547-9ei1ram3	135	3	:	:	:
cord-029547-9ei1ram3	135	4	I.	I.	NNP
cord-029547-9ei1ram3	135	5	Fever	fever	NN
cord-029547-9ei1ram3	135	6	and/or	and/or	CC
cord-029547-9ei1ram3	135	7	respiratory	respiratory	JJ
cord-029547-9ei1ram3	135	8	symptoms	symptom	NNS
cord-029547-9ei1ram3	135	9	II	II	NNP
cord-029547-9ei1ram3	135	10	.	.	.
cord-029547-9ei1ram3	136	1	With	with	IN
cord-029547-9ei1ram3	136	2	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	136	3	imaging	imaging	NN
cord-029547-9ei1ram3	136	4	characteristics	characteristic	NNS
cord-029547-9ei1ram3	136	5	III	III	NNP
cord-029547-9ei1ram3	136	6	.	.	.
cord-029547-9ei1ram3	137	1	Normal	normal	JJ
cord-029547-9ei1ram3	137	2	or	or	CC
cord-029547-9ei1ram3	137	3	reduced	reduced	JJ
cord-029547-9ei1ram3	137	4	number	number	NN
cord-029547-9ei1ram3	137	5	of	of	IN
cord-029547-9ei1ram3	137	6	white	white	JJ
cord-029547-9ei1ram3	137	7	blood	blood	NN
cord-029547-9ei1ram3	137	8	cells	cell	NNS
cord-029547-9ei1ram3	137	9	and/or	and/or	CC
cord-029547-9ei1ram3	137	10	lymphocytes	lymphocyte	NNS
cord-029547-9ei1ram3	137	11	in	in	IN
cord-029547-9ei1ram3	137	12	early	early	JJ
cord-029547-9ei1ram3	137	13	COVID-19	covid-19	NN
cord-029547-9ei1ram3	138	1	The	the	DT
cord-029547-9ei1ram3	138	2	suspected	suspect	VBN
cord-029547-9ei1ram3	138	3	cases	case	NNS
cord-029547-9ei1ram3	138	4	have	have	VBP
cord-029547-9ei1ram3	138	5	at	at	RB
cord-029547-9ei1ram3	138	6	least	least	RBS
cord-029547-9ei1ram3	138	7	one	one	CD
cord-029547-9ei1ram3	138	8	of	of	IN
cord-029547-9ei1ram3	138	9	the	the	DT
cord-029547-9ei1ram3	138	10	following	following	JJ
cord-029547-9ei1ram3	138	11	etiological	etiological	JJ
cord-029547-9ei1ram3	138	12	or	or	CC
cord-029547-9ei1ram3	138	13	serological	serological	JJ
cord-029547-9ei1ram3	138	14	evidences	evidence	NNS
cord-029547-9ei1ram3	138	15	.	.	.
cord-029547-9ei1ram3	139	1	I.	I.	NNP
cord-029547-9ei1ram3	140	1	The	the	DT
cord-029547-9ei1ram3	140	2	real	real	JJ
cord-029547-9ei1ram3	140	3	-	-	HYPH
cord-029547-9ei1ram3	140	4	time	time	NN
cord-029547-9ei1ram3	140	5	fluorescent	fluorescent	NN
cord-029547-9ei1ram3	140	6	RT	RT	NNP
cord-029547-9ei1ram3	140	7	-	-	HYPH
cord-029547-9ei1ram3	140	8	PCR	PCR	NNP
cord-029547-9ei1ram3	140	9	for	for	IN
cord-029547-9ei1ram3	140	10	specimens	specimen	NNS
cord-029547-9ei1ram3	140	11	with	with	IN
cord-029547-9ei1ram3	140	12	a	a	DT
cord-029547-9ei1ram3	140	13	positive	positive	JJ
cord-029547-9ei1ram3	140	14	result	result	NN
cord-029547-9ei1ram3	140	15	of	of	IN
cord-029547-9ei1ram3	140	16	SARS	SARS	NNP
cord-029547-9ei1ram3	140	17	-	-	HYPH
cord-029547-9ei1ram3	140	18	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	140	19	RNA	RNA	NNP
cord-029547-9ei1ram3	140	20	II	II	NNP
cord-029547-9ei1ram3	140	21	.	.	.
cord-029547-9ei1ram3	141	1	Virus	virus	NN
cord-029547-9ei1ram3	141	2	gene	gene	NN
cord-029547-9ei1ram3	141	3	sequences	sequence	NNS
cord-029547-9ei1ram3	141	4	are	be	VBP
cord-029547-9ei1ram3	141	5	highly	highly	RB
cord-029547-9ei1ram3	141	6	homologous	homologous	JJ
cord-029547-9ei1ram3	141	7	to	to	IN
cord-029547-9ei1ram3	141	8	SARS	SARS	NNP
cord-029547-9ei1ram3	141	9	-	-	HYPH
cord-029547-9ei1ram3	141	10	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	141	11	III	III	NNP
cord-029547-9ei1ram3	141	12	.	.	.
cord-029547-9ei1ram3	142	1	Positive	positive	JJ
cord-029547-9ei1ram3	142	2	SARS	SARS	NNP
cord-029547-9ei1ram3	142	3	-	-	HYPH
cord-029547-9ei1ram3	142	4	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	142	5	specific	specific	JJ
cord-029547-9ei1ram3	142	6	IgM	IgM	NNP
cord-029547-9ei1ram3	142	7	antibody	antibody	NNP
cord-029547-9ei1ram3	142	8	and	and	CC
cord-029547-9ei1ram3	142	9	IgG	IgG	NNP
cord-029547-9ei1ram3	142	10	antibody	antibody	NN
cord-029547-9ei1ram3	142	11	in	in	IN
cord-029547-9ei1ram3	142	12	serum	serum	NN
cord-029547-9ei1ram3	142	13	;	;	:
cord-029547-9ei1ram3	142	14	the	the	DT
cord-029547-9ei1ram3	142	15	serum	serum	NN
cord-029547-9ei1ram3	142	16	SARS	SARS	NNP
cord-029547-9ei1ram3	142	17	-	-	HYPH
cord-029547-9ei1ram3	142	18	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	142	19	specific	specific	JJ
cord-029547-9ei1ram3	142	20	IgG	igg	NN
cord-029547-9ei1ram3	142	21	antibody	antibody	NN
cord-029547-9ei1ram3	142	22	changes	change	NNS
cord-029547-9ei1ram3	142	23	from	from	IN
cord-029547-9ei1ram3	142	24	negative	negative	JJ
cord-029547-9ei1ram3	142	25	to	to	IN
cord-029547-9ei1ram3	142	26	positive	positive	JJ
cord-029547-9ei1ram3	142	27	or	or	CC
cord-029547-9ei1ram3	142	28	is	be	VBZ
cord-029547-9ei1ram3	142	29	four	four	CD
cord-029547-9ei1ram3	142	30	times	time	NNS
cord-029547-9ei1ram3	142	31	higher	high	JJR
cord-029547-9ei1ram3	142	32	in	in	IN
cord-029547-9ei1ram3	142	33	the	the	DT
cord-029547-9ei1ram3	142	34	recovery	recovery	NN
cord-029547-9ei1ram3	142	35	period	period	NN
cord-029547-9ei1ram3	142	36	than	than	IN
cord-029547-9ei1ram3	142	37	in	in	IN
cord-029547-9ei1ram3	142	38	the	the	DT
cord-029547-9ei1ram3	142	39	acute	acute	JJ
cord-029547-9ei1ram3	142	40	phase	phase	NN
cord-029547-9ei1ram3	142	41	is	be	VBZ
cord-029547-9ei1ram3	142	42	the	the	DT
cord-029547-9ei1ram3	142	43	most	most	RBS
cord-029547-9ei1ram3	142	44	common	common	JJ
cord-029547-9ei1ram3	142	45	method	method	NN
cord-029547-9ei1ram3	142	46	for	for	IN
cord-029547-9ei1ram3	142	47	nucleic	nucleic	JJ
cord-029547-9ei1ram3	142	48	acid	acid	NN
cord-029547-9ei1ram3	142	49	testing	testing	NN
cord-029547-9ei1ram3	142	50	,	,	,
cord-029547-9ei1ram3	142	51	but	but	CC
cord-029547-9ei1ram3	142	52	its	-PRON-	PRP$
cord-029547-9ei1ram3	142	53	sensitivity	sensitivity	NN
cord-029547-9ei1ram3	142	54	is	be	VBZ
cord-029547-9ei1ram3	142	55	not	not	RB
cord-029547-9ei1ram3	142	56	as	as	RB
cord-029547-9ei1ram3	142	57	high	high	JJ
cord-029547-9ei1ram3	142	58	as	as	IN
cord-029547-9ei1ram3	142	59	expected	expect	VBN
cord-029547-9ei1ram3	142	60	,	,	,
cord-029547-9ei1ram3	142	61	57	57	CD
cord-029547-9ei1ram3	142	62	thus	thus	RB
cord-029547-9ei1ram3	142	63	it	-PRON-	PRP
cord-029547-9ei1ram3	142	64	possibly	possibly	RB
cord-029547-9ei1ram3	142	65	causes	cause	VBZ
cord-029547-9ei1ram3	142	66	misdiagnosis	misdiagnosis	NN
cord-029547-9ei1ram3	142	67	of	of	IN
cord-029547-9ei1ram3	142	68	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	142	69	.	.	.
cord-029547-9ei1ram3	143	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	143	2	,	,	,
cord-029547-9ei1ram3	143	3	although	although	IN
cord-029547-9ei1ram3	143	4	viral	viral	JJ
cord-029547-9ei1ram3	143	5	gene	gene	NN
cord-029547-9ei1ram3	143	6	sequencing	sequencing	NN
cord-029547-9ei1ram3	143	7	is	be	VBZ
cord-029547-9ei1ram3	143	8	an	an	DT
cord-029547-9ei1ram3	143	9	accurate	accurate	JJ
cord-029547-9ei1ram3	143	10	diagnostic	diagnostic	JJ
cord-029547-9ei1ram3	143	11	method	method	NN
cord-029547-9ei1ram3	143	12	and	and	CC
cord-029547-9ei1ram3	143	13	used	use	VBN
cord-029547-9ei1ram3	143	14	on	on	IN
cord-029547-9ei1ram3	143	15	a	a	DT
cord-029547-9ei1ram3	143	16	small	small	JJ
cord-029547-9ei1ram3	143	17	scale	scale	NN
cord-029547-9ei1ram3	143	18	,	,	,
cord-029547-9ei1ram3	143	19	58	58	CD
cord-029547-9ei1ram3	143	20	its	-PRON-	PRP$
cord-029547-9ei1ram3	143	21	complex	complex	JJ
cord-029547-9ei1ram3	143	22	operation	operation	NN
cord-029547-9ei1ram3	143	23	and	and	CC
cord-029547-9ei1ram3	143	24	time	time	NN
cord-029547-9ei1ram3	143	25	-	-	HYPH
cord-029547-9ei1ram3	143	26	consuming	consume	VBG
cord-029547-9ei1ram3	143	27	process	process	NN
cord-029547-9ei1ram3	143	28	make	make	VBP
cord-029547-9ei1ram3	143	29	it	-PRON-	PRP
cord-029547-9ei1ram3	143	30	difficult	difficult	JJ
cord-029547-9ei1ram3	143	31	for	for	IN
cord-029547-9ei1ram3	143	32	wider	wide	JJR
cord-029547-9ei1ram3	143	33	clinical	clinical	JJ
cord-029547-9ei1ram3	143	34	use	use	NN
cord-029547-9ei1ram3	143	35	.	.	.
cord-029547-9ei1ram3	144	1	SARS	SARS	NNP
cord-029547-9ei1ram3	144	2	-	-	HYPH
cord-029547-9ei1ram3	144	3	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	144	4	specific	specific	JJ
cord-029547-9ei1ram3	144	5	antibody	antibody	NN
cord-029547-9ei1ram3	144	6	detection	detection	NN
cord-029547-9ei1ram3	144	7	is	be	VBZ
cord-029547-9ei1ram3	144	8	a	a	DT
cord-029547-9ei1ram3	144	9	simple	simple	JJ
cord-029547-9ei1ram3	144	10	detection	detection	NN
cord-029547-9ei1ram3	144	11	method	method	NN
cord-029547-9ei1ram3	144	12	with	with	IN
cord-029547-9ei1ram3	144	13	higher	high	JJR
cord-029547-9ei1ram3	144	14	sensitivity	sensitivity	NN
cord-029547-9ei1ram3	144	15	than	than	IN
cord-029547-9ei1ram3	144	16	RT	RT	NNP
cord-029547-9ei1ram3	144	17	-	-	HYPH
cord-029547-9ei1ram3	144	18	PCR	PCR	NNP
cord-029547-9ei1ram3	144	19	,	,	,
cord-029547-9ei1ram3	144	20	59	59	CD
cord-029547-9ei1ram3	144	21	but	but	CC
cord-029547-9ei1ram3	144	22	its	-PRON-	PRP$
cord-029547-9ei1ram3	144	23	high	high	JJ
cord-029547-9ei1ram3	144	24	sensitivity	sensitivity	NN
cord-029547-9ei1ram3	144	25	is	be	VBZ
cord-029547-9ei1ram3	144	26	only	only	RB
cord-029547-9ei1ram3	144	27	reflected	reflect	VBN
cord-029547-9ei1ram3	144	28	after	after	IN
cord-029547-9ei1ram3	144	29	5.5	5.5	CD
cord-029547-9ei1ram3	144	30	days	day	NNS
cord-029547-9ei1ram3	144	31	of	of	IN
cord-029547-9ei1ram3	144	32	symptom	symptom	NN
cord-029547-9ei1ram3	144	33	onset	onset	NN
cord-029547-9ei1ram3	144	34	,	,	,
cord-029547-9ei1ram3	144	35	60	60	CD
cord-029547-9ei1ram3	145	1	so	so	CC
cord-029547-9ei1ram3	145	2	it	-PRON-	PRP
cord-029547-9ei1ram3	145	3	is	be	VBZ
cord-029547-9ei1ram3	145	4	just	just	RB
cord-029547-9ei1ram3	145	5	a	a	DT
cord-029547-9ei1ram3	145	6	supplementary	supplementary	JJ
cord-029547-9ei1ram3	145	7	means	mean	NNS
cord-029547-9ei1ram3	145	8	to	to	IN
cord-029547-9ei1ram3	145	9	RT	RT	NNP
cord-029547-9ei1ram3	145	10	-	-	HYPH
cord-029547-9ei1ram3	145	11	PCR	PCR	NNP
cord-029547-9ei1ram3	145	12	.	.	.
cord-029547-9ei1ram3	146	1	Luckily	luckily	RB
cord-029547-9ei1ram3	146	2	,	,	,
cord-029547-9ei1ram3	146	3	the	the	DT
cord-029547-9ei1ram3	146	4	fast	fast	JJ
cord-029547-9ei1ram3	146	5	and	and	CC
cord-029547-9ei1ram3	146	6	convenient	convenient	JJ
cord-029547-9ei1ram3	146	7	method	method	NN
cord-029547-9ei1ram3	146	8	,	,	,
cord-029547-9ei1ram3	146	9	CT	CT	NNP
cord-029547-9ei1ram3	146	10	,	,	,
cord-029547-9ei1ram3	146	11	was	be	VBD
cord-029547-9ei1ram3	146	12	found	find	VBN
cord-029547-9ei1ram3	146	13	to	to	TO
cord-029547-9ei1ram3	146	14	have	have	VB
cord-029547-9ei1ram3	146	15	a	a	DT
cord-029547-9ei1ram3	146	16	higher	high	JJR
cord-029547-9ei1ram3	146	17	diagnostic	diagnostic	JJ
cord-029547-9ei1ram3	146	18	sensitivity	sensitivity	NN
cord-029547-9ei1ram3	146	19	for	for	IN
cord-029547-9ei1ram3	146	20	COVID-19	covid-19	CD
cord-029547-9ei1ram3	146	21	than	than	IN
cord-029547-9ei1ram3	146	22	other	other	JJ
cord-029547-9ei1ram3	146	23	diagnostic	diagnostic	JJ
cord-029547-9ei1ram3	146	24	methods	method	NNS
cord-029547-9ei1ram3	146	25	such	such	JJ
cord-029547-9ei1ram3	146	26	as	as	IN
cord-029547-9ei1ram3	146	27	RT	RT	NNP
cord-029547-9ei1ram3	146	28	-	-	HYPH
cord-029547-9ei1ram3	146	29	PCR	PCR	NNP
cord-029547-9ei1ram3	146	30	and	and	CC
cord-029547-9ei1ram3	146	31	can	can	MD
cord-029547-9ei1ram3	146	32	predict	predict	VB
cord-029547-9ei1ram3	146	33	the	the	DT
cord-029547-9ei1ram3	146	34	prognosis	prognosis	NN
cord-029547-9ei1ram3	146	35	of	of	IN
cord-029547-9ei1ram3	146	36	patients	patient	NNS
cord-029547-9ei1ram3	146	37	,	,	,
cord-029547-9ei1ram3	146	38	57,61	57,61	CD
cord-029547-9ei1ram3	146	39	thus	thus	RB
cord-029547-9ei1ram3	146	40	it	-PRON-	PRP
cord-029547-9ei1ram3	146	41	is	be	VBZ
cord-029547-9ei1ram3	146	42	meaningful	meaningful	JJ
cord-029547-9ei1ram3	146	43	for	for	IN
cord-029547-9ei1ram3	146	44	the	the	DT
cord-029547-9ei1ram3	146	45	initial	initial	JJ
cord-029547-9ei1ram3	146	46	screening	screening	NN
cord-029547-9ei1ram3	146	47	.	.	.
cord-029547-9ei1ram3	147	1	Zhang	Zhang	NNP
cord-029547-9ei1ram3	147	2	et	et	NNP
cord-029547-9ei1ram3	147	3	al	al	NNP
cord-029547-9ei1ram3	147	4	.	.	NNP
cord-029547-9ei1ram3	147	5	developed	develop	VBD
cord-029547-9ei1ram3	147	6	a	a	DT
cord-029547-9ei1ram3	147	7	deep	deep	JJ
cord-029547-9ei1ram3	147	8	learning	learning	NN
cord-029547-9ei1ram3	147	9	system	system	NN
cord-029547-9ei1ram3	147	10	for	for	IN
cord-029547-9ei1ram3	147	11	image	image	NN
cord-029547-9ei1ram3	147	12	recognition	recognition	NN
cord-029547-9ei1ram3	147	13	of	of	IN
cord-029547-9ei1ram3	147	14	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	147	15	patients	patient	NNS
cord-029547-9ei1ram3	147	16	.	.	.
cord-029547-9ei1ram3	148	1	They	-PRON-	PRP
cord-029547-9ei1ram3	148	2	collected	collect	VBD
cord-029547-9ei1ram3	148	3	CT	CT	NNP
cord-029547-9ei1ram3	148	4	images	image	NNS
cord-029547-9ei1ram3	148	5	from	from	IN
cord-029547-9ei1ram3	148	6	4154	4154	CD
cord-029547-9ei1ram3	148	7	patients	patient	NNS
cord-029547-9ei1ram3	148	8	for	for	IN
cord-029547-9ei1ram3	148	9	validation	validation	NN
cord-029547-9ei1ram3	148	10	and	and	CC
cord-029547-9ei1ram3	148	11	found	find	VBD
cord-029547-9ei1ram3	148	12	this	this	DT
cord-029547-9ei1ram3	148	13	system	system	NN
cord-029547-9ei1ram3	148	14	precisely	precisely	RB
cord-029547-9ei1ram3	148	15	identified	identify	VBD
cord-029547-9ei1ram3	148	16	the	the	DT
cord-029547-9ei1ram3	148	17	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	148	18	and	and	CC
cord-029547-9ei1ram3	148	19	other	other	JJ
cord-029547-9ei1ram3	148	20	forms	form	NNS
cord-029547-9ei1ram3	148	21	of	of	IN
cord-029547-9ei1ram3	148	22	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	148	23	,	,	,
cord-029547-9ei1ram3	148	24	and	and	CC
cord-029547-9ei1ram3	148	25	it	-PRON-	PRP
cord-029547-9ei1ram3	148	26	also	also	RB
cord-029547-9ei1ram3	148	27	divided	divide	VBD
cord-029547-9ei1ram3	148	28	these	these	DT
cord-029547-9ei1ram3	148	29	patients	patient	NNS
cord-029547-9ei1ram3	148	30	into	into	IN
cord-029547-9ei1ram3	148	31	high	high	JJ
cord-029547-9ei1ram3	148	32	-	-	HYPH
cord-029547-9ei1ram3	148	33	and	and	CC
cord-029547-9ei1ram3	148	34	low	low	JJ
cord-029547-9ei1ram3	148	35	-	-	HYPH
cord-029547-9ei1ram3	148	36	risk	risk	NN
cord-029547-9ei1ram3	148	37	groups	group	NNS
cord-029547-9ei1ram3	148	38	correctly	correctly	RB
cord-029547-9ei1ram3	148	39	,	,	,
cord-029547-9ei1ram3	148	40	62	62	CD
cord-029547-9ei1ram3	148	41	so	so	RB
cord-029547-9ei1ram3	148	42	rational	rational	JJ
cord-029547-9ei1ram3	148	43	use	use	NN
cord-029547-9ei1ram3	148	44	of	of	IN
cord-029547-9ei1ram3	148	45	artificial	artificial	JJ
cord-029547-9ei1ram3	148	46	intelligence	intelligence	NN
cord-029547-9ei1ram3	148	47	such	such	JJ
cord-029547-9ei1ram3	148	48	as	as	IN
cord-029547-9ei1ram3	148	49	this	this	DT
cord-029547-9ei1ram3	148	50	may	may	MD
cord-029547-9ei1ram3	148	51	be	be	VB
cord-029547-9ei1ram3	148	52	better	well	RBR
cord-029547-9ei1ram3	148	53	able	able	JJ
cord-029547-9ei1ram3	148	54	to	to	TO
cord-029547-9ei1ram3	148	55	screen	screen	VB
cord-029547-9ei1ram3	148	56	COVID-19	covid-19	CD
cord-029547-9ei1ram3	148	57	patients	patient	NNS
cord-029547-9ei1ram3	148	58	and	and	CC
cord-029547-9ei1ram3	148	59	give	give	VB
cord-029547-9ei1ram3	148	60	them	-PRON-	PRP
cord-029547-9ei1ram3	148	61	timely	timely	JJ
cord-029547-9ei1ram3	148	62	interventions	intervention	NNS
cord-029547-9ei1ram3	148	63	to	to	TO
cord-029547-9ei1ram3	148	64	ensure	ensure	VB
cord-029547-9ei1ram3	148	65	a	a	DT
cord-029547-9ei1ram3	148	66	better	well	JJR
cord-029547-9ei1ram3	148	67	prognosis	prognosis	NN
cord-029547-9ei1ram3	148	68	.	.	.
cord-029547-9ei1ram3	149	1	In	in	IN
cord-029547-9ei1ram3	149	2	addition	addition	NN
cord-029547-9ei1ram3	149	3	,	,	,
cord-029547-9ei1ram3	149	4	a	a	DT
cord-029547-9ei1ram3	149	5	CRISPR	CRISPR	NNP
cord-029547-9ei1ram3	149	6	-	-	HYPH
cord-029547-9ei1ram3	149	7	Cas12-based	cas12-base	VBN
cord-029547-9ei1ram3	149	8	technique	technique	NN
cord-029547-9ei1ram3	149	9	was	be	VBD
cord-029547-9ei1ram3	149	10	confirmed	confirm	VBN
cord-029547-9ei1ram3	149	11	to	to	TO
cord-029547-9ei1ram3	149	12	be	be	VB
cord-029547-9ei1ram3	149	13	a	a	DT
cord-029547-9ei1ram3	149	14	faster	fast	JJR
cord-029547-9ei1ram3	149	15	test	test	NN
cord-029547-9ei1ram3	149	16	for	for	IN
cord-029547-9ei1ram3	149	17	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	149	18	with	with	IN
cord-029547-9ei1ram3	149	19	higher	high	JJR
cord-029547-9ei1ram3	149	20	sensitivity	sensitivity	NN
cord-029547-9ei1ram3	149	21	,	,	,
cord-029547-9ei1ram3	149	22	63	63	CD
cord-029547-9ei1ram3	149	23	thus	thus	RB
cord-029547-9ei1ram3	149	24	it	-PRON-	PRP
cord-029547-9ei1ram3	149	25	is	be	VBZ
cord-029547-9ei1ram3	149	26	possibly	possibly	RB
cord-029547-9ei1ram3	149	27	a	a	DT
cord-029547-9ei1ram3	149	28	replacement	replacement	NN
cord-029547-9ei1ram3	149	29	for	for	IN
cord-029547-9ei1ram3	149	30	the	the	DT
cord-029547-9ei1ram3	149	31	RT	RT	NNP
cord-029547-9ei1ram3	149	32	-	-	HYPH
cord-029547-9ei1ram3	149	33	PCR	PCR	NNP
cord-029547-9ei1ram3	149	34	assay	assay	NN
cord-029547-9ei1ram3	149	35	.	.	.
cord-029547-9ei1ram3	150	1	The	the	DT
cord-029547-9ei1ram3	150	2	therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	150	3	schedule	schedule	NN
cord-029547-9ei1ram3	150	4	issued	issue	VBN
cord-029547-9ei1ram3	150	5	by	by	IN
cord-029547-9ei1ram3	150	6	the	the	DT
cord-029547-9ei1ram3	150	7	General	General	NNP
cord-029547-9ei1ram3	150	8	Office	Office	NNP
cord-029547-9ei1ram3	150	9	of	of	IN
cord-029547-9ei1ram3	150	10	National	National	NNP
cord-029547-9ei1ram3	150	11	Health	Health	NNP
cord-029547-9ei1ram3	150	12	Committee	Committee	NNP
cord-029547-9ei1ram3	150	13	of	of	IN
cord-029547-9ei1ram3	150	14	China	China	NNP
cord-029547-9ei1ram3	150	15	on	on	IN
cord-029547-9ei1ram3	150	16	3	3	CD
cord-029547-9ei1ram3	150	17	March	March	NNP
cord-029547-9ei1ram3	150	18	has	have	VBZ
cord-029547-9ei1ram3	150	19	shown	show	VBN
cord-029547-9ei1ram3	150	20	that	that	IN
cord-029547-9ei1ram3	150	21	therapy	therapy	NN
cord-029547-9ei1ram3	150	22	of	of	IN
cord-029547-9ei1ram3	150	23	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	150	24	should	should	MD
cord-029547-9ei1ram3	150	25	be	be	VB
cord-029547-9ei1ram3	150	26	combined	combine	VBN
cord-029547-9ei1ram3	150	27	with	with	IN
cord-029547-9ei1ram3	150	28	etiological	etiological	JJ
cord-029547-9ei1ram3	150	29	treatment	treatment	NN
cord-029547-9ei1ram3	150	30	and	and	CC
cord-029547-9ei1ram3	150	31	symptomatic	symptomatic	JJ
cord-029547-9ei1ram3	150	32	treatment	treatment	NN
cord-029547-9ei1ram3	150	33	,	,	,
cord-029547-9ei1ram3	150	34	and	and	CC
cord-029547-9ei1ram3	150	35	symptomatic	symptomatic	JJ
cord-029547-9ei1ram3	150	36	treatment	treatment	NN
cord-029547-9ei1ram3	150	37	is	be	VBZ
cord-029547-9ei1ram3	150	38	especially	especially	RB
cord-029547-9ei1ram3	150	39	important	important	JJ
cord-029547-9ei1ram3	150	40	for	for	IN
cord-029547-9ei1ram3	150	41	severe	severe	JJ
cord-029547-9ei1ram3	150	42	and	and	CC
cord-029547-9ei1ram3	150	43	critical	critical	JJ
cord-029547-9ei1ram3	150	44	patients	patient	NNS
cord-029547-9ei1ram3	150	45	.	.	.
cord-029547-9ei1ram3	151	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	151	2	,	,	,
cord-029547-9ei1ram3	151	3	traditional	traditional	JJ
cord-029547-9ei1ram3	151	4	Chinese	chinese	JJ
cord-029547-9ei1ram3	151	5	medicine	medicine	NN
cord-029547-9ei1ram3	151	6	can	can	MD
cord-029547-9ei1ram3	151	7	be	be	VB
cord-029547-9ei1ram3	151	8	also	also	RB
cord-029547-9ei1ram3	151	9	used	use	VBN
cord-029547-9ei1ram3	151	10	for	for	IN
cord-029547-9ei1ram3	151	11	the	the	DT
cord-029547-9ei1ram3	151	12	whole	whole	JJ
cord-029547-9ei1ram3	151	13	treatment	treatment	NN
cord-029547-9ei1ram3	151	14	cycle	cycle	NN
cord-029547-9ei1ram3	151	15	of	of	IN
cord-029547-9ei1ram3	151	16	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	151	17	patients	patient	NNS
cord-029547-9ei1ram3	151	18	.	.	.
cord-029547-9ei1ram3	152	1	55	55	CD
cord-029547-9ei1ram3	153	1	In	in	IN
cord-029547-9ei1ram3	153	2	the	the	DT
cord-029547-9ei1ram3	153	3	processes	process	NNS
cord-029547-9ei1ram3	153	4	of	of	IN
cord-029547-9ei1ram3	153	5	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	153	6	therapy	therapy	NN
cord-029547-9ei1ram3	153	7	,	,	,
cord-029547-9ei1ram3	153	8	drugs	drug	NNS
cord-029547-9ei1ram3	153	9	and	and	CC
cord-029547-9ei1ram3	153	10	bioproducts	bioproduct	NNS
cord-029547-9ei1ram3	153	11	play	play	VBP
cord-029547-9ei1ram3	153	12	important	important	JJ
cord-029547-9ei1ram3	153	13	roles	role	NNS
cord-029547-9ei1ram3	153	14	(	(	-LRB-
cord-029547-9ei1ram3	153	15	Table	table	NN
cord-029547-9ei1ram3	153	16	3	3	CD
cord-029547-9ei1ram3	153	17	)	)	-RRB-
cord-029547-9ei1ram3	153	18	.	.	.
cord-029547-9ei1ram3	154	1	Here	here	RB
cord-029547-9ei1ram3	154	2	,	,	,
cord-029547-9ei1ram3	154	3	we	-PRON-	PRP
cord-029547-9ei1ram3	154	4	summarize	summarize	VBP
cord-029547-9ei1ram3	154	5	the	the	DT
cord-029547-9ei1ram3	154	6	main	main	JJ
cord-029547-9ei1ram3	154	7	treatments	treatment	NNS
cord-029547-9ei1ram3	154	8	of	of	IN
cord-029547-9ei1ram3	154	9	novel	novel	JJ
cord-029547-9ei1ram3	154	10	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	154	11	.	.	.
cord-029547-9ei1ram3	155	1	The	the	DT
cord-029547-9ei1ram3	155	2	etiological	etiological	JJ
cord-029547-9ei1ram3	155	3	treatment	treatment	NN
cord-029547-9ei1ram3	155	4	for	for	IN
cord-029547-9ei1ram3	155	5	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	155	6	means	mean	VBZ
cord-029547-9ei1ram3	155	7	antiviral	antiviral	JJ
cord-029547-9ei1ram3	155	8	therapy	therapy	NN
cord-029547-9ei1ram3	155	9	for	for	IN
cord-029547-9ei1ram3	155	10	it	-PRON-	PRP
cord-029547-9ei1ram3	155	11	,	,	,
cord-029547-9ei1ram3	155	12	which	which	WDT
cord-029547-9ei1ram3	155	13	depends	depend	VBZ
cord-029547-9ei1ram3	155	14	on	on	IN
cord-029547-9ei1ram3	155	15	antiviral	antiviral	JJ
cord-029547-9ei1ram3	155	16	drugs	drug	NNS
cord-029547-9ei1ram3	155	17	and	and	CC
cord-029547-9ei1ram3	155	18	bioproducts	bioproduct	NNS
cord-029547-9ei1ram3	155	19	.	.	.
cord-029547-9ei1ram3	156	1	The	the	DT
cord-029547-9ei1ram3	156	2	processes	process	NNS
cord-029547-9ei1ram3	156	3	of	of	IN
cord-029547-9ei1ram3	156	4	virus	virus	NN
cord-029547-9ei1ram3	156	5	infection	infection	NN
cord-029547-9ei1ram3	156	6	could	could	MD
cord-029547-9ei1ram3	156	7	be	be	VB
cord-029547-9ei1ram3	156	8	described	describe	VBN
cord-029547-9ei1ram3	156	9	as	as	IN
cord-029547-9ei1ram3	156	10	attachment	attachment	NN
cord-029547-9ei1ram3	156	11	,	,	,
cord-029547-9ei1ram3	156	12	penetration	penetration	NN
cord-029547-9ei1ram3	156	13	,	,	,
cord-029547-9ei1ram3	156	14	uncoating	uncoating	NN
cord-029547-9ei1ram3	156	15	,	,	,
cord-029547-9ei1ram3	156	16	biosynthesis	biosynthesis	NN
cord-029547-9ei1ram3	156	17	,	,	,
cord-029547-9ei1ram3	156	18	assembly	assembly	NN
cord-029547-9ei1ram3	156	19	,	,	,
cord-029547-9ei1ram3	156	20	and	and	CC
cord-029547-9ei1ram3	156	21	release	release	NN
cord-029547-9ei1ram3	156	22	.	.	.
cord-029547-9ei1ram3	157	1	After	after	IN
cord-029547-9ei1ram3	157	2	that	that	DT
cord-029547-9ei1ram3	157	3	,	,	,
cord-029547-9ei1ram3	157	4	the	the	DT
cord-029547-9ei1ram3	157	5	virus	virus	NN
cord-029547-9ei1ram3	157	6	complete	complete	VBP
cord-029547-9ei1ram3	157	7	its	-PRON-	PRP$
cord-029547-9ei1ram3	157	8	proliferation	proliferation	NN
cord-029547-9ei1ram3	157	9	and	and	CC
cord-029547-9ei1ram3	157	10	causes	cause	VBZ
cord-029547-9ei1ram3	157	11	damage	damage	NN
cord-029547-9ei1ram3	157	12	to	to	IN
cord-029547-9ei1ram3	157	13	host	host	NN
cord-029547-9ei1ram3	157	14	cells	cell	NNS
cord-029547-9ei1ram3	157	15	.	.	.
cord-029547-9ei1ram3	158	1	Similarly	similarly	RB
cord-029547-9ei1ram3	158	2	,	,	,
cord-029547-9ei1ram3	158	3	the	the	DT
cord-029547-9ei1ram3	158	4	mechanism	mechanism	NN
cord-029547-9ei1ram3	158	5	of	of	IN
cord-029547-9ei1ram3	158	6	antiviral	antiviral	JJ
cord-029547-9ei1ram3	158	7	therapy	therapy	NN
cord-029547-9ei1ram3	158	8	is	be	VBZ
cord-029547-9ei1ram3	158	9	through	through	IN
cord-029547-9ei1ram3	158	10	disturbing	disturb	VBG
cord-029547-9ei1ram3	158	11	these	these	DT
cord-029547-9ei1ram3	158	12	processes	process	NNS
cord-029547-9ei1ram3	158	13	.	.	.
cord-029547-9ei1ram3	159	1	Thus	thus	RB
cord-029547-9ei1ram3	159	2	,	,	,
cord-029547-9ei1ram3	159	3	the	the	DT
cord-029547-9ei1ram3	159	4	medicines	medicine	NNS
cord-029547-9ei1ram3	159	5	for	for	IN
cord-029547-9ei1ram3	159	6	antiviral	antiviral	JJ
cord-029547-9ei1ram3	159	7	treatment	treatment	NN
cord-029547-9ei1ram3	159	8	of	of	IN
cord-029547-9ei1ram3	159	9	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	159	10	are	be	VBP
cord-029547-9ei1ram3	159	11	divided	divide	VBN
cord-029547-9ei1ram3	159	12	into	into	IN
cord-029547-9ei1ram3	159	13	penetration	penetration	NN
cord-029547-9ei1ram3	159	14	and	and	CC
cord-029547-9ei1ram3	159	15	uncoating	uncoating	NN
cord-029547-9ei1ram3	159	16	inhibitors	inhibitor	NNS
cord-029547-9ei1ram3	159	17	,	,	,
cord-029547-9ei1ram3	159	18	biosynthesis	biosynthesis	NN
cord-029547-9ei1ram3	159	19	inhibitors	inhibitor	NNS
cord-029547-9ei1ram3	159	20	,	,	,
cord-029547-9ei1ram3	159	21	and	and	CC
cord-029547-9ei1ram3	159	22	assembly	assembly	NN
cord-029547-9ei1ram3	159	23	inhibitors	inhibitor	NNS
cord-029547-9ei1ram3	159	24	.	.	.
cord-029547-9ei1ram3	160	1	Penetration	penetration	NN
cord-029547-9ei1ram3	160	2	and	and	CC
cord-029547-9ei1ram3	160	3	uncoating	uncoating	NN
cord-029547-9ei1ram3	160	4	inhibitors	inhibitor	NNS
cord-029547-9ei1ram3	160	5	of	of	IN
cord-029547-9ei1ram3	160	6	SARS	SARS	NNP
cord-029547-9ei1ram3	160	7	-	-	HYPH
cord-029547-9ei1ram3	160	8	Cov-2	Cov-2	NNP
cord-029547-9ei1ram3	160	9	mainly	mainly	RB
cord-029547-9ei1ram3	160	10	include	include	VBP
cord-029547-9ei1ram3	160	11	chloroquine	chloroquine	NN
cord-029547-9ei1ram3	160	12	,	,	,
cord-029547-9ei1ram3	160	13	arbidol	arbidol	NN
cord-029547-9ei1ram3	160	14	,	,	,
cord-029547-9ei1ram3	160	15	and	and	CC
cord-029547-9ei1ram3	160	16	camostat	camostat	NNP
cord-029547-9ei1ram3	160	17	mesilate	mesilate	NNP
cord-029547-9ei1ram3	160	18	.	.	.
cord-029547-9ei1ram3	161	1	Chloroquine	Chloroquine	NNP
cord-029547-9ei1ram3	161	2	is	be	VBZ
cord-029547-9ei1ram3	161	3	an	an	DT
cord-029547-9ei1ram3	161	4	efficient	efficient	JJ
cord-029547-9ei1ram3	161	5	drug	drug	NN
cord-029547-9ei1ram3	161	6	for	for	IN
cord-029547-9ei1ram3	161	7	treatment	treatment	NN
cord-029547-9ei1ram3	161	8	of	of	IN
cord-029547-9ei1ram3	161	9	malaria	malaria	NN
cord-029547-9ei1ram3	161	10	as	as	RB
cord-029547-9ei1ram3	161	11	well	well	RB
cord-029547-9ei1ram3	161	12	as	as	IN
cord-029547-9ei1ram3	161	13	autoimmune	autoimmune	JJ
cord-029547-9ei1ram3	161	14	rheumatic	rheumatic	JJ
cord-029547-9ei1ram3	161	15	diseases	disease	NNS
cord-029547-9ei1ram3	161	16	.	.	.
cord-029547-9ei1ram3	162	1	Wang	Wang	NNP
cord-029547-9ei1ram3	162	2	and	and	CC
cord-029547-9ei1ram3	162	3	colleagues	colleague	NNS
cord-029547-9ei1ram3	162	4	treated	treat	VBD
cord-029547-9ei1ram3	162	5	Vero	Vero	NNP
cord-029547-9ei1ram3	162	6	E6	E6	NNP
cord-029547-9ei1ram3	162	7	cells	cell	NNS
cord-029547-9ei1ram3	162	8	that	that	WDT
cord-029547-9ei1ram3	162	9	were	be	VBD
cord-029547-9ei1ram3	162	10	infected	infect	VBN
cord-029547-9ei1ram3	162	11	by	by	IN
cord-029547-9ei1ram3	162	12	SARS	SARS	NNP
cord-029547-9ei1ram3	162	13	-	-	HYPH
cord-029547-9ei1ram3	162	14	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	162	15	with	with	IN
cord-029547-9ei1ram3	162	16	several	several	JJ
cord-029547-9ei1ram3	162	17	drugs	drug	NNS
cord-029547-9ei1ram3	162	18	in	in	IN
cord-029547-9ei1ram3	162	19	vitro	vitro	FW
cord-029547-9ei1ram3	162	20	and	and	CC
cord-029547-9ei1ram3	162	21	found	find	VBD
cord-029547-9ei1ram3	162	22	a	a	DT
cord-029547-9ei1ram3	162	23	low	low	JJ
cord-029547-9ei1ram3	162	24	half	half	RB
cord-029547-9ei1ram3	162	25	-	-	HYPH
cord-029547-9ei1ram3	162	26	maximal	maximal	JJ
cord-029547-9ei1ram3	162	27	effective	effective	JJ
cord-029547-9ei1ram3	162	28	concentration	concentration	NN
cord-029547-9ei1ram3	162	29	at	at	IN
cord-029547-9ei1ram3	162	30	1.13	1.13	CD
cord-029547-9ei1ram3	162	31	μmol	μmol	NNP
cord-029547-9ei1ram3	162	32	and	and	CC
cord-029547-9ei1ram3	162	33	a	a	DT
cord-029547-9ei1ram3	162	34	high	high	JJ
cord-029547-9ei1ram3	162	35	selectivity	selectivity	NN
cord-029547-9ei1ram3	162	36	index	index	NN
cord-029547-9ei1ram3	162	37	of	of	IN
cord-029547-9ei1ram3	162	38	chloroquine	chloroquine	NN
cord-029547-9ei1ram3	162	39	,	,	,
cord-029547-9ei1ram3	162	40	indicating	indicate	VBG
cord-029547-9ei1ram3	162	41	that	that	IN
cord-029547-9ei1ram3	162	42	chloroquine	chloroquine	NN
cord-029547-9ei1ram3	162	43	probably	probably	RB
cord-029547-9ei1ram3	162	44	inhibits	inhibit	VBZ
cord-029547-9ei1ram3	162	45	the	the	DT
cord-029547-9ei1ram3	162	46	viral	viral	JJ
cord-029547-9ei1ram3	162	47	infection	infection	NN
cord-029547-9ei1ram3	162	48	.	.	.
cord-029547-9ei1ram3	163	1	64	64	CD
cord-029547-9ei1ram3	164	1	There	there	EX
cord-029547-9ei1ram3	164	2	have	have	VBP
cord-029547-9ei1ram3	164	3	been	be	VBN
cord-029547-9ei1ram3	164	4	tens	ten	NNS
cord-029547-9ei1ram3	164	5	of	of	IN
cord-029547-9ei1ram3	164	6	clinical	clinical	JJ
cord-029547-9ei1ram3	164	7	trials	trial	NNS
cord-029547-9ei1ram3	164	8	to	to	TO
cord-029547-9ei1ram3	164	9	confirm	confirm	VB
cord-029547-9ei1ram3	164	10	the	the	DT
cord-029547-9ei1ram3	164	11	safety	safety	NN
cord-029547-9ei1ram3	164	12	and	and	CC
cord-029547-9ei1ram3	164	13	efficiency	efficiency	NN
cord-029547-9ei1ram3	164	14	of	of	IN
cord-029547-9ei1ram3	164	15	chloroquine	chloroquine	NN
cord-029547-9ei1ram3	164	16	in	in	IN
cord-029547-9ei1ram3	164	17	treating	treat	VBG
cord-029547-9ei1ram3	164	18	COVID-19	covid-19	CD
cord-029547-9ei1ram3	164	19	patients	patient	NNS
cord-029547-9ei1ram3	164	20	,	,	,
cord-029547-9ei1ram3	164	21	and	and	CC
cord-029547-9ei1ram3	164	22	its	-PRON-	PRP$
cord-029547-9ei1ram3	164	23	mechanism	mechanism	NN
cord-029547-9ei1ram3	164	24	can	can	MD
cord-029547-9ei1ram3	164	25	be	be	VB
cord-029547-9ei1ram3	164	26	described	describe	VBN
cord-029547-9ei1ram3	164	27	as	as	IN
cord-029547-9ei1ram3	164	28	interfering	interfere	VBG
cord-029547-9ei1ram3	164	29	with	with	IN
cord-029547-9ei1ram3	164	30	the	the	DT
cord-029547-9ei1ram3	164	31	glycosylation	glycosylation	NN
cord-029547-9ei1ram3	164	32	of	of	IN
cord-029547-9ei1ram3	164	33	ACE2	ACE2	NNP
cord-029547-9ei1ram3	164	34	or	or	CC
cord-029547-9ei1ram3	164	35	alkalizing	alkalize	VBG
cord-029547-9ei1ram3	164	36	the	the	DT
cord-029547-9ei1ram3	164	37	phagolysosome	phagolysosome	NN
cord-029547-9ei1ram3	164	38	to	to	TO
cord-029547-9ei1ram3	164	39	inhibit	inhibit	VB
cord-029547-9ei1ram3	164	40	viral	viral	JJ
cord-029547-9ei1ram3	164	41	replication	replication	NN
cord-029547-9ei1ram3	164	42	,	,	,
cord-029547-9ei1ram3	164	43	65	65	CD
cord-029547-9ei1ram3	164	44	,	,	,
cord-029547-9ei1ram3	164	45	66	66	CD
cord-029547-9ei1ram3	164	46	which	which	WDT
cord-029547-9ei1ram3	164	47	prevents	prevent	VBZ
cord-029547-9ei1ram3	164	48	the	the	DT
cord-029547-9ei1ram3	164	49	SARS	SARS	NNP
cord-029547-9ei1ram3	164	50	-	-	HYPH
cord-029547-9ei1ram3	164	51	Cov-2	Cov-2	NNP
cord-029547-9ei1ram3	164	52	entering	enter	VBG
cord-029547-9ei1ram3	164	53	the	the	DT
cord-029547-9ei1ram3	164	54	host	host	NN
cord-029547-9ei1ram3	164	55	cells	cell	NNS
cord-029547-9ei1ram3	164	56	.	.	.
cord-029547-9ei1ram3	165	1	The	the	DT
cord-029547-9ei1ram3	165	2	in	in	IN
cord-029547-9ei1ram3	165	3	vitro	vitro	FW
cord-029547-9ei1ram3	165	4	study	study	NN
cord-029547-9ei1ram3	165	5	indicated	indicate	VBD
cord-029547-9ei1ram3	165	6	that	that	IN
cord-029547-9ei1ram3	165	7	chloroquine	chloroquine	NN
cord-029547-9ei1ram3	165	8	only	only	RB
cord-029547-9ei1ram3	165	9	had	have	VBD
cord-029547-9ei1ram3	165	10	an	an	DT
cord-029547-9ei1ram3	165	11	antiviral	antiviral	JJ
cord-029547-9ei1ram3	165	12	effect	effect	NN
cord-029547-9ei1ram3	165	13	under	under	IN
cord-029547-9ei1ram3	165	14	high	high	JJ
cord-029547-9ei1ram3	165	15	doses	dose	NNS
cord-029547-9ei1ram3	165	16	.	.	.
cord-029547-9ei1ram3	166	1	However	however	RB
cord-029547-9ei1ram3	166	2	,	,	,
cord-029547-9ei1ram3	166	3	the	the	DT
cord-029547-9ei1ram3	166	4	clinical	clinical	JJ
cord-029547-9ei1ram3	166	5	data	datum	NNS
cord-029547-9ei1ram3	166	6	of	of	IN
cord-029547-9ei1ram3	166	7	chloroquine	chloroquine	NN
cord-029547-9ei1ram3	166	8	showed	show	VBD
cord-029547-9ei1ram3	166	9	the	the	DT
cord-029547-9ei1ram3	166	10	mortality	mortality	NN
cord-029547-9ei1ram3	166	11	of	of	IN
cord-029547-9ei1ram3	166	12	highdosage	highdosage	NN
cord-029547-9ei1ram3	166	13	group	group	NN
cord-029547-9ei1ram3	166	14	was	be	VBD
cord-029547-9ei1ram3	166	15	apparently	apparently	RB
cord-029547-9ei1ram3	166	16	higher	high	JJR
cord-029547-9ei1ram3	166	17	than	than	IN
cord-029547-9ei1ram3	166	18	the	the	DT
cord-029547-9ei1ram3	166	19	low	low	JJ
cord-029547-9ei1ram3	166	20	-	-	HYPH
cord-029547-9ei1ram3	166	21	dosage	dosage	NN
cord-029547-9ei1ram3	166	22	group	group	NN
cord-029547-9ei1ram3	166	23	,	,	,
cord-029547-9ei1ram3	166	24	but	but	CC
cord-029547-9ei1ram3	166	25	there	there	EX
cord-029547-9ei1ram3	166	26	was	be	VBD
cord-029547-9ei1ram3	166	27	no	no	DT
cord-029547-9ei1ram3	166	28	significant	significant	JJ
cord-029547-9ei1ram3	166	29	difference	difference	NN
cord-029547-9ei1ram3	166	30	in	in	IN
cord-029547-9ei1ram3	166	31	efficacy	efficacy	NN
cord-029547-9ei1ram3	166	32	,	,	,
cord-029547-9ei1ram3	166	33	67	67	CD
cord-029547-9ei1ram3	166	34	and	and	CC
cord-029547-9ei1ram3	166	35	the	the	DT
cord-029547-9ei1ram3	166	36	QT	QT	NNP
cord-029547-9ei1ram3	166	37	interval	interval	NN
cord-029547-9ei1ram3	166	38	of	of	IN
cord-029547-9ei1ram3	166	39	some	some	DT
cord-029547-9ei1ram3	166	40	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	166	41	patients	patient	NNS
cord-029547-9ei1ram3	166	42	was	be	VBD
cord-029547-9ei1ram3	166	43	prolonged	prolong	VBN
cord-029547-9ei1ram3	166	44	after	after	IN
cord-029547-9ei1ram3	166	45	hydroxychloroquine	hydroxychloroquine	NN
cord-029547-9ei1ram3	166	46	/	/	SYM
cord-029547-9ei1ram3	166	47	azithromycin	azithromycin	NNP
cord-029547-9ei1ram3	166	48	treatment	treatment	NN
cord-029547-9ei1ram3	166	49	,	,	,
cord-029547-9ei1ram3	166	50	68	68	CD
cord-029547-9ei1ram3	167	1	thus	thus	RB
cord-029547-9ei1ram3	167	2	it	-PRON-	PRP
cord-029547-9ei1ram3	167	3	might	may	MD
cord-029547-9ei1ram3	167	4	not	not	RB
cord-029547-9ei1ram3	167	5	be	be	VB
cord-029547-9ei1ram3	167	6	an	an	DT
cord-029547-9ei1ram3	167	7	effective	effective	JJ
cord-029547-9ei1ram3	167	8	medicine	medicine	NN
cord-029547-9ei1ram3	167	9	for	for	IN
cord-029547-9ei1ram3	167	10	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	167	11	.	.	.
cord-029547-9ei1ram3	168	1	Arbidol	Arbidol	NNP
cord-029547-9ei1ram3	168	2	is	be	VBZ
cord-029547-9ei1ram3	168	3	the	the	DT
cord-029547-9ei1ram3	168	4	other	other	JJ
cord-029547-9ei1ram3	168	5	penetration	penetration	NN
cord-029547-9ei1ram3	168	6	inhibitor	inhibitor	NN
cord-029547-9ei1ram3	168	7	that	that	WDT
cord-029547-9ei1ram3	168	8	suppresses	suppress	VBZ
cord-029547-9ei1ram3	168	9	the	the	DT
cord-029547-9ei1ram3	168	10	fusion	fusion	NN
cord-029547-9ei1ram3	168	11	of	of	IN
cord-029547-9ei1ram3	168	12	the	the	DT
cord-029547-9ei1ram3	168	13	virus	virus	NN
cord-029547-9ei1ram3	168	14	lipid	lipid	NN
cord-029547-9ei1ram3	168	15	membrane	membrane	NN
cord-029547-9ei1ram3	168	16	and	and	CC
cord-029547-9ei1ram3	168	17	host	host	NN
cord-029547-9ei1ram3	168	18	cells	cell	NNS
cord-029547-9ei1ram3	168	19	to	to	TO
cord-029547-9ei1ram3	168	20	block	block	VB
cord-029547-9ei1ram3	168	21	the	the	DT
cord-029547-9ei1ram3	168	22	replication	replication	NN
cord-029547-9ei1ram3	168	23	of	of	IN
cord-029547-9ei1ram3	168	24	the	the	DT
cord-029547-9ei1ram3	168	25	virus	virus	NN
cord-029547-9ei1ram3	168	26	.	.	.
cord-029547-9ei1ram3	169	1	Arbidol	Arbidol	NNP
cord-029547-9ei1ram3	169	2	also	also	RB
cord-029547-9ei1ram3	169	3	has	have	VBZ
cord-029547-9ei1ram3	169	4	the	the	DT
cord-029547-9ei1ram3	169	5	function	function	NN
cord-029547-9ei1ram3	169	6	of	of	IN
cord-029547-9ei1ram3	169	7	interferon	interferon	NN
cord-029547-9ei1ram3	169	8	(	(	-LRB-
cord-029547-9ei1ram3	169	9	IFN	IFN	NNP
cord-029547-9ei1ram3	169	10	)	)	-RRB-
cord-029547-9ei1ram3	169	11	inducement	inducement	NN
cord-029547-9ei1ram3	169	12	,	,	,
cord-029547-9ei1ram3	169	13	thus	thus	RB
cord-029547-9ei1ram3	169	14	it	-PRON-	PRP
cord-029547-9ei1ram3	169	15	has	have	VBZ
cord-029547-9ei1ram3	169	16	been	be	VBN
cord-029547-9ei1ram3	169	17	widely	widely	RB
cord-029547-9ei1ram3	169	18	used	use	VBN
cord-029547-9ei1ram3	169	19	to	to	TO
cord-029547-9ei1ram3	169	20	treat	treat	VB
cord-029547-9ei1ram3	169	21	A	a	NN
cord-029547-9ei1ram3	169	22	and	and	CC
cord-029547-9ei1ram3	169	23	B	b	NN
cord-029547-9ei1ram3	169	24	influenza	influenza	NN
cord-029547-9ei1ram3	169	25	viruses	virus	NNS
cord-029547-9ei1ram3	169	26	.	.	.
cord-029547-9ei1ram3	170	1	It	-PRON-	PRP
cord-029547-9ei1ram3	170	2	is	be	VBZ
cord-029547-9ei1ram3	170	3	promising	promising	JJ
cord-029547-9ei1ram3	170	4	that	that	IN
cord-029547-9ei1ram3	170	5	several	several	JJ
cord-029547-9ei1ram3	170	6	studies	study	NNS
cord-029547-9ei1ram3	170	7	of	of	IN
cord-029547-9ei1ram3	170	8	arbidol	arbidol	NNP
cord-029547-9ei1ram3	170	9	have	have	VBP
cord-029547-9ei1ram3	170	10	shown	show	VBN
cord-029547-9ei1ram3	170	11	a	a	DT
cord-029547-9ei1ram3	170	12	significant	significant	JJ
cord-029547-9ei1ram3	170	13	therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	170	14	effect	effect	NN
cord-029547-9ei1ram3	170	15	for	for	IN
cord-029547-9ei1ram3	170	16	curing	cure	VBG
cord-029547-9ei1ram3	170	17	COVID-19	COVID-19	JJR
cord-029547-9ei1ram3	170	18	patients	patient	NNS
cord-029547-9ei1ram3	170	19	.	.	.
cord-029547-9ei1ram3	171	1	Wang	Wang	NNP
cord-029547-9ei1ram3	171	2	and	and	CC
cord-029547-9ei1ram3	171	3	colleagues	colleague	NNS
cord-029547-9ei1ram3	171	4	found	find	VBD
cord-029547-9ei1ram3	171	5	arbidol	arbidol	NN
cord-029547-9ei1ram3	171	6	reduced	reduce	VBD
cord-029547-9ei1ram3	171	7	the	the	DT
cord-029547-9ei1ram3	171	8	mortality	mortality	NN
cord-029547-9ei1ram3	171	9	and	and	CC
cord-029547-9ei1ram3	171	10	improved	improve	VBN
cord-029547-9ei1ram3	171	11	discharging	discharge	VBG
cord-029547-9ei1ram3	171	12	rate	rate	NN
cord-029547-9ei1ram3	171	13	by	by	IN
cord-029547-9ei1ram3	171	14	analysis	analysis	NN
cord-029547-9ei1ram3	171	15	of	of	IN
cord-029547-9ei1ram3	171	16	67	67	CD
cord-029547-9ei1ram3	171	17	discharged	discharge	VBN
cord-029547-9ei1ram3	171	18	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	171	19	patients	patient	NNS
cord-029547-9ei1ram3	171	20	.	.	.
cord-029547-9ei1ram3	172	1	69	69	CD
cord-029547-9ei1ram3	173	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	173	2	,	,	,
cord-029547-9ei1ram3	173	3	the	the	DT
cord-029547-9ei1ram3	173	4	other	other	JJ
cord-029547-9ei1ram3	173	5	study	study	NN
cord-029547-9ei1ram3	173	6	compared	compare	VBD
cord-029547-9ei1ram3	173	7	the	the	DT
cord-029547-9ei1ram3	173	8	treatment	treatment	NN
cord-029547-9ei1ram3	173	9	effects	effect	NNS
cord-029547-9ei1ram3	173	10	between	between	IN
cord-029547-9ei1ram3	173	11	combination	combination	NN
cord-029547-9ei1ram3	173	12	of	of	IN
cord-029547-9ei1ram3	173	13	arbidol	arbidol	NN
cord-029547-9ei1ram3	173	14	and	and	CC
cord-029547-9ei1ram3	173	15	lopinavir	lopinavir	NNP
cord-029547-9ei1ram3	173	16	/	/	SYM
cord-029547-9ei1ram3	173	17	ritonavir	ritonavir	NNS
cord-029547-9ei1ram3	173	18	,	,	,
cord-029547-9ei1ram3	173	19	and	and	CC
cord-029547-9ei1ram3	173	20	simple	simple	JJ
cord-029547-9ei1ram3	173	21	lopinavir	lopinavir	NNS
cord-029547-9ei1ram3	173	22	/	/	SYM
cord-029547-9ei1ram3	173	23	ritonavir	ritonavir	NNS
cord-029547-9ei1ram3	173	24	,	,	,
cord-029547-9ei1ram3	173	25	finding	find	VBG
cord-029547-9ei1ram3	173	26	that	that	IN
cord-029547-9ei1ram3	173	27	their	-PRON-	PRP$
cord-029547-9ei1ram3	173	28	CT	CT	NNP
cord-029547-9ei1ram3	173	29	scan	scan	JJ
cord-029547-9ei1ram3	173	30	improvement	improvement	NN
cord-029547-9ei1ram3	173	31	rates	rate	NNS
cord-029547-9ei1ram3	173	32	are	be	VBP
cord-029547-9ei1ram3	173	33	69	69	CD
cord-029547-9ei1ram3	173	34	%	%	NN
cord-029547-9ei1ram3	173	35	and	and	CC
cord-029547-9ei1ram3	173	36	29	29	CD
cord-029547-9ei1ram3	173	37	%	%	NN
cord-029547-9ei1ram3	173	38	,	,	,
cord-029547-9ei1ram3	173	39	and	and	CC
cord-029547-9ei1ram3	173	40	viral	viral	JJ
cord-029547-9ei1ram3	173	41	RNA	RNA	NNP
cord-029547-9ei1ram3	173	42	decrement	decrement	NN
cord-029547-9ei1ram3	173	43	rates	rate	NNS
cord-029547-9ei1ram3	173	44	are	be	VBP
cord-029547-9ei1ram3	173	45	75	75	CD
cord-029547-9ei1ram3	173	46	%	%	NN
cord-029547-9ei1ram3	173	47	and	and	CC
cord-029547-9ei1ram3	173	48	35	35	CD
cord-029547-9ei1ram3	173	49	%	%	NN
cord-029547-9ei1ram3	173	50	,	,	,
cord-029547-9ei1ram3	173	51	respectively	respectively	RB
cord-029547-9ei1ram3	173	52	.	.	.
cord-029547-9ei1ram3	174	1	70	70	CD
cord-029547-9ei1ram3	175	1	Thus	thus	RB
cord-029547-9ei1ram3	175	2	,	,	,
cord-029547-9ei1ram3	175	3	arbidol	arbidol	NN
cord-029547-9ei1ram3	175	4	perhaps	perhaps	RB
cord-029547-9ei1ram3	175	5	serves	serve	VBZ
cord-029547-9ei1ram3	175	6	as	as	IN
cord-029547-9ei1ram3	175	7	a	a	DT
cord-029547-9ei1ram3	175	8	specific	specific	JJ
cord-029547-9ei1ram3	175	9	treatment	treatment	NN
cord-029547-9ei1ram3	175	10	for	for	IN
cord-029547-9ei1ram3	175	11	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	175	12	.	.	.
cord-029547-9ei1ram3	176	1	However	however	RB
cord-029547-9ei1ram3	176	2	,	,	,
cord-029547-9ei1ram3	176	3	another	another	DT
cord-029547-9ei1ram3	176	4	clinical	clinical	JJ
cord-029547-9ei1ram3	176	5	report	report	NN
cord-029547-9ei1ram3	176	6	pointed	point	VBD
cord-029547-9ei1ram3	176	7	out	out	RP
cord-029547-9ei1ram3	176	8	arbidol	arbidol	NN
cord-029547-9ei1ram3	176	9	could	could	MD
cord-029547-9ei1ram3	176	10	not	not	RB
cord-029547-9ei1ram3	176	11	improve	improve	VB
cord-029547-9ei1ram3	176	12	the	the	DT
cord-029547-9ei1ram3	176	13	symptoms	symptom	NNS
cord-029547-9ei1ram3	176	14	or	or	CC
cord-029547-9ei1ram3	176	15	accelerate	accelerate	VB
cord-029547-9ei1ram3	176	16	the	the	DT
cord-029547-9ei1ram3	176	17	clearance	clearance	NN
cord-029547-9ei1ram3	176	18	of	of	IN
cord-029547-9ei1ram3	176	19	SARS	SARS	NNP
cord-029547-9ei1ram3	176	20	-	-	HYPH
cord-029547-9ei1ram3	176	21	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	176	22	.	.	.
cord-029547-9ei1ram3	177	1	71	71	CD
cord-029547-9ei1ram3	178	1	Thus	thus	RB
cord-029547-9ei1ram3	178	2	,	,	,
cord-029547-9ei1ram3	178	3	further	further	JJ
cord-029547-9ei1ram3	178	4	studies	study	NNS
cord-029547-9ei1ram3	178	5	are	be	VBP
cord-029547-9ei1ram3	178	6	needed	need	VBN
cord-029547-9ei1ram3	178	7	to	to	TO
cord-029547-9ei1ram3	178	8	validate	validate	VB
cord-029547-9ei1ram3	178	9	its	-PRON-	PRP$
cord-029547-9ei1ram3	178	10	antiviral	antiviral	JJ
cord-029547-9ei1ram3	178	11	efficiency	efficiency	NN
cord-029547-9ei1ram3	178	12	.	.	.
cord-029547-9ei1ram3	179	1	Camostat	Camostat	NNP
cord-029547-9ei1ram3	179	2	mesylate	mesylate	NNP
cord-029547-9ei1ram3	179	3	is	be	VBZ
cord-029547-9ei1ram3	179	4	a	a	DT
cord-029547-9ei1ram3	179	5	specific	specific	JJ
cord-029547-9ei1ram3	179	6	drug	drug	NN
cord-029547-9ei1ram3	179	7	for	for	IN
cord-029547-9ei1ram3	179	8	inhibiting	inhibit	VBG
cord-029547-9ei1ram3	179	9	TMPRSS2	TMPRSS2	NNP
cord-029547-9ei1ram3	179	10	,	,	,
cord-029547-9ei1ram3	179	11	a	a	DT
cord-029547-9ei1ram3	179	12	protease	protease	NN
cord-029547-9ei1ram3	179	13	used	use	VBN
cord-029547-9ei1ram3	179	14	for	for	IN
cord-029547-9ei1ram3	179	15	S	s	NN
cord-029547-9ei1ram3	179	16	protein	protein	NN
cord-029547-9ei1ram3	179	17	priming	prime	VBG
cord-029547-9ei1ram3	179	18	to	to	TO
cord-029547-9ei1ram3	179	19	promote	promote	VB
cord-029547-9ei1ram3	179	20	the	the	DT
cord-029547-9ei1ram3	179	21	entry	entry	NN
cord-029547-9ei1ram3	179	22	of	of	IN
cord-029547-9ei1ram3	179	23	SARS	SARS	NNP
cord-029547-9ei1ram3	179	24	-	-	HYPH
cord-029547-9ei1ram3	179	25	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	179	26	,	,	,
cord-029547-9ei1ram3	179	27	thus	thus	RB
cord-029547-9ei1ram3	179	28	it	-PRON-	PRP
cord-029547-9ei1ram3	179	29	is	be	VBZ
cord-029547-9ei1ram3	179	30	another	another	DT
cord-029547-9ei1ram3	179	31	potential	potential	JJ
cord-029547-9ei1ram3	179	32	penetration	penetration	NN
cord-029547-9ei1ram3	179	33	inhibitor	inhibitor	NN
cord-029547-9ei1ram3	179	34	.	.	.
cord-029547-9ei1ram3	180	1	23	23	CD
cord-029547-9ei1ram3	181	1	However	however	RB
cord-029547-9ei1ram3	181	2	,	,	,
cord-029547-9ei1ram3	181	3	there	there	EX
cord-029547-9ei1ram3	181	4	is	be	VBZ
cord-029547-9ei1ram3	181	5	still	still	RB
cord-029547-9ei1ram3	181	6	lack	lack	NN
cord-029547-9ei1ram3	181	7	of	of	IN
cord-029547-9ei1ram3	181	8	clinical	clinical	JJ
cord-029547-9ei1ram3	181	9	evidence	evidence	NN
cord-029547-9ei1ram3	181	10	to	to	TO
cord-029547-9ei1ram3	181	11	prove	prove	VB
cord-029547-9ei1ram3	181	12	its	-PRON-	PRP$
cord-029547-9ei1ram3	181	13	effectiveness	effectiveness	NN
cord-029547-9ei1ram3	181	14	.	.	.
cord-029547-9ei1ram3	182	1	The	the	DT
cord-029547-9ei1ram3	182	2	biosynthesis	biosynthesis	NN
cord-029547-9ei1ram3	182	3	inhibitors	inhibitor	NNS
cord-029547-9ei1ram3	182	4	for	for	IN
cord-029547-9ei1ram3	182	5	SARS	SARS	NNP
cord-029547-9ei1ram3	182	6	-	-	HYPH
cord-029547-9ei1ram3	182	7	Cov-2	Cov-2	NNP
cord-029547-9ei1ram3	182	8	chiefly	chiefly	RB
cord-029547-9ei1ram3	182	9	contain	contain	VBP
cord-029547-9ei1ram3	182	10	remdesivir	remdesivir	NNP
cord-029547-9ei1ram3	182	11	,	,	,
cord-029547-9ei1ram3	182	12	sofosbuvir	sofosbuvir	NNP
cord-029547-9ei1ram3	182	13	,	,	,
cord-029547-9ei1ram3	182	14	ribavirin	ribavirin	NN
cord-029547-9ei1ram3	182	15	,	,	,
cord-029547-9ei1ram3	182	16	and	and	CC
cord-029547-9ei1ram3	182	17	lopinavir	lopinavir	NNP
cord-029547-9ei1ram3	182	18	/	/	SYM
cord-029547-9ei1ram3	182	19	ritonavir	ritonavir	NNS
cord-029547-9ei1ram3	182	20	.	.	.
cord-029547-9ei1ram3	183	1	Remdesivir	Remdesivir	NNP
cord-029547-9ei1ram3	183	2	is	be	VBZ
cord-029547-9ei1ram3	183	3	as	as	RB
cord-029547-9ei1ram3	183	4	kind	kind	RB
cord-029547-9ei1ram3	183	5	of	of	RB
cord-029547-9ei1ram3	183	6	broad	broad	JJ
cord-029547-9ei1ram3	183	7	spectrum	spectrum	JJ
cord-029547-9ei1ram3	183	8	antiviral	antiviral	JJ
cord-029547-9ei1ram3	183	9	medicine	medicine	NN
cord-029547-9ei1ram3	183	10	that	that	WDT
cord-029547-9ei1ram3	183	11	suppresses	suppress	VBZ
cord-029547-9ei1ram3	183	12	the	the	DT
cord-029547-9ei1ram3	183	13	virus	virus	NN
cord-029547-9ei1ram3	183	14	replication	replication	NN
cord-029547-9ei1ram3	183	15	through	through	IN
cord-029547-9ei1ram3	183	16	inhibiting	inhibit	VBG
cord-029547-9ei1ram3	183	17	the	the	DT
cord-029547-9ei1ram3	183	18	activity	activity	NN
cord-029547-9ei1ram3	183	19	of	of	IN
cord-029547-9ei1ram3	183	20	RNAdependent	RNAdependent	NNP
cord-029547-9ei1ram3	183	21	RNA	RNA	NNP
cord-029547-9ei1ram3	183	22	polymerase	polymerase	NN
cord-029547-9ei1ram3	183	23	,	,	,
cord-029547-9ei1ram3	183	24	72	72	CD
cord-029547-9ei1ram3	183	25	,	,	,
cord-029547-9ei1ram3	183	26	73	73	CD
cord-029547-9ei1ram3	183	27	and	and	CC
cord-029547-9ei1ram3	183	28	its	-PRON-	PRP$
cord-029547-9ei1ram3	183	29	efficiency	efficiency	NN
cord-029547-9ei1ram3	183	30	has	have	VBZ
cord-029547-9ei1ram3	183	31	been	be	VBN
cord-029547-9ei1ram3	183	32	widely	widely	RB
cord-029547-9ei1ram3	183	33	confirmed	confirm	VBN
cord-029547-9ei1ram3	183	34	in	in	IN
cord-029547-9ei1ram3	183	35	coronaviruses	coronaviruse	NNS
cord-029547-9ei1ram3	183	36	such	such	JJ
cord-029547-9ei1ram3	183	37	as	as	IN
cord-029547-9ei1ram3	183	38	SARS	SARS	NNP
cord-029547-9ei1ram3	183	39	-	-	HYPH
cord-029547-9ei1ram3	183	40	CoV	CoV	NNP
cord-029547-9ei1ram3	183	41	and	and	CC
cord-029547-9ei1ram3	183	42	MERS	MERS	NNP
cord-029547-9ei1ram3	184	1	-CoV.	-cov.	ADD
cord-029547-9ei1ram3	185	1	Recently	recently	RB
cord-029547-9ei1ram3	185	2	,	,	,
cord-029547-9ei1ram3	185	3	remdesivir	remdesivir	NNP
cord-029547-9ei1ram3	185	4	has	have	VBZ
cord-029547-9ei1ram3	185	5	been	be	VBN
cord-029547-9ei1ram3	185	6	found	find	VBN
cord-029547-9ei1ram3	185	7	to	to	TO
cord-029547-9ei1ram3	185	8	be	be	VB
cord-029547-9ei1ram3	185	9	a	a	DT
cord-029547-9ei1ram3	185	10	potential	potential	JJ
cord-029547-9ei1ram3	185	11	drug	drug	NN
cord-029547-9ei1ram3	185	12	to	to	TO
cord-029547-9ei1ram3	185	13	treat	treat	VB
cord-029547-9ei1ram3	185	14	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	185	15	.	.	.
cord-029547-9ei1ram3	186	1	A	a	DT
cord-029547-9ei1ram3	186	2	previous	previous	JJ
cord-029547-9ei1ram3	186	3	study	study	NN
cord-029547-9ei1ram3	186	4	showed	show	VBD
cord-029547-9ei1ram3	186	5	that	that	IN
cord-029547-9ei1ram3	186	6	half	half	RB
cord-029547-9ei1ram3	186	7	-	-	HYPH
cord-029547-9ei1ram3	186	8	maximal	maximal	JJ
cord-029547-9ei1ram3	186	9	effective	effective	JJ
cord-029547-9ei1ram3	186	10	concentration	concentration	NN
cord-029547-9ei1ram3	186	11	of	of	IN
cord-029547-9ei1ram3	186	12	remdesivir	remdesivir	NNP
cord-029547-9ei1ram3	186	13	was	be	VBD
cord-029547-9ei1ram3	186	14	0.77	0.77	CD
cord-029547-9ei1ram3	186	15	in	in	IN
cord-029547-9ei1ram3	186	16	an	an	DT
cord-029547-9ei1ram3	186	17	in	in	FW
cord-029547-9ei1ram3	186	18	vitro	vitro	FW
cord-029547-9ei1ram3	186	19	test	test	NN
cord-029547-9ei1ram3	186	20	treating	treat	VBG
cord-029547-9ei1ram3	186	21	COVID-19	COVID-19	VBD
cord-029547-9ei1ram3	186	22	with	with	IN
cord-029547-9ei1ram3	186	23	a	a	DT
cord-029547-9ei1ram3	186	24	high	high	JJ
cord-029547-9ei1ram3	186	25	selectivity	selectivity	NN
cord-029547-9ei1ram3	186	26	index	index	NN
cord-029547-9ei1ram3	186	27	,	,	,
cord-029547-9ei1ram3	186	28	demonstrating	demonstrate	VBG
cord-029547-9ei1ram3	186	29	its	-PRON-	PRP$
cord-029547-9ei1ram3	186	30	therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	186	31	effect	effect	NN
cord-029547-9ei1ram3	186	32	.	.	.
cord-029547-9ei1ram3	187	1	64	64	CD
cord-029547-9ei1ram3	188	1	There	there	RB
cord-029547-9ei1ram3	188	2	,	,	,
cord-029547-9ei1ram3	188	3	the	the	DT
cord-029547-9ei1ram3	188	4	first	first	JJ
cord-029547-9ei1ram3	188	5	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	188	6	case	case	NN
cord-029547-9ei1ram3	188	7	of	of	IN
cord-029547-9ei1ram3	188	8	America	America	NNP
cord-029547-9ei1ram3	188	9	was	be	VBD
cord-029547-9ei1ram3	188	10	reported	report	VBN
cord-029547-9ei1ram3	188	11	to	to	TO
cord-029547-9ei1ram3	188	12	be	be	VB
cord-029547-9ei1ram3	188	13	cured	cure	VBN
cord-029547-9ei1ram3	188	14	completely	completely	RB
cord-029547-9ei1ram3	188	15	after	after	IN
cord-029547-9ei1ram3	188	16	intravenous	intravenous	JJ
cord-029547-9ei1ram3	188	17	injection	injection	NN
cord-029547-9ei1ram3	188	18	of	of	IN
cord-029547-9ei1ram3	188	19	remdesivir	remdesivir	NNP
cord-029547-9ei1ram3	188	20	,	,	,
cord-029547-9ei1ram3	188	21	74	74	CD
cord-029547-9ei1ram3	188	22	and	and	CC
cord-029547-9ei1ram3	188	23	clinical	clinical	JJ
cord-029547-9ei1ram3	188	24	data	datum	NNS
cord-029547-9ei1ram3	188	25	showed	show	VBD
cord-029547-9ei1ram3	188	26	that	that	IN
cord-029547-9ei1ram3	188	27	remdesivir	remdesivir	NNP
cord-029547-9ei1ram3	188	28	dramatically	dramatically	RB
cord-029547-9ei1ram3	188	29	alleviated	alleviate	VBD
cord-029547-9ei1ram3	188	30	clinical	clinical	JJ
cord-029547-9ei1ram3	188	31	symptoms	symptom	NNS
cord-029547-9ei1ram3	188	32	and	and	CC
cord-029547-9ei1ram3	188	33	reduced	reduce	VBN
cord-029547-9ei1ram3	188	34	mortality	mortality	NN
cord-029547-9ei1ram3	188	35	for	for	IN
cord-029547-9ei1ram3	188	36	severe	severe	JJ
cord-029547-9ei1ram3	188	37	patients	patient	NNS
cord-029547-9ei1ram3	188	38	,	,	,
cord-029547-9ei1ram3	188	39	75	75	CD
cord-029547-9ei1ram3	188	40	which	which	WDT
cord-029547-9ei1ram3	188	41	demonstrated	demonstrate	VBD
cord-029547-9ei1ram3	188	42	it	-PRON-	PRP
cord-029547-9ei1ram3	188	43	is	be	VBZ
cord-029547-9ei1ram3	188	44	a	a	DT
cord-029547-9ei1ram3	188	45	potential	potential	JJ
cord-029547-9ei1ram3	188	46	drug	drug	NN
cord-029547-9ei1ram3	188	47	for	for	IN
cord-029547-9ei1ram3	188	48	treating	treat	VBG
cord-029547-9ei1ram3	188	49	novel	novel	JJ
cord-029547-9ei1ram3	188	50	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	188	51	.	.	.
cord-029547-9ei1ram3	189	1	However	however	RB
cord-029547-9ei1ram3	189	2	,	,	,
cord-029547-9ei1ram3	189	3	a	a	DT
cord-029547-9ei1ram3	189	4	patient	patient	NN
cord-029547-9ei1ram3	189	5	died	die	VBD
cord-029547-9ei1ram3	189	6	of	of	IN
cord-029547-9ei1ram3	189	7	hypotension	hypotension	NN
cord-029547-9ei1ram3	189	8	and	and	CC
cord-029547-9ei1ram3	189	9	cardiac	cardiac	JJ
cord-029547-9ei1ram3	189	10	arrest	arrest	NN
cord-029547-9ei1ram3	189	11	after	after	IN
cord-029547-9ei1ram3	189	12	remdesivir	remdesivir	NNP
cord-029547-9ei1ram3	189	13	treatment	treatment	NN
cord-029547-9ei1ram3	189	14	in	in	IN
cord-029547-9ei1ram3	189	15	a	a	DT
cord-029547-9ei1ram3	189	16	randomized	randomized	JJ
cord-029547-9ei1ram3	189	17	controlled	control	VBN
cord-029547-9ei1ram3	189	18	trial	trial	NN
cord-029547-9ei1ram3	189	19	of	of	IN
cord-029547-9ei1ram3	189	20	Ebola	Ebola	NNP
cord-029547-9ei1ram3	189	21	virus	virus	NN
cord-029547-9ei1ram3	189	22	(	(	-LRB-
cord-029547-9ei1ram3	189	23	EBOV	EBOV	NNP
cord-029547-9ei1ram3	189	24	)	)	-RRB-
cord-029547-9ei1ram3	189	25	treatment	treatment	NN
cord-029547-9ei1ram3	189	26	,	,	,
cord-029547-9ei1ram3	189	27	76	76	CD
cord-029547-9ei1ram3	189	28	and	and	CC
cord-029547-9ei1ram3	189	29	60	60	CD
cord-029547-9ei1ram3	189	30	%	%	NN
cord-029547-9ei1ram3	189	31	COVID-19	covid-19	CD
cord-029547-9ei1ram3	189	32	patients	patient	NNS
cord-029547-9ei1ram3	189	33	had	have	VBD
cord-029547-9ei1ram3	189	34	side	side	NN
cord-029547-9ei1ram3	189	35	effects	effect	NNS
cord-029547-9ei1ram3	189	36	after	after	IN
cord-029547-9ei1ram3	189	37	using	use	VBG
cord-029547-9ei1ram3	189	38	remdesivir	remdesivir	NNP
cord-029547-9ei1ram3	189	39	,	,	,
cord-029547-9ei1ram3	189	40	75	75	CD
cord-029547-9ei1ram3	189	41	which	which	WDT
cord-029547-9ei1ram3	189	42	indicated	indicate	VBD
cord-029547-9ei1ram3	189	43	its	-PRON-	PRP$
cord-029547-9ei1ram3	189	44	security	security	NN
cord-029547-9ei1ram3	189	45	is	be	VBZ
cord-029547-9ei1ram3	189	46	worthy	worthy	JJ
cord-029547-9ei1ram3	189	47	of	of	IN
cord-029547-9ei1ram3	189	48	further	further	JJ
cord-029547-9ei1ram3	189	49	confirmation	confirmation	NN
cord-029547-9ei1ram3	189	50	.	.	.
cord-029547-9ei1ram3	190	1	Up	up	IN
cord-029547-9ei1ram3	190	2	to	to	IN
cord-029547-9ei1ram3	190	3	now	now	RB
cord-029547-9ei1ram3	190	4	,	,	,
cord-029547-9ei1ram3	190	5	several	several	JJ
cord-029547-9ei1ram3	190	6	agencies	agency	NNS
cord-029547-9ei1ram3	190	7	have	have	VBP
cord-029547-9ei1ram3	190	8	published	publish	VBN
cord-029547-9ei1ram3	190	9	conflicting	conflict	VBG
cord-029547-9ei1ram3	190	10	clinical	clinical	JJ
cord-029547-9ei1ram3	190	11	results	result	NNS
cord-029547-9ei1ram3	190	12	from	from	IN
cord-029547-9ei1ram3	190	13	remdesivir	remdesivir	NNP
cord-029547-9ei1ram3	190	14	.	.	.
cord-029547-9ei1ram3	191	1	77	77	CD
cord-029547-9ei1ram3	191	2	,	,	,
cord-029547-9ei1ram3	191	3	78	78	CD
cord-029547-9ei1ram3	192	1	Thus	thus	RB
cord-029547-9ei1ram3	192	2	,	,	,
cord-029547-9ei1ram3	192	3	more	more	JJR
cord-029547-9ei1ram3	192	4	research	research	NN
cord-029547-9ei1ram3	192	5	should	should	MD
cord-029547-9ei1ram3	192	6	be	be	VB
cord-029547-9ei1ram3	192	7	conducted	conduct	VBN
cord-029547-9ei1ram3	192	8	to	to	TO
cord-029547-9ei1ram3	192	9	verify	verify	VB
cord-029547-9ei1ram3	192	10	its	-PRON-	PRP$
cord-029547-9ei1ram3	192	11	curative	curative	JJ
cord-029547-9ei1ram3	192	12	efficacy	efficacy	NN
cord-029547-9ei1ram3	192	13	.	.	.
cord-029547-9ei1ram3	193	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	193	2	,	,	,
cord-029547-9ei1ram3	193	3	in	in	IN
cord-029547-9ei1ram3	193	4	vitro	vitro	FW
cord-029547-9ei1ram3	193	5	tests	test	NNS
cord-029547-9ei1ram3	193	6	showed	show	VBD
cord-029547-9ei1ram3	193	7	that	that	IN
cord-029547-9ei1ram3	193	8	other	other	JJ
cord-029547-9ei1ram3	193	9	broad	broad	JJ
cord-029547-9ei1ram3	193	10	-	-	HYPH
cord-029547-9ei1ram3	193	11	spectrum	spectrum	NN
cord-029547-9ei1ram3	193	12	antiviral	antiviral	JJ
cord-029547-9ei1ram3	193	13	medicines	medicine	NNS
cord-029547-9ei1ram3	193	14	such	such	JJ
cord-029547-9ei1ram3	193	15	as	as	IN
cord-029547-9ei1ram3	193	16	sofosbuvir	sofosbuvir	NNP
cord-029547-9ei1ram3	193	17	and	and	CC
cord-029547-9ei1ram3	193	18	ribavirin	ribavirin	NN
cord-029547-9ei1ram3	193	19	interacted	interact	VBD
cord-029547-9ei1ram3	193	20	with	with	IN
cord-029547-9ei1ram3	193	21	RNA	RNA	NNP
cord-029547-9ei1ram3	193	22	-	-	HYPH
cord-029547-9ei1ram3	193	23	dependent	dependent	JJ
cord-029547-9ei1ram3	193	24	RNA	RNA	NNP
cord-029547-9ei1ram3	193	25	polymerase	polymerase	NN
cord-029547-9ei1ram3	193	26	of	of	IN
cord-029547-9ei1ram3	193	27	SARS	SARS	NNP
cord-029547-9ei1ram3	193	28	-	-	HYPH
cord-029547-9ei1ram3	193	29	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	193	30	,	,	,
cord-029547-9ei1ram3	193	31	which	which	WDT
cord-029547-9ei1ram3	193	32	prevents	prevent	VBZ
cord-029547-9ei1ram3	193	33	the	the	DT
cord-029547-9ei1ram3	193	34	replication	replication	NN
cord-029547-9ei1ram3	193	35	of	of	IN
cord-029547-9ei1ram3	193	36	virus	virus	NN
cord-029547-9ei1ram3	193	37	,	,	,
cord-029547-9ei1ram3	193	38	thus	thus	RB
cord-029547-9ei1ram3	193	39	they	-PRON-	PRP
cord-029547-9ei1ram3	193	40	can	can	MD
cord-029547-9ei1ram3	193	41	also	also	RB
cord-029547-9ei1ram3	193	42	serve	serve	VB
cord-029547-9ei1ram3	193	43	as	as	IN
cord-029547-9ei1ram3	193	44	antiviral	antiviral	JJ
cord-029547-9ei1ram3	193	45	drugs	drug	NNS
cord-029547-9ei1ram3	193	46	for	for	IN
cord-029547-9ei1ram3	193	47	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	193	48	.	.	.
cord-029547-9ei1ram3	194	1	79	79	CD
cord-029547-9ei1ram3	194	2	Lopinavir	Lopinavir	NNP
cord-029547-9ei1ram3	194	3	and	and	CC
cord-029547-9ei1ram3	194	4	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	194	5	are	be	VBP
cord-029547-9ei1ram3	194	6	suppressors	suppressor	NNS
cord-029547-9ei1ram3	194	7	of	of	IN
cord-029547-9ei1ram3	194	8	3-chymotrypsin	3-chymotrypsin	CD
cord-029547-9ei1ram3	194	9	-	-	HYPH
cord-029547-9ei1ram3	194	10	like	like	JJ
cord-029547-9ei1ram3	194	11	protease	protease	NN
cord-029547-9ei1ram3	194	12	,	,	,
cord-029547-9ei1ram3	194	13	a	a	DT
cord-029547-9ei1ram3	194	14	protease	protease	NN
cord-029547-9ei1ram3	194	15	of	of	IN
cord-029547-9ei1ram3	194	16	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	194	17	.	.	.
cord-029547-9ei1ram3	195	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	195	2	,	,	,
cord-029547-9ei1ram3	195	3	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	195	4	suppresses	suppress	VBZ
cord-029547-9ei1ram3	195	5	the	the	DT
cord-029547-9ei1ram3	195	6	activity	activity	NN
cord-029547-9ei1ram3	195	7	of	of	IN
cord-029547-9ei1ram3	195	8	cytochrome	cytochrome	NN
cord-029547-9ei1ram3	195	9	P450	p450	JJ
cord-029547-9ei1ram3	195	10	isoenzymes	isoenzyme	NNS
cord-029547-9ei1ram3	195	11	and	and	CC
cord-029547-9ei1ram3	195	12	thus	thus	RB
cord-029547-9ei1ram3	195	13	elevates	elevate	VBZ
cord-029547-9ei1ram3	195	14	plasma	plasma	NN
cord-029547-9ei1ram3	195	15	concentration	concentration	NN
cord-029547-9ei1ram3	195	16	of	of	IN
cord-029547-9ei1ram3	195	17	other	other	JJ
cord-029547-9ei1ram3	195	18	medicines	medicine	NNS
cord-029547-9ei1ram3	195	19	.	.	.
cord-029547-9ei1ram3	196	1	Therefore	therefore	RB
cord-029547-9ei1ram3	196	2	,	,	,
cord-029547-9ei1ram3	196	3	combining	combine	VBG
cord-029547-9ei1ram3	196	4	lopinavir	lopinavir	NNS
cord-029547-9ei1ram3	196	5	and	and	CC
cord-029547-9ei1ram3	196	6	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	196	7	has	have	VBZ
cord-029547-9ei1ram3	196	8	a	a	DT
cord-029547-9ei1ram3	196	9	good	good	JJ
cord-029547-9ei1ram3	196	10	inhibitory	inhibitory	JJ
cord-029547-9ei1ram3	196	11	effect	effect	NN
cord-029547-9ei1ram3	196	12	on	on	IN
cord-029547-9ei1ram3	196	13	virus	virus	NN
cord-029547-9ei1ram3	196	14	biosynthesis	biosynthesis	NN
cord-029547-9ei1ram3	196	15	,	,	,
cord-029547-9ei1ram3	196	16	which	which	WDT
cord-029547-9ei1ram3	196	17	was	be	VBD
cord-029547-9ei1ram3	196	18	confirmed	confirm	VBN
cord-029547-9ei1ram3	196	19	in	in	IN
cord-029547-9ei1ram3	196	20	the	the	DT
cord-029547-9ei1ram3	196	21	treatment	treatment	NN
cord-029547-9ei1ram3	196	22	of	of	IN
cord-029547-9ei1ram3	196	23	SARS	SARS	NNP
cord-029547-9ei1ram3	196	24	-	-	HYPH
cord-029547-9ei1ram3	196	25	CoV	CoV	NNP
cord-029547-9ei1ram3	196	26	and	and	CC
cord-029547-9ei1ram3	196	27	MERS	MERS	NNP
cord-029547-9ei1ram3	196	28	-	-	HYPH
cord-029547-9ei1ram3	196	29	CoV.	CoV.	NNP
cord-029547-9ei1ram3	196	30	80	80	CD
cord-029547-9ei1ram3	197	1	Recently	recently	RB
cord-029547-9ei1ram3	197	2	,	,	,
cord-029547-9ei1ram3	197	3	many	many	JJ
cord-029547-9ei1ram3	197	4	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	197	5	patients	patient	NNS
cord-029547-9ei1ram3	197	6	have	have	VBP
cord-029547-9ei1ram3	197	7	received	receive	VBN
cord-029547-9ei1ram3	197	8	lopinavir	lopinavir	NNS
cord-029547-9ei1ram3	197	9	/	/	SYM
cord-029547-9ei1ram3	197	10	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	197	11	therapy	therapy	NN
cord-029547-9ei1ram3	197	12	and	and	CC
cord-029547-9ei1ram3	197	13	to	to	IN
cord-029547-9ei1ram3	197	14	good	good	JJ
cord-029547-9ei1ram3	197	15	effect	effect	NN
cord-029547-9ei1ram3	197	16	.	.	.
cord-029547-9ei1ram3	198	1	81	81	CD
cord-029547-9ei1ram3	199	1	Moreover	moreover	RB
cord-029547-9ei1ram3	199	2	,	,	,
cord-029547-9ei1ram3	199	3	the	the	DT
cord-029547-9ei1ram3	199	4	first	first	JJ
cord-029547-9ei1ram3	199	5	report	report	NN
cord-029547-9ei1ram3	199	6	of	of	IN
cord-029547-9ei1ram3	199	7	the	the	DT
cord-029547-9ei1ram3	199	8	lopinavir	lopinavir	NNPS
cord-029547-9ei1ram3	199	9	/	/	SYM
cord-029547-9ei1ram3	199	10	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	199	11	clinical	clinical	JJ
cord-029547-9ei1ram3	199	12	trial	trial	NN
cord-029547-9ei1ram3	199	13	results	result	NNS
cord-029547-9ei1ram3	199	14	have	have	VBP
cord-029547-9ei1ram3	199	15	been	be	VBN
cord-029547-9ei1ram3	199	16	published	publish	VBN
cord-029547-9ei1ram3	199	17	on	on	IN
cord-029547-9ei1ram3	199	18	19	19	CD
cord-029547-9ei1ram3	199	19	March	March	NNP
cord-029547-9ei1ram3	199	20	2020	2020	CD
cord-029547-9ei1ram3	199	21	.	.	.
cord-029547-9ei1ram3	200	1	In	in	IN
cord-029547-9ei1ram3	200	2	that	that	DT
cord-029547-9ei1ram3	200	3	study	study	NN
cord-029547-9ei1ram3	200	4	,	,	,
cord-029547-9ei1ram3	200	5	99	99	CD
cord-029547-9ei1ram3	200	6	patients	patient	NNS
cord-029547-9ei1ram3	200	7	were	be	VBD
cord-029547-9ei1ram3	200	8	assigned	assign	VBN
cord-029547-9ei1ram3	200	9	to	to	IN
cord-029547-9ei1ram3	200	10	the	the	DT
cord-029547-9ei1ram3	200	11	lopinavir	lopinavir	NNS
cord-029547-9ei1ram3	200	12	/	/	SYM
cord-029547-9ei1ram3	200	13	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	200	14	group	group	NNP
cord-029547-9ei1ram3	200	15	and	and	CC
cord-029547-9ei1ram3	200	16	100	100	CD
cord-029547-9ei1ram3	200	17	patients	patient	NNS
cord-029547-9ei1ram3	200	18	were	be	VBD
cord-029547-9ei1ram3	200	19	treated	treat	VBN
cord-029547-9ei1ram3	200	20	with	with	IN
cord-029547-9ei1ram3	200	21	the	the	DT
cord-029547-9ei1ram3	200	22	routine	routine	JJ
cord-029547-9ei1ram3	200	23	therapy	therapy	NN
cord-029547-9ei1ram3	200	24	,	,	,
cord-029547-9ei1ram3	200	25	and	and	CC
cord-029547-9ei1ram3	200	26	the	the	DT
cord-029547-9ei1ram3	200	27	median	median	JJ
cord-029547-9ei1ram3	200	28	time	time	NN
cord-029547-9ei1ram3	200	29	of	of	IN
cord-029547-9ei1ram3	200	30	clinical	clinical	JJ
cord-029547-9ei1ram3	200	31	improvement	improvement	NN
cord-029547-9ei1ram3	200	32	was	be	VBD
cord-029547-9ei1ram3	200	33	advanced	advance	VBN
cord-029547-9ei1ram3	200	34	by	by	IN
cord-029547-9ei1ram3	200	35	1	1	CD
cord-029547-9ei1ram3	200	36	day	day	NN
cord-029547-9ei1ram3	200	37	when	when	WRB
cord-029547-9ei1ram3	200	38	given	give	VBN
cord-029547-9ei1ram3	200	39	the	the	DT
cord-029547-9ei1ram3	200	40	lopinavir	lopinavir	NNS
cord-029547-9ei1ram3	200	41	/	/	SYM
cord-029547-9ei1ram3	200	42	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	200	43	treatment	treatment	NN
cord-029547-9ei1ram3	200	44	.	.	.
cord-029547-9ei1ram3	201	1	82	82	CD
cord-029547-9ei1ram3	202	1	But	but	CC
cord-029547-9ei1ram3	202	2	it	-PRON-	PRP
cord-029547-9ei1ram3	202	3	failed	fail	VBD
cord-029547-9ei1ram3	202	4	to	to	TO
cord-029547-9ei1ram3	202	5	accelerate	accelerate	VB
cord-029547-9ei1ram3	202	6	clinical	clinical	JJ
cord-029547-9ei1ram3	202	7	improvement	improvement	NN
cord-029547-9ei1ram3	202	8	significantly	significantly	RB
cord-029547-9ei1ram3	202	9	,	,	,
cord-029547-9ei1ram3	202	10	and	and	CC
cord-029547-9ei1ram3	202	11	reduce	reduce	VB
cord-029547-9ei1ram3	202	12	mortality	mortality	NN
cord-029547-9ei1ram3	202	13	and	and	CC
cord-029547-9ei1ram3	202	14	viral	viral	JJ
cord-029547-9ei1ram3	202	15	RNA	RNA	NNP
cord-029547-9ei1ram3	202	16	detected	detect	VBN
cord-029547-9ei1ram3	202	17	in	in	IN
cord-029547-9ei1ram3	202	18	the	the	DT
cord-029547-9ei1ram3	202	19	throat	throat	NN
cord-029547-9ei1ram3	202	20	.	.	.
cord-029547-9ei1ram3	203	1	82	82	CD
cord-029547-9ei1ram3	204	1	Similarly	similarly	RB
cord-029547-9ei1ram3	204	2	,	,	,
cord-029547-9ei1ram3	204	3	the	the	DT
cord-029547-9ei1ram3	204	4	clinical	clinical	JJ
cord-029547-9ei1ram3	204	5	trial	trial	NN
cord-029547-9ei1ram3	204	6	in	in	IN
cord-029547-9ei1ram3	204	7	severe	severe	JJ
cord-029547-9ei1ram3	204	8	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	204	9	patients	patient	NNS
cord-029547-9ei1ram3	204	10	indicated	indicate	VBD
cord-029547-9ei1ram3	204	11	lopinavir	lopinavir	NNP
cord-029547-9ei1ram3	204	12	/	/	SYM
cord-029547-9ei1ram3	204	13	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	204	14	was	be	VBD
cord-029547-9ei1ram3	204	15	of	of	IN
cord-029547-9ei1ram3	204	16	no	no	DT
cord-029547-9ei1ram3	204	17	benefit	benefit	NN
cord-029547-9ei1ram3	204	18	compared	compare	VBN
cord-029547-9ei1ram3	204	19	to	to	IN
cord-029547-9ei1ram3	204	20	standard	standard	JJ
cord-029547-9ei1ram3	204	21	care	care	NN
cord-029547-9ei1ram3	204	22	.	.	.
cord-029547-9ei1ram3	205	1	83	83	CD
cord-029547-9ei1ram3	206	1	Therefore	therefore	RB
cord-029547-9ei1ram3	206	2	,	,	,
cord-029547-9ei1ram3	206	3	further	further	JJ
cord-029547-9ei1ram3	206	4	studies	study	NNS
cord-029547-9ei1ram3	206	5	are	be	VBP
cord-029547-9ei1ram3	206	6	needed	need	VBN
cord-029547-9ei1ram3	206	7	to	to	TO
cord-029547-9ei1ram3	206	8	identify	identify	VB
cord-029547-9ei1ram3	206	9	or	or	CC
cord-029547-9ei1ram3	206	10	exclude	exclude	VB
cord-029547-9ei1ram3	206	11	the	the	DT
cord-029547-9ei1ram3	206	12	possible	possible	JJ
cord-029547-9ei1ram3	206	13	benefits	benefit	NNS
cord-029547-9ei1ram3	206	14	of	of	IN
cord-029547-9ei1ram3	206	15	lopinavir	lopinavir	NNS
cord-029547-9ei1ram3	206	16	/	/	SYM
cord-029547-9ei1ram3	206	17	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	206	18	-	-	HYPH
cord-029547-9ei1ram3	206	19	based	base	VBN
cord-029547-9ei1ram3	206	20	therapies	therapy	NNS
cord-029547-9ei1ram3	206	21	.	.	.
cord-029547-9ei1ram3	207	1	The	the	DT
cord-029547-9ei1ram3	207	2	most	most	RBS
cord-029547-9ei1ram3	207	3	common	common	JJ
cord-029547-9ei1ram3	207	4	antiviral	antiviral	JJ
cord-029547-9ei1ram3	207	5	products	product	NNS
cord-029547-9ei1ram3	207	6	are	be	VBP
cord-029547-9ei1ram3	207	7	IFNs	ifn	NNS
cord-029547-9ei1ram3	207	8	,	,	,
cord-029547-9ei1ram3	207	9	which	which	WDT
cord-029547-9ei1ram3	207	10	induce	induce	VBP
cord-029547-9ei1ram3	207	11	cells	cell	NNS
cord-029547-9ei1ram3	207	12	to	to	TO
cord-029547-9ei1ram3	207	13	synthesize	synthesize	VB
cord-029547-9ei1ram3	207	14	antiviral	antiviral	JJ
cord-029547-9ei1ram3	207	15	proteins	protein	NNS
cord-029547-9ei1ram3	207	16	and	and	CC
cord-029547-9ei1ram3	207	17	thus	thus	RB
cord-029547-9ei1ram3	207	18	inhibit	inhibit	VB
cord-029547-9ei1ram3	207	19	all	all	DT
cord-029547-9ei1ram3	207	20	processes	process	NNS
cord-029547-9ei1ram3	207	21	of	of	IN
cord-029547-9ei1ram3	207	22	the	the	DT
cord-029547-9ei1ram3	207	23	viral	viral	JJ
cord-029547-9ei1ram3	207	24	replication	replication	NN
cord-029547-9ei1ram3	207	25	cycle	cycle	NN
cord-029547-9ei1ram3	207	26	.	.	.
cord-029547-9ei1ram3	208	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	208	2	,	,	,
cord-029547-9ei1ram3	208	3	it	-PRON-	PRP
cord-029547-9ei1ram3	208	4	could	could	MD
cord-029547-9ei1ram3	208	5	also	also	RB
cord-029547-9ei1ram3	208	6	enhance	enhance	VB
cord-029547-9ei1ram3	208	7	immunity	immunity	NN
cord-029547-9ei1ram3	208	8	of	of	IN
cord-029547-9ei1ram3	208	9	patients	patient	NNS
cord-029547-9ei1ram3	208	10	,	,	,
cord-029547-9ei1ram3	208	11	so	so	CC
cord-029547-9ei1ram3	208	12	it	-PRON-	PRP
cord-029547-9ei1ram3	208	13	is	be	VBZ
cord-029547-9ei1ram3	208	14	widely	widely	RB
cord-029547-9ei1ram3	208	15	used	use	VBN
cord-029547-9ei1ram3	208	16	for	for	IN
cord-029547-9ei1ram3	208	17	therapy	therapy	NN
cord-029547-9ei1ram3	208	18	for	for	IN
cord-029547-9ei1ram3	208	19	multiple	multiple	JJ
cord-029547-9ei1ram3	208	20	viruses	virus	NNS
cord-029547-9ei1ram3	208	21	such	such	JJ
cord-029547-9ei1ram3	208	22	as	as	IN
cord-029547-9ei1ram3	208	23	MERS-	MERS-	NNP
cord-029547-9ei1ram3	209	1	CoV.	CoV.	NNP
cord-029547-9ei1ram3	209	2	84	84	CD
cord-029547-9ei1ram3	210	1	In	in	IN
cord-029547-9ei1ram3	210	2	this	this	DT
cord-029547-9ei1ram3	210	3	outbreak	outbreak	NN
cord-029547-9ei1ram3	210	4	,	,	,
cord-029547-9ei1ram3	210	5	IFNs	ifn	NNS
cord-029547-9ei1ram3	210	6	combined	combine	VBN
cord-029547-9ei1ram3	210	7	with	with	IN
cord-029547-9ei1ram3	210	8	antiviral	antiviral	JJ
cord-029547-9ei1ram3	210	9	drugs	drug	NNS
cord-029547-9ei1ram3	210	10	were	be	VBD
cord-029547-9ei1ram3	210	11	recommended	recommend	VBN
cord-029547-9ei1ram3	210	12	to	to	TO
cord-029547-9ei1ram3	210	13	treat	treat	VB
cord-029547-9ei1ram3	210	14	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	210	15	,	,	,
cord-029547-9ei1ram3	210	16	85	85	CD
cord-029547-9ei1ram3	210	17	which	which	WDT
cord-029547-9ei1ram3	210	18	has	have	VBZ
cord-029547-9ei1ram3	210	19	achieved	achieve	VBN
cord-029547-9ei1ram3	210	20	good	good	JJ
cord-029547-9ei1ram3	210	21	clinical	clinical	JJ
cord-029547-9ei1ram3	210	22	therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	210	23	effect	effect	NN
cord-029547-9ei1ram3	210	24	.	.	.
cord-029547-9ei1ram3	211	1	Xu	Xu	NNP
cord-029547-9ei1ram3	211	2	et	et	NNP
cord-029547-9ei1ram3	211	3	al	al	NNP
cord-029547-9ei1ram3	211	4	.	.	NNP
cord-029547-9ei1ram3	211	5	reported	report	VBD
cord-029547-9ei1ram3	211	6	that	that	IN
cord-029547-9ei1ram3	211	7	the	the	DT
cord-029547-9ei1ram3	211	8	combination	combination	NN
cord-029547-9ei1ram3	211	9	of	of	IN
cord-029547-9ei1ram3	211	10	IFNs	ifn	NNS
cord-029547-9ei1ram3	211	11	and	and	CC
cord-029547-9ei1ram3	211	12	arbidol	arbidol	NN
cord-029547-9ei1ram3	211	13	or	or	CC
cord-029547-9ei1ram3	211	14	lopinavir	lopinavir	NNP
cord-029547-9ei1ram3	211	15	/	/	SYM
cord-029547-9ei1ram3	211	16	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	211	17	cured	cure	VBD
cord-029547-9ei1ram3	211	18	62	62	CD
cord-029547-9ei1ram3	211	19	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	211	20	patients	patient	NNS
cord-029547-9ei1ram3	211	21	in	in	IN
cord-029547-9ei1ram3	211	22	the	the	DT
cord-029547-9ei1ram3	211	23	Zhejiang	Zhejiang	NNP
cord-029547-9ei1ram3	211	24	province	province	NN
cord-029547-9ei1ram3	211	25	.	.	.
cord-029547-9ei1ram3	212	1	50	50	CD
cord-029547-9ei1ram3	213	1	In	in	IN
cord-029547-9ei1ram3	213	2	addition	addition	NN
cord-029547-9ei1ram3	213	3	,	,	,
cord-029547-9ei1ram3	213	4	a	a	DT
cord-029547-9ei1ram3	213	5	combination	combination	NN
cord-029547-9ei1ram3	213	6	use	use	NN
cord-029547-9ei1ram3	213	7	of	of	IN
cord-029547-9ei1ram3	213	8	IFN	IFN	NNP
cord-029547-9ei1ram3	213	9	beta-1b	beta-1b	NNP
cord-029547-9ei1ram3	213	10	,	,	,
cord-029547-9ei1ram3	213	11	ribavirin	ribavirin	RB
cord-029547-9ei1ram3	213	12	,	,	,
cord-029547-9ei1ram3	213	13	and	and	CC
cord-029547-9ei1ram3	213	14	lopinavir	lopinavir	NNS
cord-029547-9ei1ram3	213	15	-	-	HYPH
cord-029547-9ei1ram3	213	16	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	213	17	was	be	VBD
cord-029547-9ei1ram3	213	18	found	find	VBN
cord-029547-9ei1ram3	213	19	to	to	TO
cord-029547-9ei1ram3	213	20	be	be	VB
cord-029547-9ei1ram3	213	21	more	more	RBR
cord-029547-9ei1ram3	213	22	effective	effective	JJ
cord-029547-9ei1ram3	213	23	than	than	IN
cord-029547-9ei1ram3	213	24	pure	pure	JJ
cord-029547-9ei1ram3	213	25	lopinavir	lopinavir	NNS
cord-029547-9ei1ram3	213	26	-	-	HYPH
cord-029547-9ei1ram3	213	27	ritonavir	ritonavir	NNS
cord-029547-9ei1ram3	213	28	.	.	.
cord-029547-9ei1ram3	214	1	86	86	CD
cord-029547-9ei1ram3	215	1	These	these	DT
cord-029547-9ei1ram3	215	2	therapies	therapy	NNS
cord-029547-9ei1ram3	215	3	have	have	VBP
cord-029547-9ei1ram3	215	4	been	be	VBN
cord-029547-9ei1ram3	215	5	initiated	initiate	VBN
cord-029547-9ei1ram3	215	6	into	into	IN
cord-029547-9ei1ram3	215	7	multiple	multiple	JJ
cord-029547-9ei1ram3	215	8	clinical	clinical	JJ
cord-029547-9ei1ram3	215	9	trials	trial	NNS
cord-029547-9ei1ram3	215	10	.	.	.
cord-029547-9ei1ram3	216	1	Convalescent	convalescent	JJ
cord-029547-9ei1ram3	216	2	plasma	plasma	NN
cord-029547-9ei1ram3	216	3	therapy	therapy	NN
cord-029547-9ei1ram3	216	4	(	(	-LRB-
cord-029547-9ei1ram3	216	5	CPT	CPT	NNP
cord-029547-9ei1ram3	216	6	)	)	-RRB-
cord-029547-9ei1ram3	216	7	is	be	VBZ
cord-029547-9ei1ram3	216	8	based	base	VBN
cord-029547-9ei1ram3	216	9	on	on	IN
cord-029547-9ei1ram3	216	10	the	the	DT
cord-029547-9ei1ram3	216	11	principle	principle	NN
cord-029547-9ei1ram3	216	12	of	of	IN
cord-029547-9ei1ram3	216	13	using	use	VBG
cord-029547-9ei1ram3	216	14	a	a	DT
cord-029547-9ei1ram3	216	15	certain	certain	JJ
cord-029547-9ei1ram3	216	16	titer	titer	NN
cord-029547-9ei1ram3	216	17	of	of	IN
cord-029547-9ei1ram3	216	18	viral	viral	JJ
cord-029547-9ei1ram3	216	19	-	-	HYPH
cord-029547-9ei1ram3	216	20	specific	specific	JJ
cord-029547-9ei1ram3	216	21	antibodies	antibody	NNS
cord-029547-9ei1ram3	216	22	in	in	IN
cord-029547-9ei1ram3	216	23	the	the	DT
cord-029547-9ei1ram3	216	24	recovered	recovered	JJ
cord-029547-9ei1ram3	216	25	plasma	plasma	NN
cord-029547-9ei1ram3	216	26	to	to	TO
cord-029547-9ei1ram3	216	27	obtain	obtain	VB
cord-029547-9ei1ram3	216	28	passive	passive	JJ
cord-029547-9ei1ram3	216	29	immunity	immunity	NN
cord-029547-9ei1ram3	216	30	,	,	,
cord-029547-9ei1ram3	216	31	neutralize	neutralize	VB
cord-029547-9ei1ram3	216	32	specific	specific	JJ
cord-029547-9ei1ram3	216	33	pathogens	pathogen	NNS
cord-029547-9ei1ram3	216	34	,	,	,
cord-029547-9ei1ram3	216	35	and	and	CC
cord-029547-9ei1ram3	216	36	eventually	eventually	RB
cord-029547-9ei1ram3	216	37	clear	clear	VB
cord-029547-9ei1ram3	216	38	the	the	DT
cord-029547-9ei1ram3	216	39	pathogens	pathogen	NNS
cord-029547-9ei1ram3	216	40	in	in	IN
cord-029547-9ei1ram3	216	41	blood	blood	NN
cord-029547-9ei1ram3	216	42	circulation	circulation	NN
cord-029547-9ei1ram3	216	43	,	,	,
cord-029547-9ei1ram3	216	44	thus	thus	RB
cord-029547-9ei1ram3	216	45	achieving	achieve	VBG
cord-029547-9ei1ram3	216	46	the	the	DT
cord-029547-9ei1ram3	216	47	treatment	treatment	NN
cord-029547-9ei1ram3	216	48	expectation	expectation	NN
cord-029547-9ei1ram3	216	49	.	.	.
cord-029547-9ei1ram3	217	1	87	87	CD
cord-029547-9ei1ram3	218	1	Luckily	luckily	RB
cord-029547-9ei1ram3	218	2	,	,	,
cord-029547-9ei1ram3	218	3	key	key	JJ
cord-029547-9ei1ram3	218	4	indicators	indicator	NNS
cord-029547-9ei1ram3	218	5	of	of	IN
cord-029547-9ei1ram3	218	6	laboratory	laboratory	NN
cord-029547-9ei1ram3	218	7	testing	testing	NN
cord-029547-9ei1ram3	218	8	,	,	,
cord-029547-9ei1ram3	218	9	clinical	clinical	JJ
cord-029547-9ei1ram3	218	10	signs	sign	NNS
cord-029547-9ei1ram3	218	11	,	,	,
cord-029547-9ei1ram3	218	12	and	and	CC
cord-029547-9ei1ram3	218	13	symptoms	symptom	NNS
cord-029547-9ei1ram3	218	14	of	of	IN
cord-029547-9ei1ram3	218	15	several	several	JJ
cord-029547-9ei1ram3	218	16	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	218	17	patients	patient	NNS
cord-029547-9ei1ram3	218	18	were	be	VBD
cord-029547-9ei1ram3	218	19	confirmed	confirm	VBN
cord-029547-9ei1ram3	218	20	to	to	TO
cord-029547-9ei1ram3	218	21	improve	improve	VB
cord-029547-9ei1ram3	218	22	significantly	significantly	RB
cord-029547-9ei1ram3	218	23	after	after	IN
cord-029547-9ei1ram3	218	24	CPT	CPT	NNP
cord-029547-9ei1ram3	218	25	,	,	,
cord-029547-9ei1ram3	218	26	88	88	CD
cord-029547-9ei1ram3	219	1	so	so	CC
cord-029547-9ei1ram3	219	2	CPT	CPT	NNP
cord-029547-9ei1ram3	219	3	is	be	VBZ
cord-029547-9ei1ram3	219	4	recommended	recommend	VBN
cord-029547-9ei1ram3	219	5	for	for	IN
cord-029547-9ei1ram3	219	6	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	219	7	treatment	treatment	NN
cord-029547-9ei1ram3	219	8	.	.	.
cord-029547-9ei1ram3	220	1	Currently	currently	RB
cord-029547-9ei1ram3	220	2	,	,	,
cord-029547-9ei1ram3	220	3	clinical	clinical	JJ
cord-029547-9ei1ram3	220	4	trials	trial	NNS
cord-029547-9ei1ram3	220	5	are	be	VBP
cord-029547-9ei1ram3	220	6	under	under	IN
cord-029547-9ei1ram3	220	7	way	way	NN
cord-029547-9ei1ram3	220	8	to	to	TO
cord-029547-9ei1ram3	220	9	further	further	RB
cord-029547-9ei1ram3	220	10	evaluate	evaluate	VB
cord-029547-9ei1ram3	220	11	the	the	DT
cord-029547-9ei1ram3	220	12	efficiency	efficiency	NN
cord-029547-9ei1ram3	220	13	and	and	CC
cord-029547-9ei1ram3	220	14	safety	safety	NN
cord-029547-9ei1ram3	220	15	of	of	IN
cord-029547-9ei1ram3	220	16	CPT	CPT	NNP
cord-029547-9ei1ram3	220	17	to	to	IN
cord-029547-9ei1ram3	220	18	COVID-19	covid-19	VB
cord-029547-9ei1ram3	220	19	.	.	.
cord-029547-9ei1ram3	221	1	The	the	DT
cord-029547-9ei1ram3	221	2	monoclonal	monoclonal	JJ
cord-029547-9ei1ram3	221	3	antibody	antibody	NN
cord-029547-9ei1ram3	221	4	is	be	VBZ
cord-029547-9ei1ram3	221	5	a	a	DT
cord-029547-9ei1ram3	221	6	highly	highly	RB
cord-029547-9ei1ram3	221	7	uniform	uniform	JJ
cord-029547-9ei1ram3	221	8	antibody	antibody	NN
cord-029547-9ei1ram3	221	9	that	that	WDT
cord-029547-9ei1ram3	221	10	is	be	VBZ
cord-029547-9ei1ram3	221	11	produced	produce	VBN
cord-029547-9ei1ram3	221	12	by	by	IN
cord-029547-9ei1ram3	221	13	a	a	DT
cord-029547-9ei1ram3	221	14	single	single	JJ
cord-029547-9ei1ram3	221	15	B	b	NN
cord-029547-9ei1ram3	221	16	cell	cell	NN
cord-029547-9ei1ram3	221	17	and	and	CC
cord-029547-9ei1ram3	221	18	specific	specific	JJ
cord-029547-9ei1ram3	221	19	to	to	TO
cord-029547-9ei1ram3	221	20	target	target	VB
cord-029547-9ei1ram3	221	21	the	the	DT
cord-029547-9ei1ram3	221	22	antigen	antigen	NN
cord-029547-9ei1ram3	221	23	epitopes	epitope	NNS
cord-029547-9ei1ram3	221	24	,	,	,
cord-029547-9ei1ram3	221	25	which	which	WDT
cord-029547-9ei1ram3	221	26	have	have	VBP
cord-029547-9ei1ram3	221	27	been	be	VBN
cord-029547-9ei1ram3	221	28	confirmed	confirm	VBN
cord-029547-9ei1ram3	221	29	to	to	TO
cord-029547-9ei1ram3	221	30	suppress	suppress	VB
cord-029547-9ei1ram3	221	31	viruses	virus	NNS
cord-029547-9ei1ram3	221	32	entering	enter	VBG
cord-029547-9ei1ram3	221	33	host	host	NN
cord-029547-9ei1ram3	221	34	cells	cell	NNS
cord-029547-9ei1ram3	221	35	extracellularly	extracellularly	RB
cord-029547-9ei1ram3	221	36	for	for	IN
cord-029547-9ei1ram3	221	37	many	many	JJ
cord-029547-9ei1ram3	221	38	coronaviruses	coronaviruse	NNS
cord-029547-9ei1ram3	221	39	including	include	VBG
cord-029547-9ei1ram3	221	40	SARS	SARS	NNP
cord-029547-9ei1ram3	221	41	-	-	HYPH
cord-029547-9ei1ram3	221	42	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	221	43	.	.	.
cord-029547-9ei1ram3	222	1	89	89	CD
cord-029547-9ei1ram3	222	2	 	 	_SP
cord-029547-9ei1ram3	223	1	Like	like	IN
cord-029547-9ei1ram3	223	2	most	most	JJS
cord-029547-9ei1ram3	223	3	diseases	disease	NNS
cord-029547-9ei1ram3	223	4	,	,	,
cord-029547-9ei1ram3	223	5	the	the	DT
cord-029547-9ei1ram3	223	6	main	main	JJ
cord-029547-9ei1ram3	223	7	treatments	treatment	NNS
cord-029547-9ei1ram3	223	8	of	of	IN
cord-029547-9ei1ram3	223	9	the	the	DT
cord-029547-9ei1ram3	223	10	complications	complication	NNS
cord-029547-9ei1ram3	223	11	of	of	IN
cord-029547-9ei1ram3	223	12	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	223	13	are	be	VBP
cord-029547-9ei1ram3	223	14	to	to	TO
cord-029547-9ei1ram3	223	15	strengthen	strengthen	VB
cord-029547-9ei1ram3	223	16	supportive	supportive	JJ
cord-029547-9ei1ram3	223	17	treatment	treatment	NN
cord-029547-9ei1ram3	223	18	,	,	,
cord-029547-9ei1ram3	223	19	ensure	ensure	VB
cord-029547-9ei1ram3	223	20	adequate	adequate	JJ
cord-029547-9ei1ram3	223	21	energy	energy	NN
cord-029547-9ei1ram3	223	22	,	,	,
cord-029547-9ei1ram3	223	23	and	and	CC
cord-029547-9ei1ram3	223	24	pay	pay	VB
cord-029547-9ei1ram3	223	25	attention	attention	NN
cord-029547-9ei1ram3	223	26	to	to	IN
cord-029547-9ei1ram3	223	27	water	water	NN
cord-029547-9ei1ram3	223	28	and	and	CC
cord-029547-9ei1ram3	223	29	electrolyte	electrolyte	JJ
cord-029547-9ei1ram3	223	30	balance	balance	NN
cord-029547-9ei1ram3	223	31	to	to	TO
cord-029547-9ei1ram3	223	32	maintain	maintain	VB
cord-029547-9ei1ram3	223	33	internal	internal	JJ
cord-029547-9ei1ram3	223	34	environment	environment	NN
cord-029547-9ei1ram3	223	35	homeostasis	homeostasis	NN
cord-029547-9ei1ram3	223	36	.	.	.
cord-029547-9ei1ram3	224	1	55	55	CD
cord-029547-9ei1ram3	225	1	For	for	IN
cord-029547-9ei1ram3	225	2	COVID-19	covid-19	NN
cord-029547-9ei1ram3	225	3	,	,	,
cord-029547-9ei1ram3	225	4	hypoxia	hypoxia	NN
cord-029547-9ei1ram3	225	5	is	be	VBZ
cord-029547-9ei1ram3	225	6	a	a	DT
cord-029547-9ei1ram3	225	7	typical	typical	JJ
cord-029547-9ei1ram3	225	8	clinical	clinical	JJ
cord-029547-9ei1ram3	225	9	symptom	symptom	NN
cord-029547-9ei1ram3	225	10	of	of	IN
cord-029547-9ei1ram3	225	11	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	225	12	,	,	,
cord-029547-9ei1ram3	225	13	thus	thus	RB
cord-029547-9ei1ram3	225	14	oxygen	oxygen	NN
cord-029547-9ei1ram3	225	15	inhalation	inhalation	NN
cord-029547-9ei1ram3	225	16	is	be	VBZ
cord-029547-9ei1ram3	225	17	the	the	DT
cord-029547-9ei1ram3	225	18	essential	essential	JJ
cord-029547-9ei1ram3	225	19	treatment	treatment	NN
cord-029547-9ei1ram3	225	20	for	for	IN
cord-029547-9ei1ram3	225	21	both	both	CC
cord-029547-9ei1ram3	225	22	mild	mild	JJ
cord-029547-9ei1ram3	225	23	and	and	CC
cord-029547-9ei1ram3	225	24	severe	severe	JJ
cord-029547-9ei1ram3	225	25	patients	patient	NNS
cord-029547-9ei1ram3	225	26	.	.	.
cord-029547-9ei1ram3	226	1	92	92	CD
cord-029547-9ei1ram3	226	2	,	,	,
cord-029547-9ei1ram3	226	3	93	93	CD
cord-029547-9ei1ram3	227	1	It	-PRON-	PRP
cord-029547-9ei1ram3	227	2	is	be	VBZ
cord-029547-9ei1ram3	227	3	worth	worth	JJ
cord-029547-9ei1ram3	227	4	noting	note	VBG
cord-029547-9ei1ram3	227	5	that	that	IN
cord-029547-9ei1ram3	227	6	severe	severe	JJ
cord-029547-9ei1ram3	227	7	cases	case	NNS
cord-029547-9ei1ram3	227	8	of	of	IN
cord-029547-9ei1ram3	227	9	COVID-19	COVID-19	,
cord-029547-9ei1ram3	227	10	often	often	RB
cord-029547-9ei1ram3	227	11	develop	develop	VBP
cord-029547-9ei1ram3	227	12	severe	severe	JJ
cord-029547-9ei1ram3	227	13	inflammation	inflammation	NN
cord-029547-9ei1ram3	227	14	,	,	,
cord-029547-9ei1ram3	227	15	shock	shock	NN
cord-029547-9ei1ram3	227	16	,	,	,
cord-029547-9ei1ram3	227	17	combination	combination	NN
cord-029547-9ei1ram3	227	18	of	of	IN
cord-029547-9ei1ram3	227	19	bacterial	bacterial	JJ
cord-029547-9ei1ram3	227	20	infection	infection	NN
cord-029547-9ei1ram3	227	21	,	,	,
cord-029547-9ei1ram3	227	22	and	and	CC
cord-029547-9ei1ram3	227	23	severe	severe	JJ
cord-029547-9ei1ram3	227	24	kidney	kidney	NN
cord-029547-9ei1ram3	227	25	damage	damage	NN
cord-029547-9ei1ram3	227	26	as	as	RB
cord-029547-9ei1ram3	227	27	well	well	RB
cord-029547-9ei1ram3	227	28	as	as	IN
cord-029547-9ei1ram3	227	29	acute	acute	JJ
cord-029547-9ei1ram3	227	30	respiratory	respiratory	JJ
cord-029547-9ei1ram3	227	31	distress	distress	NN
cord-029547-9ei1ram3	227	32	syndrome	syndrome	NN
cord-029547-9ei1ram3	227	33	(	(	-LRB-
cord-029547-9ei1ram3	227	34	ARDS	ARDS	NNP
cord-029547-9ei1ram3	227	35	)	)	-RRB-
cord-029547-9ei1ram3	227	36	,	,	,
cord-029547-9ei1ram3	227	37	which	which	WDT
cord-029547-9ei1ram3	227	38	often	often	RB
cord-029547-9ei1ram3	227	39	result	result	VBP
cord-029547-9ei1ram3	227	40	in	in	IN
cord-029547-9ei1ram3	227	41	death	death	NN
cord-029547-9ei1ram3	227	42	.	.	.
cord-029547-9ei1ram3	228	1	94	94	CD
cord-029547-9ei1ram3	229	1	Thus	thus	RB
cord-029547-9ei1ram3	229	2	,	,	,
cord-029547-9ei1ram3	229	3	timely	timely	JJ
cord-029547-9ei1ram3	229	4	complications	complication	NNS
cord-029547-9ei1ram3	229	5	treatment	treatment	NN
cord-029547-9ei1ram3	229	6	is	be	VBZ
cord-029547-9ei1ram3	229	7	necessary	necessary	JJ
cord-029547-9ei1ram3	229	8	for	for	IN
cord-029547-9ei1ram3	229	9	critical	critical	JJ
cord-029547-9ei1ram3	229	10	patients	patient	NNS
cord-029547-9ei1ram3	229	11	.	.	.
cord-029547-9ei1ram3	230	1	Glucocorticoids	Glucocorticoids	NNP
cord-029547-9ei1ram3	230	2	such	such	JJ
cord-029547-9ei1ram3	230	3	as	as	IN
cord-029547-9ei1ram3	230	4	methylprednisolone	methylprednisolone	NN
cord-029547-9ei1ram3	230	5	and	and	CC
cord-029547-9ei1ram3	230	6	dexamethasone	dexamethasone	NN
cord-029547-9ei1ram3	230	7	have	have	VBP
cord-029547-9ei1ram3	230	8	strong	strong	JJ
cord-029547-9ei1ram3	230	9	anti	anti	JJ
cord-029547-9ei1ram3	230	10	-	-	JJ
cord-029547-9ei1ram3	230	11	inflammatory	inflammatory	JJ
cord-029547-9ei1ram3	230	12	as	as	RB
cord-029547-9ei1ram3	230	13	well	well	RB
cord-029547-9ei1ram3	230	14	as	as	IN
cord-029547-9ei1ram3	230	15	antishock	antishock	NN
cord-029547-9ei1ram3	230	16	effects	effect	NNS
cord-029547-9ei1ram3	230	17	,	,	,
cord-029547-9ei1ram3	230	18	so	so	IN
cord-029547-9ei1ram3	230	19	they	-PRON-	PRP
cord-029547-9ei1ram3	230	20	are	be	VBP
cord-029547-9ei1ram3	230	21	usually	usually	RB
cord-029547-9ei1ram3	230	22	used	use	VBN
cord-029547-9ei1ram3	230	23	to	to	TO
cord-029547-9ei1ram3	230	24	save	save	VB
cord-029547-9ei1ram3	230	25	critical	critical	JJ
cord-029547-9ei1ram3	230	26	patients	patient	NNS
cord-029547-9ei1ram3	230	27	,	,	,
cord-029547-9ei1ram3	230	28	especially	especially	RB
cord-029547-9ei1ram3	230	29	patients	patient	NNS
cord-029547-9ei1ram3	230	30	with	with	IN
cord-029547-9ei1ram3	230	31	ARDS	ARDS	NNP
cord-029547-9ei1ram3	230	32	.	.	.
cord-029547-9ei1ram3	231	1	95	95	CD
cord-029547-9ei1ram3	232	1	However	however	RB
cord-029547-9ei1ram3	232	2	,	,	,
cord-029547-9ei1ram3	232	3	they	-PRON-	PRP
cord-029547-9ei1ram3	232	4	suppress	suppress	VBP
cord-029547-9ei1ram3	232	5	immunity	immunity	NN
cord-029547-9ei1ram3	232	6	,	,	,
cord-029547-9ei1ram3	232	7	cause	cause	VB
cord-029547-9ei1ram3	232	8	femoral	femoral	JJ
cord-029547-9ei1ram3	232	9	head	head	NN
cord-029547-9ei1ram3	232	10	necrosis	necrosis	NN
cord-029547-9ei1ram3	232	11	of	of	IN
cord-029547-9ei1ram3	232	12	patients	patient	NNS
cord-029547-9ei1ram3	232	13	,	,	,
cord-029547-9ei1ram3	232	14	and	and	CC
cord-029547-9ei1ram3	232	15	can	can	MD
cord-029547-9ei1ram3	232	16	not	not	RB
cord-029547-9ei1ram3	232	17	save	save	VB
cord-029547-9ei1ram3	232	18	patients	patient	NNS
cord-029547-9ei1ram3	232	19	with	with	IN
cord-029547-9ei1ram3	232	20	shock	shock	NN
cord-029547-9ei1ram3	232	21	who	who	WP
cord-029547-9ei1ram3	232	22	have	have	VBP
cord-029547-9ei1ram3	232	23	increased	increase	VBN
cord-029547-9ei1ram3	232	24	intrathoracic	intrathoracic	JJ
cord-029547-9ei1ram3	232	25	pressure	pressure	NN
cord-029547-9ei1ram3	232	26	,	,	,
cord-029547-9ei1ram3	232	27	thus	thus	RB
cord-029547-9ei1ram3	232	28	WHO	who	WP
cord-029547-9ei1ram3	232	29	did	do	VBD
cord-029547-9ei1ram3	232	30	not	not	RB
cord-029547-9ei1ram3	232	31	recommend	recommend	VB
cord-029547-9ei1ram3	232	32	using	use	VBG
cord-029547-9ei1ram3	232	33	glucocorticoids	glucocorticoid	NNS
cord-029547-9ei1ram3	232	34	initially	initially	RB
cord-029547-9ei1ram3	232	35	.	.	.
cord-029547-9ei1ram3	233	1	96	96	CD
cord-029547-9ei1ram3	234	1	For	for	IN
cord-029547-9ei1ram3	234	2	these	these	DT
cord-029547-9ei1ram3	234	3	situations	situation	NNS
cord-029547-9ei1ram3	234	4	,	,	,
cord-029547-9ei1ram3	234	5	physicians	physician	NNS
cord-029547-9ei1ram3	234	6	suggested	suggest	VBD
cord-029547-9ei1ram3	234	7	that	that	IN
cord-029547-9ei1ram3	234	8	short	short	JJ
cord-029547-9ei1ram3	234	9	-	-	HYPH
cord-029547-9ei1ram3	234	10	term	term	NN
cord-029547-9ei1ram3	234	11	administration	administration	NN
cord-029547-9ei1ram3	234	12	of	of	IN
cord-029547-9ei1ram3	234	13	glucocorticoids	glucocorticoid	NNS
cord-029547-9ei1ram3	234	14	should	should	MD
cord-029547-9ei1ram3	234	15	be	be	VB
cord-029547-9ei1ram3	234	16	adopted	adopt	VBN
cord-029547-9ei1ram3	234	17	to	to	TO
cord-029547-9ei1ram3	234	18	decrease	decrease	VB
cord-029547-9ei1ram3	234	19	the	the	DT
cord-029547-9ei1ram3	234	20	side	side	NN
cord-029547-9ei1ram3	234	21	effects	effect	NNS
cord-029547-9ei1ram3	234	22	.	.	.
cord-029547-9ei1ram3	235	1	97	97	CD
cord-029547-9ei1ram3	236	1	Moreover	moreover	RB
cord-029547-9ei1ram3	236	2	,	,	,
cord-029547-9ei1ram3	236	3	considering	consider	VBG
cord-029547-9ei1ram3	236	4	the	the	DT
cord-029547-9ei1ram3	236	5	immunosuppressive	immunosuppressive	JJ
cord-029547-9ei1ram3	236	6	action	action	NN
cord-029547-9ei1ram3	236	7	,	,	,
cord-029547-9ei1ram3	236	8	immune	immune	JJ
cord-029547-9ei1ram3	236	9	boosters	booster	NNS
cord-029547-9ei1ram3	236	10	such	such	JJ
cord-029547-9ei1ram3	236	11	as	as	IN
cord-029547-9ei1ram3	236	12	α	α	NN
cord-029547-9ei1ram3	236	13	-	-	HYPH
cord-029547-9ei1ram3	236	14	IFN	IFN	NNP
cord-029547-9ei1ram3	236	15	and	and	CC
cord-029547-9ei1ram3	236	16	thymosin	thymosin	NN
cord-029547-9ei1ram3	236	17	are	be	VBP
cord-029547-9ei1ram3	236	18	important	important	JJ
cord-029547-9ei1ram3	236	19	for	for	IN
cord-029547-9ei1ram3	236	20	use	use	NN
cord-029547-9ei1ram3	236	21	in	in	IN
cord-029547-9ei1ram3	236	22	avoiding	avoid	VBG
cord-029547-9ei1ram3	236	23	adverse	adverse	JJ
cord-029547-9ei1ram3	236	24	events	event	NNS
cord-029547-9ei1ram3	236	25	.	.	.
cord-029547-9ei1ram3	237	1	For	for	IN
cord-029547-9ei1ram3	237	2	severe	severe	JJ
cord-029547-9ei1ram3	237	3	cytokine	cytokine	NN
cord-029547-9ei1ram3	237	4	storms	storm	NNS
cord-029547-9ei1ram3	237	5	,	,	,
cord-029547-9ei1ram3	237	6	simple	simple	JJ
cord-029547-9ei1ram3	237	7	glucocorticoids	glucocorticoid	NNS
cord-029547-9ei1ram3	237	8	can	can	MD
cord-029547-9ei1ram3	237	9	not	not	RB
cord-029547-9ei1ram3	237	10	suppress	suppress	VB
cord-029547-9ei1ram3	237	11	the	the	DT
cord-029547-9ei1ram3	237	12	inflammation	inflammation	NN
cord-029547-9ei1ram3	237	13	efficiently	efficiently	RB
cord-029547-9ei1ram3	237	14	,	,	,
cord-029547-9ei1ram3	237	15	so	so	RB
cord-029547-9ei1ram3	237	16	potent	potent	JJ
cord-029547-9ei1ram3	237	17	blood	blood	NN
cord-029547-9ei1ram3	237	18	purification	purification	NN
cord-029547-9ei1ram3	237	19	measures	measure	NNS
cord-029547-9ei1ram3	237	20	such	such	JJ
cord-029547-9ei1ram3	237	21	as	as	IN
cord-029547-9ei1ram3	237	22	an	an	DT
cord-029547-9ei1ram3	237	23	artificial	artificial	JJ
cord-029547-9ei1ram3	237	24	liver	liver	NN
cord-029547-9ei1ram3	237	25	system	system	NN
cord-029547-9ei1ram3	237	26	are	be	VBP
cord-029547-9ei1ram3	237	27	essential	essential	JJ
cord-029547-9ei1ram3	237	28	.	.	.
cord-029547-9ei1ram3	238	1	98	98	CD
cord-029547-9ei1ram3	239	1	The	the	DT
cord-029547-9ei1ram3	239	2	processes	process	NNS
cord-029547-9ei1ram3	239	3	of	of	IN
cord-029547-9ei1ram3	239	4	urgent	urgent	JJ
cord-029547-9ei1ram3	239	5	antishock	antishock	NN
cord-029547-9ei1ram3	239	6	therapy	therapy	NN
cord-029547-9ei1ram3	239	7	mainly	mainly	RB
cord-029547-9ei1ram3	239	8	contain	contain	VBP
cord-029547-9ei1ram3	239	9	complements	complement	NNS
cord-029547-9ei1ram3	239	10	of	of	IN
cord-029547-9ei1ram3	239	11	blood	blood	NN
cord-029547-9ei1ram3	239	12	volume	volume	NN
cord-029547-9ei1ram3	239	13	,	,	,
cord-029547-9ei1ram3	239	14	improving	improve	VBG
cord-029547-9ei1ram3	239	15	cardiac	cardiac	JJ
cord-029547-9ei1ram3	239	16	contractility	contractility	NN
cord-029547-9ei1ram3	239	17	and	and	CC
cord-029547-9ei1ram3	239	18	vascular	vascular	JJ
cord-029547-9ei1ram3	239	19	activity	activity	NN
cord-029547-9ei1ram3	239	20	,	,	,
cord-029547-9ei1ram3	239	21	thus	thus	RB
cord-029547-9ei1ram3	239	22	vasoactive	vasoactive	JJ
cord-029547-9ei1ram3	239	23	agents	agent	NNS
cord-029547-9ei1ram3	239	24	and	and	CC
cord-029547-9ei1ram3	239	25	positive	positive	JJ
cord-029547-9ei1ram3	239	26	inotropic	inotropic	JJ
cord-029547-9ei1ram3	239	27	drugs	drug	NNS
cord-029547-9ei1ram3	239	28	such	such	JJ
cord-029547-9ei1ram3	239	29	as	as	IN
cord-029547-9ei1ram3	239	30	epinephrine	epinephrine	NN
cord-029547-9ei1ram3	239	31	,	,	,
cord-029547-9ei1ram3	239	32	dopamine	dopamine	NN
cord-029547-9ei1ram3	239	33	,	,	,
cord-029547-9ei1ram3	239	34	and	and	CC
cord-029547-9ei1ram3	239	35	norepinephrine	norepinephrine	NN
cord-029547-9ei1ram3	239	36	99	99	CD
cord-029547-9ei1ram3	239	37	are	be	VBP
cord-029547-9ei1ram3	239	38	necessary	necessary	JJ
cord-029547-9ei1ram3	239	39	for	for	IN
cord-029547-9ei1ram3	239	40	first	first	JJ
cord-029547-9ei1ram3	239	41	aid	aid	NN
cord-029547-9ei1ram3	239	42	of	of	IN
cord-029547-9ei1ram3	239	43	critical	critical	JJ
cord-029547-9ei1ram3	239	44	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	239	45	patients	patient	NNS
cord-029547-9ei1ram3	239	46	.	.	.
cord-029547-9ei1ram3	240	1	For	for	IN
cord-029547-9ei1ram3	240	2	patients	patient	NNS
cord-029547-9ei1ram3	240	3	with	with	IN
cord-029547-9ei1ram3	240	4	severe	severe	JJ
cord-029547-9ei1ram3	240	5	kidney	kidney	NN
cord-029547-9ei1ram3	240	6	damage	damage	NN
cord-029547-9ei1ram3	240	7	,	,	,
cord-029547-9ei1ram3	240	8	we	-PRON-	PRP
cord-029547-9ei1ram3	240	9	should	should	MD
cord-029547-9ei1ram3	240	10	actively	actively	RB
cord-029547-9ei1ram3	240	11	search	search	VB
cord-029547-9ei1ram3	240	12	for	for	IN
cord-029547-9ei1ram3	240	13	the	the	DT
cord-029547-9ei1ram3	240	14	primary	primary	JJ
cord-029547-9ei1ram3	240	15	cause	cause	NN
cord-029547-9ei1ram3	240	16	and	and	CC
cord-029547-9ei1ram3	240	17	pay	pay	VB
cord-029547-9ei1ram3	240	18	attention	attention	NN
cord-029547-9ei1ram3	240	19	to	to	IN
cord-029547-9ei1ram3	240	20	the	the	DT
cord-029547-9ei1ram3	240	21	water	water	NN
cord-029547-9ei1ram3	240	22	,	,	,
cord-029547-9ei1ram3	240	23	electrolyte	electrolyte	NN
cord-029547-9ei1ram3	240	24	,	,	,
cord-029547-9ei1ram3	240	25	and	and	CC
cord-029547-9ei1ram3	240	26	acid	acid	NN
cord-029547-9ei1ram3	240	27	-	-	HYPH
cord-029547-9ei1ram3	240	28	base	base	NN
cord-029547-9ei1ram3	240	29	balance	balance	NN
cord-029547-9ei1ram3	240	30	.	.	.
cord-029547-9ei1ram3	241	1	When	when	WRB
cord-029547-9ei1ram3	241	2	homeostasis	homeostasis	NN
cord-029547-9ei1ram3	241	3	is	be	VBZ
cord-029547-9ei1ram3	241	4	decompensated	decompensate	VBN
cord-029547-9ei1ram3	241	5	and/or	and/or	CC
cord-029547-9ei1ram3	241	6	multiple	multiple	JJ
cord-029547-9ei1ram3	241	7	organ	organ	NN
cord-029547-9ei1ram3	241	8	failure	failure	NN
cord-029547-9ei1ram3	241	9	occurs	occur	VBZ
cord-029547-9ei1ram3	241	10	,	,	,
cord-029547-9ei1ram3	241	11	continuous	continuous	JJ
cord-029547-9ei1ram3	241	12	renal	renal	JJ
cord-029547-9ei1ram3	241	13	replacement	replacement	NN
cord-029547-9ei1ram3	241	14	therapy	therapy	NN
cord-029547-9ei1ram3	241	15	(	(	-LRB-
cord-029547-9ei1ram3	241	16	CRRT	CRRT	NNP
cord-029547-9ei1ram3	241	17	)	)	-RRB-
cord-029547-9ei1ram3	241	18	should	should	MD
cord-029547-9ei1ram3	241	19	be	be	VB
cord-029547-9ei1ram3	241	20	adopted	adopt	VBN
cord-029547-9ei1ram3	241	21	for	for	IN
cord-029547-9ei1ram3	241	22	treatment	treatment	NN
cord-029547-9ei1ram3	241	23	.	.	.
cord-029547-9ei1ram3	242	1	100	100	CD
cord-029547-9ei1ram3	242	2	ARDS	ARDS	NNP
cord-029547-9ei1ram3	242	3	is	be	VBZ
cord-029547-9ei1ram3	242	4	one	one	CD
cord-029547-9ei1ram3	242	5	of	of	IN
cord-029547-9ei1ram3	242	6	most	most	JJS
cord-029547-9ei1ram3	242	7	critical	critical	JJ
cord-029547-9ei1ram3	242	8	complications	complication	NNS
cord-029547-9ei1ram3	242	9	for	for	IN
cord-029547-9ei1ram3	242	10	patients	patient	NNS
cord-029547-9ei1ram3	242	11	,	,	,
cord-029547-9ei1ram3	242	12	which	which	WDT
cord-029547-9ei1ram3	242	13	is	be	VBZ
cord-029547-9ei1ram3	242	14	known	know	VBN
cord-029547-9ei1ram3	242	15	for	for	IN
cord-029547-9ei1ram3	242	16	its	-PRON-	PRP$
cord-029547-9ei1ram3	242	17	high	high	JJ
cord-029547-9ei1ram3	242	18	mortality	mortality	NN
cord-029547-9ei1ram3	242	19	rate	rate	NN
cord-029547-9ei1ram3	242	20	,	,	,
cord-029547-9ei1ram3	242	21	especially	especially	RB
cord-029547-9ei1ram3	242	22	for	for	IN
cord-029547-9ei1ram3	242	23	pregnant	pregnant	JJ
cord-029547-9ei1ram3	242	24	patients	patient	NNS
cord-029547-9ei1ram3	242	25	.	.	.
cord-029547-9ei1ram3	243	1	101	101	CD
cord-029547-9ei1ram3	244	1	For	for	IN
cord-029547-9ei1ram3	244	2	its	-PRON-	PRP$
cord-029547-9ei1ram3	244	3	therapy	therapy	NN
cord-029547-9ei1ram3	244	4	,	,	,
cord-029547-9ei1ram3	244	5	ECMO	ECMO	NNP
cord-029547-9ei1ram3	244	6	is	be	VBZ
cord-029547-9ei1ram3	244	7	usually	usually	RB
cord-029547-9ei1ram3	244	8	recommended	recommend	VBN
cord-029547-9ei1ram3	244	9	and	and	CC
cord-029547-9ei1ram3	244	10	has	have	VBZ
cord-029547-9ei1ram3	244	11	a	a	DT
cord-029547-9ei1ram3	244	12	certain	certain	JJ
cord-029547-9ei1ram3	244	13	curative	curative	JJ
cord-029547-9ei1ram3	244	14	effect	effect	NN
cord-029547-9ei1ram3	244	15	.	.	.
cord-029547-9ei1ram3	245	1	102	102	CD
cord-029547-9ei1ram3	246	1	However	however	RB
cord-029547-9ei1ram3	246	2	,	,	,
cord-029547-9ei1ram3	246	3	its	-PRON-	PRP$
cord-029547-9ei1ram3	246	4	complex	complex	JJ
cord-029547-9ei1ram3	246	5	operation	operation	NN
cord-029547-9ei1ram3	246	6	and	and	CC
cord-029547-9ei1ram3	246	7	low	low	JJ
cord-029547-9ei1ram3	246	8	cure	cure	NN
cord-029547-9ei1ram3	246	9	rate	rate	NN
cord-029547-9ei1ram3	246	10	make	make	VBP
cord-029547-9ei1ram3	246	11	it	-PRON-	PRP
cord-029547-9ei1ram3	246	12	difficult	difficult	JJ
cord-029547-9ei1ram3	246	13	to	to	TO
cord-029547-9ei1ram3	246	14	perform	perform	VB
cord-029547-9ei1ram3	246	15	in	in	IN
cord-029547-9ei1ram3	246	16	a	a	DT
cord-029547-9ei1ram3	246	17	primary	primary	JJ
cord-029547-9ei1ram3	246	18	hospital	hospital	NN
cord-029547-9ei1ram3	246	19	.	.	.
cord-029547-9ei1ram3	247	1	Luckily	luckily	RB
cord-029547-9ei1ram3	247	2	,	,	,
cord-029547-9ei1ram3	247	3	stem	stem	NN
cord-029547-9ei1ram3	247	4	cells	cell	NNS
cord-029547-9ei1ram3	247	5	and	and	CC
cord-029547-9ei1ram3	247	6	their	-PRON-	PRP$
cord-029547-9ei1ram3	247	7	extracellular	extracellular	JJ
cord-029547-9ei1ram3	247	8	vesicles	vesicle	NNS
cord-029547-9ei1ram3	247	9	are	be	VBP
cord-029547-9ei1ram3	247	10	able	able	JJ
cord-029547-9ei1ram3	247	11	to	to	TO
cord-029547-9ei1ram3	247	12	repair	repair	VB
cord-029547-9ei1ram3	247	13	the	the	DT
cord-029547-9ei1ram3	247	14	damage	damage	NN
cord-029547-9ei1ram3	247	15	and	and	CC
cord-029547-9ei1ram3	247	16	relieve	relieve	VB
cord-029547-9ei1ram3	247	17	lung	lung	NN
cord-029547-9ei1ram3	247	18	symptoms	symptom	NNS
cord-029547-9ei1ram3	247	19	,	,	,
cord-029547-9ei1ram3	247	20	thus	thus	RB
cord-029547-9ei1ram3	247	21	they	-PRON-	PRP
cord-029547-9ei1ram3	247	22	have	have	VBP
cord-029547-9ei1ram3	247	23	been	be	VBN
cord-029547-9ei1ram3	247	24	used	use	VBN
cord-029547-9ei1ram3	247	25	to	to	TO
cord-029547-9ei1ram3	247	26	cure	cure	VB
cord-029547-9ei1ram3	247	27	ARDS	ARDS	NNP
cord-029547-9ei1ram3	247	28	.	.	.
cord-029547-9ei1ram3	248	1	103	103	CD
cord-029547-9ei1ram3	249	1	Currently	currently	RB
cord-029547-9ei1ram3	249	2	,	,	,
cord-029547-9ei1ram3	249	3	some	some	DT
cord-029547-9ei1ram3	249	4	COVID-19	covid-19	CD
cord-029547-9ei1ram3	249	5	patients	patient	NNS
cord-029547-9ei1ram3	249	6	have	have	VBP
cord-029547-9ei1ram3	249	7	been	be	VBN
cord-029547-9ei1ram3	249	8	treated	treat	VBN
cord-029547-9ei1ram3	249	9	with	with	IN
cord-029547-9ei1ram3	249	10	umbilical	umbilical	JJ
cord-029547-9ei1ram3	249	11	cord	cord	NN
cord-029547-9ei1ram3	249	12	mesenchymal	mesenchymal	JJ
cord-029547-9ei1ram3	249	13	stem	stem	NN
cord-029547-9ei1ram3	249	14	cells	cell	NNS
cord-029547-9ei1ram3	249	15	and	and	CC
cord-029547-9ei1ram3	249	16	achieved	achieve	VBN
cord-029547-9ei1ram3	249	17	good	good	JJ
cord-029547-9ei1ram3	249	18	effects	effect	NNS
cord-029547-9ei1ram3	249	19	.	.	.
cord-029547-9ei1ram3	250	1	104	104	CD
cord-029547-9ei1ram3	251	1	Therefore	therefore	RB
cord-029547-9ei1ram3	251	2	,	,	,
cord-029547-9ei1ram3	251	3	stem	stem	NN
cord-029547-9ei1ram3	251	4	cells	cell	NNS
cord-029547-9ei1ram3	251	5	may	may	MD
cord-029547-9ei1ram3	251	6	be	be	VB
cord-029547-9ei1ram3	251	7	the	the	DT
cord-029547-9ei1ram3	251	8	hope	hope	NN
cord-029547-9ei1ram3	251	9	for	for	IN
cord-029547-9ei1ram3	251	10	the	the	DT
cord-029547-9ei1ram3	251	11	treatment	treatment	NN
cord-029547-9ei1ram3	251	12	of	of	IN
cord-029547-9ei1ram3	251	13	severe	severe	JJ
cord-029547-9ei1ram3	251	14	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	251	15	patients	patient	NNS
cord-029547-9ei1ram3	251	16	.	.	.
cord-029547-9ei1ram3	252	1	Tens	ten	NNS
cord-029547-9ei1ram3	252	2	of	of	IN
cord-029547-9ei1ram3	252	3	clinical	clinical	JJ
cord-029547-9ei1ram3	252	4	trials	trial	NNS
cord-029547-9ei1ram3	252	5	of	of	IN
cord-029547-9ei1ram3	252	6	stem	stem	NN
cord-029547-9ei1ram3	252	7	cell	cell	NN
cord-029547-9ei1ram3	252	8	treatment	treatment	NN
cord-029547-9ei1ram3	252	9	have	have	VBP
cord-029547-9ei1ram3	252	10	been	be	VBN
cord-029547-9ei1ram3	252	11	registered	register	VBN
cord-029547-9ei1ram3	252	12	in	in	IN
cord-029547-9ei1ram3	252	13	Chinese	Chinese	NNP
cord-029547-9ei1ram3	252	14	Clinical	Clinical	NNP
cord-029547-9ei1ram3	252	15	Trial	Trial	NNP
cord-029547-9ei1ram3	252	16	Registry	Registry	NNP
cord-029547-9ei1ram3	252	17	.	.	.
cord-029547-9ei1ram3	253	1	Recently	recently	RB
cord-029547-9ei1ram3	253	2	,	,	,
cord-029547-9ei1ram3	253	3	many	many	JJ
cord-029547-9ei1ram3	253	4	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	253	5	patients	patient	NNS
cord-029547-9ei1ram3	253	6	were	be	VBD
cord-029547-9ei1ram3	253	7	found	find	VBN
cord-029547-9ei1ram3	253	8	to	to	TO
cord-029547-9ei1ram3	253	9	have	have	VB
cord-029547-9ei1ram3	253	10	thrombotic	thrombotic	JJ
cord-029547-9ei1ram3	253	11	risk	risk	NN
cord-029547-9ei1ram3	253	12	,	,	,
cord-029547-9ei1ram3	253	13	105	105	CD
cord-029547-9ei1ram3	253	14	therefore	therefore	RB
cord-029547-9ei1ram3	253	15	,	,	,
cord-029547-9ei1ram3	253	16	antithrombotic	antithrombotic	JJ
cord-029547-9ei1ram3	253	17	treatments	treatment	NNS
cord-029547-9ei1ram3	253	18	have	have	VBP
cord-029547-9ei1ram3	253	19	potential	potential	JJ
cord-029547-9ei1ram3	253	20	application	application	NN
cord-029547-9ei1ram3	253	21	value	value	NN
cord-029547-9ei1ram3	253	22	in	in	IN
cord-029547-9ei1ram3	253	23	the	the	DT
cord-029547-9ei1ram3	253	24	treatment	treatment	NN
cord-029547-9ei1ram3	253	25	of	of	IN
cord-029547-9ei1ram3	253	26	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	253	27	.	.	.
cord-029547-9ei1ram3	254	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	254	2	,	,	,
cord-029547-9ei1ram3	254	3	patients	patient	NNS
cord-029547-9ei1ram3	254	4	with	with	IN
cord-029547-9ei1ram3	254	5	underlying	underlie	VBG
cord-029547-9ei1ram3	254	6	diseases	disease	NNS
cord-029547-9ei1ram3	254	7	such	such	JJ
cord-029547-9ei1ram3	254	8	as	as	IN
cord-029547-9ei1ram3	254	9	hypertension	hypertension	NN
cord-029547-9ei1ram3	254	10	,	,	,
cord-029547-9ei1ram3	254	11	diabetes	diabetes	NN
cord-029547-9ei1ram3	254	12	,	,	,
cord-029547-9ei1ram3	254	13	and	and	CC
cord-029547-9ei1ram3	254	14	cardiovascular	cardiovascular	JJ
cord-029547-9ei1ram3	254	15	disease	disease	NN
cord-029547-9ei1ram3	254	16	have	have	VBP
cord-029547-9ei1ram3	254	17	a	a	DT
cord-029547-9ei1ram3	254	18	potential	potential	JJ
cord-029547-9ei1ram3	254	19	bad	bad	JJ
cord-029547-9ei1ram3	254	20	prognosis	prognosis	NN
cord-029547-9ei1ram3	254	21	,	,	,
cord-029547-9ei1ram3	254	22	106	106	CD
cord-029547-9ei1ram3	254	23	-	-	SYM
cord-029547-9ei1ram3	254	24	108	108	CD
cord-029547-9ei1ram3	254	25	so	so	IN
cord-029547-9ei1ram3	254	26	care	care	NN
cord-029547-9ei1ram3	254	27	should	should	MD
cord-029547-9ei1ram3	254	28	be	be	VB
cord-029547-9ei1ram3	254	29	taken	take	VBN
cord-029547-9ei1ram3	254	30	to	to	TO
cord-029547-9ei1ram3	254	31	cure	cure	VB
cord-029547-9ei1ram3	254	32	these	these	DT
cord-029547-9ei1ram3	254	33	basic	basic	JJ
cord-029547-9ei1ram3	254	34	diseases	disease	NNS
cord-029547-9ei1ram3	254	35	during	during	IN
cord-029547-9ei1ram3	254	36	treatment	treatment	NN
cord-029547-9ei1ram3	254	37	.	.	.
cord-029547-9ei1ram3	255	1	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	255	2	patients	patient	NNS
cord-029547-9ei1ram3	255	3	with	with	IN
cord-029547-9ei1ram3	255	4	low	low	JJ
cord-029547-9ei1ram3	255	5	immunity	immunity	NN
cord-029547-9ei1ram3	255	6	are	be	VBP
cord-029547-9ei1ram3	255	7	susceptible	susceptible	JJ
cord-029547-9ei1ram3	255	8	to	to	IN
cord-029547-9ei1ram3	255	9	hospital	hospital	NN
cord-029547-9ei1ram3	255	10	-	-	HYPH
cord-029547-9ei1ram3	255	11	acquired	acquire	VBN
cord-029547-9ei1ram3	255	12	bacterial	bacterial	JJ
cord-029547-9ei1ram3	255	13	infections	infection	NNS
cord-029547-9ei1ram3	255	14	,	,	,
cord-029547-9ei1ram3	255	15	109	109	CD
cord-029547-9ei1ram3	255	16	therefore	therefore	RB
cord-029547-9ei1ram3	255	17	,	,	,
cord-029547-9ei1ram3	255	18	antibiotics	antibiotic	NNS
cord-029547-9ei1ram3	255	19	such	such	JJ
cord-029547-9ei1ram3	255	20	as	as	IN
cord-029547-9ei1ram3	255	21	amoxicillin	amoxicillin	NNP
cord-029547-9ei1ram3	255	22	are	be	VBP
cord-029547-9ei1ram3	255	23	another	another	DT
cord-029547-9ei1ram3	255	24	symptomatic	symptomatic	JJ
cord-029547-9ei1ram3	255	25	treatment	treatment	NN
cord-029547-9ei1ram3	255	26	medicine	medicine	NN
cord-029547-9ei1ram3	255	27	for	for	IN
cord-029547-9ei1ram3	255	28	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	255	29	.	.	.
cord-029547-9ei1ram3	256	1	Traditional	traditional	JJ
cord-029547-9ei1ram3	256	2	Chinese	chinese	JJ
cord-029547-9ei1ram3	256	3	medicine	medicine	NN
cord-029547-9ei1ram3	256	4	has	have	VBZ
cord-029547-9ei1ram3	256	5	been	be	VBN
cord-029547-9ei1ram3	256	6	confirmed	confirm	VBN
cord-029547-9ei1ram3	256	7	to	to	TO
cord-029547-9ei1ram3	256	8	play	play	VB
cord-029547-9ei1ram3	256	9	a	a	DT
cord-029547-9ei1ram3	256	10	vital	vital	JJ
cord-029547-9ei1ram3	256	11	role	role	NN
cord-029547-9ei1ram3	256	12	in	in	IN
cord-029547-9ei1ram3	256	13	treating	treat	VBG
cord-029547-9ei1ram3	256	14	many	many	JJ
cord-029547-9ei1ram3	256	15	respiratory	respiratory	JJ
cord-029547-9ei1ram3	256	16	viruses	virus	NNS
cord-029547-9ei1ram3	256	17	such	such	JJ
cord-029547-9ei1ram3	256	18	as	as	IN
cord-029547-9ei1ram3	257	1	SARS	SARS	NNP
cord-029547-9ei1ram3	257	2	-	-	HYPH
cord-029547-9ei1ram3	257	3	CoV.	CoV.	NNP
cord-029547-9ei1ram3	258	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	258	2	,	,	,
cord-029547-9ei1ram3	258	3	the	the	DT
cord-029547-9ei1ram3	258	4	General	General	NNP
cord-029547-9ei1ram3	258	5	Office	Office	NNP
cord-029547-9ei1ram3	258	6	of	of	IN
cord-029547-9ei1ram3	258	7	National	National	NNP
cord-029547-9ei1ram3	258	8	Health	Health	NNP
cord-029547-9ei1ram3	258	9	Committee	Committee	NNP
cord-029547-9ei1ram3	258	10	pointed	point	VBD
cord-029547-9ei1ram3	258	11	out	out	RP
cord-029547-9ei1ram3	258	12	that	that	IN
cord-029547-9ei1ram3	258	13	Chinese	chinese	JJ
cord-029547-9ei1ram3	258	14	medicines	medicine	NNS
cord-029547-9ei1ram3	258	15	such	such	JJ
cord-029547-9ei1ram3	258	16	as	as	IN
cord-029547-9ei1ram3	258	17	qingfei	qingfei	NNP
cord-029547-9ei1ram3	258	18	paidu	paidu	NNP
cord-029547-9ei1ram3	258	19	decoction	decoction	NNP
cord-029547-9ei1ram3	258	20	,	,	,
cord-029547-9ei1ram3	258	21	qingfei	qingfei	NNP
cord-029547-9ei1ram3	258	22	touxie	touxie	NNP
cord-029547-9ei1ram3	258	23	fuzheng	fuzheng	NNP
cord-029547-9ei1ram3	258	24	recipe	recipe	NNP
cord-029547-9ei1ram3	258	25	,	,	,
cord-029547-9ei1ram3	258	26	and	and	CC
cord-029547-9ei1ram3	258	27	sheganmahuang	sheganmahuang	NNP
cord-029547-9ei1ram3	258	28	decoction	decoction	NN
cord-029547-9ei1ram3	258	29	could	could	MD
cord-029547-9ei1ram3	258	30	be	be	VB
cord-029547-9ei1ram3	258	31	used	use	VBN
cord-029547-9ei1ram3	258	32	for	for	IN
cord-029547-9ei1ram3	258	33	the	the	DT
cord-029547-9ei1ram3	258	34	whole	whole	JJ
cord-029547-9ei1ram3	258	35	therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	258	36	process	process	NN
cord-029547-9ei1ram3	258	37	of	of	IN
cord-029547-9ei1ram3	258	38	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	258	39	,	,	,
cord-029547-9ei1ram3	258	40	55	55	CD
cord-029547-9ei1ram3	258	41	thus	thus	RB
cord-029547-9ei1ram3	258	42	they	-PRON-	PRP
cord-029547-9ei1ram3	258	43	are	be	VBP
cord-029547-9ei1ram3	258	44	widely	widely	RB
cord-029547-9ei1ram3	258	45	used	use	VBN
cord-029547-9ei1ram3	258	46	for	for	IN
cord-029547-9ei1ram3	258	47	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	258	48	treatment	treatment	NN
cord-029547-9ei1ram3	258	49	currently	currently	RB
cord-029547-9ei1ram3	258	50	.	.	.
cord-029547-9ei1ram3	259	1	The	the	DT
cord-029547-9ei1ram3	259	2	present	present	JJ
cord-029547-9ei1ram3	259	3	clinical	clinical	JJ
cord-029547-9ei1ram3	259	4	evidence	evidence	NN
cord-029547-9ei1ram3	259	5	has	have	VBZ
cord-029547-9ei1ram3	259	6	shown	show	VBN
cord-029547-9ei1ram3	259	7	that	that	IN
cord-029547-9ei1ram3	259	8	a	a	DT
cord-029547-9ei1ram3	259	9	combination	combination	NN
cord-029547-9ei1ram3	259	10	of	of	IN
cord-029547-9ei1ram3	259	11	western	western	JJ
cord-029547-9ei1ram3	259	12	and	and	CC
cord-029547-9ei1ram3	259	13	Chinese	chinese	JJ
cord-029547-9ei1ram3	259	14	medicines	medicine	NNS
cord-029547-9ei1ram3	259	15	apparently	apparently	RB
cord-029547-9ei1ram3	259	16	improved	improve	VBD
cord-029547-9ei1ram3	259	17	curative	curative	JJ
cord-029547-9ei1ram3	259	18	effect	effect	NN
cord-029547-9ei1ram3	259	19	.	.	.
cord-029547-9ei1ram3	260	1	110	110	CD
cord-029547-9ei1ram3	261	1	For	for	IN
cord-029547-9ei1ram3	261	2	example	example	NN
cord-029547-9ei1ram3	261	3	,	,	,
cord-029547-9ei1ram3	261	4	Wan	Wan	NNP
cord-029547-9ei1ram3	261	5	et	et	NNP
cord-029547-9ei1ram3	261	6	al	al	NNP
cord-029547-9ei1ram3	261	7	.	.	NNP
cord-029547-9ei1ram3	261	8	treated	treat	VBN
cord-029547-9ei1ram3	261	9	124	124	CD
cord-029547-9ei1ram3	261	10	patients	patient	NNS
cord-029547-9ei1ram3	261	11	with	with	IN
cord-029547-9ei1ram3	261	12	multiple	multiple	JJ
cord-029547-9ei1ram3	261	13	traditional	traditional	JJ
cord-029547-9ei1ram3	261	14	Chinese	chinese	JJ
cord-029547-9ei1ram3	261	15	medicines	medicine	NNS
cord-029547-9ei1ram3	261	16	such	such	JJ
cord-029547-9ei1ram3	261	17	as	as	IN
cord-029547-9ei1ram3	261	18	Suhuang	Suhuang	NNP
cord-029547-9ei1ram3	261	19	Zhike	Zhike	NNP
cord-029547-9ei1ram3	261	20	capsule	capsule	NN
cord-029547-9ei1ram3	261	21	and	and	CC
cord-029547-9ei1ram3	261	22	Xuebijing	Xuebijing	NNP
cord-029547-9ei1ram3	261	23	,	,	,
cord-029547-9ei1ram3	261	24	and	and	CC
cord-029547-9ei1ram3	261	25	found	find	VBD
cord-029547-9ei1ram3	261	26	their	-PRON-	PRP$
cord-029547-9ei1ram3	261	27	respiratory	respiratory	JJ
cord-029547-9ei1ram3	261	28	symptoms	symptom	NNS
cord-029547-9ei1ram3	261	29	were	be	VBD
cord-029547-9ei1ram3	261	30	significantly	significantly	RB
cord-029547-9ei1ram3	261	31	improved	improve	VBN
cord-029547-9ei1ram3	261	32	in	in	IN
cord-029547-9ei1ram3	261	33	a	a	DT
cord-029547-9ei1ram3	261	34	shorter	short	JJR
cord-029547-9ei1ram3	261	35	time	time	NN
cord-029547-9ei1ram3	261	36	.	.	.
cord-029547-9ei1ram3	262	1	109	109	CD
cord-029547-9ei1ram3	262	2	Furthermore	furthermore	RB
cord-029547-9ei1ram3	262	3	,	,	,
cord-029547-9ei1ram3	262	4	four	four	CD
cord-029547-9ei1ram3	262	5	cases	case	NNS
cord-029547-9ei1ram3	262	6	treated	treat	VBN
cord-029547-9ei1ram3	262	7	with	with	IN
cord-029547-9ei1ram3	262	8	antiviral	antiviral	JJ
cord-029547-9ei1ram3	262	9	drugs	drug	NNS
cord-029547-9ei1ram3	262	10	and	and	CC
cord-029547-9ei1ram3	262	11	Shufeng	Shufeng	NNP
cord-029547-9ei1ram3	262	12	Jiedu	Jiedu	NNP
cord-029547-9ei1ram3	262	13	Capsule	Capsule	NNP
cord-029547-9ei1ram3	262	14	had	have	VBD
cord-029547-9ei1ram3	262	15	an	an	DT
cord-029547-9ei1ram3	262	16	obvious	obvious	JJ
cord-029547-9ei1ram3	262	17	improvement	improvement	NN
cord-029547-9ei1ram3	262	18	both	both	CC
cord-029547-9ei1ram3	262	19	in	in	IN
cord-029547-9ei1ram3	262	20	symptoms	symptom	NNS
cord-029547-9ei1ram3	262	21	and	and	CC
cord-029547-9ei1ram3	262	22	blood	blood	NN
cord-029547-9ei1ram3	262	23	biochemical	biochemical	JJ
cord-029547-9ei1ram3	262	24	indexes	index	NNS
cord-029547-9ei1ram3	262	25	.	.	.
cord-029547-9ei1ram3	263	1	111	111	CD
cord-029547-9ei1ram3	264	1	However	however	RB
cord-029547-9ei1ram3	264	2	,	,	,
cord-029547-9ei1ram3	264	3	lack	lack	NN
cord-029547-9ei1ram3	264	4	of	of	IN
cord-029547-9ei1ram3	264	5	a	a	DT
cord-029547-9ei1ram3	264	6	control	control	NN
cord-029547-9ei1ram3	264	7	group	group	NN
cord-029547-9ei1ram3	264	8	means	mean	VBZ
cord-029547-9ei1ram3	264	9	these	these	DT
cord-029547-9ei1ram3	264	10	results	result	NNS
cord-029547-9ei1ram3	264	11	are	be	VBP
cord-029547-9ei1ram3	264	12	not	not	RB
cord-029547-9ei1ram3	264	13	reliable	reliable	JJ
cord-029547-9ei1ram3	264	14	enough	enough	RB
cord-029547-9ei1ram3	264	15	.	.	.
cord-029547-9ei1ram3	265	1	Although	although	IN
cord-029547-9ei1ram3	265	2	treatment	treatment	NN
cord-029547-9ei1ram3	265	3	based	base	VBN
cord-029547-9ei1ram3	265	4	on	on	IN
cord-029547-9ei1ram3	265	5	syndrome	syndrome	NN
cord-029547-9ei1ram3	265	6	differentiation	differentiation	NN
cord-029547-9ei1ram3	265	7	and	and	CC
cord-029547-9ei1ram3	265	8	lack	lack	NN
cord-029547-9ei1ram3	265	9	of	of	IN
cord-029547-9ei1ram3	265	10	scientific	scientific	JJ
cord-029547-9ei1ram3	265	11	evidence	evidence	NN
cord-029547-9ei1ram3	265	12	on	on	IN
cord-029547-9ei1ram3	265	13	mechanisms	mechanism	NNS
cord-029547-9ei1ram3	265	14	are	be	VBP
cord-029547-9ei1ram3	265	15	typical	typical	JJ
cord-029547-9ei1ram3	265	16	characteristics	characteristic	NNS
cord-029547-9ei1ram3	265	17	of	of	IN
cord-029547-9ei1ram3	265	18	traditional	traditional	JJ
cord-029547-9ei1ram3	265	19	Chinese	chinese	JJ
cord-029547-9ei1ram3	265	20	medicines	medicine	NNS
cord-029547-9ei1ram3	265	21	,	,	,
cord-029547-9ei1ram3	265	22	many	many	JJ
cord-029547-9ei1ram3	265	23	of	of	IN
cord-029547-9ei1ram3	265	24	them	-PRON-	PRP
cord-029547-9ei1ram3	265	25	are	be	VBP
cord-029547-9ei1ram3	265	26	gradually	gradually	RB
cord-029547-9ei1ram3	265	27	found	find	VBN
cord-029547-9ei1ram3	265	28	to	to	TO
cord-029547-9ei1ram3	265	29	have	have	VB
cord-029547-9ei1ram3	265	30	antiviral	antiviral	JJ
cord-029547-9ei1ram3	265	31	potential	potential	NN
cord-029547-9ei1ram3	265	32	for	for	IN
cord-029547-9ei1ram3	265	33	SARS	SARS	NNP
cord-029547-9ei1ram3	265	34	-	-	HYPH
cord-029547-9ei1ram3	265	35	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	265	36	.	.	.
cord-029547-9ei1ram3	266	1	Theaflavin	Theaflavin	NNP
cord-029547-9ei1ram3	266	2	is	be	VBZ
cord-029547-9ei1ram3	266	3	conventional	conventional	JJ
cord-029547-9ei1ram3	266	4	ingredient	ingredient	NN
cord-029547-9ei1ram3	266	5	of	of	IN
cord-029547-9ei1ram3	266	6	Chinese	chinese	JJ
cord-029547-9ei1ram3	266	7	medicine	medicine	NN
cord-029547-9ei1ram3	266	8	,	,	,
cord-029547-9ei1ram3	266	9	which	which	WDT
cord-029547-9ei1ram3	266	10	was	be	VBD
cord-029547-9ei1ram3	266	11	found	find	VBN
cord-029547-9ei1ram3	266	12	to	to	TO
cord-029547-9ei1ram3	266	13	have	have	VB
cord-029547-9ei1ram3	266	14	hydrogen	hydrogen	NN
cord-029547-9ei1ram3	266	15	bonds	bond	NNS
cord-029547-9ei1ram3	266	16	to	to	IN
cord-029547-9ei1ram3	266	17	RNA	RNA	NNP
cord-029547-9ei1ram3	266	18	-	-	HYPH
cord-029547-9ei1ram3	266	19	dependent	dependent	JJ
cord-029547-9ei1ram3	266	20	RNA	RNA	NNP
cord-029547-9ei1ram3	266	21	polymerase	polymerase	NN
cord-029547-9ei1ram3	266	22	with	with	IN
cord-029547-9ei1ram3	266	23	a	a	DT
cord-029547-9ei1ram3	266	24	binding	bind	VBG
cord-029547-9ei1ram3	266	25	energy	energy	NN
cord-029547-9ei1ram3	266	26	of	of	IN
cord-029547-9ei1ram3	266	27	−8.8	−8.8	CD
cord-029547-9ei1ram3	266	28	kcal	kcal	NNP
cord-029547-9ei1ram3	266	29	/	/	SYM
cord-029547-9ei1ram3	266	30	mol	mol	NN
cord-029547-9ei1ram3	266	31	,	,	,
cord-029547-9ei1ram3	266	32	112	112	CD
cord-029547-9ei1ram3	267	1	thus	thus	RB
cord-029547-9ei1ram3	267	2	it	-PRON-	PRP
cord-029547-9ei1ram3	267	3	possibly	possibly	RB
cord-029547-9ei1ram3	267	4	inhibits	inhibit	VBZ
cord-029547-9ei1ram3	267	5	the	the	DT
cord-029547-9ei1ram3	267	6	proliferation	proliferation	NN
cord-029547-9ei1ram3	267	7	of	of	IN
cord-029547-9ei1ram3	267	8	SARS	SARS	NNP
cord-029547-9ei1ram3	267	9	-	-	HYPH
cord-029547-9ei1ram3	267	10	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	267	11	.	.	.
cord-029547-9ei1ram3	268	1	Lianhuaqingwen	Lianhuaqingwen	NNP
cord-029547-9ei1ram3	268	2	was	be	VBD
cord-029547-9ei1ram3	268	3	also	also	RB
cord-029547-9ei1ram3	268	4	confirmed	confirm	VBN
cord-029547-9ei1ram3	268	5	to	to	TO
cord-029547-9ei1ram3	268	6	significantly	significantly	RB
cord-029547-9ei1ram3	268	7	inhibit	inhibit	VB
cord-029547-9ei1ram3	268	8	the	the	DT
cord-029547-9ei1ram3	268	9	replication	replication	NN
cord-029547-9ei1ram3	268	10	of	of	IN
cord-029547-9ei1ram3	268	11	SARS	SARS	NNP
cord-029547-9ei1ram3	268	12	-	-	HYPH
cord-029547-9ei1ram3	268	13	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	268	14	and	and	CC
cord-029547-9ei1ram3	268	15	suppress	suppress	VB
cord-029547-9ei1ram3	268	16	the	the	DT
cord-029547-9ei1ram3	268	17	inflammatory	inflammatory	JJ
cord-029547-9ei1ram3	268	18	factors	factor	NNS
cord-029547-9ei1ram3	268	19	TNF	TNF	NNP
cord-029547-9ei1ram3	268	20	-	-	HYPH
cord-029547-9ei1ram3	268	21	α	α	NNP
cord-029547-9ei1ram3	268	22	,	,	,
cord-029547-9ei1ram3	268	23	IL-6	IL-6	NNP
cord-029547-9ei1ram3	268	24	,	,	,
cord-029547-9ei1ram3	268	25	CCL-2	CCL-2	NNP
cord-029547-9ei1ram3	268	26	/	/	SYM
cord-029547-9ei1ram3	268	27	MCP-1	MCP-1	NNP
cord-029547-9ei1ram3	268	28	,	,	,
cord-029547-9ei1ram3	268	29	and	and	CC
cord-029547-9ei1ram3	268	30	CXCL-10	cxcl-10	NN
cord-029547-9ei1ram3	268	31	/	/	SYM
cord-029547-9ei1ram3	268	32	IP-10	IP-10	NNP
cord-029547-9ei1ram3	268	33	in	in	IN
cord-029547-9ei1ram3	268	34	Vero	Vero	NNP
cord-029547-9ei1ram3	268	35	E6	E6	NNP
cord-029547-9ei1ram3	268	36	cells	cell	NNS
cord-029547-9ei1ram3	268	37	,	,	,
cord-029547-9ei1ram3	268	38	113	113	CD
cord-029547-9ei1ram3	269	1	so	so	CC
cord-029547-9ei1ram3	269	2	it	-PRON-	PRP
cord-029547-9ei1ram3	269	3	is	be	VBZ
cord-029547-9ei1ram3	269	4	potentially	potentially	RB
cord-029547-9ei1ram3	269	5	a	a	DT
cord-029547-9ei1ram3	269	6	specific	specific	JJ
cord-029547-9ei1ram3	269	7	medicine	medicine	NN
cord-029547-9ei1ram3	269	8	for	for	IN
cord-029547-9ei1ram3	269	9	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	269	10	both	both	CC
cord-029547-9ei1ram3	269	11	etiologically	etiologically	RB
cord-029547-9ei1ram3	269	12	and	and	CC
cord-029547-9ei1ram3	269	13	symptomatically	symptomatically	RB
cord-029547-9ei1ram3	269	14	.	.	.
cord-029547-9ei1ram3	270	1	The	the	DT
cord-029547-9ei1ram3	270	2	prevention	prevention	NN
cord-029547-9ei1ram3	270	3	and	and	CC
cord-029547-9ei1ram3	270	4	control	control	NN
cord-029547-9ei1ram3	270	5	of	of	IN
cord-029547-9ei1ram3	270	6	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	270	7	can	can	MD
cord-029547-9ei1ram3	270	8	be	be	VB
cord-029547-9ei1ram3	270	9	divided	divide	VBN
cord-029547-9ei1ram3	270	10	into	into	IN
cord-029547-9ei1ram3	270	11	controlling	control	VBG
cord-029547-9ei1ram3	270	12	the	the	DT
cord-029547-9ei1ram3	270	13	source	source	NN
cord-029547-9ei1ram3	270	14	of	of	IN
cord-029547-9ei1ram3	270	15	infection	infection	NN
cord-029547-9ei1ram3	270	16	,	,	,
cord-029547-9ei1ram3	270	17	cutting	cut	VBG
cord-029547-9ei1ram3	270	18	off	off	RP
cord-029547-9ei1ram3	270	19	the	the	DT
cord-029547-9ei1ram3	270	20	transmission	transmission	NN
cord-029547-9ei1ram3	270	21	route	route	NN
cord-029547-9ei1ram3	270	22	,	,	,
cord-029547-9ei1ram3	270	23	and	and	CC
cord-029547-9ei1ram3	270	24	protecting	protect	VBG
cord-029547-9ei1ram3	270	25	susceptible	susceptible	JJ
cord-029547-9ei1ram3	270	26	people	people	NNS
cord-029547-9ei1ram3	270	27	.	.	.
cord-029547-9ei1ram3	271	1	Controlling	control	VBG
cord-029547-9ei1ram3	271	2	the	the	DT
cord-029547-9ei1ram3	271	3	source	source	NN
cord-029547-9ei1ram3	271	4	of	of	IN
cord-029547-9ei1ram3	271	5	infection	infection	NN
cord-029547-9ei1ram3	271	6	in	in	IN
cord-029547-9ei1ram3	271	7	this	this	DT
cord-029547-9ei1ram3	271	8	outbreak	outbreak	NN
cord-029547-9ei1ram3	271	9	mainly	mainly	RB
cord-029547-9ei1ram3	271	10	refers	refer	VBZ
cord-029547-9ei1ram3	271	11	to	to	IN
cord-029547-9ei1ram3	271	12	timely	timely	JJ
cord-029547-9ei1ram3	271	13	isolation	isolation	NN
cord-029547-9ei1ram3	271	14	of	of	IN
cord-029547-9ei1ram3	271	15	suspected	suspect	VBN
cord-029547-9ei1ram3	271	16	and	and	CC
cord-029547-9ei1ram3	271	17	confirmed	confirm	VBN
cord-029547-9ei1ram3	271	18	cases	case	NNS
cord-029547-9ei1ram3	271	19	,	,	,
cord-029547-9ei1ram3	271	20	which	which	WDT
cord-029547-9ei1ram3	271	21	greatly	greatly	RB
cord-029547-9ei1ram3	271	22	depends	depend	VBZ
cord-029547-9ei1ram3	271	23	on	on	IN
cord-029547-9ei1ram3	271	24	wireless	wireless	JJ
cord-029547-9ei1ram3	271	25	communication	communication	NN
cord-029547-9ei1ram3	271	26	data	datum	NNS
cord-029547-9ei1ram3	271	27	.	.	.
cord-029547-9ei1ram3	272	1	114	114	CD
cord-029547-9ei1ram3	272	2	Isolation	isolation	NN
cord-029547-9ei1ram3	272	3	of	of	IN
cord-029547-9ei1ram3	272	4	convalescent	convalescent	JJ
cord-029547-9ei1ram3	272	5	patients	patient	NNS
cord-029547-9ei1ram3	272	6	is	be	VBZ
cord-029547-9ei1ram3	272	7	also	also	RB
cord-029547-9ei1ram3	272	8	necessary	necessary	JJ
cord-029547-9ei1ram3	272	9	,	,	,
cord-029547-9ei1ram3	272	10	because	because	IN
cord-029547-9ei1ram3	272	11	some	some	DT
cord-029547-9ei1ram3	272	12	of	of	IN
cord-029547-9ei1ram3	272	13	them	-PRON-	PRP
cord-029547-9ei1ram3	272	14	have	have	VBP
cord-029547-9ei1ram3	272	15	a	a	DT
cord-029547-9ei1ram3	272	16	positive	positive	JJ
cord-029547-9ei1ram3	272	17	RT	RT	NNP
cord-029547-9ei1ram3	272	18	-	-	HYPH
cord-029547-9ei1ram3	272	19	PCR	PCR	NNP
cord-029547-9ei1ram3	272	20	test	test	NN
cord-029547-9ei1ram3	272	21	even	even	RB
cord-029547-9ei1ram3	272	22	after	after	IN
cord-029547-9ei1ram3	272	23	13	13	CD
cord-029547-9ei1ram3	272	24	days	day	NNS
cord-029547-9ei1ram3	272	25	of	of	IN
cord-029547-9ei1ram3	272	26	recovery	recovery	NN
cord-029547-9ei1ram3	272	27	.	.	.
cord-029547-9ei1ram3	273	1	115	115	CD
cord-029547-9ei1ram3	273	2	Cutting	cut	VBG
cord-029547-9ei1ram3	273	3	off	off	RP
cord-029547-9ei1ram3	273	4	the	the	DT
cord-029547-9ei1ram3	273	5	transmission	transmission	NN
cord-029547-9ei1ram3	273	6	route	route	NN
cord-029547-9ei1ram3	273	7	includes	include	VBZ
cord-029547-9ei1ram3	273	8	sterilizing	sterilize	VBG
cord-029547-9ei1ram3	273	9	and	and	CC
cord-029547-9ei1ram3	273	10	wearing	wear	VBG
cord-029547-9ei1ram3	273	11	suitable	suitable	JJ
cord-029547-9ei1ram3	273	12	masks	mask	NNS
cord-029547-9ei1ram3	273	13	such	such	JJ
cord-029547-9ei1ram3	273	14	as	as	IN
cord-029547-9ei1ram3	273	15	N95	N95	NNP
cord-029547-9ei1ram3	273	16	,	,	,
cord-029547-9ei1ram3	273	17	KN95	KN95	NNP
cord-029547-9ei1ram3	273	18	,	,	,
cord-029547-9ei1ram3	273	19	and	and	CC
cord-029547-9ei1ram3	273	20	medical	medical	JJ
cord-029547-9ei1ram3	273	21	surgical	surgical	JJ
cord-029547-9ei1ram3	273	22	masks	mask	NNS
cord-029547-9ei1ram3	273	23	.	.	.
cord-029547-9ei1ram3	274	1	116	116	LS
cord-029547-9ei1ram3	274	2	Protecting	protect	VBG
cord-029547-9ei1ram3	274	3	susceptible	susceptible	JJ
cord-029547-9ei1ram3	274	4	people	people	NNS
cord-029547-9ei1ram3	274	5	means	mean	VBZ
cord-029547-9ei1ram3	274	6	self	self	NN
cord-029547-9ei1ram3	274	7	-	-	HYPH
cord-029547-9ei1ram3	274	8	segregation	segregation	NN
cord-029547-9ei1ram3	274	9	,	,	,
cord-029547-9ei1ram3	274	10	improving	improve	VBG
cord-029547-9ei1ram3	274	11	constitution	constitution	NN
cord-029547-9ei1ram3	274	12	,	,	,
cord-029547-9ei1ram3	274	13	and	and	CC
cord-029547-9ei1ram3	274	14	prophylactic	prophylactic	JJ
cord-029547-9ei1ram3	274	15	vaccination	vaccination	NN
cord-029547-9ei1ram3	274	16	.	.	.
cord-029547-9ei1ram3	275	1	Considering	consider	VBG
cord-029547-9ei1ram3	275	2	the	the	DT
cord-029547-9ei1ram3	275	3	strong	strong	JJ
cord-029547-9ei1ram3	275	4	infectivity	infectivity	NN
cord-029547-9ei1ram3	275	5	of	of	IN
cord-029547-9ei1ram3	275	6	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	275	7	,	,	,
cord-029547-9ei1ram3	275	8	the	the	DT
cord-029547-9ei1ram3	275	9	secondary	secondary	JJ
cord-029547-9ei1ram3	275	10	outbreak	outbreak	NN
cord-029547-9ei1ram3	275	11	of	of	IN
cord-029547-9ei1ram3	275	12	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	275	13	can	can	MD
cord-029547-9ei1ram3	275	14	be	be	VB
cord-029547-9ei1ram3	275	15	prevented	prevent	VBN
cord-029547-9ei1ram3	275	16	only	only	RB
cord-029547-9ei1ram3	275	17	if	if	IN
cord-029547-9ei1ram3	275	18	the	the	DT
cord-029547-9ei1ram3	275	19	public	public	NN
cord-029547-9ei1ram3	275	20	has	have	VBZ
cord-029547-9ei1ram3	275	21	immunity	immunity	NN
cord-029547-9ei1ram3	275	22	to	to	IN
cord-029547-9ei1ram3	275	23	SARS	SARS	NNP
cord-029547-9ei1ram3	275	24	-	-	HYPH
cord-029547-9ei1ram3	275	25	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	275	26	,	,	,
cord-029547-9ei1ram3	275	27	thus	thus	RB
cord-029547-9ei1ram3	275	28	vaccine	vaccine	NN
cord-029547-9ei1ram3	275	29	is	be	VBZ
cord-029547-9ei1ram3	275	30	the	the	DT
cord-029547-9ei1ram3	275	31	key	key	JJ
cord-029547-9ei1ram3	275	32	area	area	NN
cord-029547-9ei1ram3	275	33	among	among	IN
cord-029547-9ei1ram3	275	34	all	all	DT
cord-029547-9ei1ram3	275	35	prevention	prevention	NN
cord-029547-9ei1ram3	275	36	measures	measure	NNS
cord-029547-9ei1ram3	275	37	.	.	.
cord-029547-9ei1ram3	276	1	Therefore	therefore	RB
cord-029547-9ei1ram3	276	2	,	,	,
cord-029547-9ei1ram3	276	3	scientists	scientist	NNS
cord-029547-9ei1ram3	276	4	all	all	RB
cord-029547-9ei1ram3	276	5	over	over	IN
cord-029547-9ei1ram3	276	6	the	the	DT
cord-029547-9ei1ram3	276	7	world	world	NN
cord-029547-9ei1ram3	276	8	are	be	VBP
cord-029547-9ei1ram3	276	9	working	work	VBG
cord-029547-9ei1ram3	276	10	on	on	IN
cord-029547-9ei1ram3	276	11	the	the	DT
cord-029547-9ei1ram3	276	12	vaccine	vaccine	NN
cord-029547-9ei1ram3	276	13	for	for	IN
cord-029547-9ei1ram3	276	14	SARS	SARS	NNP
cord-029547-9ei1ram3	276	15	-	-	HYPH
cord-029547-9ei1ram3	276	16	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	276	17	,	,	,
cord-029547-9ei1ram3	276	18	aiming	aim	VBG
cord-029547-9ei1ram3	276	19	to	to	TO
cord-029547-9ei1ram3	276	20	completely	completely	RB
cord-029547-9ei1ram3	276	21	control	control	VB
cord-029547-9ei1ram3	276	22	the	the	DT
cord-029547-9ei1ram3	276	23	outbreak	outbreak	NN
cord-029547-9ei1ram3	276	24	.	.	.
cord-029547-9ei1ram3	277	1	After	after	IN
cord-029547-9ei1ram3	277	2	a	a	DT
cord-029547-9ei1ram3	277	3	long	long	JJ
cord-029547-9ei1ram3	277	4	period	period	NN
cord-029547-9ei1ram3	277	5	of	of	IN
cord-029547-9ei1ram3	277	6	effort	effort	NN
cord-029547-9ei1ram3	277	7	,	,	,
cord-029547-9ei1ram3	277	8	the	the	DT
cord-029547-9ei1ram3	277	9	vaccine	vaccine	NN
cord-029547-9ei1ram3	277	10	targets	target	NNS
cord-029547-9ei1ram3	277	11	of	of	IN
cord-029547-9ei1ram3	277	12	the	the	DT
cord-029547-9ei1ram3	277	13	virus	virus	NN
cord-029547-9ei1ram3	277	14	had	have	VBD
cord-029547-9ei1ram3	277	15	been	be	VBN
cord-029547-9ei1ram3	277	16	found	find	VBN
cord-029547-9ei1ram3	277	17	and	and	CC
cord-029547-9ei1ram3	277	18	shared	share	VBN
cord-029547-9ei1ram3	277	19	with	with	IN
cord-029547-9ei1ram3	277	20	the	the	DT
cord-029547-9ei1ram3	277	21	world	world	NN
cord-029547-9ei1ram3	277	22	.	.	.
cord-029547-9ei1ram3	278	1	117	117	CD
cord-029547-9ei1ram3	278	2	,	,	,
cord-029547-9ei1ram3	278	3	118	118	CD
cord-029547-9ei1ram3	278	4	Soon	soon	RB
cord-029547-9ei1ram3	278	5	afterward	afterward	RB
cord-029547-9ei1ram3	278	6	,	,	,
cord-029547-9ei1ram3	278	7	medical	medical	JJ
cord-029547-9ei1ram3	278	8	institutions	institution	NNS
cord-029547-9ei1ram3	278	9	around	around	IN
cord-029547-9ei1ram3	278	10	the	the	DT
cord-029547-9ei1ram3	278	11	world	world	NN
cord-029547-9ei1ram3	278	12	adapted	adapt	VBD
cord-029547-9ei1ram3	278	13	joint	joint	JJ
cord-029547-9ei1ram3	278	14	research	research	NN
cord-029547-9ei1ram3	278	15	and	and	CC
cord-029547-9ei1ram3	278	16	identified	identify	VBD
cord-029547-9ei1ram3	278	17	five	five	CD
cord-029547-9ei1ram3	278	18	development	development	NN
cord-029547-9ei1ram3	278	19	approaches	approach	NNS
cord-029547-9ei1ram3	278	20	,	,	,
cord-029547-9ei1ram3	278	21	including	include	VBG
cord-029547-9ei1ram3	278	22	a	a	DT
cord-029547-9ei1ram3	278	23	live	live	JJ
cord-029547-9ei1ram3	278	24	attenuated	attenuated	JJ
cord-029547-9ei1ram3	278	25	vaccine	vaccine	NN
cord-029547-9ei1ram3	278	26	,	,	,
cord-029547-9ei1ram3	278	27	inactivated	inactivate	VBN
cord-029547-9ei1ram3	278	28	whole	whole	JJ
cord-029547-9ei1ram3	278	29	-	-	HYPH
cord-029547-9ei1ram3	278	30	virus	virus	NN
cord-029547-9ei1ram3	278	31	vaccine	vaccine	NN
cord-029547-9ei1ram3	278	32	,	,	,
cord-029547-9ei1ram3	278	33	nucleic	nucleic	JJ
cord-029547-9ei1ram3	278	34	acid	acid	NN
cord-029547-9ei1ram3	278	35	vaccine	vaccine	NN
cord-029547-9ei1ram3	278	36	,	,	,
cord-029547-9ei1ram3	278	37	protein	protein	NN
cord-029547-9ei1ram3	278	38	vaccine	vaccine	NN
cord-029547-9ei1ram3	278	39	,	,	,
cord-029547-9ei1ram3	278	40	and	and	CC
cord-029547-9ei1ram3	278	41	viral	viral	JJ
cord-029547-9ei1ram3	278	42	vector	vector	NN
cord-029547-9ei1ram3	278	43	-	-	HYPH
cord-029547-9ei1ram3	278	44	based	base	VBN
cord-029547-9ei1ram3	278	45	vaccine	vaccine	NN
cord-029547-9ei1ram3	278	46	(	(	-LRB-
cord-029547-9ei1ram3	278	47	Table	Table	NNP
cord-029547-9ei1ram3	278	48	4	4	CD
cord-029547-9ei1ram3	278	49	)	)	-RRB-
cord-029547-9ei1ram3	278	50	,	,	,
cord-029547-9ei1ram3	278	51	119	119	CD
cord-029547-9ei1ram3	278	52	and	and	CC
cord-029547-9ei1ram3	278	53	most	most	JJS
cord-029547-9ei1ram3	278	54	of	of	IN
cord-029547-9ei1ram3	278	55	them	-PRON-	PRP
cord-029547-9ei1ram3	278	56	used	use	VBD
cord-029547-9ei1ram3	278	57	the	the	DT
cord-029547-9ei1ram3	278	58	S	S	NNP
cord-029547-9ei1ram3	278	59	protein	protein	NN
cord-029547-9ei1ram3	278	60	of	of	IN
cord-029547-9ei1ram3	278	61	SARS	SARS	NNP
cord-029547-9ei1ram3	278	62	-	-	HYPH
cord-029547-9ei1ram3	278	63	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	278	64	as	as	IN
cord-029547-9ei1ram3	278	65	the	the	DT
cord-029547-9ei1ram3	278	66	main	main	JJ
cord-029547-9ei1ram3	278	67	inducer	inducer	NN
cord-029547-9ei1ram3	278	68	of	of	IN
cord-029547-9ei1ram3	278	69	neutralizing	neutralize	VBG
cord-029547-9ei1ram3	278	70	antibodies	antibody	NNS
cord-029547-9ei1ram3	278	71	directly	directly	RB
cord-029547-9ei1ram3	278	72	,	,	,
cord-029547-9ei1ram3	278	73	or	or	CC
cord-029547-9ei1ram3	278	74	inducing	induce	VBG
cord-029547-9ei1ram3	278	75	the	the	DT
cord-029547-9ei1ram3	278	76	expression	expression	NN
cord-029547-9ei1ram3	278	77	of	of	IN
cord-029547-9ei1ram3	278	78	the	the	DT
cord-029547-9ei1ram3	278	79	whole	whole	JJ
cord-029547-9ei1ram3	278	80	S	S	NNP
cord-029547-9ei1ram3	278	81	protein	protein	NN
cord-029547-9ei1ram3	278	82	or	or	CC
cord-029547-9ei1ram3	278	83	receptor	receptor	NN
cord-029547-9ei1ram3	278	84	-	-	HYPH
cord-029547-9ei1ram3	278	85	binding	bind	VBG
cord-029547-9ei1ram3	278	86	domain	domain	NN
cord-029547-9ei1ram3	278	87	of	of	IN
cord-029547-9ei1ram3	278	88	the	the	DT
cord-029547-9ei1ram3	278	89	S	S	NNP
cord-029547-9ei1ram3	278	90	protein	protein	NN
cord-029547-9ei1ram3	278	91	indirectly	indirectly	RB
cord-029547-9ei1ram3	278	92	.	.	.
cord-029547-9ei1ram3	279	1	120	120	CD
cord-029547-9ei1ram3	280	1	By	by	IN
cord-029547-9ei1ram3	280	2	interaction	interaction	NN
cord-029547-9ei1ram3	280	3	of	of	IN
cord-029547-9ei1ram3	280	4	the	the	DT
cord-029547-9ei1ram3	280	5	S	S	NNP
cord-029547-9ei1ram3	280	6	protein	protein	NN
cord-029547-9ei1ram3	280	7	and	and	CC
cord-029547-9ei1ram3	280	8	ACE2	ACE2	NNP
cord-029547-9ei1ram3	280	9	of	of	IN
cord-029547-9ei1ram3	280	10	host	host	NN
cord-029547-9ei1ram3	280	11	cells	cell	NNS
cord-029547-9ei1ram3	280	12	,	,	,
cord-029547-9ei1ram3	280	13	uncoating	uncoating	NN
cord-029547-9ei1ram3	280	14	and	and	CC
cord-029547-9ei1ram3	280	15	penetration	penetration	NN
cord-029547-9ei1ram3	280	16	of	of	IN
cord-029547-9ei1ram3	280	17	SARS	SARS	NNP
cord-029547-9ei1ram3	280	18	-	-	HYPH
cord-029547-9ei1ram3	280	19	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	280	20	are	be	VBP
cord-029547-9ei1ram3	280	21	induced	induce	VBN
cord-029547-9ei1ram3	280	22	.	.	.
cord-029547-9ei1ram3	281	1	23	23	CD
cord-029547-9ei1ram3	282	1	Thus	thus	RB
cord-029547-9ei1ram3	282	2	,	,	,
cord-029547-9ei1ram3	282	3	S	s	NN
cord-029547-9ei1ram3	282	4	-	-	HYPH
cord-029547-9ei1ram3	282	5	protein	protein	NN
cord-029547-9ei1ram3	282	6	-	-	HYPH
cord-029547-9ei1ram3	282	7	based	base	VBN
cord-029547-9ei1ram3	282	8	vaccines	vaccine	NNS
cord-029547-9ei1ram3	282	9	potentially	potentially	RB
cord-029547-9ei1ram3	282	10	inhibit	inhibit	VBP
cord-029547-9ei1ram3	282	11	the	the	DT
cord-029547-9ei1ram3	282	12	uncoating	uncoating	NN
cord-029547-9ei1ram3	282	13	and	and	CC
cord-029547-9ei1ram3	282	14	penetration	penetration	NN
cord-029547-9ei1ram3	282	15	of	of	IN
cord-029547-9ei1ram3	282	16	the	the	DT
cord-029547-9ei1ram3	282	17	virus	virus	NN
cord-029547-9ei1ram3	282	18	.	.	.
cord-029547-9ei1ram3	283	1	Whole	whole	JJ
cord-029547-9ei1ram3	283	2	-	-	HYPH
cord-029547-9ei1ram3	283	3	virus	virus	NN
cord-029547-9ei1ram3	283	4	vaccines	vaccine	NNS
cord-029547-9ei1ram3	283	5	are	be	VBP
cord-029547-9ei1ram3	283	6	conventional	conventional	JJ
cord-029547-9ei1ram3	283	7	strategies	strategy	NNS
cord-029547-9ei1ram3	283	8	to	to	TO
cord-029547-9ei1ram3	283	9	develop	develop	VB
cord-029547-9ei1ram3	283	10	a	a	DT
cord-029547-9ei1ram3	283	11	vaccine	vaccine	NN
cord-029547-9ei1ram3	283	12	for	for	IN
cord-029547-9ei1ram3	283	13	most	most	JJS
cord-029547-9ei1ram3	283	14	viruses	virus	NNS
cord-029547-9ei1ram3	283	15	.	.	.
cord-029547-9ei1ram3	284	1	By	by	IN
cord-029547-9ei1ram3	284	2	injecting	inject	VBG
cord-029547-9ei1ram3	284	3	artificially	artificially	RB
cord-029547-9ei1ram3	284	4	attenuated	attenuate	VBN
cord-029547-9ei1ram3	284	5	or	or	CC
cord-029547-9ei1ram3	284	6	inactivated	inactivate	VBN
cord-029547-9ei1ram3	284	7	viruses	virus	NNS
cord-029547-9ei1ram3	284	8	,	,	,
cord-029547-9ei1ram3	284	9	pathogens	pathogen	NNS
cord-029547-9ei1ram3	284	10	trigger	trigger	VBP
cord-029547-9ei1ram3	284	11	the	the	DT
cord-029547-9ei1ram3	284	12	body	body	NN
cord-029547-9ei1ram3	284	13	's	's	POS
cord-029547-9ei1ram3	284	14	immune	immune	JJ
cord-029547-9ei1ram3	284	15	response	response	NN
cord-029547-9ei1ram3	284	16	without	without	IN
cord-029547-9ei1ram3	284	17	causing	cause	VBG
cord-029547-9ei1ram3	284	18	disease	disease	NN
cord-029547-9ei1ram3	284	19	.	.	.
cord-029547-9ei1ram3	285	1	Compared	compare	VBN
cord-029547-9ei1ram3	285	2	to	to	IN
cord-029547-9ei1ram3	285	3	other	other	JJ
cord-029547-9ei1ram3	285	4	vaccines	vaccine	NNS
cord-029547-9ei1ram3	285	5	,	,	,
cord-029547-9ei1ram3	285	6	these	these	DT
cord-029547-9ei1ram3	285	7	keep	keep	VBP
cord-029547-9ei1ram3	285	8	the	the	DT
cord-029547-9ei1ram3	285	9	inherent	inherent	JJ
cord-029547-9ei1ram3	285	10	immunogenicity	immunogenicity	NN
cord-029547-9ei1ram3	285	11	of	of	IN
cord-029547-9ei1ram3	285	12	SARS	SARS	NNP
cord-029547-9ei1ram3	285	13	-	-	HYPH
cord-029547-9ei1ram3	285	14	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	285	15	and	and	CC
cord-029547-9ei1ram3	285	16	stimulate	stimulate	VB
cord-029547-9ei1ram3	285	17	the	the	DT
cord-029547-9ei1ram3	285	18	body	body	NN
cord-029547-9ei1ram3	285	19	's	's	POS
cord-029547-9ei1ram3	285	20	innate	innate	JJ
cord-029547-9ei1ram3	285	21	immunity	immunity	NN
cord-029547-9ei1ram3	285	22	such	such	JJ
cord-029547-9ei1ram3	285	23	as	as	IN
cord-029547-9ei1ram3	285	24	releasing	release	VBG
cord-029547-9ei1ram3	285	25	toll	toll	NN
cord-029547-9ei1ram3	285	26	-	-	HYPH
cord-029547-9ei1ram3	285	27	like	like	JJ
cord-029547-9ei1ram3	285	28	receptors	receptor	NNS
cord-029547-9ei1ram3	285	29	.	.	.
cord-029547-9ei1ram3	286	1	However	however	RB
cord-029547-9ei1ram3	286	2	,	,	,
cord-029547-9ei1ram3	286	3	live	live	JJ
cord-029547-9ei1ram3	286	4	viruses	virus	NNS
cord-029547-9ei1ram3	286	5	have	have	VBP
cord-029547-9ei1ram3	286	6	the	the	DT
cord-029547-9ei1ram3	286	7	potential	potential	NN
cord-029547-9ei1ram3	286	8	to	to	TO
cord-029547-9ei1ram3	286	9	cause	cause	VB
cord-029547-9ei1ram3	286	10	disease	disease	NN
cord-029547-9ei1ram3	286	11	.	.	.
cord-029547-9ei1ram3	287	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	287	2	,	,	,
cord-029547-9ei1ram3	287	3	it	-PRON-	PRP
cord-029547-9ei1ram3	287	4	has	have	VBZ
cord-029547-9ei1ram3	287	5	been	be	VBN
cord-029547-9ei1ram3	287	6	reported	report	VBN
cord-029547-9ei1ram3	287	7	that	that	IN
cord-029547-9ei1ram3	287	8	patients	patient	NNS
cord-029547-9ei1ram3	287	9	were	be	VBD
cord-029547-9ei1ram3	287	10	more	more	RBR
cord-029547-9ei1ram3	287	11	easily	easily	RB
cord-029547-9ei1ram3	287	12	infected	infect	VBN
cord-029547-9ei1ram3	287	13	by	by	IN
cord-029547-9ei1ram3	287	14	SARS	SARS	NNP
cord-029547-9ei1ram3	287	15	-	-	HYPH
cord-029547-9ei1ram3	287	16	CoV	CoV	NNP
cord-029547-9ei1ram3	287	17	after	after	IN
cord-029547-9ei1ram3	287	18	immunization	immunization	NN
cord-029547-9ei1ram3	287	19	with	with	IN
cord-029547-9ei1ram3	287	20	a	a	DT
cord-029547-9ei1ram3	287	21	live	live	JJ
cord-029547-9ei1ram3	287	22	attenuated	attenuated	JJ
cord-029547-9ei1ram3	287	23	vaccine	vaccine	NN
cord-029547-9ei1ram3	287	24	or	or	CC
cord-029547-9ei1ram3	287	25	inactivated	inactivate	VBN
cord-029547-9ei1ram3	287	26	wholevirus	wholevirus	NNP
cord-029547-9ei1ram3	287	27	vaccine	vaccine	NN
cord-029547-9ei1ram3	287	28	.	.	.
cord-029547-9ei1ram3	288	1	121	121	CD
cord-029547-9ei1ram3	289	1	Thus	thus	RB
cord-029547-9ei1ram3	289	2	,	,	,
cord-029547-9ei1ram3	289	3	sufficient	sufficient	JJ
cord-029547-9ei1ram3	289	4	experiments	experiment	NNS
cord-029547-9ei1ram3	289	5	are	be	VBP
cord-029547-9ei1ram3	289	6	necessary	necessary	JJ
cord-029547-9ei1ram3	289	7	to	to	TO
cord-029547-9ei1ram3	289	8	verify	verify	VB
cord-029547-9ei1ram3	289	9	their	-PRON-	PRP$
cord-029547-9ei1ram3	289	10	safety	safety	NN
cord-029547-9ei1ram3	289	11	.	.	.
cord-029547-9ei1ram3	290	1	Currently	currently	RB
cord-029547-9ei1ram3	290	2	,	,	,
cord-029547-9ei1ram3	290	3	three	three	CD
cord-029547-9ei1ram3	290	4	inactivated	inactivate	VBN
cord-029547-9ei1ram3	290	5	novel	novel	JJ
cord-029547-9ei1ram3	290	6	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	290	7	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	290	8	vaccines	vaccine	NNS
cord-029547-9ei1ram3	290	9	have	have	VBP
cord-029547-9ei1ram3	290	10	entered	enter	VBN
cord-029547-9ei1ram3	290	11	the	the	DT
cord-029547-9ei1ram3	290	12	phase	phase	NN
cord-029547-9ei1ram3	290	13	I	-PRON-	PRP
cord-029547-9ei1ram3	290	14	/	/	SYM
cord-029547-9ei1ram3	290	15	II	II	NNP
cord-029547-9ei1ram3	290	16	clinical	clinical	JJ
cord-029547-9ei1ram3	290	17	trials	trial	NNS
cord-029547-9ei1ram3	290	18	.	.	.
cord-029547-9ei1ram3	291	1	[	[	-LRB-
cord-029547-9ei1ram3	291	2	122	122	CD
cord-029547-9ei1ram3	291	3	]	]	-RRB-
cord-029547-9ei1ram3	291	4	[	[	-LRB-
cord-029547-9ei1ram3	291	5	123	123	CD
cord-029547-9ei1ram3	291	6	]	]	-RRB-
cord-029547-9ei1ram3	292	1	[	[	-LRB-
cord-029547-9ei1ram3	292	2	124	124	CD
cord-029547-9ei1ram3	292	3	]	]	-RRB-
cord-029547-9ei1ram3	292	4	Nucleic	nucleic	JJ
cord-029547-9ei1ram3	292	5	acid	acid	NN
cord-029547-9ei1ram3	292	6	vaccine	vaccine	NN
cord-029547-9ei1ram3	292	7	Nucleic	nucleic	JJ
cord-029547-9ei1ram3	292	8	acid	acid	NN
cord-029547-9ei1ram3	292	9	vaccines	vaccine	NNS
cord-029547-9ei1ram3	292	10	,	,	,
cord-029547-9ei1ram3	292	11	including	include	VBG
cord-029547-9ei1ram3	292	12	DNA	dna	NN
cord-029547-9ei1ram3	292	13	vaccines	vaccine	NNS
cord-029547-9ei1ram3	292	14	and	and	CC
cord-029547-9ei1ram3	292	15	mRNA	mrna	NN
cord-029547-9ei1ram3	292	16	vaccines	vaccine	NNS
cord-029547-9ei1ram3	292	17	,	,	,
cord-029547-9ei1ram3	292	18	are	be	VBP
cord-029547-9ei1ram3	292	19	to	to	TO
cord-029547-9ei1ram3	292	20	directly	directly	RB
cord-029547-9ei1ram3	292	21	deliver	deliver	VB
cord-029547-9ei1ram3	292	22	foreign	foreign	JJ
cord-029547-9ei1ram3	292	23	genes	gene	NNS
cord-029547-9ei1ram3	292	24	encoding	encode	VBG
cord-029547-9ei1ram3	292	25	antigenic	antigenic	JJ
cord-029547-9ei1ram3	292	26	proteins	protein	NNS
cord-029547-9ei1ram3	292	27	into	into	IN
cord-029547-9ei1ram3	292	28	host	host	NN
cord-029547-9ei1ram3	292	29	cells	cell	NNS
cord-029547-9ei1ram3	292	30	and	and	CC
cord-029547-9ei1ram3	292	31	synthesize	synthesize	VB
cord-029547-9ei1ram3	292	32	the	the	DT
cord-029547-9ei1ram3	292	33	antigenic	antigenic	JJ
cord-029547-9ei1ram3	292	34	proteins	protein	NNS
cord-029547-9ei1ram3	292	35	by	by	IN
cord-029547-9ei1ram3	292	36	host	host	NN
cord-029547-9ei1ram3	292	37	cells	cell	NNS
cord-029547-9ei1ram3	292	38	to	to	TO
cord-029547-9ei1ram3	292	39	induce	induce	VB
cord-029547-9ei1ram3	292	40	the	the	DT
cord-029547-9ei1ram3	292	41	immunity	immunity	NN
cord-029547-9ei1ram3	292	42	of	of	IN
cord-029547-9ei1ram3	292	43	hosts	host	NNS
cord-029547-9ei1ram3	292	44	.	.	.
cord-029547-9ei1ram3	293	1	Nucleic	nucleic	JJ
cord-029547-9ei1ram3	293	2	acid	acid	JJ
cord-029547-9ei1ram3	293	3	vaccines	vaccine	NNS
cord-029547-9ei1ram3	293	4	of	of	IN
cord-029547-9ei1ram3	293	5	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	293	6	mainly	mainly	RB
cord-029547-9ei1ram3	293	7	aim	aim	VBP
cord-029547-9ei1ram3	293	8	to	to	TO
cord-029547-9ei1ram3	293	9	induce	induce	VB
cord-029547-9ei1ram3	293	10	the	the	DT
cord-029547-9ei1ram3	293	11	whole	whole	JJ
cord-029547-9ei1ram3	293	12	S	S	NNP
cord-029547-9ei1ram3	293	13	protein	protein	NN
cord-029547-9ei1ram3	293	14	or	or	CC
cord-029547-9ei1ram3	293	15	receptorbinding	receptorbinding	NN
cord-029547-9ei1ram3	293	16	domain	domain	NN
cord-029547-9ei1ram3	293	17	of	of	IN
cord-029547-9ei1ram3	293	18	S	S	NNP
cord-029547-9ei1ram3	293	19	protein	protein	NN
cord-029547-9ei1ram3	293	20	expression	expression	NN
cord-029547-9ei1ram3	293	21	,	,	,
cord-029547-9ei1ram3	293	22	and	and	CC
cord-029547-9ei1ram3	293	23	several	several	JJ
cord-029547-9ei1ram3	293	24	of	of	IN
cord-029547-9ei1ram3	293	25	them	-PRON-	PRP
cord-029547-9ei1ram3	293	26	have	have	VBP
cord-029547-9ei1ram3	293	27	entered	enter	VBN
cord-029547-9ei1ram3	293	28	clinical	clinical	JJ
cord-029547-9ei1ram3	293	29	trials	trial	NNS
cord-029547-9ei1ram3	293	30	.	.	.
cord-029547-9ei1ram3	294	1	125	125	CD
cord-029547-9ei1ram3	295	1	For	for	IN
cord-029547-9ei1ram3	295	2	example	example	NN
cord-029547-9ei1ram3	295	3	,	,	,
cord-029547-9ei1ram3	295	4	researchers	researcher	NNS
cord-029547-9ei1ram3	295	5	of	of	IN
cord-029547-9ei1ram3	295	6	Inovio	Inovio	NNP
cord-029547-9ei1ram3	295	7	Pharmaceuticals	Pharmaceuticals	NNPS
cord-029547-9ei1ram3	295	8	are	be	VBP
cord-029547-9ei1ram3	295	9	conducting	conduct	VBG
cord-029547-9ei1ram3	295	10	the	the	DT
cord-029547-9ei1ram3	295	11	clinical	clinical	JJ
cord-029547-9ei1ram3	295	12	trial	trial	NN
cord-029547-9ei1ram3	295	13	of	of	IN
cord-029547-9ei1ram3	295	14	a	a	DT
cord-029547-9ei1ram3	295	15	DNA	dna	NN
cord-029547-9ei1ram3	295	16	vaccine	vaccine	NN
cord-029547-9ei1ram3	295	17	.	.	.
cord-029547-9ei1ram3	296	1	126	126	CD
cord-029547-9ei1ram3	297	1	In	in	IN
cord-029547-9ei1ram3	297	2	the	the	DT
cord-029547-9ei1ram3	297	3	meantime	meantime	NN
cord-029547-9ei1ram3	297	4	,	,	,
cord-029547-9ei1ram3	297	5	the	the	DT
cord-029547-9ei1ram3	297	6	National	National	NNP
cord-029547-9ei1ram3	297	7	Institute	Institute	NNP
cord-029547-9ei1ram3	297	8	of	of	IN
cord-029547-9ei1ram3	297	9	Allergy	Allergy	NNP
cord-029547-9ei1ram3	297	10	and	and	CC
cord-029547-9ei1ram3	297	11	Infectious	Infectious	NNP
cord-029547-9ei1ram3	297	12	Diseases	Diseases	NNPS
cord-029547-9ei1ram3	297	13	have	have	VBP
cord-029547-9ei1ram3	297	14	developed	develop	VBN
cord-029547-9ei1ram3	297	15	a	a	DT
cord-029547-9ei1ram3	297	16	mRNA	mRNA	NNP
cord-029547-9ei1ram3	297	17	vaccine	vaccine	NN
cord-029547-9ei1ram3	297	18	,	,	,
cord-029547-9ei1ram3	297	19	mRNA-1273	mrna-1273	XX
cord-029547-9ei1ram3	297	20	,	,	,
cord-029547-9ei1ram3	297	21	which	which	WDT
cord-029547-9ei1ram3	297	22	uses	use	VBZ
cord-029547-9ei1ram3	297	23	lipid	lipid	NN
cord-029547-9ei1ram3	297	24	nanoparticles	nanoparticle	NNS
cord-029547-9ei1ram3	297	25	to	to	TO
cord-029547-9ei1ram3	297	26	encapsulate	encapsulate	VB
cord-029547-9ei1ram3	297	27	the	the	DT
cord-029547-9ei1ram3	297	28	mRNA	mrna	NN
cord-029547-9ei1ram3	297	29	encoding	encode	VBG
cord-029547-9ei1ram3	297	30	S	S	NNP
cord-029547-9ei1ram3	297	31	protein	protein	NN
cord-029547-9ei1ram3	297	32	of	of	IN
cord-029547-9ei1ram3	297	33	SARS	SARS	NNP
cord-029547-9ei1ram3	297	34	-	-	HYPH
cord-029547-9ei1ram3	297	35	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	297	36	.	.	.
cord-029547-9ei1ram3	298	1	127	127	CD
cord-029547-9ei1ram3	299	1	Interestingly	interestingly	RB
cord-029547-9ei1ram3	299	2	,	,	,
cord-029547-9ei1ram3	299	3	Symvivo	Symvivo	NNP
cord-029547-9ei1ram3	299	4	Corporation	Corporation	NNP
cord-029547-9ei1ram3	299	5	have	have	VBP
cord-029547-9ei1ram3	299	6	developed	develop	VBN
cord-029547-9ei1ram3	299	7	an	an	DT
cord-029547-9ei1ram3	299	8	oral	oral	JJ
cord-029547-9ei1ram3	299	9	DNA	dna	NN
cord-029547-9ei1ram3	299	10	vaccine	vaccine	NN
cord-029547-9ei1ram3	299	11	to	to	TO
cord-029547-9ei1ram3	299	12	avoid	avoid	VB
cord-029547-9ei1ram3	299	13	invasive	invasive	JJ
cord-029547-9ei1ram3	299	14	injection	injection	NN
cord-029547-9ei1ram3	299	15	.	.	.
cord-029547-9ei1ram3	300	1	It	-PRON-	PRP
cord-029547-9ei1ram3	300	2	consists	consist	VBZ
cord-029547-9ei1ram3	300	3	of	of	IN
cord-029547-9ei1ram3	300	4	live	live	JJ
cord-029547-9ei1ram3	300	5	Bifidobacterium	Bifidobacterium	NNP
cord-029547-9ei1ram3	300	6	longum	longum	NN
cord-029547-9ei1ram3	300	7	,	,	,
cord-029547-9ei1ram3	300	8	which	which	WDT
cord-029547-9ei1ram3	300	9	contain	contain	VBP
cord-029547-9ei1ram3	300	10	the	the	DT
cord-029547-9ei1ram3	300	11	synthetic	synthetic	JJ
cord-029547-9ei1ram3	300	12	DNA	dna	NN
cord-029547-9ei1ram3	300	13	encoding	encoding	NN
cord-029547-9ei1ram3	300	14	S	s	NN
cord-029547-9ei1ram3	300	15	protein	protein	NN
cord-029547-9ei1ram3	300	16	.	.	.
cord-029547-9ei1ram3	301	1	128	128	CD
cord-029547-9ei1ram3	301	2	 	 	_SP
cord-029547-9ei1ram3	302	1	Although	although	IN
cord-029547-9ei1ram3	302	2	patients	patient	NNS
cord-029547-9ei1ram3	302	3	with	with	IN
cord-029547-9ei1ram3	302	4	typical	typical	JJ
cord-029547-9ei1ram3	302	5	symptoms	symptom	NNS
cord-029547-9ei1ram3	302	6	are	be	VBP
cord-029547-9ei1ram3	302	7	easily	easily	RB
cord-029547-9ei1ram3	302	8	diagnosed	diagnose	VBN
cord-029547-9ei1ram3	302	9	and	and	CC
cord-029547-9ei1ram3	302	10	isolated	isolate	VBN
cord-029547-9ei1ram3	302	11	,	,	,
cord-029547-9ei1ram3	302	12	we	-PRON-	PRP
cord-029547-9ei1ram3	302	13	still	still	RB
cord-029547-9ei1ram3	302	14	need	need	VBP
cord-029547-9ei1ram3	302	15	to	to	TO
cord-029547-9ei1ram3	302	16	pay	pay	VB
cord-029547-9ei1ram3	302	17	attention	attention	NN
cord-029547-9ei1ram3	302	18	to	to	IN
cord-029547-9ei1ram3	302	19	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	302	20	carriers	carrier	NNS
cord-029547-9ei1ram3	302	21	.	.	.
cord-029547-9ei1ram3	303	1	135	135	CD
cord-029547-9ei1ram3	304	1	In	in	IN
cord-029547-9ei1ram3	304	2	January	January	NNP
cord-029547-9ei1ram3	304	3	2020	2020	CD
cord-029547-9ei1ram3	304	4	,	,	,
cord-029547-9ei1ram3	304	5	a	a	DT
cord-029547-9ei1ram3	304	6	family	family	NN
cord-029547-9ei1ram3	304	7	cluster	cluster	NN
cord-029547-9ei1ram3	304	8	of	of	IN
cord-029547-9ei1ram3	304	9	three	three	CD
cord-029547-9ei1ram3	304	10	COVID-19	covid-19	CD
cord-029547-9ei1ram3	304	11	patients	patient	NNS
cord-029547-9ei1ram3	304	12	with	with	IN
cord-029547-9ei1ram3	304	13	one	one	CD
cord-029547-9ei1ram3	304	14	symptomatic	symptomatic	JJ
cord-029547-9ei1ram3	304	15	and	and	CC
cord-029547-9ei1ram3	304	16	two	two	CD
cord-029547-9ei1ram3	304	17	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	304	18	carriers	carrier	NNS
cord-029547-9ei1ram3	304	19	drew	draw	VBD
cord-029547-9ei1ram3	304	20	great	great	JJ
cord-029547-9ei1ram3	304	21	attention	attention	NN
cord-029547-9ei1ram3	304	22	.	.	.
cord-029547-9ei1ram3	305	1	11	11	CD
cord-029547-9ei1ram3	306	1	Because	because	IN
cord-029547-9ei1ram3	306	2	any	any	DT
cord-029547-9ei1ram3	306	3	one	one	CD
cord-029547-9ei1ram3	306	4	of	of	IN
cord-029547-9ei1ram3	306	5	them	-PRON-	PRP
cord-029547-9ei1ram3	306	6	could	could	MD
cord-029547-9ei1ram3	306	7	have	have	VB
cord-029547-9ei1ram3	306	8	the	the	DT
cord-029547-9ei1ram3	306	9	first	first	JJ
cord-029547-9ei1ram3	306	10	one	one	CD
cord-029547-9ei1ram3	306	11	to	to	TO
cord-029547-9ei1ram3	306	12	transmit	transmit	VB
cord-029547-9ei1ram3	306	13	the	the	DT
cord-029547-9ei1ram3	306	14	virus	virus	NN
cord-029547-9ei1ram3	306	15	to	to	IN
cord-029547-9ei1ram3	306	16	others	other	NNS
cord-029547-9ei1ram3	306	17	,	,	,
cord-029547-9ei1ram3	306	18	there	there	EX
cord-029547-9ei1ram3	306	19	may	may	MD
cord-029547-9ei1ram3	306	20	exist	exist	VB
cord-029547-9ei1ram3	306	21	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	306	22	patients	patient	NNS
cord-029547-9ei1ram3	306	23	with	with	IN
cord-029547-9ei1ram3	306	24	high	high	JJ
cord-029547-9ei1ram3	306	25	infectivity	infectivity	NN
cord-029547-9ei1ram3	306	26	who	who	WP
cord-029547-9ei1ram3	306	27	have	have	VBP
cord-029547-9ei1ram3	306	28	not	not	RB
cord-029547-9ei1ram3	306	29	been	be	VBN
cord-029547-9ei1ram3	306	30	detected	detect	VBN
cord-029547-9ei1ram3	306	31	.	.	.
cord-029547-9ei1ram3	307	1	At	at	IN
cord-029547-9ei1ram3	307	2	the	the	DT
cord-029547-9ei1ram3	307	3	same	same	JJ
cord-029547-9ei1ram3	307	4	time	time	NN
cord-029547-9ei1ram3	307	5	,	,	,
cord-029547-9ei1ram3	307	6	another	another	DT
cord-029547-9ei1ram3	307	7	family	family	NN
cord-029547-9ei1ram3	307	8	cluster	cluster	NN
cord-029547-9ei1ram3	307	9	of	of	IN
cord-029547-9ei1ram3	307	10	five	five	CD
cord-029547-9ei1ram3	307	11	patients	patient	NNS
cord-029547-9ei1ram3	307	12	was	be	VBD
cord-029547-9ei1ram3	307	13	found	find	VBN
cord-029547-9ei1ram3	307	14	to	to	TO
cord-029547-9ei1ram3	307	15	have	have	VB
cord-029547-9ei1ram3	307	16	contact	contact	NN
cord-029547-9ei1ram3	307	17	with	with	IN
cord-029547-9ei1ram3	307	18	an	an	DT
cord-029547-9ei1ram3	307	19	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	307	20	carrier	carrier	NN
cord-029547-9ei1ram3	307	21	before	before	IN
cord-029547-9ei1ram3	307	22	onset	onset	NN
cord-029547-9ei1ram3	307	23	of	of	IN
cord-029547-9ei1ram3	307	24	their	-PRON-	PRP$
cord-029547-9ei1ram3	307	25	symptoms	symptom	NNS
cord-029547-9ei1ram3	307	26	.	.	.
cord-029547-9ei1ram3	308	1	136	136	CD
cord-029547-9ei1ram3	309	1	According	accord	VBG
cord-029547-9ei1ram3	309	2	to	to	IN
cord-029547-9ei1ram3	309	3	time	time	NN
cord-029547-9ei1ram3	309	4	sequence	sequence	NN
cord-029547-9ei1ram3	309	5	,	,	,
cord-029547-9ei1ram3	309	6	it	-PRON-	PRP
cord-029547-9ei1ram3	309	7	is	be	VBZ
cord-029547-9ei1ram3	309	8	obvious	obvious	JJ
cord-029547-9ei1ram3	309	9	that	that	IN
cord-029547-9ei1ram3	309	10	the	the	DT
cord-029547-9ei1ram3	309	11	virus	virus	NN
cord-029547-9ei1ram3	309	12	was	be	VBD
cord-029547-9ei1ram3	309	13	transmitted	transmit	VBN
cord-029547-9ei1ram3	309	14	by	by	IN
cord-029547-9ei1ram3	309	15	an	an	DT
cord-029547-9ei1ram3	309	16	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	309	17	carrier	carrier	NN
cord-029547-9ei1ram3	309	18	.	.	.
cord-029547-9ei1ram3	310	1	Hereafter	hereafter	RB
cord-029547-9ei1ram3	310	2	,	,	,
cord-029547-9ei1ram3	310	3	the	the	DT
cord-029547-9ei1ram3	310	4	phenomenon	phenomenon	NN
cord-029547-9ei1ram3	310	5	of	of	IN
cord-029547-9ei1ram3	310	6	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	310	7	infection	infection	NN
cord-029547-9ei1ram3	310	8	has	have	VBZ
cord-029547-9ei1ram3	310	9	been	be	VBN
cord-029547-9ei1ram3	310	10	reported	report	VBN
cord-029547-9ei1ram3	310	11	in	in	IN
cord-029547-9ei1ram3	310	12	several	several	JJ
cord-029547-9ei1ram3	310	13	articles	article	NNS
cord-029547-9ei1ram3	310	14	.	.	.
cord-029547-9ei1ram3	311	1	137	137	CD
cord-029547-9ei1ram3	311	2	,	,	,
cord-029547-9ei1ram3	311	3	138	138	CD
cord-029547-9ei1ram3	312	1	On	on	IN
cord-029547-9ei1ram3	312	2	the	the	DT
cord-029547-9ei1ram3	312	3	basis	basis	NN
cord-029547-9ei1ram3	312	4	of	of	IN
cord-029547-9ei1ram3	312	5	virology	virology	NN
cord-029547-9ei1ram3	312	6	of	of	IN
cord-029547-9ei1ram3	312	7	SARS	SARS	NNP
cord-029547-9ei1ram3	312	8	-	-	HYPH
cord-029547-9ei1ram3	312	9	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	312	10	,	,	,
cord-029547-9ei1ram3	312	11	quantity	quantity	NN
cord-029547-9ei1ram3	312	12	of	of	IN
cord-029547-9ei1ram3	312	13	shedding	shed	VBG
cord-029547-9ei1ram3	312	14	SARS	SARS	NNP
cord-029547-9ei1ram3	312	15	-	-	HYPH
cord-029547-9ei1ram3	312	16	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	312	17	from	from	IN
cord-029547-9ei1ram3	312	18	pharyngeal	pharyngeal	JJ
cord-029547-9ei1ram3	312	19	sources	source	NNS
cord-029547-9ei1ram3	312	20	is	be	VBZ
cord-029547-9ei1ram3	312	21	very	very	RB
cord-029547-9ei1ram3	312	22	high	high	JJ
cord-029547-9ei1ram3	312	23	in	in	IN
cord-029547-9ei1ram3	312	24	the	the	DT
cord-029547-9ei1ram3	312	25	first	first	JJ
cord-029547-9ei1ram3	312	26	week	week	NN
cord-029547-9ei1ram3	312	27	of	of	IN
cord-029547-9ei1ram3	312	28	symptoms	symptom	NNS
cord-029547-9ei1ram3	312	29	,	,	,
cord-029547-9ei1ram3	312	30	and	and	CC
cord-029547-9ei1ram3	312	31	they	-PRON-	PRP
cord-029547-9ei1ram3	312	32	also	also	RB
cord-029547-9ei1ram3	312	33	replicate	replicate	VBP
cord-029547-9ei1ram3	312	34	actively	actively	RB
cord-029547-9ei1ram3	312	35	during	during	IN
cord-029547-9ei1ram3	312	36	this	this	DT
cord-029547-9ei1ram3	312	37	time	time	NN
cord-029547-9ei1ram3	312	38	,	,	,
cord-029547-9ei1ram3	313	1	thus	thus	RB
cord-029547-9ei1ram3	313	2	the	the	DT
cord-029547-9ei1ram3	313	3	first	first	JJ
cord-029547-9ei1ram3	313	4	week	week	NN
cord-029547-9ei1ram3	313	5	after	after	IN
cord-029547-9ei1ram3	313	6	onset	onset	NN
cord-029547-9ei1ram3	313	7	of	of	IN
cord-029547-9ei1ram3	313	8	symptoms	symptom	NNS
cord-029547-9ei1ram3	313	9	is	be	VBZ
cord-029547-9ei1ram3	313	10	when	when	WRB
cord-029547-9ei1ram3	313	11	the	the	DT
cord-029547-9ei1ram3	313	12	patients	patient	NNS
cord-029547-9ei1ram3	313	13	have	have	VBP
cord-029547-9ei1ram3	313	14	the	the	DT
cord-029547-9ei1ram3	313	15	highest	high	JJS
cord-029547-9ei1ram3	313	16	infectivity	infectivity	NN
cord-029547-9ei1ram3	313	17	.	.	.
cord-029547-9ei1ram3	314	1	139	139	CD
cord-029547-9ei1ram3	315	1	But	but	CC
cord-029547-9ei1ram3	315	2	in	in	IN
cord-029547-9ei1ram3	315	3	this	this	DT
cord-029547-9ei1ram3	315	4	time	time	NN
cord-029547-9ei1ram3	315	5	period	period	NN
cord-029547-9ei1ram3	315	6	,	,	,
cord-029547-9ei1ram3	315	7	some	some	DT
cord-029547-9ei1ram3	315	8	patients	patient	NNS
cord-029547-9ei1ram3	315	9	only	only	RB
cord-029547-9ei1ram3	315	10	have	have	VBP
cord-029547-9ei1ram3	315	11	mild	mild	JJ
cord-029547-9ei1ram3	315	12	symptoms	symptom	NNS
cord-029547-9ei1ram3	315	13	or	or	CC
cord-029547-9ei1ram3	315	14	even	even	RB
cord-029547-9ei1ram3	315	15	no	no	DT
cord-029547-9ei1ram3	315	16	symptoms	symptom	NNS
cord-029547-9ei1ram3	315	17	,	,	,
cord-029547-9ei1ram3	315	18	so	so	IN
cord-029547-9ei1ram3	315	19	they	-PRON-	PRP
cord-029547-9ei1ram3	315	20	might	may	MD
cord-029547-9ei1ram3	315	21	be	be	VB
cord-029547-9ei1ram3	315	22	invisible	invisible	JJ
cord-029547-9ei1ram3	315	23	sources	source	NNS
cord-029547-9ei1ram3	315	24	of	of	IN
cord-029547-9ei1ram3	315	25	infection	infection	NN
cord-029547-9ei1ram3	315	26	.	.	.
cord-029547-9ei1ram3	316	1	Therefore	therefore	RB
cord-029547-9ei1ram3	316	2	,	,	,
cord-029547-9ei1ram3	316	3	people	people	NNS
cord-029547-9ei1ram3	316	4	who	who	WP
cord-029547-9ei1ram3	316	5	have	have	VBP
cord-029547-9ei1ram3	316	6	traveled	travel	VBN
cord-029547-9ei1ram3	316	7	to	to	IN
cord-029547-9ei1ram3	316	8	endemic	endemic	JJ
cord-029547-9ei1ram3	316	9	areas	area	NNS
cord-029547-9ei1ram3	316	10	or	or	CC
cord-029547-9ei1ram3	316	11	had	have	VBD
cord-029547-9ei1ram3	316	12	contact	contact	NN
cord-029547-9ei1ram3	316	13	with	with	IN
cord-029547-9ei1ram3	316	14	patients	patient	NNS
cord-029547-9ei1ram3	316	15	should	should	MD
cord-029547-9ei1ram3	316	16	be	be	VB
cord-029547-9ei1ram3	316	17	isolated	isolate	VBN
cord-029547-9ei1ram3	316	18	,	,	,
cord-029547-9ei1ram3	316	19	monitored	monitor	VBN
cord-029547-9ei1ram3	316	20	,	,	,
cord-029547-9ei1ram3	316	21	and	and	CC
cord-029547-9ei1ram3	316	22	screened	screen	VBN
cord-029547-9ei1ram3	316	23	strictly	strictly	RB
cord-029547-9ei1ram3	316	24	,	,	,
cord-029547-9ei1ram3	316	25	even	even	RB
cord-029547-9ei1ram3	316	26	if	if	IN
cord-029547-9ei1ram3	316	27	they	-PRON-	PRP
cord-029547-9ei1ram3	316	28	are	be	VBP
cord-029547-9ei1ram3	316	29	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	316	30	,	,	,
cord-029547-9ei1ram3	316	31	to	to	TO
cord-029547-9ei1ram3	316	32	rule	rule	VB
cord-029547-9ei1ram3	316	33	out	out	RP
cord-029547-9ei1ram3	316	34	the	the	DT
cord-029547-9ei1ram3	316	35	possibility	possibility	NN
cord-029547-9ei1ram3	316	36	of	of	IN
cord-029547-9ei1ram3	316	37	infection	infection	NN
cord-029547-9ei1ram3	316	38	.	.	.
cord-029547-9ei1ram3	317	1	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	317	2	,	,	,
cord-029547-9ei1ram3	317	3	a	a	DT
cord-029547-9ei1ram3	317	4	disease	disease	NN
cord-029547-9ei1ram3	317	5	that	that	WDT
cord-029547-9ei1ram3	317	6	seriously	seriously	RB
cord-029547-9ei1ram3	317	7	endanger	endanger	VBP
cord-029547-9ei1ram3	317	8	the	the	DT
cord-029547-9ei1ram3	317	9	safety	safety	NN
cord-029547-9ei1ram3	317	10	of	of	IN
cord-029547-9ei1ram3	317	11	human	human	JJ
cord-029547-9ei1ram3	317	12	life	life	NN
cord-029547-9ei1ram3	317	13	and	and	CC
cord-029547-9ei1ram3	317	14	properties	property	NNS
cord-029547-9ei1ram3	317	15	,	,	,
cord-029547-9ei1ram3	317	16	is	be	VBZ
cord-029547-9ei1ram3	317	17	caused	cause	VBN
cord-029547-9ei1ram3	317	18	by	by	IN
cord-029547-9ei1ram3	317	19	SARS	SARS	NNP
cord-029547-9ei1ram3	317	20	-	-	HYPH
cord-029547-9ei1ram3	317	21	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	317	22	,	,	,
cord-029547-9ei1ram3	317	23	which	which	WDT
cord-029547-9ei1ram3	317	24	attacks	attack	VBZ
cord-029547-9ei1ram3	317	25	host	host	NN
cord-029547-9ei1ram3	317	26	cells	cell	NNS
cord-029547-9ei1ram3	317	27	through	through	IN
cord-029547-9ei1ram3	317	28	ACE2	ACE2	NNP
cord-029547-9ei1ram3	317	29	.	.	.
cord-029547-9ei1ram3	318	1	The	the	DT
cord-029547-9ei1ram3	318	2	spread	spread	NN
cord-029547-9ei1ram3	318	3	of	of	IN
cord-029547-9ei1ram3	318	4	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	318	5	mainly	mainly	RB
cord-029547-9ei1ram3	318	6	depends	depend	VBZ
cord-029547-9ei1ram3	318	7	on	on	IN
cord-029547-9ei1ram3	318	8	airborne	airborne	JJ
cord-029547-9ei1ram3	318	9	and	and	CC
cord-029547-9ei1ram3	318	10	droplet	droplet	NN
cord-029547-9ei1ram3	318	11	transmission	transmission	NN
cord-029547-9ei1ram3	318	12	.	.	.
cord-029547-9ei1ram3	319	1	Some	some	DT
cord-029547-9ei1ram3	319	2	researchers	researcher	NNS
cord-029547-9ei1ram3	319	3	pointed	point	VBD
cord-029547-9ei1ram3	319	4	out	out	RP
cord-029547-9ei1ram3	319	5	the	the	DT
cord-029547-9ei1ram3	319	6	possibility	possibility	NN
cord-029547-9ei1ram3	319	7	of	of	IN
cord-029547-9ei1ram3	319	8	fecal	fecal	JJ
cord-029547-9ei1ram3	319	9	-	-	HYPH
cord-029547-9ei1ram3	319	10	oral	oral	JJ
cord-029547-9ei1ram3	319	11	transmission	transmission	NN
cord-029547-9ei1ram3	319	12	and	and	CC
cord-029547-9ei1ram3	319	13	vertical	vertical	JJ
cord-029547-9ei1ram3	319	14	transmission	transmission	NN
cord-029547-9ei1ram3	319	15	,	,	,
cord-029547-9ei1ram3	319	16	but	but	CC
cord-029547-9ei1ram3	319	17	these	these	DT
cord-029547-9ei1ram3	319	18	opinions	opinion	NNS
cord-029547-9ei1ram3	319	19	need	need	VBP
cord-029547-9ei1ram3	319	20	further	further	JJ
cord-029547-9ei1ram3	319	21	confirmation	confirmation	NN
cord-029547-9ei1ram3	319	22	.	.	.
cord-029547-9ei1ram3	320	1	An	an	DT
cord-029547-9ei1ram3	320	2	accurate	accurate	JJ
cord-029547-9ei1ram3	320	3	diagnosis	diagnosis	NN
cord-029547-9ei1ram3	320	4	of	of	IN
cord-029547-9ei1ram3	320	5	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	320	6	is	be	VBZ
cord-029547-9ei1ram3	320	7	essential	essential	JJ
cord-029547-9ei1ram3	320	8	for	for	IN
cord-029547-9ei1ram3	320	9	containing	contain	VBG
cord-029547-9ei1ram3	320	10	disease	disease	NN
cord-029547-9ei1ram3	320	11	,	,	,
cord-029547-9ei1ram3	320	12	thus	thus	RB
cord-029547-9ei1ram3	320	13	combnation	combnation	NN
cord-029547-9ei1ram3	320	14	of	of	IN
cord-029547-9ei1ram3	320	15	RT	RT	NNP
cord-029547-9ei1ram3	320	16	-	-	HYPH
cord-029547-9ei1ram3	320	17	PCR	PCR	NNP
cord-029547-9ei1ram3	320	18	and	and	CC
cord-029547-9ei1ram3	320	19	clinical	clinical	JJ
cord-029547-9ei1ram3	320	20	characteristics	characteristic	NNS
cord-029547-9ei1ram3	320	21	is	be	VBZ
cord-029547-9ei1ram3	320	22	widely	widely	RB
cord-029547-9ei1ram3	320	23	used	use	VBN
cord-029547-9ei1ram3	320	24	for	for	IN
cord-029547-9ei1ram3	320	25	its	-PRON-	PRP$
cord-029547-9ei1ram3	320	26	detection	detection	NN
cord-029547-9ei1ram3	320	27	currently	currently	RB
cord-029547-9ei1ram3	320	28	.	.	.
cord-029547-9ei1ram3	321	1	The	the	DT
cord-029547-9ei1ram3	321	2	typical	typical	JJ
cord-029547-9ei1ram3	321	3	clinical	clinical	JJ
cord-029547-9ei1ram3	321	4	features	feature	NNS
cord-029547-9ei1ram3	321	5	of	of	IN
cord-029547-9ei1ram3	321	6	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	321	7	patients	patient	NNS
cord-029547-9ei1ram3	321	8	include	include	VBP
cord-029547-9ei1ram3	321	9	fever	fever	NN
cord-029547-9ei1ram3	321	10	,	,	,
cord-029547-9ei1ram3	321	11	cough	cough	NN
cord-029547-9ei1ram3	321	12	,	,	,
cord-029547-9ei1ram3	321	13	and	and	CC
cord-029547-9ei1ram3	321	14	dyspnea	dyspnea	NN
cord-029547-9ei1ram3	321	15	.	.	.
cord-029547-9ei1ram3	322	1	Moreover	moreover	RB
cord-029547-9ei1ram3	322	2	,	,	,
cord-029547-9ei1ram3	322	3	GGO	GGO	NNP
cord-029547-9ei1ram3	322	4	,	,	,
cord-029547-9ei1ram3	322	5	consolidation	consolidation	NN
cord-029547-9ei1ram3	322	6	,	,	,
cord-029547-9ei1ram3	322	7	and	and	CC
cord-029547-9ei1ram3	322	8	interlobular	interlobular	JJ
cord-029547-9ei1ram3	322	9	septal	septal	JJ
cord-029547-9ei1ram3	322	10	thickening	thickening	NN
cord-029547-9ei1ram3	322	11	are	be	VBP
cord-029547-9ei1ram3	322	12	also	also	RB
cord-029547-9ei1ram3	322	13	typical	typical	JJ
cord-029547-9ei1ram3	322	14	CT	CT	NNP
cord-029547-9ei1ram3	322	15	signals	signal	NNS
cord-029547-9ei1ram3	322	16	of	of	IN
cord-029547-9ei1ram3	322	17	COVID-19	covid-19	NN
cord-029547-9ei1ram3	322	18	.	.	.
cord-029547-9ei1ram3	323	1	Using	use	VBG
cord-029547-9ei1ram3	323	2	artificial	artificial	JJ
cord-029547-9ei1ram3	323	3	intelligence	intelligence	NN
cord-029547-9ei1ram3	323	4	to	to	TO
cord-029547-9ei1ram3	323	5	screen	screen	VB
cord-029547-9ei1ram3	323	6	COVID-19	covid-19	VB
cord-029547-9ei1ram3	323	7	early	early	RB
cord-029547-9ei1ram3	323	8	on	on	RB
cord-029547-9ei1ram3	323	9	is	be	VBZ
cord-029547-9ei1ram3	323	10	likely	likely	JJ
cord-029547-9ei1ram3	323	11	to	to	TO
cord-029547-9ei1ram3	323	12	be	be	VB
cord-029547-9ei1ram3	323	13	the	the	DT
cord-029547-9ei1ram3	323	14	future	future	JJ
cord-029547-9ei1ram3	323	15	diagnostic	diagnostic	JJ
cord-029547-9ei1ram3	323	16	directions	direction	NNS
cord-029547-9ei1ram3	323	17	of	of	IN
cord-029547-9ei1ram3	323	18	it	-PRON-	PRP
cord-029547-9ei1ram3	323	19	.	.	.
cord-029547-9ei1ram3	324	1	Good	good	JJ
cord-029547-9ei1ram3	324	2	treatment	treatment	NN
cord-029547-9ei1ram3	324	3	is	be	VBZ
cord-029547-9ei1ram3	324	4	necessary	necessary	JJ
cord-029547-9ei1ram3	324	5	to	to	TO
cord-029547-9ei1ram3	324	6	reduce	reduce	VB
cord-029547-9ei1ram3	324	7	mortality	mortality	NN
cord-029547-9ei1ram3	324	8	,	,	,
cord-029547-9ei1ram3	324	9	and	and	CC
cord-029547-9ei1ram3	324	10	drug	drug	NN
cord-029547-9ei1ram3	324	11	therapy	therapy	NN
cord-029547-9ei1ram3	324	12	is	be	VBZ
cord-029547-9ei1ram3	324	13	the	the	DT
cord-029547-9ei1ram3	324	14	main	main	JJ
cord-029547-9ei1ram3	324	15	treatment	treatment	NN
cord-029547-9ei1ram3	324	16	of	of	IN
cord-029547-9ei1ram3	324	17	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	324	18	.	.	.
cord-029547-9ei1ram3	325	1	Thus	thus	RB
cord-029547-9ei1ram3	325	2	,	,	,
cord-029547-9ei1ram3	325	3	we	-PRON-	PRP
cord-029547-9ei1ram3	325	4	summarize	summarize	VBP
cord-029547-9ei1ram3	325	5	the	the	DT
cord-029547-9ei1ram3	325	6	chief	chief	JJ
cord-029547-9ei1ram3	325	7	medicines	medicine	NNS
cord-029547-9ei1ram3	325	8	and	and	CC
cord-029547-9ei1ram3	325	9	bioproducts	bioproduct	NNS
cord-029547-9ei1ram3	325	10	for	for	IN
cord-029547-9ei1ram3	325	11	its	-PRON-	PRP$
cord-029547-9ei1ram3	325	12	treatment	treatment	NN
cord-029547-9ei1ram3	325	13	.	.	.
cord-029547-9ei1ram3	326	1	According	accord	VBG
cord-029547-9ei1ram3	326	2	to	to	IN
cord-029547-9ei1ram3	326	3	the	the	DT
cord-029547-9ei1ram3	326	4	current	current	JJ
cord-029547-9ei1ram3	326	5	reports	report	NNS
cord-029547-9ei1ram3	326	6	,	,	,
cord-029547-9ei1ram3	326	7	combined	combine	VBN
cord-029547-9ei1ram3	326	8	use	use	NN
cord-029547-9ei1ram3	326	9	of	of	IN
cord-029547-9ei1ram3	326	10	the	the	DT
cord-029547-9ei1ram3	326	11	drugs	drug	NNS
cord-029547-9ei1ram3	326	12	and	and	CC
cord-029547-9ei1ram3	326	13	bioproducts	bioproduct	NNS
cord-029547-9ei1ram3	326	14	to	to	TO
cord-029547-9ei1ram3	326	15	treat	treat	VB
cord-029547-9ei1ram3	326	16	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	326	17	both	both	CC
cord-029547-9ei1ram3	326	18	etiologically	etiologically	RB
cord-029547-9ei1ram3	326	19	and	and	CC
cord-029547-9ei1ram3	326	20	symptomatically	symptomatically	RB
cord-029547-9ei1ram3	326	21	has	have	VBZ
cord-029547-9ei1ram3	326	22	received	receive	VBN
cord-029547-9ei1ram3	326	23	great	great	JJ
cord-029547-9ei1ram3	326	24	clinical	clinical	JJ
cord-029547-9ei1ram3	326	25	effect	effect	NN
cord-029547-9ei1ram3	326	26	.	.	.
cord-029547-9ei1ram3	327	1	However	however	RB
cord-029547-9ei1ram3	327	2	,	,	,
cord-029547-9ei1ram3	327	3	not	not	RB
cord-029547-9ei1ram3	327	4	all	all	DT
cord-029547-9ei1ram3	327	5	antiviral	antiviral	JJ
cord-029547-9ei1ram3	327	6	drugs	drug	NNS
cord-029547-9ei1ram3	327	7	for	for	IN
cord-029547-9ei1ram3	327	8	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	327	9	have	have	VBP
cord-029547-9ei1ram3	327	10	passed	pass	VBN
cord-029547-9ei1ram3	327	11	the	the	DT
cord-029547-9ei1ram3	327	12	clinical	clinical	JJ
cord-029547-9ei1ram3	327	13	trials	trial	NNS
cord-029547-9ei1ram3	327	14	.	.	.
cord-029547-9ei1ram3	328	1	A	a	DT
cord-029547-9ei1ram3	328	2	few	few	JJ
cord-029547-9ei1ram3	328	3	clinical	clinical	JJ
cord-029547-9ei1ram3	328	4	trial	trial	NN
cord-029547-9ei1ram3	328	5	reports	report	NNS
cord-029547-9ei1ram3	328	6	demonstrated	demonstrate	VBD
cord-029547-9ei1ram3	328	7	that	that	IN
cord-029547-9ei1ram3	328	8	lopinavir	lopinavir	NNP
cord-029547-9ei1ram3	328	9	-	-	HYPH
cord-029547-9ei1ram3	328	10	ritonavir	ritonavir	NNP
cord-029547-9ei1ram3	328	11	,	,	,
cord-029547-9ei1ram3	328	12	chloroquine	chloroquine	NN
cord-029547-9ei1ram3	328	13	,	,	,
cord-029547-9ei1ram3	328	14	and	and	CC
cord-029547-9ei1ram3	328	15	remdesivir	remdesivir	NNP
cord-029547-9ei1ram3	328	16	did	do	VBD
cord-029547-9ei1ram3	328	17	not	not	RB
cord-029547-9ei1ram3	328	18	work	work	VB
cord-029547-9ei1ram3	328	19	as	as	RB
cord-029547-9ei1ram3	328	20	well	well	RB
cord-029547-9ei1ram3	328	21	as	as	IN
cord-029547-9ei1ram3	328	22	expected	expect	VBN
cord-029547-9ei1ram3	328	23	,	,	,
cord-029547-9ei1ram3	328	24	67	67	CD
cord-029547-9ei1ram3	328	25	,	,	,
cord-029547-9ei1ram3	328	26	75	75	CD
cord-029547-9ei1ram3	328	27	,	,	,
cord-029547-9ei1ram3	328	28	82	82	CD
cord-029547-9ei1ram3	328	29	which	which	WDT
cord-029547-9ei1ram3	328	30	reflects	reflect	VBZ
cord-029547-9ei1ram3	328	31	the	the	DT
cord-029547-9ei1ram3	328	32	fact	fact	NN
cord-029547-9ei1ram3	328	33	that	that	IN
cord-029547-9ei1ram3	328	34	many	many	JJ
cord-029547-9ei1ram3	328	35	antiviral	antiviral	JJ
cord-029547-9ei1ram3	328	36	drugs	drug	NNS
cord-029547-9ei1ram3	328	37	have	have	VBP
cord-029547-9ei1ram3	328	38	gone	go	VBN
cord-029547-9ei1ram3	328	39	through	through	IN
cord-029547-9ei1ram3	328	40	many	many	JJ
cord-029547-9ei1ram3	328	41	extensive	extensive	JJ
cord-029547-9ei1ram3	328	42	clinical	clinical	JJ
cord-029547-9ei1ram3	328	43	trials	trial	NNS
cord-029547-9ei1ram3	328	44	with	with	IN
cord-029547-9ei1ram3	328	45	currently	currently	RB
cord-029547-9ei1ram3	328	46	only	only	RB
cord-029547-9ei1ram3	328	47	modest	modest	JJ
cord-029547-9ei1ram3	328	48	effect	effect	NN
cord-029547-9ei1ram3	328	49	.	.	.
cord-029547-9ei1ram3	329	1	Instead	instead	RB
cord-029547-9ei1ram3	329	2	,	,	,
cord-029547-9ei1ram3	329	3	some	some	DT
cord-029547-9ei1ram3	329	4	bioproducts	bioproduct	NNS
cord-029547-9ei1ram3	329	5	such	such	JJ
cord-029547-9ei1ram3	329	6	as	as	IN
cord-029547-9ei1ram3	329	7	monoclonal	monoclonal	JJ
cord-029547-9ei1ram3	329	8	antibodies	antibody	NNS
cord-029547-9ei1ram3	329	9	and	and	CC
cord-029547-9ei1ram3	329	10	stem	stem	NN
cord-029547-9ei1ram3	329	11	cells	cell	NNS
cord-029547-9ei1ram3	329	12	are	be	VBP
cord-029547-9ei1ram3	329	13	more	more	RBR
cord-029547-9ei1ram3	329	14	likely	likely	JJ
cord-029547-9ei1ram3	329	15	to	to	TO
cord-029547-9ei1ram3	329	16	play	play	VB
cord-029547-9ei1ram3	329	17	important	important	JJ
cord-029547-9ei1ram3	329	18	roles	role	NNS
cord-029547-9ei1ram3	329	19	in	in	IN
cord-029547-9ei1ram3	329	20	treatment	treatment	NN
cord-029547-9ei1ram3	329	21	of	of	IN
cord-029547-9ei1ram3	329	22	severely	severely	RB
cord-029547-9ei1ram3	329	23	affected	affect	VBN
cord-029547-9ei1ram3	329	24	patients	patient	NNS
cord-029547-9ei1ram3	329	25	in	in	IN
cord-029547-9ei1ram3	329	26	the	the	DT
cord-029547-9ei1ram3	329	27	future	future	NN
cord-029547-9ei1ram3	329	28	.	.	.
cord-029547-9ei1ram3	330	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	330	2	,	,	,
cord-029547-9ei1ram3	330	3	we	-PRON-	PRP
cord-029547-9ei1ram3	330	4	should	should	MD
cord-029547-9ei1ram3	330	5	also	also	RB
cord-029547-9ei1ram3	330	6	focus	focus	VB
cord-029547-9ei1ram3	330	7	on	on	IN
cord-029547-9ei1ram3	330	8	vaccine	vaccine	NN
cord-029547-9ei1ram3	330	9	research	research	NN
cord-029547-9ei1ram3	330	10	and	and	CC
cord-029547-9ei1ram3	330	11	artificial	artificial	JJ
cord-029547-9ei1ram3	330	12	intelligence	intelligence	NN
cord-029547-9ei1ram3	330	13	-	-	HYPH
cord-029547-9ei1ram3	330	14	based	base	VBN
cord-029547-9ei1ram3	330	15	studies	study	NNS
cord-029547-9ei1ram3	330	16	for	for	IN
cord-029547-9ei1ram3	330	17	fighting	fight	VBG
cord-029547-9ei1ram3	330	18	the	the	DT
cord-029547-9ei1ram3	330	19	outbreak	outbreak	NN
cord-029547-9ei1ram3	330	20	,	,	,
cord-029547-9ei1ram3	330	21	both	both	DT
cord-029547-9ei1ram3	330	22	of	of	IN
cord-029547-9ei1ram3	330	23	which	which	WDT
cord-029547-9ei1ram3	330	24	play	play	VBP
cord-029547-9ei1ram3	330	25	vital	vital	JJ
cord-029547-9ei1ram3	330	26	roles	role	NNS
cord-029547-9ei1ram3	330	27	in	in	IN
cord-029547-9ei1ram3	330	28	controlling	control	VBG
cord-029547-9ei1ram3	330	29	the	the	DT
cord-029547-9ei1ram3	330	30	it	-PRON-	PRP
cord-029547-9ei1ram3	330	31	.	.	.
cord-029547-9ei1ram3	331	1	Although	although	IN
cord-029547-9ei1ram3	331	2	antiviral	antiviral	JJ
cord-029547-9ei1ram3	331	3	effects	effect	NNS
cord-029547-9ei1ram3	331	4	of	of	IN
cord-029547-9ei1ram3	331	5	many	many	JJ
cord-029547-9ei1ram3	331	6	drugs	drug	NNS
cord-029547-9ei1ram3	331	7	and	and	CC
cord-029547-9ei1ram3	331	8	vaccines	vaccine	NNS
cord-029547-9ei1ram3	331	9	have	have	VBP
cord-029547-9ei1ram3	331	10	been	be	VBN
cord-029547-9ei1ram3	331	11	obtained	obtain	VBN
cord-029547-9ei1ram3	331	12	in	in	IN
cord-029547-9ei1ram3	331	13	vitro	vitro	FW
cord-029547-9ei1ram3	331	14	,	,	,
cord-029547-9ei1ram3	331	15	it	-PRON-	PRP
cord-029547-9ei1ram3	331	16	remains	remain	VBZ
cord-029547-9ei1ram3	331	17	to	to	TO
cord-029547-9ei1ram3	331	18	be	be	VB
cord-029547-9ei1ram3	331	19	seen	see	VBN
cord-029547-9ei1ram3	331	20	as	as	IN
cord-029547-9ei1ram3	331	21	to	to	IN
cord-029547-9ei1ram3	331	22	whether	whether	IN
cord-029547-9ei1ram3	331	23	they	-PRON-	PRP
cord-029547-9ei1ram3	331	24	have	have	VBP
cord-029547-9ei1ram3	331	25	comparable	comparable	JJ
cord-029547-9ei1ram3	331	26	activity	activity	NN
cord-029547-9ei1ram3	331	27	in	in	IN
cord-029547-9ei1ram3	331	28	vivo	vivo	NN
cord-029547-9ei1ram3	331	29	.	.	.
cord-029547-9ei1ram3	332	1	Therefore	therefore	RB
cord-029547-9ei1ram3	332	2	,	,	,
cord-029547-9ei1ram3	332	3	establishing	establish	VBG
cord-029547-9ei1ram3	332	4	efficient	efficient	JJ
cord-029547-9ei1ram3	332	5	animal	animal	NN
cord-029547-9ei1ram3	332	6	models	model	NNS
cord-029547-9ei1ram3	332	7	as	as	RB
cord-029547-9ei1ram3	332	8	soon	soon	RB
cord-029547-9ei1ram3	332	9	as	as	IN
cord-029547-9ei1ram3	332	10	possible	possible	JJ
cord-029547-9ei1ram3	332	11	is	be	VBZ
cord-029547-9ei1ram3	332	12	important	important	JJ
cord-029547-9ei1ram3	332	13	for	for	IN
cord-029547-9ei1ram3	332	14	virology	virology	NN
cord-029547-9ei1ram3	332	15	research	research	NN
cord-029547-9ei1ram3	332	16	,	,	,
cord-029547-9ei1ram3	332	17	drug	drug	NN
cord-029547-9ei1ram3	332	18	,	,	,
cord-029547-9ei1ram3	332	19	and	and	CC
cord-029547-9ei1ram3	332	20	vaccine	vaccine	NN
cord-029547-9ei1ram3	332	21	development	development	NN
cord-029547-9ei1ram3	332	22	.	.	.
cord-029547-9ei1ram3	333	1	Currently	currently	RB
cord-029547-9ei1ram3	333	2	,	,	,
cord-029547-9ei1ram3	333	3	rhesus	rhesu	NNS
cord-029547-9ei1ram3	333	4	macaques	macaque	NNS
cord-029547-9ei1ram3	333	5	models	model	NNS
cord-029547-9ei1ram3	333	6	have	have	VBP
cord-029547-9ei1ram3	333	7	been	be	VBN
cord-029547-9ei1ram3	333	8	established	establish	VBN
cord-029547-9ei1ram3	333	9	to	to	TO
cord-029547-9ei1ram3	333	10	study	study	VB
cord-029547-9ei1ram3	333	11	the	the	DT
cord-029547-9ei1ram3	333	12	transmission	transmission	NN
cord-029547-9ei1ram3	333	13	and	and	CC
cord-029547-9ei1ram3	333	14	distribution	distribution	NN
cord-029547-9ei1ram3	333	15	of	of	IN
cord-029547-9ei1ram3	333	16	SARS	SARS	NNP
cord-029547-9ei1ram3	333	17	-	-	HYPH
cord-029547-9ei1ram3	333	18	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	333	19	as	as	RB
cord-029547-9ei1ram3	333	20	well	well	RB
cord-029547-9ei1ram3	333	21	as	as	IN
cord-029547-9ei1ram3	333	22	effects	effect	NNS
cord-029547-9ei1ram3	333	23	of	of	IN
cord-029547-9ei1ram3	333	24	viral	viral	JJ
cord-029547-9ei1ram3	333	25	infection	infection	NN
cord-029547-9ei1ram3	333	26	on	on	IN
cord-029547-9ei1ram3	333	27	host	host	NN
cord-029547-9ei1ram3	333	28	prognosis	prognosis	NN
cord-029547-9ei1ram3	333	29	,	,	,
cord-029547-9ei1ram3	333	30	140	140	CD
cord-029547-9ei1ram3	333	31	,	,	,
cord-029547-9ei1ram3	333	32	141	141	CD
cord-029547-9ei1ram3	333	33	which	which	WDT
cord-029547-9ei1ram3	333	34	is	be	VBZ
cord-029547-9ei1ram3	333	35	meaningful	meaningful	JJ
cord-029547-9ei1ram3	333	36	for	for	IN
cord-029547-9ei1ram3	333	37	virology	virology	NN
cord-029547-9ei1ram3	333	38	study	study	NN
cord-029547-9ei1ram3	333	39	.	.	.
cord-029547-9ei1ram3	334	1	Furthermore	furthermore	RB
cord-029547-9ei1ram3	334	2	,	,	,
cord-029547-9ei1ram3	334	3	hACE2	hace2	NN
cord-029547-9ei1ram3	334	4	transgenic	transgenic	JJ
cord-029547-9ei1ram3	334	5	mice	mouse	NNS
cord-029547-9ei1ram3	334	6	have	have	VBP
cord-029547-9ei1ram3	334	7	been	be	VBN
cord-029547-9ei1ram3	334	8	found	find	VBN
cord-029547-9ei1ram3	334	9	to	to	TO
cord-029547-9ei1ram3	334	10	own	own	VB
cord-029547-9ei1ram3	334	11	typical	typical	JJ
cord-029547-9ei1ram3	334	12	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	334	13	clinical	clinical	JJ
cord-029547-9ei1ram3	334	14	symptoms	symptom	NNS
cord-029547-9ei1ram3	334	15	,	,	,
cord-029547-9ei1ram3	334	16	which	which	WDT
cord-029547-9ei1ram3	334	17	could	could	MD
cord-029547-9ei1ram3	334	18	not	not	RB
cord-029547-9ei1ram3	334	19	be	be	VB
cord-029547-9ei1ram3	334	20	found	find	VBN
cord-029547-9ei1ram3	334	21	in	in	IN
cord-029547-9ei1ram3	334	22	wild	wild	JJ
cord-029547-9ei1ram3	334	23	-	-	HYPH
cord-029547-9ei1ram3	334	24	type	type	NN
cord-029547-9ei1ram3	334	25	mice	mouse	NNS
cord-029547-9ei1ram3	334	26	,	,	,
cord-029547-9ei1ram3	334	27	142	142	CD
cord-029547-9ei1ram3	334	28	indicating	indicate	VBG
cord-029547-9ei1ram3	334	29	this	this	DT
cord-029547-9ei1ram3	334	30	model	model	NN
cord-029547-9ei1ram3	334	31	may	may	MD
cord-029547-9ei1ram3	334	32	be	be	VB
cord-029547-9ei1ram3	334	33	used	use	VBN
cord-029547-9ei1ram3	334	34	for	for	IN
cord-029547-9ei1ram3	334	35	development	development	NN
cord-029547-9ei1ram3	334	36	of	of	IN
cord-029547-9ei1ram3	334	37	therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	334	38	drugs	drug	NNS
cord-029547-9ei1ram3	334	39	and	and	CC
cord-029547-9ei1ram3	334	40	vaccines	vaccine	NNS
cord-029547-9ei1ram3	334	41	.	.	.
cord-029547-9ei1ram3	335	1	Thus	thus	RB
cord-029547-9ei1ram3	335	2	,	,	,
cord-029547-9ei1ram3	335	3	perhaps	perhaps	RB
cord-029547-9ei1ram3	335	4	further	further	RB
cord-029547-9ei1ram3	335	5	researching	research	VBG
cord-029547-9ei1ram3	335	6	effective	effective	JJ
cord-029547-9ei1ram3	335	7	animal	animal	NN
cord-029547-9ei1ram3	335	8	models	model	NNS
cord-029547-9ei1ram3	335	9	and	and	CC
cord-029547-9ei1ram3	335	10	making	make	VBG
cord-029547-9ei1ram3	335	11	full	full	JJ
cord-029547-9ei1ram3	335	12	use	use	NN
cord-029547-9ei1ram3	335	13	of	of	IN
cord-029547-9ei1ram3	335	14	them	-PRON-	PRP
cord-029547-9ei1ram3	335	15	shows	show	VBZ
cord-029547-9ei1ram3	335	16	the	the	DT
cord-029547-9ei1ram3	335	17	future	future	JJ
cord-029547-9ei1ram3	335	18	direction	direction	NN
cord-029547-9ei1ram3	335	19	to	to	TO
cord-029547-9ei1ram3	335	20	develop	develop	VB
cord-029547-9ei1ram3	335	21	drugs	drug	NNS
cord-029547-9ei1ram3	335	22	and	and	CC
cord-029547-9ei1ram3	335	23	vaccines	vaccine	NNS
cord-029547-9ei1ram3	335	24	with	with	IN
cord-029547-9ei1ram3	335	25	high	high	JJ
cord-029547-9ei1ram3	335	26	specificity	specificity	NN
cord-029547-9ei1ram3	335	27	as	as	RB
cord-029547-9ei1ram3	335	28	soon	soon	RB
cord-029547-9ei1ram3	335	29	as	as	IN
cord-029547-9ei1ram3	335	30	possible	possible	JJ
cord-029547-9ei1ram3	335	31	.	.	.
cord-029547-9ei1ram3	336	1	J.L.	J.L.	NNP
cord-029547-9ei1ram3	336	2	,	,	,
cord-029547-9ei1ram3	336	3	J.S.	J.S.	NNP
cord-029547-9ei1ram3	336	4	,	,	,
cord-029547-9ei1ram3	336	5	and	and	CC
cord-029547-9ei1ram3	336	6	C.W.	C.W.	NNP
cord-029547-9ei1ram3	336	7	wrote	write	VBD
cord-029547-9ei1ram3	336	8	the	the	DT
cord-029547-9ei1ram3	336	9	initial	initial	JJ
cord-029547-9ei1ram3	336	10	draft	draft	NN
cord-029547-9ei1ram3	336	11	of	of	IN
cord-029547-9ei1ram3	336	12	the	the	DT
cord-029547-9ei1ram3	336	13	manuscript	manuscript	NN
cord-029547-9ei1ram3	336	14	.	.	.
cord-029547-9ei1ram3	337	1	J.L.	J.L.	NNP
cord-029547-9ei1ram3	337	2	and	and	CC
cord-029547-9ei1ram3	337	3	C.W.	C.W.	NNP
cord-029547-9ei1ram3	337	4	gathered	gather	VBD
cord-029547-9ei1ram3	337	5	important	important	JJ
cord-029547-9ei1ram3	337	6	information	information	NN
cord-029547-9ei1ram3	337	7	.	.	.
cord-029547-9ei1ram3	338	1	C.W.	C.W.	NNP
cord-029547-9ei1ram3	338	2	and	and	CC
cord-029547-9ei1ram3	338	3	W.L.	W.L.	NNP
cord-029547-9ei1ram3	338	4	provided	provide	VBD
cord-029547-9ei1ram3	338	5	critical	critical	JJ
cord-029547-9ei1ram3	338	6	revision	revision	NN
cord-029547-9ei1ram3	338	7	of	of	IN
cord-029547-9ei1ram3	338	8	the	the	DT
cord-029547-9ei1ram3	338	9	manuscript	manuscript	NN
cord-029547-9ei1ram3	338	10	.	.	.
cord-029547-9ei1ram3	339	1	Early	early	JJ
cord-029547-9ei1ram3	339	2	transmission	transmission	NN
cord-029547-9ei1ram3	339	3	dynamics	dynamic	NNS
cord-029547-9ei1ram3	339	4	in	in	IN
cord-029547-9ei1ram3	339	5	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	339	6	,	,	,
cord-029547-9ei1ram3	339	7	China	China	NNP
cord-029547-9ei1ram3	339	8	,	,	,
cord-029547-9ei1ram3	339	9	of	of	IN
cord-029547-9ei1ram3	339	10	novel	novel	JJ
cord-029547-9ei1ram3	339	11	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	339	12	-	-	HYPH
cord-029547-9ei1ram3	339	13	infected	infect	VBN
cord-029547-9ei1ram3	339	14	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	340	1	A	a	DT
cord-029547-9ei1ram3	340	2	novel	novel	JJ
cord-029547-9ei1ram3	340	3	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	340	4	from	from	IN
cord-029547-9ei1ram3	340	5	patients	patient	NNS
cord-029547-9ei1ram3	340	6	with	with	IN
cord-029547-9ei1ram3	340	7	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	340	8	in	in	IN
cord-029547-9ei1ram3	340	9	China	China	NNP
cord-029547-9ei1ram3	340	10	Case	case	NN
cord-029547-9ei1ram3	340	11	-	-	HYPH
cord-029547-9ei1ram3	340	12	fatality	fatality	NN
cord-029547-9ei1ram3	340	13	rate	rate	NN
cord-029547-9ei1ram3	340	14	and	and	CC
cord-029547-9ei1ram3	340	15	characteristics	characteristic	NNS
cord-029547-9ei1ram3	340	16	of	of	IN
cord-029547-9ei1ram3	340	17	patients	patient	NNS
cord-029547-9ei1ram3	340	18	dying	die	VBG
cord-029547-9ei1ram3	340	19	in	in	IN
cord-029547-9ei1ram3	340	20	relation	relation	NN
cord-029547-9ei1ram3	340	21	to	to	IN
cord-029547-9ei1ram3	340	22	COVID-19	covid-19	VB
cord-029547-9ei1ram3	340	23	in	in	IN
cord-029547-9ei1ram3	340	24	Italy	Italy	NNP
cord-029547-9ei1ram3	340	25	Community	Community	NNP
cord-029547-9ei1ram3	340	26	prevalence	prevalence	NN
cord-029547-9ei1ram3	340	27	of	of	IN
cord-029547-9ei1ram3	340	28	SARS	SARS	NNP
cord-029547-9ei1ram3	340	29	-	-	HYPH
cord-029547-9ei1ram3	340	30	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	340	31	among	among	IN
cord-029547-9ei1ram3	340	32	patients	patient	NNS
cord-029547-9ei1ram3	340	33	with	with	IN
cord-029547-9ei1ram3	340	34	influenzalike	influenzalike	JJ
cord-029547-9ei1ram3	340	35	illnesses	illness	NNS
cord-029547-9ei1ram3	340	36	presenting	present	VBG
cord-029547-9ei1ram3	340	37	to	to	IN
cord-029547-9ei1ram3	340	38	a	a	DT
cord-029547-9ei1ram3	340	39	Los	Los	NNP
cord-029547-9ei1ram3	340	40	Angeles	Angeles	NNP
cord-029547-9ei1ram3	340	41	Medical	Medical	NNP
cord-029547-9ei1ram3	340	42	Center	Center	NNP
cord-029547-9ei1ram3	340	43	Importation	Importation	NNP
cord-029547-9ei1ram3	340	44	and	and	CC
cord-029547-9ei1ram3	340	45	human	human	NN
cord-029547-9ei1ram3	340	46	-	-	HYPH
cord-029547-9ei1ram3	340	47	to	to	IN
cord-029547-9ei1ram3	340	48	-	-	HYPH
cord-029547-9ei1ram3	340	49	human	human	JJ
cord-029547-9ei1ram3	340	50	transmission	transmission	NN
cord-029547-9ei1ram3	340	51	of	of	IN
cord-029547-9ei1ram3	340	52	a	a	DT
cord-029547-9ei1ram3	340	53	novel	novel	JJ
cord-029547-9ei1ram3	340	54	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	340	55	in	in	IN
cord-029547-9ei1ram3	340	56	Vietnam	Vietnam	NNP
cord-029547-9ei1ram3	340	57	Epidemiology	Epidemiology	NNP
cord-029547-9ei1ram3	340	58	of	of	IN
cord-029547-9ei1ram3	340	59	Covid-19	covid-19	NN
cord-029547-9ei1ram3	340	60	in	in	IN
cord-029547-9ei1ram3	340	61	a	a	DT
cord-029547-9ei1ram3	340	62	long	long	JJ
cord-029547-9ei1ram3	340	63	-	-	HYPH
cord-029547-9ei1ram3	340	64	term	term	NN
cord-029547-9ei1ram3	340	65	care	care	NN
cord-029547-9ei1ram3	340	66	facility	facility	NN
cord-029547-9ei1ram3	340	67	in	in	IN
cord-029547-9ei1ram3	340	68	King	King	NNP
cord-029547-9ei1ram3	340	69	County	County	NNP
cord-029547-9ei1ram3	340	70	,	,	,
cord-029547-9ei1ram3	340	71	Washington	Washington	NNP
cord-029547-9ei1ram3	341	1	The	the	DT
cord-029547-9ei1ram3	341	2	author	author	NN
cord-029547-9ei1ram3	341	3	's	's	POS
cord-029547-9ei1ram3	341	4	response	response	NN
cord-029547-9ei1ram3	341	5	:	:	:
cord-029547-9ei1ram3	341	6	case	case	NN
cord-029547-9ei1ram3	341	7	of	of	IN
cord-029547-9ei1ram3	341	8	the	the	DT
cord-029547-9ei1ram3	341	9	index	index	NN
cord-029547-9ei1ram3	341	10	patient	patient	NN
cord-029547-9ei1ram3	341	11	who	who	WP
cord-029547-9ei1ram3	341	12	caused	cause	VBD
cord-029547-9ei1ram3	341	13	tertiary	tertiary	JJ
cord-029547-9ei1ram3	341	14	transmission	transmission	NN
cord-029547-9ei1ram3	341	15	of	of	IN
cord-029547-9ei1ram3	341	16	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	341	17	disease	disease	NN
cord-029547-9ei1ram3	341	18	2019	2019	CD
cord-029547-9ei1ram3	341	19	in	in	IN
cord-029547-9ei1ram3	341	20	Korea	Korea	NNP
cord-029547-9ei1ram3	341	21	:	:	:
cord-029547-9ei1ram3	341	22	the	the	DT
cord-029547-9ei1ram3	341	23	application	application	NN
cord-029547-9ei1ram3	341	24	of	of	IN
cord-029547-9ei1ram3	341	25	Lopinavir	Lopinavir	NNP
cord-029547-9ei1ram3	341	26	/	/	SYM
cord-029547-9ei1ram3	341	27	Ritonavir	Ritonavir	NNP
cord-029547-9ei1ram3	341	28	for	for	IN
cord-029547-9ei1ram3	341	29	the	the	DT
cord-029547-9ei1ram3	341	30	treatment	treatment	NN
cord-029547-9ei1ram3	341	31	of	of	IN
cord-029547-9ei1ram3	341	32	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	341	33	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	341	34	monitored	monitor	VBN
cord-029547-9ei1ram3	341	35	by	by	IN
cord-029547-9ei1ram3	341	36	quantitative	quantitative	JJ
cord-029547-9ei1ram3	341	37	RT	RT	NNP
cord-029547-9ei1ram3	341	38	-	-	HYPH
cord-029547-9ei1ram3	341	39	PCR	PCR	NNP
cord-029547-9ei1ram3	341	40	Combination	Combination	NNP
cord-029547-9ei1ram3	341	41	of	of	IN
cord-029547-9ei1ram3	341	42	RT	RT	NNP
cord-029547-9ei1ram3	341	43	-	-	HYPH
cord-029547-9ei1ram3	341	44	qPCR	qpcr	NN
cord-029547-9ei1ram3	341	45	testing	testing	NN
cord-029547-9ei1ram3	341	46	and	and	CC
cord-029547-9ei1ram3	341	47	clinical	clinical	JJ
cord-029547-9ei1ram3	341	48	features	feature	NNS
cord-029547-9ei1ram3	341	49	for	for	IN
cord-029547-9ei1ram3	341	50	diagnosis	diagnosis	NN
cord-029547-9ei1ram3	341	51	of	of	IN
cord-029547-9ei1ram3	341	52	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	341	53	facilitates	facilitate	VBZ
cord-029547-9ei1ram3	341	54	management	management	NN
cord-029547-9ei1ram3	341	55	of	of	IN
cord-029547-9ei1ram3	341	56	SARS	SARS	NNP
cord-029547-9ei1ram3	341	57	-	-	HYPH
cord-029547-9ei1ram3	341	58	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	341	59	outbreak	outbreak	NN
cord-029547-9ei1ram3	341	60	Planning	planning	NN
cord-029547-9ei1ram3	341	61	and	and	CC
cord-029547-9ei1ram3	341	62	provision	provision	NN
cord-029547-9ei1ram3	341	63	of	of	IN
cord-029547-9ei1ram3	341	64	ECMO	ECMO	NNP
cord-029547-9ei1ram3	341	65	services	service	NNS
cord-029547-9ei1ram3	341	66	for	for	IN
cord-029547-9ei1ram3	341	67	severe	severe	JJ
cord-029547-9ei1ram3	341	68	ARDS	ARDS	NNP
cord-029547-9ei1ram3	341	69	during	during	IN
cord-029547-9ei1ram3	341	70	the	the	DT
cord-029547-9ei1ram3	341	71	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	341	72	pandemic	pandemic	NN
cord-029547-9ei1ram3	341	73	and	and	CC
cord-029547-9ei1ram3	341	74	other	other	JJ
cord-029547-9ei1ram3	341	75	outbreaks	outbreak	NNS
cord-029547-9ei1ram3	341	76	of	of	IN
cord-029547-9ei1ram3	341	77	emerging	emerge	VBG
cord-029547-9ei1ram3	341	78	infectious	infectious	JJ
cord-029547-9ei1ram3	341	79	diseases	disease	NNS
cord-029547-9ei1ram3	341	80	Treatment	treatment	NN
cord-029547-9ei1ram3	341	81	for	for	IN
cord-029547-9ei1ram3	341	82	severe	severe	JJ
cord-029547-9ei1ram3	341	83	acute	acute	JJ
cord-029547-9ei1ram3	341	84	respiratory	respiratory	JJ
cord-029547-9ei1ram3	341	85	distress	distress	NN
cord-029547-9ei1ram3	341	86	syndrome	syndrome	NN
cord-029547-9ei1ram3	341	87	from	from	IN
cord-029547-9ei1ram3	341	88	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	341	89	Asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	341	90	cases	case	NNS
cord-029547-9ei1ram3	341	91	in	in	IN
cord-029547-9ei1ram3	341	92	a	a	DT
cord-029547-9ei1ram3	341	93	family	family	NN
cord-029547-9ei1ram3	341	94	cluster	cluster	NN
cord-029547-9ei1ram3	341	95	with	with	IN
cord-029547-9ei1ram3	341	96	SARS	SARS	NNP
cord-029547-9ei1ram3	341	97	-	-	HYPH
cord-029547-9ei1ram3	341	98	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	341	99	infection	infection	NN
cord-029547-9ei1ram3	341	100	Coronaviridae	Coronaviridae	NNP
cord-029547-9ei1ram3	341	101	Study	Study	NNP
cord-029547-9ei1ram3	341	102	Group	Group	NNP
cord-029547-9ei1ram3	341	103	of	of	IN
cord-029547-9ei1ram3	341	104	the	the	DT
cord-029547-9ei1ram3	341	105	International	International	NNP
cord-029547-9ei1ram3	341	106	Committee	Committee	NNP
cord-029547-9ei1ram3	341	107	on	on	IN
cord-029547-9ei1ram3	341	108	Taxonomy	Taxonomy	NNP
cord-029547-9ei1ram3	341	109	of	of	IN
cord-029547-9ei1ram3	341	110	Viruses	Viruses	NNPS
cord-029547-9ei1ram3	341	111	.	.	.
cord-029547-9ei1ram3	342	1	The	the	DT
cord-029547-9ei1ram3	342	2	species	specie	NNS
cord-029547-9ei1ram3	342	3	severe	severe	JJ
cord-029547-9ei1ram3	342	4	acute	acute	JJ
cord-029547-9ei1ram3	342	5	respiratory	respiratory	JJ
cord-029547-9ei1ram3	342	6	syndrome	syndrome	NN
cord-029547-9ei1ram3	342	7	-	-	HYPH
cord-029547-9ei1ram3	342	8	related	relate	VBN
cord-029547-9ei1ram3	342	9	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	342	10	:	:	:
cord-029547-9ei1ram3	342	11	classifying	classify	VBG
cord-029547-9ei1ram3	342	12	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	342	13	and	and	CC
cord-029547-9ei1ram3	342	14	naming	name	VBG
cord-029547-9ei1ram3	342	15	it	-PRON-	PRP
cord-029547-9ei1ram3	342	16	SARS	SARS	NNP
cord-029547-9ei1ram3	342	17	-	-	HYPH
cord-029547-9ei1ram3	342	18	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	343	1	A	a	DT
cord-029547-9ei1ram3	343	2	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	343	3	outbreak	outbreak	NN
cord-029547-9ei1ram3	343	4	associated	associate	VBN
cord-029547-9ei1ram3	343	5	with	with	IN
cord-029547-9ei1ram3	343	6	a	a	DT
cord-029547-9ei1ram3	343	7	new	new	JJ
cord-029547-9ei1ram3	343	8	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	343	9	of	of	IN
cord-029547-9ei1ram3	343	10	probable	probable	JJ
cord-029547-9ei1ram3	343	11	bat	bat	NN
cord-029547-9ei1ram3	343	12	origin	origin	NN
cord-029547-9ei1ram3	344	1	A	a	DT
cord-029547-9ei1ram3	344	2	new	new	JJ
cord-029547-9ei1ram3	344	3	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	344	4	associated	associate	VBN
cord-029547-9ei1ram3	344	5	with	with	IN
cord-029547-9ei1ram3	344	6	human	human	JJ
cord-029547-9ei1ram3	344	7	respiratory	respiratory	JJ
cord-029547-9ei1ram3	344	8	disease	disease	NN
cord-029547-9ei1ram3	344	9	in	in	IN
cord-029547-9ei1ram3	344	10	China	China	NNP
cord-029547-9ei1ram3	344	11	A	a	DT
cord-029547-9ei1ram3	344	12	genomic	genomic	JJ
cord-029547-9ei1ram3	344	13	perspective	perspective	NN
cord-029547-9ei1ram3	344	14	on	on	IN
cord-029547-9ei1ram3	344	15	the	the	DT
cord-029547-9ei1ram3	344	16	origin	origin	NN
cord-029547-9ei1ram3	344	17	and	and	CC
cord-029547-9ei1ram3	344	18	emergence	emergence	NN
cord-029547-9ei1ram3	344	19	of	of	IN
cord-029547-9ei1ram3	344	20	SARS	SARS	NNP
cord-029547-9ei1ram3	344	21	-	-	HYPH
cord-029547-9ei1ram3	344	22	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	344	23	Genomic	genomic	JJ
cord-029547-9ei1ram3	344	24	characterisation	characterisation	NN
cord-029547-9ei1ram3	344	25	and	and	CC
cord-029547-9ei1ram3	344	26	epidemiology	epidemiology	NN
cord-029547-9ei1ram3	344	27	of	of	IN
cord-029547-9ei1ram3	344	28	2019	2019	CD
cord-029547-9ei1ram3	344	29	novel	novel	JJ
cord-029547-9ei1ram3	344	30	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	344	31	:	:	:
cord-029547-9ei1ram3	344	32	implications	implication	NNS
cord-029547-9ei1ram3	344	33	for	for	IN
cord-029547-9ei1ram3	344	34	virus	virus	NN
cord-029547-9ei1ram3	344	35	origins	origin	NNS
cord-029547-9ei1ram3	344	36	and	and	CC
cord-029547-9ei1ram3	344	37	receptor	receptor	NN
cord-029547-9ei1ram3	344	38	binding	bind	VBG
cord-029547-9ei1ram3	344	39	Cross	Cross	NNP
cord-029547-9ei1ram3	344	40	-	-	HYPH
cord-029547-9ei1ram3	344	41	species	species	JJ
cord-029547-9ei1ram3	344	42	transmission	transmission	NN
cord-029547-9ei1ram3	344	43	of	of	IN
cord-029547-9ei1ram3	344	44	the	the	DT
cord-029547-9ei1ram3	344	45	newly	newly	RB
cord-029547-9ei1ram3	344	46	identified	identify	VBN
cord-029547-9ei1ram3	344	47	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	345	1	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	346	1	The	the	DT
cord-029547-9ei1ram3	346	2	origin	origin	NN
cord-029547-9ei1ram3	346	3	and	and	CC
cord-029547-9ei1ram3	346	4	underlying	underlying	JJ
cord-029547-9ei1ram3	346	5	driving	drive	VBG
cord-029547-9ei1ram3	346	6	forces	force	NNS
cord-029547-9ei1ram3	346	7	of	of	IN
cord-029547-9ei1ram3	346	8	the	the	DT
cord-029547-9ei1ram3	346	9	SARS	SARS	NNP
cord-029547-9ei1ram3	346	10	-	-	HYPH
cord-029547-9ei1ram3	346	11	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	346	12	outbreak	outbreak	NN
cord-029547-9ei1ram3	346	13	Composition	composition	NN
cord-029547-9ei1ram3	346	14	and	and	CC
cord-029547-9ei1ram3	346	15	divergence	divergence	NN
cord-029547-9ei1ram3	346	16	of	of	IN
cord-029547-9ei1ram3	346	17	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	346	18	spike	spike	NN
cord-029547-9ei1ram3	346	19	proteins	protein	NNS
cord-029547-9ei1ram3	346	20	and	and	CC
cord-029547-9ei1ram3	346	21	host	host	NN
cord-029547-9ei1ram3	346	22	ACE2	ACE2	NNP
cord-029547-9ei1ram3	346	23	receptors	receptor	NNS
cord-029547-9ei1ram3	346	24	predict	predict	VBP
cord-029547-9ei1ram3	346	25	potential	potential	JJ
cord-029547-9ei1ram3	346	26	intermediate	intermediate	JJ
cord-029547-9ei1ram3	346	27	hosts	host	NNS
cord-029547-9ei1ram3	346	28	of	of	IN
cord-029547-9ei1ram3	346	29	SARS	SARS	NNP
cord-029547-9ei1ram3	346	30	-	-	HYPH
cord-029547-9ei1ram3	346	31	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	346	32	SARS	SARS	NNP
cord-029547-9ei1ram3	346	33	-	-	HYPH
cord-029547-9ei1ram3	346	34	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	346	35	and	and	CC
cord-029547-9ei1ram3	346	36	viral	viral	JJ
cord-029547-9ei1ram3	346	37	sepsis	sepsis	NN
cord-029547-9ei1ram3	346	38	:	:	:
cord-029547-9ei1ram3	346	39	observations	observation	NNS
cord-029547-9ei1ram3	346	40	and	and	CC
cord-029547-9ei1ram3	346	41	hypotheses	hypothesis	NNS
cord-029547-9ei1ram3	347	1	Structural	structural	JJ
cord-029547-9ei1ram3	347	2	insights	insight	NNS
cord-029547-9ei1ram3	347	3	into	into	IN
cord-029547-9ei1ram3	347	4	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	347	5	entry	entry	NN
cord-029547-9ei1ram3	347	6	Fusion	Fusion	NNP
cord-029547-9ei1ram3	347	7	mechanism	mechanism	NN
cord-029547-9ei1ram3	347	8	of	of	IN
cord-029547-9ei1ram3	347	9	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	347	10	and	and	CC
cord-029547-9ei1ram3	347	11	fusion	fusion	NN
cord-029547-9ei1ram3	347	12	inhibitors	inhibitor	NNS
cord-029547-9ei1ram3	347	13	targeting	target	VBG
cord-029547-9ei1ram3	347	14	HR1	HR1	NNP
cord-029547-9ei1ram3	347	15	domain	domain	NN
cord-029547-9ei1ram3	347	16	in	in	IN
cord-029547-9ei1ram3	347	17	spike	spike	NN
cord-029547-9ei1ram3	347	18	protein	protein	NN
cord-029547-9ei1ram3	347	19	SARS	SARS	NNP
cord-029547-9ei1ram3	347	20	-	-	HYPH
cord-029547-9ei1ram3	347	21	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	347	22	cell	cell	NN
cord-029547-9ei1ram3	347	23	entry	entry	NN
cord-029547-9ei1ram3	347	24	depends	depend	VBZ
cord-029547-9ei1ram3	347	25	on	on	IN
cord-029547-9ei1ram3	347	26	ACE2	ACE2	NNP
cord-029547-9ei1ram3	347	27	and	and	CC
cord-029547-9ei1ram3	347	28	TMPRSS2	TMPRSS2	NNP
cord-029547-9ei1ram3	347	29	and	and	CC
cord-029547-9ei1ram3	347	30	is	be	VBZ
cord-029547-9ei1ram3	347	31	blocked	block	VBN
cord-029547-9ei1ram3	347	32	by	by	IN
cord-029547-9ei1ram3	347	33	a	a	DT
cord-029547-9ei1ram3	347	34	clinically	clinically	RB
cord-029547-9ei1ram3	347	35	proven	prove	VBN
cord-029547-9ei1ram3	347	36	protease	protease	NN
cord-029547-9ei1ram3	347	37	inhibitor	inhibitor	NN
cord-029547-9ei1ram3	347	38	Rigidity	rigidity	NN
cord-029547-9ei1ram3	347	39	of	of	IN
cord-029547-9ei1ram3	347	40	the	the	DT
cord-029547-9ei1ram3	347	41	outer	outer	JJ
cord-029547-9ei1ram3	347	42	shell	shell	NN
cord-029547-9ei1ram3	347	43	predicted	predict	VBN
cord-029547-9ei1ram3	347	44	by	by	IN
cord-029547-9ei1ram3	347	45	a	a	DT
cord-029547-9ei1ram3	347	46	protein	protein	NN
cord-029547-9ei1ram3	347	47	intrinsic	intrinsic	JJ
cord-029547-9ei1ram3	347	48	disorder	disorder	NN
cord-029547-9ei1ram3	347	49	model	model	NN
cord-029547-9ei1ram3	347	50	sheds	shed	VBZ
cord-029547-9ei1ram3	347	51	light	light	NN
cord-029547-9ei1ram3	347	52	on	on	IN
cord-029547-9ei1ram3	347	53	the	the	DT
cord-029547-9ei1ram3	347	54	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	347	55	(	(	-LRB-
cord-029547-9ei1ram3	347	56	Wuhan-2019-nCoV	wuhan-2019-ncov	NN
cord-029547-9ei1ram3	347	57	)	)	-RRB-
cord-029547-9ei1ram3	347	58	infectivity	infectivity	NN
cord-029547-9ei1ram3	347	59	Altered	alter	VBD
cord-029547-9ei1ram3	347	60	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	347	61	receptor	receptor	NN
cord-029547-9ei1ram3	347	62	ACE2	ACE2	NNP
cord-029547-9ei1ram3	347	63	expression	expression	NN
cord-029547-9ei1ram3	347	64	in	in	IN
cord-029547-9ei1ram3	347	65	a	a	DT
cord-029547-9ei1ram3	347	66	higher	high	JJR
cord-029547-9ei1ram3	347	67	risk	risk	NN
cord-029547-9ei1ram3	347	68	group	group	NN
cord-029547-9ei1ram3	347	69	for	for	IN
cord-029547-9ei1ram3	347	70	cerebrovascular	cerebrovascular	JJ
cord-029547-9ei1ram3	347	71	disease	disease	NN
cord-029547-9ei1ram3	347	72	and	and	CC
cord-029547-9ei1ram3	347	73	ischemic	ischemic	JJ
cord-029547-9ei1ram3	347	74	stroke	stroke	NN
cord-029547-9ei1ram3	347	75	Information	information	NN
cord-029547-9ei1ram3	347	76	about	about	IN
cord-029547-9ei1ram3	347	77	the	the	DT
cord-029547-9ei1ram3	347	78	current	current	JJ
cord-029547-9ei1ram3	347	79	situation	situation	NN
cord-029547-9ei1ram3	347	80	of	of	IN
cord-029547-9ei1ram3	347	81	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	347	82	in	in	IN
cord-029547-9ei1ram3	347	83	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	347	84	WHO	WHO	NNP
cord-029547-9ei1ram3	347	85	.	.	.
cord-029547-9ei1ram3	348	1	Coronavirus	Coronavirus	NNP
cord-029547-9ei1ram3	348	2	disease	disease	NN
cord-029547-9ei1ram3	348	3	2019	2019	CD
cord-029547-9ei1ram3	349	1	(	(	-LRB-
cord-029547-9ei1ram3	349	2	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	349	3	)	)	-RRB-
cord-029547-9ei1ram3	349	4	Situation	Situation	NNP
cord-029547-9ei1ram3	349	5	Report	Report	NNP
cord-029547-9ei1ram3	349	6	-117	-117	NNP
cord-029547-9ei1ram3	350	1	Incubation	incubation	NN
cord-029547-9ei1ram3	350	2	period	period	NN
cord-029547-9ei1ram3	350	3	and	and	CC
cord-029547-9ei1ram3	350	4	other	other	JJ
cord-029547-9ei1ram3	350	5	epidemiological	epidemiological	JJ
cord-029547-9ei1ram3	350	6	characteristics	characteristic	NNS
cord-029547-9ei1ram3	350	7	of	of	IN
cord-029547-9ei1ram3	350	8	2019	2019	CD
cord-029547-9ei1ram3	350	9	novel	novel	JJ
cord-029547-9ei1ram3	350	10	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	350	11	infections	infection	NNS
cord-029547-9ei1ram3	350	12	with	with	IN
cord-029547-9ei1ram3	350	13	right	right	JJ
cord-029547-9ei1ram3	350	14	truncation	truncation	NN
cord-029547-9ei1ram3	350	15	:	:	:
cord-029547-9ei1ram3	350	16	a	a	DT
cord-029547-9ei1ram3	350	17	statistical	statistical	JJ
cord-029547-9ei1ram3	350	18	analysis	analysis	NN
cord-029547-9ei1ram3	350	19	of	of	IN
cord-029547-9ei1ram3	351	1	publicly	publicly	RB
cord-029547-9ei1ram3	351	2	available	available	JJ
cord-029547-9ei1ram3	351	3	case	case	NN
cord-029547-9ei1ram3	351	4	data	datum	NNS
cord-029547-9ei1ram3	352	1	A	a	DT
cord-029547-9ei1ram3	352	2	familial	familial	JJ
cord-029547-9ei1ram3	352	3	cluster	cluster	NN
cord-029547-9ei1ram3	352	4	of	of	IN
cord-029547-9ei1ram3	352	5	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	352	6	associated	associate	VBN
cord-029547-9ei1ram3	352	7	with	with	IN
cord-029547-9ei1ram3	352	8	the	the	DT
cord-029547-9ei1ram3	352	9	2019	2019	CD
cord-029547-9ei1ram3	352	10	novel	novel	NN
cord-029547-9ei1ram3	352	11	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	352	12	indicating	indicate	VBG
cord-029547-9ei1ram3	352	13	person	person	NN
cord-029547-9ei1ram3	352	14	-	-	HYPH
cord-029547-9ei1ram3	352	15	to	to	IN
cord-029547-9ei1ram3	352	16	-	-	HYPH
cord-029547-9ei1ram3	352	17	person	person	NN
cord-029547-9ei1ram3	352	18	transmission	transmission	NN
cord-029547-9ei1ram3	352	19	:	:	:
cord-029547-9ei1ram3	352	20	a	a	DT
cord-029547-9ei1ram3	352	21	study	study	NN
cord-029547-9ei1ram3	352	22	of	of	IN
cord-029547-9ei1ram3	352	23	a	a	DT
cord-029547-9ei1ram3	352	24	family	family	NN
cord-029547-9ei1ram3	352	25	cluster	cluster	NN
cord-029547-9ei1ram3	352	26	Characteristics	characteristic	NNS
cord-029547-9ei1ram3	352	27	of	of	IN
cord-029547-9ei1ram3	352	28	ocular	ocular	JJ
cord-029547-9ei1ram3	352	29	findings	finding	NNS
cord-029547-9ei1ram3	352	30	of	of	IN
cord-029547-9ei1ram3	352	31	patients	patient	NNS
cord-029547-9ei1ram3	352	32	with	with	IN
cord-029547-9ei1ram3	352	33	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	352	34	disease	disease	NN
cord-029547-9ei1ram3	352	35	2019	2019	CD
cord-029547-9ei1ram3	352	36	(	(	-LRB-
cord-029547-9ei1ram3	352	37	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	352	38	Enteric	enteric	JJ
cord-029547-9ei1ram3	352	39	involvement	involvement	NN
cord-029547-9ei1ram3	352	40	of	of	IN
cord-029547-9ei1ram3	352	41	coronaviruses	coronaviruse	NNS
cord-029547-9ei1ram3	352	42	:	:	:
cord-029547-9ei1ram3	352	43	is	be	VBZ
cord-029547-9ei1ram3	352	44	faecal	faecal	JJ
cord-029547-9ei1ram3	352	45	-	-	HYPH
cord-029547-9ei1ram3	352	46	oral	oral	JJ
cord-029547-9ei1ram3	352	47	transmission	transmission	NN
cord-029547-9ei1ram3	352	48	of	of	IN
cord-029547-9ei1ram3	352	49	SARS	SARS	NNP
cord-029547-9ei1ram3	352	50	-	-	HYPH
cord-029547-9ei1ram3	352	51	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	352	52	possible	possible	JJ
cord-029547-9ei1ram3	352	53	?	?	.
cord-029547-9ei1ram3	353	1	Characteristics	characteristic	NNS
cord-029547-9ei1ram3	353	2	of	of	IN
cord-029547-9ei1ram3	353	3	pediatric	pediatric	JJ
cord-029547-9ei1ram3	353	4	SARS	SARS	NNP
cord-029547-9ei1ram3	353	5	-	-	HYPH
cord-029547-9ei1ram3	353	6	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	353	7	infection	infection	NN
cord-029547-9ei1ram3	353	8	and	and	CC
cord-029547-9ei1ram3	353	9	potential	potential	JJ
cord-029547-9ei1ram3	353	10	evidence	evidence	NN
cord-029547-9ei1ram3	353	11	for	for	IN
cord-029547-9ei1ram3	353	12	persistent	persistent	JJ
cord-029547-9ei1ram3	353	13	fecal	fecal	JJ
cord-029547-9ei1ram3	353	14	viral	viral	JJ
cord-029547-9ei1ram3	353	15	shedding	shed	VBG
cord-029547-9ei1ram3	353	16	Detection	Detection	NNP
cord-029547-9ei1ram3	353	17	of	of	IN
cord-029547-9ei1ram3	353	18	SARS	SARS	NNP
cord-029547-9ei1ram3	353	19	-	-	HYPH
cord-029547-9ei1ram3	353	20	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	353	21	in	in	IN
cord-029547-9ei1ram3	353	22	different	different	JJ
cord-029547-9ei1ram3	353	23	types	type	NNS
cord-029547-9ei1ram3	353	24	of	of	IN
cord-029547-9ei1ram3	353	25	clinical	clinical	JJ
cord-029547-9ei1ram3	353	26	specimens	specimen	NNS
cord-029547-9ei1ram3	353	27	Possible	possible	JJ
cord-029547-9ei1ram3	353	28	vertical	vertical	JJ
cord-029547-9ei1ram3	353	29	transmission	transmission	NN
cord-029547-9ei1ram3	353	30	of	of	IN
cord-029547-9ei1ram3	353	31	SARS	SARS	NNP
cord-029547-9ei1ram3	353	32	-	-	HYPH
cord-029547-9ei1ram3	353	33	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	353	34	from	from	IN
cord-029547-9ei1ram3	353	35	an	an	DT
cord-029547-9ei1ram3	353	36	infected	infected	JJ
cord-029547-9ei1ram3	353	37	mother	mother	NN
cord-029547-9ei1ram3	353	38	to	to	IN
cord-029547-9ei1ram3	353	39	her	-PRON-	PRP$
cord-029547-9ei1ram3	353	40	newborn	newborn	JJ
cord-029547-9ei1ram3	353	41	Clinical	clinical	JJ
cord-029547-9ei1ram3	353	42	characteristics	characteristic	NNS
cord-029547-9ei1ram3	353	43	and	and	CC
cord-029547-9ei1ram3	353	44	intrauterine	intrauterine	JJ
cord-029547-9ei1ram3	353	45	vertical	vertical	JJ
cord-029547-9ei1ram3	353	46	transmission	transmission	NN
cord-029547-9ei1ram3	353	47	potential	potential	NN
cord-029547-9ei1ram3	353	48	of	of	IN
cord-029547-9ei1ram3	353	49	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	353	50	infection	infection	NN
cord-029547-9ei1ram3	353	51	in	in	IN
cord-029547-9ei1ram3	353	52	nine	nine	CD
cord-029547-9ei1ram3	353	53	pregnant	pregnant	JJ
cord-029547-9ei1ram3	353	54	women	woman	NNS
cord-029547-9ei1ram3	353	55	:	:	:
cord-029547-9ei1ram3	353	56	a	a	DT
cord-029547-9ei1ram3	353	57	retrospective	retrospective	JJ
cord-029547-9ei1ram3	353	58	review	review	NN
cord-029547-9ei1ram3	353	59	of	of	IN
cord-029547-9ei1ram3	353	60	medical	medical	JJ
cord-029547-9ei1ram3	353	61	records	record	NNS
cord-029547-9ei1ram3	353	62	Novel	Novel	NNP
cord-029547-9ei1ram3	353	63	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	353	64	infection	infection	NN
cord-029547-9ei1ram3	353	65	in	in	IN
cord-029547-9ei1ram3	353	66	hospitalized	hospitalize	VBN
cord-029547-9ei1ram3	353	67	infants	infant	NNS
cord-029547-9ei1ram3	353	68	under	under	IN
cord-029547-9ei1ram3	353	69	1	1	CD
cord-029547-9ei1ram3	353	70	year	year	NN
cord-029547-9ei1ram3	353	71	of	of	IN
cord-029547-9ei1ram3	353	72	age	age	NN
cord-029547-9ei1ram3	353	73	in	in	IN
cord-029547-9ei1ram3	353	74	China	China	NNP
cord-029547-9ei1ram3	353	75	Antibodies	Antibodies	NNP
cord-029547-9ei1ram3	353	76	in	in	IN
cord-029547-9ei1ram3	353	77	infants	infant	NNS
cord-029547-9ei1ram3	353	78	born	bear	VBN
cord-029547-9ei1ram3	353	79	to	to	IN
cord-029547-9ei1ram3	353	80	mothers	mother	NNS
cord-029547-9ei1ram3	353	81	with	with	IN
cord-029547-9ei1ram3	353	82	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	353	83	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	354	1	The	the	DT
cord-029547-9ei1ram3	354	2	Novel	Novel	NNP
cord-029547-9ei1ram3	354	3	Coronavirus	Coronavirus	NNP
cord-029547-9ei1ram3	354	4	Pneumonia	Pneumonia	NNP
cord-029547-9ei1ram3	354	5	Emergency	Emergency	NNP
cord-029547-9ei1ram3	354	6	Response	Response	NNP
cord-029547-9ei1ram3	354	7	Epidemiology	Epidemiology	NNP
cord-029547-9ei1ram3	354	8	.	.	.
cord-029547-9ei1ram3	355	1	The	the	DT
cord-029547-9ei1ram3	355	2	epidemiological	epidemiological	JJ
cord-029547-9ei1ram3	355	3	characteristics	characteristic	NNS
cord-029547-9ei1ram3	355	4	of	of	IN
cord-029547-9ei1ram3	355	5	an	an	DT
cord-029547-9ei1ram3	355	6	outbreak	outbreak	NN
cord-029547-9ei1ram3	355	7	of	of	IN
cord-029547-9ei1ram3	355	8	2019	2019	CD
cord-029547-9ei1ram3	355	9	novel	novel	JJ
cord-029547-9ei1ram3	355	10	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	355	11	diseases	disease	NNS
cord-029547-9ei1ram3	355	12	(	(	-LRB-
cord-029547-9ei1ram3	355	13	COVID-19)-China	COVID-19)-China	NNP
cord-029547-9ei1ram3	355	14	Severe	severe	JJ
cord-029547-9ei1ram3	355	15	outcomes	outcome	NNS
cord-029547-9ei1ram3	355	16	among	among	IN
cord-029547-9ei1ram3	355	17	patients	patient	NNS
cord-029547-9ei1ram3	355	18	with	with	IN
cord-029547-9ei1ram3	355	19	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	355	20	disease	disease	NN
cord-029547-9ei1ram3	355	21	2019	2019	CD
cord-029547-9ei1ram3	355	22	(	(	-LRB-
cord-029547-9ei1ram3	355	23	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	355	24	)	)	-RRB-
cord-029547-9ei1ram3	355	25	-United	-unite	VBD
cord-029547-9ei1ram3	355	26	States	States	NNP
cord-029547-9ei1ram3	355	27	High	High	NNP
cord-029547-9ei1ram3	355	28	contagiousness	contagiousness	NN
cord-029547-9ei1ram3	355	29	and	and	CC
cord-029547-9ei1ram3	355	30	rapid	rapid	JJ
cord-029547-9ei1ram3	355	31	spread	spread	NN
cord-029547-9ei1ram3	355	32	of	of	IN
cord-029547-9ei1ram3	355	33	severe	severe	JJ
cord-029547-9ei1ram3	355	34	acute	acute	JJ
cord-029547-9ei1ram3	355	35	respiratory	respiratory	JJ
cord-029547-9ei1ram3	355	36	syndrome	syndrome	NN
cord-029547-9ei1ram3	355	37	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	355	38	2	2	CD
cord-029547-9ei1ram3	355	39	Report	Report	NNP
cord-029547-9ei1ram3	355	40	13	13	CD
cord-029547-9ei1ram3	356	1	-Estimating	-estimate	VBG
cord-029547-9ei1ram3	357	1	the	the	DT
cord-029547-9ei1ram3	357	2	number	number	NN
cord-029547-9ei1ram3	357	3	of	of	IN
cord-029547-9ei1ram3	357	4	infections	infection	NNS
cord-029547-9ei1ram3	357	5	and	and	CC
cord-029547-9ei1ram3	357	6	the	the	DT
cord-029547-9ei1ram3	357	7	impact	impact	NN
cord-029547-9ei1ram3	357	8	of	of	IN
cord-029547-9ei1ram3	357	9	non	non	JJ
cord-029547-9ei1ram3	357	10	-	-	JJ
cord-029547-9ei1ram3	357	11	pharmaceutical	pharmaceutical	JJ
cord-029547-9ei1ram3	357	12	interventions	intervention	NNS
cord-029547-9ei1ram3	357	13	on	on	IN
cord-029547-9ei1ram3	357	14	COVID-19	covid-19	CD
cord-029547-9ei1ram3	357	15	in	in	IN
cord-029547-9ei1ram3	357	16	11	11	CD
cord-029547-9ei1ram3	357	17	European	european	JJ
cord-029547-9ei1ram3	357	18	countries	country	NNS
cord-029547-9ei1ram3	357	19	Characteristics	characteristic	NNS
cord-029547-9ei1ram3	357	20	of	of	IN
cord-029547-9ei1ram3	357	21	and	and	CC
cord-029547-9ei1ram3	357	22	important	important	JJ
cord-029547-9ei1ram3	357	23	lessons	lesson	NNS
cord-029547-9ei1ram3	357	24	from	from	IN
cord-029547-9ei1ram3	357	25	the	the	DT
cord-029547-9ei1ram3	357	26	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	357	27	disease	disease	NN
cord-029547-9ei1ram3	357	28	2019	2019	CD
cord-029547-9ei1ram3	357	29	(	(	-LRB-
cord-029547-9ei1ram3	357	30	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	357	31	)	)	-RRB-
cord-029547-9ei1ram3	357	32	outbreak	outbreak	NN
cord-029547-9ei1ram3	357	33	in	in	IN
cord-029547-9ei1ram3	357	34	China	China	NNP
cord-029547-9ei1ram3	357	35	:	:	:
cord-029547-9ei1ram3	357	36	summary	summary	NN
cord-029547-9ei1ram3	357	37	of	of	IN
cord-029547-9ei1ram3	357	38	a	a	DT
cord-029547-9ei1ram3	357	39	report	report	NN
cord-029547-9ei1ram3	357	40	of	of	IN
cord-029547-9ei1ram3	357	41	72314	72314	CD
cord-029547-9ei1ram3	357	42	cases	case	NNS
cord-029547-9ei1ram3	357	43	from	from	IN
cord-029547-9ei1ram3	357	44	the	the	DT
cord-029547-9ei1ram3	357	45	Chinese	Chinese	NNP
cord-029547-9ei1ram3	357	46	Center	Center	NNP
cord-029547-9ei1ram3	357	47	for	for	IN
cord-029547-9ei1ram3	357	48	Disease	Disease	NNP
cord-029547-9ei1ram3	357	49	Control	Control	NNP
cord-029547-9ei1ram3	357	50	and	and	CC
cord-029547-9ei1ram3	357	51	Prevention	Prevention	NNP
cord-029547-9ei1ram3	357	52	Epidemiologic	Epidemiologic	NNP
cord-029547-9ei1ram3	357	53	and	and	CC
cord-029547-9ei1ram3	357	54	clinical	clinical	JJ
cord-029547-9ei1ram3	357	55	characteristics	characteristic	NNS
cord-029547-9ei1ram3	357	56	of	of	IN
cord-029547-9ei1ram3	357	57	novel	novel	JJ
cord-029547-9ei1ram3	357	58	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	357	59	infections	infection	NNS
cord-029547-9ei1ram3	357	60	involving	involve	VBG
cord-029547-9ei1ram3	357	61	13	13	CD
cord-029547-9ei1ram3	357	62	patients	patient	NNS
cord-029547-9ei1ram3	357	63	outside	outside	IN
cord-029547-9ei1ram3	357	64	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	357	65	,	,	,
cord-029547-9ei1ram3	357	66	China	China	NNP
cord-029547-9ei1ram3	357	67	Estimating	estimate	VBG
cord-029547-9ei1ram3	357	68	clinical	clinical	JJ
cord-029547-9ei1ram3	357	69	severity	severity	NN
cord-029547-9ei1ram3	357	70	of	of	IN
cord-029547-9ei1ram3	357	71	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	357	72	from	from	IN
cord-029547-9ei1ram3	357	73	the	the	DT
cord-029547-9ei1ram3	357	74	transmission	transmission	NN
cord-029547-9ei1ram3	357	75	dynamics	dynamic	NNS
cord-029547-9ei1ram3	357	76	in	in	IN
cord-029547-9ei1ram3	357	77	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	357	78	,	,	,
cord-029547-9ei1ram3	357	79	China	China	NNP
cord-029547-9ei1ram3	357	80	Clinical	clinical	JJ
cord-029547-9ei1ram3	357	81	characteristics	characteristic	NNS
cord-029547-9ei1ram3	357	82	of	of	IN
cord-029547-9ei1ram3	357	83	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	357	84	disease	disease	NN
cord-029547-9ei1ram3	357	85	2019	2019	CD
cord-029547-9ei1ram3	357	86	in	in	IN
cord-029547-9ei1ram3	357	87	China	China	NNP
cord-029547-9ei1ram3	357	88	Epidemiological	epidemiological	JJ
cord-029547-9ei1ram3	357	89	and	and	CC
cord-029547-9ei1ram3	357	90	clinical	clinical	JJ
cord-029547-9ei1ram3	357	91	characteristics	characteristic	NNS
cord-029547-9ei1ram3	357	92	of	of	IN
cord-029547-9ei1ram3	357	93	99	99	CD
cord-029547-9ei1ram3	357	94	cases	case	NNS
cord-029547-9ei1ram3	357	95	of	of	IN
cord-029547-9ei1ram3	357	96	2019	2019	CD
cord-029547-9ei1ram3	357	97	novel	novel	JJ
cord-029547-9ei1ram3	357	98	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	357	99	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	357	100	in	in	IN
cord-029547-9ei1ram3	357	101	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	357	102	,	,	,
cord-029547-9ei1ram3	357	103	China	China	NNP
cord-029547-9ei1ram3	357	104	:	:	:
cord-029547-9ei1ram3	357	105	a	a	DT
cord-029547-9ei1ram3	357	106	descriptive	descriptive	JJ
cord-029547-9ei1ram3	357	107	study	study	NN
cord-029547-9ei1ram3	357	108	Clinical	clinical	JJ
cord-029547-9ei1ram3	357	109	characteristics	characteristic	NNS
cord-029547-9ei1ram3	357	110	of	of	IN
cord-029547-9ei1ram3	357	111	138	138	CD
cord-029547-9ei1ram3	357	112	hospitalized	hospitalize	VBN
cord-029547-9ei1ram3	357	113	patients	patient	NNS
cord-029547-9ei1ram3	357	114	with	with	IN
cord-029547-9ei1ram3	357	115	2019	2019	CD
cord-029547-9ei1ram3	357	116	novel	novel	JJ
cord-029547-9ei1ram3	357	117	coronavirusinfected	coronavirusinfecte	VBN
cord-029547-9ei1ram3	357	118	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	357	119	in	in	IN
cord-029547-9ei1ram3	357	120	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	357	121	,	,	,
cord-029547-9ei1ram3	357	122	China	China	NNP
cord-029547-9ei1ram3	357	123	Characteristics	Characteristics	NNPS
cord-029547-9ei1ram3	357	124	and	and	CC
cord-029547-9ei1ram3	357	125	outcomes	outcome	NNS
cord-029547-9ei1ram3	357	126	of	of	IN
cord-029547-9ei1ram3	357	127	21	21	CD
cord-029547-9ei1ram3	357	128	critically	critically	RB
cord-029547-9ei1ram3	357	129	Ill	ill	JJ
cord-029547-9ei1ram3	357	130	patients	patient	NNS
cord-029547-9ei1ram3	357	131	with	with	IN
cord-029547-9ei1ram3	357	132	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	357	133	in	in	IN
cord-029547-9ei1ram3	357	134	Washington	Washington	NNP
cord-029547-9ei1ram3	357	135	State	State	NNP
cord-029547-9ei1ram3	357	136	Clinical	Clinical	NNP
cord-029547-9ei1ram3	357	137	findings	finding	NNS
cord-029547-9ei1ram3	357	138	in	in	IN
cord-029547-9ei1ram3	357	139	a	a	DT
cord-029547-9ei1ram3	357	140	group	group	NN
cord-029547-9ei1ram3	357	141	of	of	IN
cord-029547-9ei1ram3	357	142	patients	patient	NNS
cord-029547-9ei1ram3	357	143	infected	infect	VBN
cord-029547-9ei1ram3	357	144	with	with	IN
cord-029547-9ei1ram3	357	145	the	the	DT
cord-029547-9ei1ram3	357	146	2019	2019	CD
cord-029547-9ei1ram3	357	147	novel	novel	NN
cord-029547-9ei1ram3	357	148	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	357	149	(	(	-LRB-
cord-029547-9ei1ram3	357	150	SARS	SARS	NNP
cord-029547-9ei1ram3	357	151	-	-	HYPH
cord-029547-9ei1ram3	357	152	Cov-2	Cov-2	NNP
cord-029547-9ei1ram3	357	153	)	)	-RRB-
cord-029547-9ei1ram3	357	154	outside	outside	IN
cord-029547-9ei1ram3	357	155	of	of	IN
cord-029547-9ei1ram3	357	156	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	357	157	,	,	,
cord-029547-9ei1ram3	357	158	China	China	NNP
cord-029547-9ei1ram3	357	159	:	:	:
cord-029547-9ei1ram3	357	160	retrospective	retrospective	JJ
cord-029547-9ei1ram3	357	161	case	case	NN
cord-029547-9ei1ram3	357	162	series	series	NN
cord-029547-9ei1ram3	357	163	Clinical	clinical	JJ
cord-029547-9ei1ram3	357	164	characteristics	characteristic	NNS
cord-029547-9ei1ram3	357	165	of	of	IN
cord-029547-9ei1ram3	357	166	140	140	CD
cord-029547-9ei1ram3	357	167	patients	patient	NNS
cord-029547-9ei1ram3	357	168	infected	infect	VBN
cord-029547-9ei1ram3	357	169	with	with	IN
cord-029547-9ei1ram3	357	170	SARS	SARS	NNP
cord-029547-9ei1ram3	357	171	-	-	HYPH
cord-029547-9ei1ram3	357	172	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	357	173	in	in	IN
cord-029547-9ei1ram3	357	174	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	357	175	novel	novel	JJ
cord-029547-9ei1ram3	357	176	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	357	177	(	(	-LRB-
cord-029547-9ei1ram3	357	178	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	357	179	)	)	-RRB-
cord-029547-9ei1ram3	357	180	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	357	181	:	:	:
cord-029547-9ei1ram3	357	182	serial	serial	JJ
cord-029547-9ei1ram3	357	183	computed	compute	VBN
cord-029547-9ei1ram3	357	184	tomography	tomography	NN
cord-029547-9ei1ram3	357	185	findings	finding	NNS
cord-029547-9ei1ram3	357	186	Clinical	clinical	JJ
cord-029547-9ei1ram3	357	187	characteristics	characteristic	NNS
cord-029547-9ei1ram3	357	188	of	of	IN
cord-029547-9ei1ram3	357	189	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	357	190	disease	disease	NN
cord-029547-9ei1ram3	357	191	2019	2019	CD
cord-029547-9ei1ram3	357	192	in	in	IN
cord-029547-9ei1ram3	357	193	China	China	NNP
cord-029547-9ei1ram3	358	1	The	the	DT
cord-029547-9ei1ram3	358	2	clinical	clinical	JJ
cord-029547-9ei1ram3	358	3	and	and	CC
cord-029547-9ei1ram3	358	4	chest	chest	NN
cord-029547-9ei1ram3	358	5	CT	CT	NNP
cord-029547-9ei1ram3	358	6	features	feature	VBZ
cord-029547-9ei1ram3	358	7	associated	associate	VBN
cord-029547-9ei1ram3	358	8	with	with	IN
cord-029547-9ei1ram3	358	9	severe	severe	JJ
cord-029547-9ei1ram3	358	10	and	and	CC
cord-029547-9ei1ram3	358	11	critical	critical	JJ
cord-029547-9ei1ram3	358	12	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	358	13	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	358	14	Diagnosis	Diagnosis	NNP
cord-029547-9ei1ram3	358	15	and	and	CC
cord-029547-9ei1ram3	358	16	Treatment	Treatment	NNP
cord-029547-9ei1ram3	358	17	Program	Program	NNP
cord-029547-9ei1ram3	358	18	of	of	IN
cord-029547-9ei1ram3	358	19	Novel	Novel	NNP
cord-029547-9ei1ram3	358	20	Coronavirus	Coronavirus	NNP
cord-029547-9ei1ram3	358	21	Pneumonia	Pneumonia	NNP
cord-029547-9ei1ram3	359	1	(	(	-LRB-
cord-029547-9ei1ram3	359	2	trial	trial	JJ
cord-029547-9ei1ram3	359	3	seventh	seventh	JJ
cord-029547-9ei1ram3	359	4	version	version	NN
cord-029547-9ei1ram3	359	5	Therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	359	6	and	and	CC
cord-029547-9ei1ram3	359	7	triage	triage	NN
cord-029547-9ei1ram3	359	8	strategies	strategy	NNS
cord-029547-9ei1ram3	359	9	for	for	IN
cord-029547-9ei1ram3	359	10	2019	2019	CD
cord-029547-9ei1ram3	359	11	novel	novel	JJ
cord-029547-9ei1ram3	359	12	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	359	13	disease	disease	NN
cord-029547-9ei1ram3	359	14	in	in	IN
cord-029547-9ei1ram3	359	15	fever	fever	NN
cord-029547-9ei1ram3	359	16	clinics	clinic	NNS
cord-029547-9ei1ram3	359	17	Correlation	Correlation	NNP
cord-029547-9ei1ram3	359	18	of	of	IN
cord-029547-9ei1ram3	359	19	chest	chest	NN
cord-029547-9ei1ram3	359	20	CT	CT	NNP
cord-029547-9ei1ram3	359	21	and	and	CC
cord-029547-9ei1ram3	359	22	RT	RT	NNP
cord-029547-9ei1ram3	359	23	-	-	HYPH
cord-029547-9ei1ram3	359	24	PCR	PCR	NNP
cord-029547-9ei1ram3	359	25	testing	testing	NN
cord-029547-9ei1ram3	359	26	in	in	IN
cord-029547-9ei1ram3	359	27	Coronavirus	Coronavirus	NNP
cord-029547-9ei1ram3	359	28	Disease	Disease	NNP
cord-029547-9ei1ram3	359	29	2019	2019	CD
cord-029547-9ei1ram3	359	30	(	(	-LRB-
cord-029547-9ei1ram3	359	31	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	359	32	)	)	-RRB-
cord-029547-9ei1ram3	359	33	in	in	IN
cord-029547-9ei1ram3	359	34	China	China	NNP
cord-029547-9ei1ram3	359	35	:	:	:
cord-029547-9ei1ram3	359	36	a	a	DT
cord-029547-9ei1ram3	359	37	report	report	NN
cord-029547-9ei1ram3	359	38	of	of	IN
cord-029547-9ei1ram3	359	39	1014	1014	CD
cord-029547-9ei1ram3	359	40	cases	case	NNS
cord-029547-9ei1ram3	359	41	Clinical	clinical	JJ
cord-029547-9ei1ram3	359	42	features	feature	NNS
cord-029547-9ei1ram3	359	43	of	of	IN
cord-029547-9ei1ram3	359	44	patients	patient	NNS
cord-029547-9ei1ram3	359	45	infected	infect	VBN
cord-029547-9ei1ram3	359	46	with	with	IN
cord-029547-9ei1ram3	359	47	2019	2019	CD
cord-029547-9ei1ram3	359	48	novel	novel	JJ
cord-029547-9ei1ram3	359	49	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	359	50	in	in	IN
cord-029547-9ei1ram3	359	51	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	359	52	,	,	,
cord-029547-9ei1ram3	359	53	China	China	NNP
cord-029547-9ei1ram3	359	54	Temporal	temporal	JJ
cord-029547-9ei1ram3	359	55	profiles	profile	NNS
cord-029547-9ei1ram3	359	56	of	of	IN
cord-029547-9ei1ram3	359	57	viral	viral	JJ
cord-029547-9ei1ram3	359	58	load	load	NN
cord-029547-9ei1ram3	359	59	in	in	IN
cord-029547-9ei1ram3	359	60	posterior	posterior	JJ
cord-029547-9ei1ram3	359	61	oropharyngeal	oropharyngeal	JJ
cord-029547-9ei1ram3	359	62	saliva	saliva	NN
cord-029547-9ei1ram3	359	63	samples	sample	NNS
cord-029547-9ei1ram3	359	64	and	and	CC
cord-029547-9ei1ram3	359	65	serum	serum	NN
cord-029547-9ei1ram3	359	66	antibody	antibody	NN
cord-029547-9ei1ram3	359	67	responses	response	NNS
cord-029547-9ei1ram3	359	68	during	during	IN
cord-029547-9ei1ram3	359	69	infection	infection	NN
cord-029547-9ei1ram3	359	70	by	by	IN
cord-029547-9ei1ram3	359	71	SARS	SARS	NNP
cord-029547-9ei1ram3	359	72	-	-	HYPH
cord-029547-9ei1ram3	359	73	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	359	74	:	:	:
cord-029547-9ei1ram3	360	1	an	an	DT
cord-029547-9ei1ram3	360	2	observational	observational	JJ
cord-029547-9ei1ram3	360	3	cohort	cohort	NN
cord-029547-9ei1ram3	360	4	study	study	NN
cord-029547-9ei1ram3	360	5	Profiling	profile	VBG
cord-029547-9ei1ram3	360	6	early	early	JJ
cord-029547-9ei1ram3	360	7	humoral	humoral	JJ
cord-029547-9ei1ram3	360	8	response	response	NN
cord-029547-9ei1ram3	360	9	to	to	TO
cord-029547-9ei1ram3	360	10	diagnose	diagnose	VB
cord-029547-9ei1ram3	360	11	novel	novel	JJ
cord-029547-9ei1ram3	360	12	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	360	13	disease	disease	NN
cord-029547-9ei1ram3	360	14	(	(	-LRB-
cord-029547-9ei1ram3	360	15	COVID-19	covid-19	VB
cord-029547-9ei1ram3	360	16	)	)	-RRB-
cord-029547-9ei1ram3	361	1	Time	time	NN
cord-029547-9ei1ram3	361	2	course	course	NN
cord-029547-9ei1ram3	361	3	of	of	IN
cord-029547-9ei1ram3	361	4	lung	lung	NN
cord-029547-9ei1ram3	361	5	changes	change	NNS
cord-029547-9ei1ram3	361	6	on	on	IN
cord-029547-9ei1ram3	361	7	chest	chest	NN
cord-029547-9ei1ram3	361	8	CT	CT	NNP
cord-029547-9ei1ram3	361	9	during	during	IN
cord-029547-9ei1ram3	361	10	recovery	recovery	NN
cord-029547-9ei1ram3	361	11	from	from	IN
cord-029547-9ei1ram3	361	12	2019	2019	CD
cord-029547-9ei1ram3	361	13	novel	novel	JJ
cord-029547-9ei1ram3	361	14	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	361	15	(	(	-LRB-
cord-029547-9ei1ram3	361	16	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	361	17	)	)	-RRB-
cord-029547-9ei1ram3	361	18	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	361	19	Clinically	clinically	RB
cord-029547-9ei1ram3	361	20	applicable	applicable	JJ
cord-029547-9ei1ram3	361	21	AI	ai	NN
cord-029547-9ei1ram3	361	22	system	system	NN
cord-029547-9ei1ram3	361	23	for	for	IN
cord-029547-9ei1ram3	361	24	accurate	accurate	JJ
cord-029547-9ei1ram3	361	25	diagnosis	diagnosis	NN
cord-029547-9ei1ram3	361	26	,	,	,
cord-029547-9ei1ram3	361	27	quantitative	quantitative	JJ
cord-029547-9ei1ram3	361	28	measurements	measurement	NNS
cord-029547-9ei1ram3	361	29	,	,	,
cord-029547-9ei1ram3	361	30	and	and	CC
cord-029547-9ei1ram3	361	31	prognosis	prognosis	NN
cord-029547-9ei1ram3	361	32	of	of	IN
cord-029547-9ei1ram3	361	33	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	361	34	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	361	35	using	use	VBG
cord-029547-9ei1ram3	361	36	computed	compute	VBN
cord-029547-9ei1ram3	361	37	tomography	tomography	NN
cord-029547-9ei1ram3	361	38	CRISPR	CRISPR	NNP
cord-029547-9ei1ram3	361	39	-	-	HYPH
cord-029547-9ei1ram3	361	40	Cas12-based	cas12-base	VBN
cord-029547-9ei1ram3	361	41	detection	detection	NN
cord-029547-9ei1ram3	361	42	of	of	IN
cord-029547-9ei1ram3	361	43	SARS	SARS	NNP
cord-029547-9ei1ram3	361	44	-	-	HYPH
cord-029547-9ei1ram3	361	45	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	361	46	Remdesivir	Remdesivir	NNP
cord-029547-9ei1ram3	361	47	and	and	CC
cord-029547-9ei1ram3	361	48	chloroquine	chloroquine	NN
cord-029547-9ei1ram3	361	49	effectively	effectively	RB
cord-029547-9ei1ram3	361	50	inhibit	inhibit	VBP
cord-029547-9ei1ram3	361	51	the	the	DT
cord-029547-9ei1ram3	361	52	recently	recently	RB
cord-029547-9ei1ram3	361	53	emerged	emerge	VBN
cord-029547-9ei1ram3	361	54	novel	novel	JJ
cord-029547-9ei1ram3	361	55	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	361	56	(	(	-LRB-
cord-029547-9ei1ram3	361	57	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	361	58	)	)	-RRB-
cord-029547-9ei1ram3	361	59	in	in	IN
cord-029547-9ei1ram3	361	60	vitro	vitro	FW
cord-029547-9ei1ram3	361	61	Breakthrough	Breakthrough	NNP
cord-029547-9ei1ram3	361	62	:	:	:
cord-029547-9ei1ram3	361	63	chloroquine	chloroquine	NN
cord-029547-9ei1ram3	361	64	phosphate	phosphate	NN
cord-029547-9ei1ram3	361	65	has	have	VBZ
cord-029547-9ei1ram3	361	66	shown	show	VBN
cord-029547-9ei1ram3	361	67	apparent	apparent	JJ
cord-029547-9ei1ram3	361	68	efficacy	efficacy	NN
cord-029547-9ei1ram3	361	69	in	in	IN
cord-029547-9ei1ram3	361	70	treatment	treatment	NN
cord-029547-9ei1ram3	361	71	of	of	IN
cord-029547-9ei1ram3	361	72	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	361	73	associated	associated	JJ
cord-029547-9ei1ram3	361	74	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	361	75	in	in	IN
cord-029547-9ei1ram3	361	76	clinical	clinical	JJ
cord-029547-9ei1ram3	361	77	studies	study	NNS
cord-029547-9ei1ram3	361	78	Chloroquine	Chloroquine	NNP
cord-029547-9ei1ram3	361	79	for	for	IN
cord-029547-9ei1ram3	361	80	the	the	DT
cord-029547-9ei1ram3	361	81	2019	2019	CD
cord-029547-9ei1ram3	361	82	novel	novel	NN
cord-029547-9ei1ram3	361	83	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	361	84	SARS	SARS	NNP
cord-029547-9ei1ram3	361	85	-	-	HYPH
cord-029547-9ei1ram3	361	86	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	361	87	Effect	Effect	NNP
cord-029547-9ei1ram3	361	88	of	of	IN
cord-029547-9ei1ram3	361	89	high	high	JJ
cord-029547-9ei1ram3	361	90	vs	vs	IN
cord-029547-9ei1ram3	361	91	low	low	JJ
cord-029547-9ei1ram3	361	92	doses	dose	NNS
cord-029547-9ei1ram3	361	93	of	of	IN
cord-029547-9ei1ram3	361	94	chloroquine	chloroquine	NN
cord-029547-9ei1ram3	361	95	diphosphate	diphosphate	NN
cord-029547-9ei1ram3	361	96	as	as	IN
cord-029547-9ei1ram3	361	97	adjunctive	adjunctive	JJ
cord-029547-9ei1ram3	361	98	therapy	therapy	NN
cord-029547-9ei1ram3	361	99	for	for	IN
cord-029547-9ei1ram3	361	100	patients	patient	NNS
cord-029547-9ei1ram3	361	101	hospitalized	hospitalize	VBN
cord-029547-9ei1ram3	361	102	with	with	IN
cord-029547-9ei1ram3	361	103	severe	severe	JJ
cord-029547-9ei1ram3	361	104	acute	acute	JJ
cord-029547-9ei1ram3	361	105	respiratory	respiratory	JJ
cord-029547-9ei1ram3	361	106	syndrome	syndrome	NN
cord-029547-9ei1ram3	361	107	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	361	108	2	2	CD
cord-029547-9ei1ram3	362	1	(	(	-LRB-
cord-029547-9ei1ram3	362	2	SARS	SARS	NNP
cord-029547-9ei1ram3	362	3	-	-	HYPH
cord-029547-9ei1ram3	362	4	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	362	5	)	)	-RRB-
cord-029547-9ei1ram3	362	6	infection	infection	NN
cord-029547-9ei1ram3	362	7	:	:	:
cord-029547-9ei1ram3	362	8	a	a	DT
cord-029547-9ei1ram3	362	9	randomized	randomized	JJ
cord-029547-9ei1ram3	362	10	clinical	clinical	JJ
cord-029547-9ei1ram3	362	11	trial	trial	NN
cord-029547-9ei1ram3	363	1	The	the	DT
cord-029547-9ei1ram3	363	2	QT	QT	NNP
cord-029547-9ei1ram3	363	3	interval	interval	NN
cord-029547-9ei1ram3	363	4	in	in	IN
cord-029547-9ei1ram3	363	5	patients	patient	NNS
cord-029547-9ei1ram3	363	6	with	with	IN
cord-029547-9ei1ram3	363	7	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	363	8	treated	treat	VBN
cord-029547-9ei1ram3	363	9	with	with	IN
cord-029547-9ei1ram3	363	10	hydroxychloroquine	hydroxychloroquine	NN
cord-029547-9ei1ram3	363	11	and	and	CC
cord-029547-9ei1ram3	363	12	azithromycin	azithromycin	NNP
cord-029547-9ei1ram3	363	13	Clinical	clinical	JJ
cord-029547-9ei1ram3	363	14	features	feature	NNS
cord-029547-9ei1ram3	363	15	of	of	IN
cord-029547-9ei1ram3	363	16	69	69	CD
cord-029547-9ei1ram3	363	17	cases	case	NNS
cord-029547-9ei1ram3	363	18	with	with	IN
cord-029547-9ei1ram3	363	19	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	363	20	disease	disease	NN
cord-029547-9ei1ram3	363	21	2019	2019	CD
cord-029547-9ei1ram3	363	22	in	in	IN
cord-029547-9ei1ram3	363	23	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	363	24	,	,	,
cord-029547-9ei1ram3	363	25	China	China	NNP
cord-029547-9ei1ram3	363	26	.	.	.
cord-029547-9ei1ram3	364	1	Clin	Clin	NNP
cord-029547-9ei1ram3	364	2	Infectious	Infectious	NNP
cord-029547-9ei1ram3	364	3	Dis	Dis	NNP
cord-029547-9ei1ram3	364	4	Arbidol	Arbidol	NNP
cord-029547-9ei1ram3	364	5	combined	combine	VBN
cord-029547-9ei1ram3	364	6	with	with	IN
cord-029547-9ei1ram3	364	7	LPV	LPV	NNP
cord-029547-9ei1ram3	364	8	/	/	SYM
cord-029547-9ei1ram3	364	9	r	r	NN
cord-029547-9ei1ram3	364	10	versus	versus	IN
cord-029547-9ei1ram3	364	11	LPV	LPV	NNP
cord-029547-9ei1ram3	364	12	/	/	SYM
cord-029547-9ei1ram3	364	13	r	r	NN
cord-029547-9ei1ram3	364	14	alone	alone	RB
cord-029547-9ei1ram3	364	15	against	against	IN
cord-029547-9ei1ram3	364	16	corona	corona	NN
cord-029547-9ei1ram3	364	17	virus	virus	NN
cord-029547-9ei1ram3	364	18	disease	disease	NNP
cord-029547-9ei1ram3	364	19	2019	2019	CD
cord-029547-9ei1ram3	365	1	:	:	:
cord-029547-9ei1ram3	365	2	a	a	DT
cord-029547-9ei1ram3	365	3	retrospective	retrospective	JJ
cord-029547-9ei1ram3	365	4	cohort	cohort	NN
cord-029547-9ei1ram3	365	5	study	study	NN
cord-029547-9ei1ram3	366	1	Umifenovir	Umifenovir	NNP
cord-029547-9ei1ram3	366	2	treatment	treatment	NN
cord-029547-9ei1ram3	366	3	is	be	VBZ
cord-029547-9ei1ram3	366	4	not	not	RB
cord-029547-9ei1ram3	366	5	associated	associate	VBN
cord-029547-9ei1ram3	366	6	with	with	IN
cord-029547-9ei1ram3	366	7	improved	improved	JJ
cord-029547-9ei1ram3	366	8	outcomes	outcome	NNS
cord-029547-9ei1ram3	366	9	in	in	IN
cord-029547-9ei1ram3	366	10	patients	patient	NNS
cord-029547-9ei1ram3	366	11	with	with	IN
cord-029547-9ei1ram3	366	12	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	366	13	disease	disease	NN
cord-029547-9ei1ram3	366	14	2019	2019	CD
cord-029547-9ei1ram3	366	15	:	:	:
cord-029547-9ei1ram3	366	16	a	a	DT
cord-029547-9ei1ram3	366	17	retrospective	retrospective	JJ
cord-029547-9ei1ram3	366	18	study	study	NN
cord-029547-9ei1ram3	366	19	Structure	Structure	NNP
cord-029547-9ei1ram3	366	20	of	of	IN
cord-029547-9ei1ram3	366	21	the	the	DT
cord-029547-9ei1ram3	366	22	RNAdependent	RNAdependent	NNP
cord-029547-9ei1ram3	366	23	RNA	RNA	NNP
cord-029547-9ei1ram3	366	24	polymerase	polymerase	NN
cord-029547-9ei1ram3	366	25	from	from	IN
cord-029547-9ei1ram3	366	26	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	366	27	virus	virus	NN
cord-029547-9ei1ram3	366	28	Structural	structural	JJ
cord-029547-9ei1ram3	366	29	basis	basis	NN
cord-029547-9ei1ram3	366	30	for	for	IN
cord-029547-9ei1ram3	366	31	inhibition	inhibition	NN
cord-029547-9ei1ram3	366	32	of	of	IN
cord-029547-9ei1ram3	366	33	the	the	DT
cord-029547-9ei1ram3	366	34	RNA	RNA	NNP
cord-029547-9ei1ram3	366	35	-	-	HYPH
cord-029547-9ei1ram3	366	36	dependent	dependent	JJ
cord-029547-9ei1ram3	366	37	RNA	RNA	NNP
cord-029547-9ei1ram3	366	38	polymerase	polymerase	NN
cord-029547-9ei1ram3	366	39	from	from	IN
cord-029547-9ei1ram3	366	40	SARS	SARS	NNP
cord-029547-9ei1ram3	366	41	-	-	HYPH
cord-029547-9ei1ram3	366	42	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	366	43	by	by	IN
cord-029547-9ei1ram3	366	44	remdesivir	remdesivir	NNP
cord-029547-9ei1ram3	366	45	First	First	NNP
cord-029547-9ei1ram3	366	46	case	case	NN
cord-029547-9ei1ram3	366	47	of	of	IN
cord-029547-9ei1ram3	366	48	2019	2019	CD
cord-029547-9ei1ram3	366	49	novel	novel	JJ
cord-029547-9ei1ram3	366	50	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	366	51	in	in	IN
cord-029547-9ei1ram3	366	52	the	the	DT
cord-029547-9ei1ram3	366	53	United	United	NNP
cord-029547-9ei1ram3	366	54	States	States	NNP
cord-029547-9ei1ram3	366	55	Compassionate	compassionate	JJ
cord-029547-9ei1ram3	366	56	use	use	NN
cord-029547-9ei1ram3	366	57	of	of	IN
cord-029547-9ei1ram3	366	58	remdesivir	remdesivir	NNS
cord-029547-9ei1ram3	366	59	for	for	IN
cord-029547-9ei1ram3	366	60	patients	patient	NNS
cord-029547-9ei1ram3	366	61	with	with	IN
cord-029547-9ei1ram3	366	62	severe	severe	JJ
cord-029547-9ei1ram3	366	63	Covid-19	covid-19	NN
cord-029547-9ei1ram3	366	64	A	A	NNP
cord-029547-9ei1ram3	366	65	randomized	randomize	VBN
cord-029547-9ei1ram3	366	66	,	,	,
cord-029547-9ei1ram3	366	67	controlled	control	VBN
cord-029547-9ei1ram3	366	68	trial	trial	NN
cord-029547-9ei1ram3	366	69	of	of	IN
cord-029547-9ei1ram3	366	70	ebola	ebola	NNP
cord-029547-9ei1ram3	366	71	virus	virus	NN
cord-029547-9ei1ram3	366	72	disease	disease	NN
cord-029547-9ei1ram3	366	73	therapeutics	therapeutics	NNP
cord-029547-9ei1ram3	366	74	Remdesivir	Remdesivir	NNP
cord-029547-9ei1ram3	366	75	in	in	IN
cord-029547-9ei1ram3	366	76	adults	adult	NNS
cord-029547-9ei1ram3	366	77	with	with	IN
cord-029547-9ei1ram3	366	78	severe	severe	JJ
cord-029547-9ei1ram3	366	79	COVID-19	covid-19	NN
cord-029547-9ei1ram3	366	80	:	:	:
cord-029547-9ei1ram3	366	81	a	a	DT
cord-029547-9ei1ram3	366	82	randomised	randomised	JJ
cord-029547-9ei1ram3	366	83	,	,	,
cord-029547-9ei1ram3	366	84	double	double	JJ
cord-029547-9ei1ram3	366	85	-	-	HYPH
cord-029547-9ei1ram3	366	86	blind	blind	JJ
cord-029547-9ei1ram3	366	87	,	,	,
cord-029547-9ei1ram3	366	88	placebo	placebo	NN
cord-029547-9ei1ram3	366	89	-	-	HYPH
cord-029547-9ei1ram3	366	90	controlled	control	VBN
cord-029547-9ei1ram3	366	91	,	,	,
cord-029547-9ei1ram3	366	92	multicentre	multicentre	NNP
cord-029547-9ei1ram3	366	93	trial	trial	NN
cord-029547-9ei1ram3	366	94	National	National	NNP
cord-029547-9ei1ram3	366	95	Institutes	Institutes	NNPS
cord-029547-9ei1ram3	366	96	of	of	IN
cord-029547-9ei1ram3	366	97	Health	Health	NNP
cord-029547-9ei1ram3	366	98	.	.	.
cord-029547-9ei1ram3	367	1	NIH	NIH	NNP
cord-029547-9ei1ram3	367	2	Clinical	Clinical	NNP
cord-029547-9ei1ram3	367	3	Trial	Trial	NNP
cord-029547-9ei1ram3	367	4	Shows	show	VBZ
cord-029547-9ei1ram3	367	5	Remdesivir	Remdesivir	NNP
cord-029547-9ei1ram3	367	6	Accelerates	accelerate	VBZ
cord-029547-9ei1ram3	367	7	Recovery	Recovery	NNP
cord-029547-9ei1ram3	367	8	from	from	IN
cord-029547-9ei1ram3	367	9	Advanced	Advanced	NNP
cord-029547-9ei1ram3	367	10	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	367	11	Anti	Anti	NNP
cord-029547-9ei1ram3	367	12	-	-	NNP
cord-029547-9ei1ram3	367	13	HCV	HCV	NNP
cord-029547-9ei1ram3	367	14	,	,	,
cord-029547-9ei1ram3	367	15	nucleotide	nucleotide	JJ
cord-029547-9ei1ram3	367	16	inhibitors	inhibitor	NNS
cord-029547-9ei1ram3	367	17	,	,	,
cord-029547-9ei1ram3	367	18	repurposing	repurpose	VBG
cord-029547-9ei1ram3	367	19	against	against	IN
cord-029547-9ei1ram3	367	20	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	367	21	More	More	JJR
cord-029547-9ei1ram3	367	22	than	than	IN
cord-029547-9ei1ram3	367	23	80	80	CD
cord-029547-9ei1ram3	367	24	clinical	clinical	JJ
cord-029547-9ei1ram3	367	25	trials	trial	NNS
cord-029547-9ei1ram3	367	26	launch	launch	VBP
cord-029547-9ei1ram3	367	27	to	to	TO
cord-029547-9ei1ram3	367	28	test	test	VB
cord-029547-9ei1ram3	367	29	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	367	30	treatments	treatment	NNS
cord-029547-9ei1ram3	367	31	Epidemiologic	epidemiologic	JJ
cord-029547-9ei1ram3	367	32	features	feature	NNS
cord-029547-9ei1ram3	367	33	and	and	CC
cord-029547-9ei1ram3	367	34	clinical	clinical	JJ
cord-029547-9ei1ram3	367	35	course	course	NN
cord-029547-9ei1ram3	367	36	of	of	IN
cord-029547-9ei1ram3	367	37	patients	patient	NNS
cord-029547-9ei1ram3	367	38	infected	infect	VBN
cord-029547-9ei1ram3	367	39	with	with	IN
cord-029547-9ei1ram3	367	40	SARS	SARS	NNP
cord-029547-9ei1ram3	367	41	-	-	HYPH
cord-029547-9ei1ram3	367	42	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	367	43	in	in	IN
cord-029547-9ei1ram3	367	44	Singapore	Singapore	NNP
cord-029547-9ei1ram3	368	1	A	a	DT
cord-029547-9ei1ram3	368	2	trial	trial	NN
cord-029547-9ei1ram3	368	3	of	of	IN
cord-029547-9ei1ram3	368	4	Lopinavir	Lopinavir	NNP
cord-029547-9ei1ram3	368	5	-	-	HYPH
cord-029547-9ei1ram3	368	6	Ritonavir	Ritonavir	NNP
cord-029547-9ei1ram3	368	7	in	in	IN
cord-029547-9ei1ram3	368	8	adults	adult	NNS
cord-029547-9ei1ram3	368	9	hospitalized	hospitalize	VBN
cord-029547-9ei1ram3	368	10	with	with	IN
cord-029547-9ei1ram3	368	11	severe	severe	JJ
cord-029547-9ei1ram3	368	12	Covid-19	covid-19	NN
cord-029547-9ei1ram3	368	13	A	A	NNP
cord-029547-9ei1ram3	368	14	trial	trial	NN
cord-029547-9ei1ram3	368	15	of	of	IN
cord-029547-9ei1ram3	368	16	Lopinavir	Lopinavir	NNP
cord-029547-9ei1ram3	368	17	-	-	HYPH
cord-029547-9ei1ram3	368	18	Ritonavir	Ritonavir	NNP
cord-029547-9ei1ram3	368	19	in	in	IN
cord-029547-9ei1ram3	368	20	adults	adult	NNS
cord-029547-9ei1ram3	368	21	hospitalized	hospitalize	VBN
cord-029547-9ei1ram3	368	22	with	with	IN
cord-029547-9ei1ram3	368	23	severe	severe	JJ
cord-029547-9ei1ram3	368	24	Covid-19	covid-19	NN
cord-029547-9ei1ram3	368	25	Effect	effect	NN
cord-029547-9ei1ram3	368	26	of	of	IN
cord-029547-9ei1ram3	368	27	interferon	interferon	NN
cord-029547-9ei1ram3	368	28	alpha	alpha	NN
cord-029547-9ei1ram3	368	29	and	and	CC
cord-029547-9ei1ram3	368	30	cyclosporine	cyclosporine	JJ
cord-029547-9ei1ram3	368	31	treatment	treatment	NN
cord-029547-9ei1ram3	368	32	separately	separately	RB
cord-029547-9ei1ram3	368	33	and	and	CC
cord-029547-9ei1ram3	368	34	in	in	IN
cord-029547-9ei1ram3	368	35	combination	combination	NN
cord-029547-9ei1ram3	368	36	on	on	IN
cord-029547-9ei1ram3	368	37	Middle	Middle	NNP
cord-029547-9ei1ram3	368	38	East	East	NNP
cord-029547-9ei1ram3	368	39	Respiratory	Respiratory	NNP
cord-029547-9ei1ram3	368	40	Syndrome	Syndrome	NNP
cord-029547-9ei1ram3	368	41	Coronavirus	Coronavirus	NNP
cord-029547-9ei1ram3	368	42	(	(	-LRB-
cord-029547-9ei1ram3	368	43	MERS	MERS	NNP
cord-029547-9ei1ram3	368	44	-	-	HYPH
cord-029547-9ei1ram3	368	45	CoV	CoV	NNP
cord-029547-9ei1ram3	368	46	)	)	-RRB-
cord-029547-9ei1ram3	368	47	replication	replication	NN
cord-029547-9ei1ram3	368	48	in	in	IN
cord-029547-9ei1ram3	368	49	a	a	DT
cord-029547-9ei1ram3	368	50	human	human	NN
cord-029547-9ei1ram3	368	51	in	in	IN
cord-029547-9ei1ram3	368	52	-	-	HYPH
cord-029547-9ei1ram3	368	53	vitro	vitro	FW
cord-029547-9ei1ram3	368	54	and	and	CC
cord-029547-9ei1ram3	368	55	ex	ex	JJ
cord-029547-9ei1ram3	368	56	-	-	JJ
cord-029547-9ei1ram3	368	57	vivo	vivo	JJ
cord-029547-9ei1ram3	368	58	culture	culture	NN
cord-029547-9ei1ram3	368	59	model	model	NN
cord-029547-9ei1ram3	368	60	Therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	368	61	options	option	NNS
cord-029547-9ei1ram3	368	62	for	for	IN
cord-029547-9ei1ram3	368	63	the	the	DT
cord-029547-9ei1ram3	368	64	2019	2019	CD
cord-029547-9ei1ram3	368	65	novel	novel	NN
cord-029547-9ei1ram3	368	66	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	368	67	(	(	-LRB-
cord-029547-9ei1ram3	368	68	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	368	69	)	)	-RRB-
cord-029547-9ei1ram3	368	70	Triple	triple	JJ
cord-029547-9ei1ram3	368	71	combination	combination	NN
cord-029547-9ei1ram3	368	72	of	of	IN
cord-029547-9ei1ram3	368	73	interferon	interferon	NN
cord-029547-9ei1ram3	368	74	beta-1b	beta-1b	NNP
cord-029547-9ei1ram3	368	75	,	,	,
cord-029547-9ei1ram3	368	76	lopinavir	lopinavir	NNS
cord-029547-9ei1ram3	368	77	-	-	HYPH
cord-029547-9ei1ram3	368	78	ritonavir	ritonavir	NNS
cord-029547-9ei1ram3	368	79	,	,	,
cord-029547-9ei1ram3	368	80	and	and	CC
cord-029547-9ei1ram3	368	81	ribavirin	ribavirin	NN
cord-029547-9ei1ram3	368	82	in	in	IN
cord-029547-9ei1ram3	368	83	the	the	DT
cord-029547-9ei1ram3	368	84	treatment	treatment	NN
cord-029547-9ei1ram3	368	85	of	of	IN
cord-029547-9ei1ram3	368	86	patients	patient	NNS
cord-029547-9ei1ram3	368	87	admitted	admit	VBN
cord-029547-9ei1ram3	368	88	to	to	IN
cord-029547-9ei1ram3	368	89	hospital	hospital	NN
cord-029547-9ei1ram3	368	90	with	with	IN
cord-029547-9ei1ram3	368	91	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	368	92	:	:	:
cord-029547-9ei1ram3	368	93	an	an	DT
cord-029547-9ei1ram3	368	94	open	open	JJ
cord-029547-9ei1ram3	368	95	-	-	HYPH
cord-029547-9ei1ram3	368	96	label	label	NN
cord-029547-9ei1ram3	368	97	,	,	,
cord-029547-9ei1ram3	368	98	randomised	randomised	JJ
cord-029547-9ei1ram3	368	99	,	,	,
cord-029547-9ei1ram3	368	100	phase	phase	NN
cord-029547-9ei1ram3	368	101	2	2	CD
cord-029547-9ei1ram3	368	102	trial	trial	NN
cord-029547-9ei1ram3	368	103	Convalescent	convalescent	JJ
cord-029547-9ei1ram3	368	104	plasma	plasma	NN
cord-029547-9ei1ram3	368	105	as	as	IN
cord-029547-9ei1ram3	368	106	a	a	DT
cord-029547-9ei1ram3	368	107	potential	potential	JJ
cord-029547-9ei1ram3	368	108	therapy	therapy	NN
cord-029547-9ei1ram3	368	109	for	for	IN
cord-029547-9ei1ram3	368	110	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	368	111	Treatment	Treatment	NNP
cord-029547-9ei1ram3	368	112	of	of	IN
cord-029547-9ei1ram3	368	113	5	5	CD
cord-029547-9ei1ram3	368	114	critically	critically	RB
cord-029547-9ei1ram3	368	115	Ill	ill	JJ
cord-029547-9ei1ram3	368	116	patients	patient	NNS
cord-029547-9ei1ram3	368	117	with	with	IN
cord-029547-9ei1ram3	368	118	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	368	119	with	with	IN
cord-029547-9ei1ram3	368	120	convalescent	convalescent	JJ
cord-029547-9ei1ram3	368	121	plasma	plasma	NN
cord-029547-9ei1ram3	368	122	A	a	DT
cord-029547-9ei1ram3	368	123	human	human	JJ
cord-029547-9ei1ram3	368	124	monoclonal	monoclonal	JJ
cord-029547-9ei1ram3	368	125	antibody	antibody	NN
cord-029547-9ei1ram3	368	126	blocking	block	VBG
cord-029547-9ei1ram3	368	127	SARS	SARS	NNP
cord-029547-9ei1ram3	368	128	-	-	HYPH
cord-029547-9ei1ram3	368	129	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	368	130	infection	infection	NN
cord-029547-9ei1ram3	369	1	A	a	DT
cord-029547-9ei1ram3	369	2	noncompeting	noncompeting	JJ
cord-029547-9ei1ram3	369	3	pair	pair	NN
cord-029547-9ei1ram3	369	4	of	of	IN
cord-029547-9ei1ram3	369	5	human	human	JJ
cord-029547-9ei1ram3	369	6	neutralizing	neutralize	VBG
cord-029547-9ei1ram3	369	7	antibodies	antibody	NNS
cord-029547-9ei1ram3	369	8	block	block	VBP
cord-029547-9ei1ram3	369	9	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	369	10	virus	virus	NN
cord-029547-9ei1ram3	369	11	binding	bind	VBG
cord-029547-9ei1ram3	369	12	to	to	IN
cord-029547-9ei1ram3	369	13	its	-PRON-	PRP$
cord-029547-9ei1ram3	369	14	receptor	receptor	NN
cord-029547-9ei1ram3	369	15	ACE2	ACE2	NNP
cord-029547-9ei1ram3	369	16	Potent	Potent	NNP
cord-029547-9ei1ram3	369	17	binding	binding	NN
cord-029547-9ei1ram3	369	18	of	of	IN
cord-029547-9ei1ram3	369	19	2019	2019	CD
cord-029547-9ei1ram3	369	20	novel	novel	JJ
cord-029547-9ei1ram3	369	21	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	369	22	spike	spike	NN
cord-029547-9ei1ram3	369	23	protein	protein	NN
cord-029547-9ei1ram3	369	24	by	by	IN
cord-029547-9ei1ram3	369	25	a	a	DT
cord-029547-9ei1ram3	369	26	SARS	SARS	NNP
cord-029547-9ei1ram3	369	27	coronavirusspecific	coronavirusspecific	NNP
cord-029547-9ei1ram3	369	28	human	human	JJ
cord-029547-9ei1ram3	369	29	monoclonal	monoclonal	JJ
cord-029547-9ei1ram3	369	30	antibody	antibody	NN
cord-029547-9ei1ram3	369	31	Clinical	clinical	JJ
cord-029547-9ei1ram3	369	32	and	and	CC
cord-029547-9ei1ram3	369	33	epidemiological	epidemiological	JJ
cord-029547-9ei1ram3	369	34	features	feature	NNS
cord-029547-9ei1ram3	369	35	of	of	IN
cord-029547-9ei1ram3	369	36	36	36	CD
cord-029547-9ei1ram3	369	37	children	child	NNS
cord-029547-9ei1ram3	369	38	with	with	IN
cord-029547-9ei1ram3	369	39	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	369	40	disease	disease	NN
cord-029547-9ei1ram3	369	41	2019	2019	CD
cord-029547-9ei1ram3	369	42	(	(	-LRB-
cord-029547-9ei1ram3	369	43	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	369	44	)	)	-RRB-
cord-029547-9ei1ram3	369	45	in	in	IN
cord-029547-9ei1ram3	369	46	Zhejiang	Zhejiang	NNP
cord-029547-9ei1ram3	369	47	,	,	,
cord-029547-9ei1ram3	369	48	China	China	NNP
cord-029547-9ei1ram3	369	49	:	:	:
cord-029547-9ei1ram3	370	1	an	an	DT
cord-029547-9ei1ram3	370	2	observational	observational	JJ
cord-029547-9ei1ram3	370	3	cohort	cohort	NN
cord-029547-9ei1ram3	370	4	study	study	NN
cord-029547-9ei1ram3	370	5	The	the	DT
cord-029547-9ei1ram3	370	6	Italian	italian	JJ
cord-029547-9ei1ram3	370	7	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	370	8	disease	disease	NN
cord-029547-9ei1ram3	370	9	2019	2019	CD
cord-029547-9ei1ram3	370	10	outbreak	outbreak	NN
cord-029547-9ei1ram3	370	11	:	:	:
cord-029547-9ei1ram3	370	12	recommendations	recommendation	NNS
cord-029547-9ei1ram3	370	13	from	from	IN
cord-029547-9ei1ram3	370	14	clinical	clinical	JJ
cord-029547-9ei1ram3	370	15	practice	practice	NN
cord-029547-9ei1ram3	370	16	Clinical	clinical	JJ
cord-029547-9ei1ram3	370	17	characteristics	characteristic	NNS
cord-029547-9ei1ram3	370	18	of	of	IN
cord-029547-9ei1ram3	370	19	113	113	CD
cord-029547-9ei1ram3	370	20	deceased	deceased	JJ
cord-029547-9ei1ram3	370	21	patients	patient	NNS
cord-029547-9ei1ram3	370	22	with	with	IN
cord-029547-9ei1ram3	370	23	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	370	24	disease	disease	NN
cord-029547-9ei1ram3	370	25	2019	2019	CD
cord-029547-9ei1ram3	370	26	:	:	:
cord-029547-9ei1ram3	370	27	retrospective	retrospective	JJ
cord-029547-9ei1ram3	370	28	study	study	NN
cord-029547-9ei1ram3	371	1	Dexamethasone	dexamethasone	NN
cord-029547-9ei1ram3	371	2	treatment	treatment	NN
cord-029547-9ei1ram3	371	3	for	for	IN
cord-029547-9ei1ram3	371	4	the	the	DT
cord-029547-9ei1ram3	371	5	acute	acute	JJ
cord-029547-9ei1ram3	371	6	respiratory	respiratory	JJ
cord-029547-9ei1ram3	371	7	distress	distress	NN
cord-029547-9ei1ram3	371	8	syndrome	syndrome	NN
cord-029547-9ei1ram3	371	9	:	:	:
cord-029547-9ei1ram3	371	10	a	a	DT
cord-029547-9ei1ram3	371	11	multicentre	multicentre	NNP
cord-029547-9ei1ram3	371	12	,	,	,
cord-029547-9ei1ram3	371	13	randomised	randomised	JJ
cord-029547-9ei1ram3	371	14	controlled	control	VBN
cord-029547-9ei1ram3	371	15	trial	trial	NN
cord-029547-9ei1ram3	371	16	Clinical	clinical	JJ
cord-029547-9ei1ram3	371	17	evidence	evidence	NN
cord-029547-9ei1ram3	371	18	does	do	VBZ
cord-029547-9ei1ram3	371	19	not	not	RB
cord-029547-9ei1ram3	371	20	support	support	VB
cord-029547-9ei1ram3	371	21	corticosteroid	corticosteroid	NN
cord-029547-9ei1ram3	371	22	treatment	treatment	NN
cord-029547-9ei1ram3	371	23	for	for	IN
cord-029547-9ei1ram3	371	24	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	371	25	lung	lung	NNP
cord-029547-9ei1ram3	371	26	injury	injury	NN
cord-029547-9ei1ram3	371	27	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	371	28	:	:	:
cord-029547-9ei1ram3	371	29	combining	combine	VBG
cord-029547-9ei1ram3	371	30	antiviral	antiviral	JJ
cord-029547-9ei1ram3	371	31	and	and	CC
cord-029547-9ei1ram3	371	32	anti	anti	JJ
cord-029547-9ei1ram3	371	33	-	-	JJ
cord-029547-9ei1ram3	371	34	inflammatory	inflammatory	JJ
cord-029547-9ei1ram3	371	35	treatments	treatment	NNS
cord-029547-9ei1ram3	371	36	Controversial	controversial	JJ
cord-029547-9ei1ram3	371	37	treatments	treatment	NNS
cord-029547-9ei1ram3	371	38	:	:	:
cord-029547-9ei1ram3	372	1	an	an	DT
cord-029547-9ei1ram3	372	2	updated	update	VBN
cord-029547-9ei1ram3	372	3	understanding	understanding	NN
cord-029547-9ei1ram3	372	4	of	of	IN
cord-029547-9ei1ram3	372	5	the	the	DT
cord-029547-9ei1ram3	372	6	Coronavirus	Coronavirus	NNP
cord-029547-9ei1ram3	372	7	Disease	Disease	NNP
cord-029547-9ei1ram3	372	8	Impact	Impact	NNP
cord-029547-9ei1ram3	372	9	of	of	IN
cord-029547-9ei1ram3	372	10	concomitant	concomitant	JJ
cord-029547-9ei1ram3	372	11	vasoactive	vasoactive	JJ
cord-029547-9ei1ram3	372	12	treatment	treatment	NN
cord-029547-9ei1ram3	372	13	and	and	CC
cord-029547-9ei1ram3	372	14	mechanical	mechanical	JJ
cord-029547-9ei1ram3	372	15	left	left	JJ
cord-029547-9ei1ram3	372	16	ventricular	ventricular	JJ
cord-029547-9ei1ram3	372	17	unloading	unloading	NN
cord-029547-9ei1ram3	372	18	in	in	IN
cord-029547-9ei1ram3	372	19	a	a	DT
cord-029547-9ei1ram3	372	20	porcine	porcine	JJ
cord-029547-9ei1ram3	372	21	model	model	NN
cord-029547-9ei1ram3	372	22	of	of	IN
cord-029547-9ei1ram3	372	23	profound	profound	JJ
cord-029547-9ei1ram3	372	24	cardiogenic	cardiogenic	JJ
cord-029547-9ei1ram3	372	25	shock	shock	NN
cord-029547-9ei1ram3	372	26	Coronavirus	Coronavirus	NNP
cord-029547-9ei1ram3	372	27	disease	disease	NN
cord-029547-9ei1ram3	373	1	19	19	CD
cord-029547-9ei1ram3	373	2	infection	infection	NN
cord-029547-9ei1ram3	373	3	does	do	VBZ
cord-029547-9ei1ram3	373	4	not	not	RB
cord-029547-9ei1ram3	373	5	result	result	VB
cord-029547-9ei1ram3	373	6	in	in	IN
cord-029547-9ei1ram3	373	7	acute	acute	JJ
cord-029547-9ei1ram3	373	8	kidney	kidney	NN
cord-029547-9ei1ram3	373	9	injury	injury	NN
cord-029547-9ei1ram3	373	10	:	:	:
cord-029547-9ei1ram3	373	11	An	an	DT
cord-029547-9ei1ram3	373	12	analysis	analysis	NN
cord-029547-9ei1ram3	373	13	of	of	IN
cord-029547-9ei1ram3	373	14	116	116	CD
cord-029547-9ei1ram3	373	15	hospitalized	hospitalize	VBN
cord-029547-9ei1ram3	373	16	patients	patient	NNS
cord-029547-9ei1ram3	373	17	from	from	IN
cord-029547-9ei1ram3	373	18	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	373	19	,	,	,
cord-029547-9ei1ram3	373	20	China	China	NNP
cord-029547-9ei1ram3	373	21	Early	early	RB
cord-029547-9ei1ram3	373	22	acute	acute	JJ
cord-029547-9ei1ram3	373	23	respiratory	respiratory	JJ
cord-029547-9ei1ram3	373	24	support	support	NN
cord-029547-9ei1ram3	373	25	for	for	IN
cord-029547-9ei1ram3	373	26	pregnant	pregnant	JJ
cord-029547-9ei1ram3	373	27	patients	patient	NNS
cord-029547-9ei1ram3	373	28	with	with	IN
cord-029547-9ei1ram3	373	29	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	373	30	disease	disease	NN
cord-029547-9ei1ram3	373	31	2019	2019	CD
cord-029547-9ei1ram3	373	32	(	(	-LRB-
cord-029547-9ei1ram3	373	33	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	373	34	)	)	-RRB-
cord-029547-9ei1ram3	373	35	infection	infection	NN
cord-029547-9ei1ram3	373	36	Preparing	prepare	VBG
cord-029547-9ei1ram3	373	37	for	for	IN
cord-029547-9ei1ram3	373	38	the	the	DT
cord-029547-9ei1ram3	373	39	most	most	RBS
cord-029547-9ei1ram3	373	40	critically	critically	RB
cord-029547-9ei1ram3	373	41	Ill	ill	JJ
cord-029547-9ei1ram3	373	42	patients	patient	NNS
cord-029547-9ei1ram3	373	43	with	with	IN
cord-029547-9ei1ram3	373	44	COVID-19	covid-19	CD
cord-029547-9ei1ram3	373	45	:	:	:
cord-029547-9ei1ram3	373	46	the	the	DT
cord-029547-9ei1ram3	373	47	potential	potential	JJ
cord-029547-9ei1ram3	373	48	role	role	NN
cord-029547-9ei1ram3	373	49	of	of	IN
cord-029547-9ei1ram3	373	50	extracorporeal	extracorporeal	JJ
cord-029547-9ei1ram3	373	51	membrane	membrane	NN
cord-029547-9ei1ram3	373	52	oxygenation	oxygenation	NN
cord-029547-9ei1ram3	373	53	Therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	373	54	use	use	NN
cord-029547-9ei1ram3	373	55	of	of	IN
cord-029547-9ei1ram3	373	56	extracellular	extracellular	JJ
cord-029547-9ei1ram3	373	57	vesicles	vesicle	NNS
cord-029547-9ei1ram3	373	58	for	for	IN
cord-029547-9ei1ram3	373	59	acute	acute	JJ
cord-029547-9ei1ram3	373	60	and	and	CC
cord-029547-9ei1ram3	373	61	chronic	chronic	JJ
cord-029547-9ei1ram3	373	62	lung	lung	NN
cord-029547-9ei1ram3	373	63	disease	disease	NN
cord-029547-9ei1ram3	374	1	Expanded	expand	VBN
cord-029547-9ei1ram3	374	2	umbilical	umbilical	JJ
cord-029547-9ei1ram3	374	3	cord	cord	NN
cord-029547-9ei1ram3	374	4	mesenchymal	mesenchymal	JJ
cord-029547-9ei1ram3	374	5	stem	stem	NN
cord-029547-9ei1ram3	374	6	cells	cell	NNS
cord-029547-9ei1ram3	374	7	(	(	-LRB-
cord-029547-9ei1ram3	374	8	UC	UC	NNP
cord-029547-9ei1ram3	374	9	-	-	HYPH
cord-029547-9ei1ram3	374	10	MSCs	MSCs	NNP
cord-029547-9ei1ram3	374	11	)	)	-RRB-
cord-029547-9ei1ram3	374	12	as	as	IN
cord-029547-9ei1ram3	374	13	a	a	DT
cord-029547-9ei1ram3	374	14	therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	374	15	strategy	strategy	NN
cord-029547-9ei1ram3	374	16	in	in	IN
cord-029547-9ei1ram3	374	17	managing	manage	VBG
cord-029547-9ei1ram3	374	18	critically	critically	RB
cord-029547-9ei1ram3	374	19	Ill	ill	JJ
cord-029547-9ei1ram3	375	1	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	375	2	patients	patient	NNS
cord-029547-9ei1ram3	375	3	:	:	:
cord-029547-9ei1ram3	375	4	the	the	DT
cord-029547-9ei1ram3	375	5	case	case	NN
cord-029547-9ei1ram3	375	6	for	for	IN
cord-029547-9ei1ram3	375	7	compassionate	compassionate	JJ
cord-029547-9ei1ram3	375	8	use	use	NN
cord-029547-9ei1ram3	375	9	Hypercoagulation	Hypercoagulation	NNP
cord-029547-9ei1ram3	375	10	and	and	CC
cord-029547-9ei1ram3	375	11	antithrombotic	antithrombotic	JJ
cord-029547-9ei1ram3	375	12	treatment	treatment	NN
cord-029547-9ei1ram3	375	13	in	in	IN
cord-029547-9ei1ram3	375	14	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	375	15	2019	2019	CD
cord-029547-9ei1ram3	375	16	:	:	:
cord-029547-9ei1ram3	375	17	a	a	DT
cord-029547-9ei1ram3	375	18	new	new	JJ
cord-029547-9ei1ram3	375	19	challenge	challenge	NN
cord-029547-9ei1ram3	375	20	Association	Association	NNP
cord-029547-9ei1ram3	375	21	of	of	IN
cord-029547-9ei1ram3	375	22	coronavirus	coronavirus	NNP
cord-029547-9ei1ram3	375	23	disease	disease	NNP
cord-029547-9ei1ram3	375	24	2019	2019	CD
cord-029547-9ei1ram3	375	25	(	(	-LRB-
cord-029547-9ei1ram3	375	26	COVID-19	covid-19	VB
cord-029547-9ei1ram3	375	27	)	)	-RRB-
cord-029547-9ei1ram3	375	28	with	with	IN
cord-029547-9ei1ram3	375	29	myocardial	myocardial	JJ
cord-029547-9ei1ram3	375	30	injury	injury	NN
cord-029547-9ei1ram3	375	31	and	and	CC
cord-029547-9ei1ram3	375	32	mortality	mortality	NN
cord-029547-9ei1ram3	375	33	Clinical	clinical	JJ
cord-029547-9ei1ram3	375	34	course	course	NN
cord-029547-9ei1ram3	375	35	and	and	CC
cord-029547-9ei1ram3	375	36	risk	risk	NN
cord-029547-9ei1ram3	375	37	factors	factor	NNS
cord-029547-9ei1ram3	375	38	for	for	IN
cord-029547-9ei1ram3	375	39	mortality	mortality	NN
cord-029547-9ei1ram3	375	40	of	of	IN
cord-029547-9ei1ram3	375	41	adult	adult	NN
cord-029547-9ei1ram3	375	42	inpatients	inpatient	NNS
cord-029547-9ei1ram3	375	43	with	with	IN
cord-029547-9ei1ram3	375	44	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	375	45	in	in	IN
cord-029547-9ei1ram3	375	46	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	375	47	,	,	,
cord-029547-9ei1ram3	375	48	China	China	NNP
cord-029547-9ei1ram3	375	49	:	:	:
cord-029547-9ei1ram3	375	50	a	a	DT
cord-029547-9ei1ram3	375	51	retrospective	retrospective	JJ
cord-029547-9ei1ram3	375	52	cohort	cohort	NN
cord-029547-9ei1ram3	375	53	study	study	NN
cord-029547-9ei1ram3	375	54	Role	role	NN
cord-029547-9ei1ram3	375	55	of	of	IN
cord-029547-9ei1ram3	375	56	dipeptidyl	dipeptidyl	JJ
cord-029547-9ei1ram3	375	57	peptidase	peptidase	NN
cord-029547-9ei1ram3	375	58	4	4	CD
cord-029547-9ei1ram3	375	59	inhibitors	inhibitor	NNS
cord-029547-9ei1ram3	375	60	in	in	IN
cord-029547-9ei1ram3	375	61	diabetic	diabetic	JJ
cord-029547-9ei1ram3	375	62	patients	patient	NNS
cord-029547-9ei1ram3	375	63	with	with	IN
cord-029547-9ei1ram3	375	64	Coronavirus-19	Coronavirus-19	NNP
cord-029547-9ei1ram3	375	65	infection	infection	NN
cord-029547-9ei1ram3	375	66	Clinical	clinical	JJ
cord-029547-9ei1ram3	375	67	features	feature	NNS
cord-029547-9ei1ram3	375	68	and	and	CC
cord-029547-9ei1ram3	375	69	treatment	treatment	NN
cord-029547-9ei1ram3	375	70	of	of	IN
cord-029547-9ei1ram3	375	71	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	375	72	patients	patient	NNS
cord-029547-9ei1ram3	375	73	in	in	IN
cord-029547-9ei1ram3	375	74	northeast	northeast	JJ
cord-029547-9ei1ram3	375	75	Chongqing	Chongqing	NNP
cord-029547-9ei1ram3	375	76	Traditional	traditional	JJ
cord-029547-9ei1ram3	375	77	Chinese	chinese	JJ
cord-029547-9ei1ram3	375	78	medicine	medicine	NN
cord-029547-9ei1ram3	375	79	for	for	IN
cord-029547-9ei1ram3	375	80	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	375	81	treatment	treatment	NN
cord-029547-9ei1ram3	375	82	Clinical	clinical	JJ
cord-029547-9ei1ram3	375	83	characteristics	characteristic	NNS
cord-029547-9ei1ram3	375	84	and	and	CC
cord-029547-9ei1ram3	375	85	therapeutic	therapeutic	JJ
cord-029547-9ei1ram3	375	86	procedure	procedure	NN
cord-029547-9ei1ram3	375	87	for	for	IN
cord-029547-9ei1ram3	375	88	four	four	CD
cord-029547-9ei1ram3	375	89	cases	case	NNS
cord-029547-9ei1ram3	375	90	with	with	IN
cord-029547-9ei1ram3	375	91	2019	2019	CD
cord-029547-9ei1ram3	375	92	novel	novel	JJ
cord-029547-9ei1ram3	375	93	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	375	94	pneumonia	pneumonia	NN
cord-029547-9ei1ram3	375	95	receiving	receive	VBG
cord-029547-9ei1ram3	375	96	combined	combine	VBN
cord-029547-9ei1ram3	375	97	Chinese	chinese	JJ
cord-029547-9ei1ram3	375	98	and	and	CC
cord-029547-9ei1ram3	375	99	Western	western	JJ
cord-029547-9ei1ram3	375	100	medicine	medicine	NN
cord-029547-9ei1ram3	375	101	treatment	treatment	NN
cord-029547-9ei1ram3	376	1	The	the	DT
cord-029547-9ei1ram3	376	2	potential	potential	JJ
cord-029547-9ei1ram3	376	3	chemical	chemical	NN
cord-029547-9ei1ram3	376	4	structure	structure	NN
cord-029547-9ei1ram3	376	5	of	of	IN
cord-029547-9ei1ram3	376	6	anti	anti	JJ
cord-029547-9ei1ram3	376	7	-	-	JJ
cord-029547-9ei1ram3	376	8	SARS	SARS	NNP
cord-029547-9ei1ram3	376	9	-	-	HYPH
cord-029547-9ei1ram3	376	10	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	376	11	RNA	RNA	NNP
cord-029547-9ei1ram3	376	12	-	-	HYPH
cord-029547-9ei1ram3	376	13	dependent	dependent	JJ
cord-029547-9ei1ram3	376	14	RNA	RNA	NNP
cord-029547-9ei1ram3	376	15	polymerase	polymerase	NN
cord-029547-9ei1ram3	377	1	Lianhuaqingwen	Lianhuaqingwen	NNP
cord-029547-9ei1ram3	377	2	exerts	exert	VBZ
cord-029547-9ei1ram3	377	3	anti	anti	JJ
cord-029547-9ei1ram3	377	4	-	-	JJ
cord-029547-9ei1ram3	377	5	viral	viral	JJ
cord-029547-9ei1ram3	377	6	and	and	CC
cord-029547-9ei1ram3	377	7	anti	anti	JJ
cord-029547-9ei1ram3	377	8	-	-	JJ
cord-029547-9ei1ram3	377	9	inflammatory	inflammatory	JJ
cord-029547-9ei1ram3	377	10	activity	activity	NN
cord-029547-9ei1ram3	377	11	against	against	IN
cord-029547-9ei1ram3	377	12	novel	novel	JJ
cord-029547-9ei1ram3	377	13	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	377	14	(	(	-LRB-
cord-029547-9ei1ram3	377	15	SARS	SARS	NNP
cord-029547-9ei1ram3	377	16	-	-	HYPH
cord-029547-9ei1ram3	377	17	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	377	18	)	)	-RRB-
cord-029547-9ei1ram3	378	1	Geographical	geographical	JJ
cord-029547-9ei1ram3	378	2	tracking	tracking	NN
cord-029547-9ei1ram3	378	3	and	and	CC
cord-029547-9ei1ram3	378	4	mapping	mapping	NN
cord-029547-9ei1ram3	378	5	of	of	IN
cord-029547-9ei1ram3	378	6	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	378	7	disease	disease	NN
cord-029547-9ei1ram3	379	1	COVID-19	covid-19	JJ
cord-029547-9ei1ram3	379	2	/	/	SYM
cord-029547-9ei1ram3	379	3	severe	severe	JJ
cord-029547-9ei1ram3	379	4	acute	acute	JJ
cord-029547-9ei1ram3	379	5	respiratory	respiratory	JJ
cord-029547-9ei1ram3	379	6	syndrome	syndrome	NN
cord-029547-9ei1ram3	379	7	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	379	8	2	2	CD
cord-029547-9ei1ram3	380	1	(	(	-LRB-
cord-029547-9ei1ram3	380	2	SARS	SARS	NNP
cord-029547-9ei1ram3	380	3	-	-	HYPH
cord-029547-9ei1ram3	380	4	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	380	5	)	)	-RRB-
cord-029547-9ei1ram3	380	6	epidemic	epidemic	NN
cord-029547-9ei1ram3	380	7	and	and	CC
cord-029547-9ei1ram3	380	8	associated	associate	VBD
cord-029547-9ei1ram3	380	9	events	event	NNS
cord-029547-9ei1ram3	380	10	around	around	IN
cord-029547-9ei1ram3	380	11	the	the	DT
cord-029547-9ei1ram3	380	12	world	world	NN
cord-029547-9ei1ram3	380	13	:	:	:
cord-029547-9ei1ram3	381	1	how	how	WRB
cord-029547-9ei1ram3	381	2	21st	21st	JJ
cord-029547-9ei1ram3	381	3	century	century	NN
cord-029547-9ei1ram3	381	4	GIS	GIS	NNP
cord-029547-9ei1ram3	381	5	technologies	technology	NNS
cord-029547-9ei1ram3	381	6	are	be	VBP
cord-029547-9ei1ram3	381	7	supporting	support	VBG
cord-029547-9ei1ram3	381	8	the	the	DT
cord-029547-9ei1ram3	381	9	global	global	JJ
cord-029547-9ei1ram3	381	10	fight	fight	NN
cord-029547-9ei1ram3	381	11	against	against	IN
cord-029547-9ei1ram3	381	12	outbreaks	outbreak	NNS
cord-029547-9ei1ram3	381	13	and	and	CC
cord-029547-9ei1ram3	381	14	epidemics	epidemic	NNS
cord-029547-9ei1ram3	382	1	Positive	positive	JJ
cord-029547-9ei1ram3	382	2	RT	RT	NNP
cord-029547-9ei1ram3	382	3	-	-	HYPH
cord-029547-9ei1ram3	382	4	PCR	PCR	NNP
cord-029547-9ei1ram3	382	5	test	test	NN
cord-029547-9ei1ram3	382	6	results	result	NNS
cord-029547-9ei1ram3	382	7	in	in	IN
cord-029547-9ei1ram3	382	8	patients	patient	NNS
cord-029547-9ei1ram3	382	9	recovered	recover	VBN
cord-029547-9ei1ram3	382	10	from	from	IN
cord-029547-9ei1ram3	382	11	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	382	12	Training	Training	NNP
cord-029547-9ei1ram3	382	13	and	and	CC
cord-029547-9ei1ram3	382	14	fit	fit	JJ
cord-029547-9ei1ram3	382	15	testing	testing	NN
cord-029547-9ei1ram3	382	16	of	of	IN
cord-029547-9ei1ram3	382	17	health	health	NN
cord-029547-9ei1ram3	382	18	care	care	NN
cord-029547-9ei1ram3	382	19	personnel	personnel	NNS
cord-029547-9ei1ram3	382	20	for	for	IN
cord-029547-9ei1ram3	382	21	reusable	reusable	JJ
cord-029547-9ei1ram3	382	22	elastomeric	elastomeric	JJ
cord-029547-9ei1ram3	382	23	half	half	JJ
cord-029547-9ei1ram3	382	24	-	-	HYPH
cord-029547-9ei1ram3	382	25	mask	mask	NN
cord-029547-9ei1ram3	382	26	respirators	respirator	NNS
cord-029547-9ei1ram3	382	27	compared	compare	VBN
cord-029547-9ei1ram3	382	28	with	with	IN
cord-029547-9ei1ram3	382	29	disposable	disposable	JJ
cord-029547-9ei1ram3	382	30	N95	N95	NNP
cord-029547-9ei1ram3	382	31	respirators	respirator	NNS
cord-029547-9ei1ram3	382	32	A	a	DT
cord-029547-9ei1ram3	382	33	sequence	sequence	NN
cord-029547-9ei1ram3	382	34	homology	homology	NN
cord-029547-9ei1ram3	382	35	and	and	CC
cord-029547-9ei1ram3	382	36	bioinformatic	bioinformatic	JJ
cord-029547-9ei1ram3	382	37	approach	approach	NN
cord-029547-9ei1ram3	382	38	can	can	MD
cord-029547-9ei1ram3	382	39	predict	predict	VB
cord-029547-9ei1ram3	382	40	candidate	candidate	NN
cord-029547-9ei1ram3	382	41	targets	target	NNS
cord-029547-9ei1ram3	382	42	for	for	IN
cord-029547-9ei1ram3	382	43	immune	immune	JJ
cord-029547-9ei1ram3	382	44	responses	response	NNS
cord-029547-9ei1ram3	382	45	to	to	IN
cord-029547-9ei1ram3	382	46	SARS	SARS	NNP
cord-029547-9ei1ram3	382	47	-	-	HYPH
cord-029547-9ei1ram3	382	48	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	382	49	Structure	Structure	NNP
cord-029547-9ei1ram3	382	50	,	,	,
cord-029547-9ei1ram3	382	51	function	function	NN
cord-029547-9ei1ram3	382	52	,	,	,
cord-029547-9ei1ram3	382	53	and	and	CC
cord-029547-9ei1ram3	382	54	antigenicity	antigenicity	NN
cord-029547-9ei1ram3	382	55	of	of	IN
cord-029547-9ei1ram3	382	56	the	the	DT
cord-029547-9ei1ram3	382	57	SARS	SARS	NNP
cord-029547-9ei1ram3	382	58	-	-	HYPH
cord-029547-9ei1ram3	382	59	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	382	60	spike	spike	NN
cord-029547-9ei1ram3	382	61	glycoprotein	glycoprotein	NN
cord-029547-9ei1ram3	382	62	Potential	potential	JJ
cord-029547-9ei1ram3	382	63	rapid	rapid	JJ
cord-029547-9ei1ram3	382	64	diagnostics	diagnostic	NNS
cord-029547-9ei1ram3	382	65	,	,	,
cord-029547-9ei1ram3	382	66	vaccine	vaccine	NN
cord-029547-9ei1ram3	382	67	and	and	CC
cord-029547-9ei1ram3	382	68	therapeutics	therapeutic	NNS
cord-029547-9ei1ram3	382	69	for	for	IN
cord-029547-9ei1ram3	382	70	2019	2019	CD
cord-029547-9ei1ram3	382	71	novel	novel	JJ
cord-029547-9ei1ram3	382	72	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	382	73	(	(	-LRB-
cord-029547-9ei1ram3	382	74	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	382	75	)	)	-RRB-
cord-029547-9ei1ram3	382	76	:	:	:
cord-029547-9ei1ram3	382	77	a	a	DT
cord-029547-9ei1ram3	382	78	systematic	systematic	JJ
cord-029547-9ei1ram3	382	79	review	review	NN
cord-029547-9ei1ram3	382	80	Preliminary	preliminary	JJ
cord-029547-9ei1ram3	382	81	identification	identification	NN
cord-029547-9ei1ram3	382	82	of	of	IN
cord-029547-9ei1ram3	382	83	potential	potential	JJ
cord-029547-9ei1ram3	382	84	vaccine	vaccine	NN
cord-029547-9ei1ram3	382	85	targets	target	NNS
cord-029547-9ei1ram3	382	86	for	for	IN
cord-029547-9ei1ram3	382	87	the	the	DT
cord-029547-9ei1ram3	382	88	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	382	89	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	382	90	(	(	-LRB-
cord-029547-9ei1ram3	382	91	SARS	SARS	NNP
cord-029547-9ei1ram3	382	92	-	-	HYPH
cord-029547-9ei1ram3	382	93	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	382	94	)	)	-RRB-
cord-029547-9ei1ram3	383	1	based	base	VBN
cord-029547-9ei1ram3	383	2	on	on	IN
cord-029547-9ei1ram3	383	3	SARS	SARS	NNP
cord-029547-9ei1ram3	383	4	-	-	HYPH
cord-029547-9ei1ram3	383	5	CoV	CoV	NNP
cord-029547-9ei1ram3	383	6	immunological	immunological	JJ
cord-029547-9ei1ram3	383	7	studies	study	NNS
cord-029547-9ei1ram3	383	8	Roadmap	Roadmap	NNP
cord-029547-9ei1ram3	383	9	to	to	IN
cord-029547-9ei1ram3	383	10	developing	develop	VBG
cord-029547-9ei1ram3	383	11	a	a	DT
cord-029547-9ei1ram3	383	12	recombinant	recombinant	JJ
cord-029547-9ei1ram3	383	13	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	383	14	S	s	NN
cord-029547-9ei1ram3	383	15	protein	protein	NN
cord-029547-9ei1ram3	383	16	receptor	receptor	NN
cord-029547-9ei1ram3	383	17	-	-	HYPH
cord-029547-9ei1ram3	383	18	binding	bind	VBG
cord-029547-9ei1ram3	383	19	domain	domain	NN
cord-029547-9ei1ram3	383	20	vaccine	vaccine	NN
cord-029547-9ei1ram3	383	21	for	for	IN
cord-029547-9ei1ram3	383	22	severe	severe	JJ
cord-029547-9ei1ram3	383	23	acute	acute	JJ
cord-029547-9ei1ram3	383	24	respiratory	respiratory	JJ
cord-029547-9ei1ram3	383	25	syndrome	syndrome	NN
cord-029547-9ei1ram3	383	26	Henan	Henan	NNP
cord-029547-9ei1ram3	383	27	Provincial	Provincial	NNP
cord-029547-9ei1ram3	383	28	Center	Center	NNP
cord-029547-9ei1ram3	383	29	for	for	IN
cord-029547-9ei1ram3	383	30	Disease	Disease	NNP
cord-029547-9ei1ram3	383	31	Control	Control	NNP
cord-029547-9ei1ram3	383	32	and	and	CC
cord-029547-9ei1ram3	383	33	Prevention	Prevention	NNP
cord-029547-9ei1ram3	383	34	.	.	.
cord-029547-9ei1ram3	384	1	A	a	DT
cord-029547-9ei1ram3	384	2	randomized	randomized	JJ
cord-029547-9ei1ram3	384	3	,	,	,
cord-029547-9ei1ram3	384	4	double	double	JJ
cord-029547-9ei1ram3	384	5	-	-	HYPH
cord-029547-9ei1ram3	384	6	blind	blind	JJ
cord-029547-9ei1ram3	384	7	,	,	,
cord-029547-9ei1ram3	384	8	placebo	placebo	NN
cord-029547-9ei1ram3	384	9	parallel	parallel	NN
cord-029547-9ei1ram3	384	10	-	-	HYPH
cord-029547-9ei1ram3	384	11	controlled	control	VBN
cord-029547-9ei1ram3	384	12	phase	phase	NN
cord-029547-9ei1ram3	384	13	I	I	NNP
cord-029547-9ei1ram3	384	14	/	/	SYM
cord-029547-9ei1ram3	384	15	II	II	NNP
cord-029547-9ei1ram3	384	16	clinical	clinical	JJ
cord-029547-9ei1ram3	384	17	trial	trial	NN
cord-029547-9ei1ram3	384	18	for	for	IN
cord-029547-9ei1ram3	384	19	inactivated	inactivate	VBN
cord-029547-9ei1ram3	384	20	Novel	Novel	NNP
cord-029547-9ei1ram3	384	21	Coronavirus	Coronavirus	NNP
cord-029547-9ei1ram3	384	22	Pneumonia	Pneumonia	NNP
cord-029547-9ei1ram3	384	23	vaccine	vaccine	NN
cord-029547-9ei1ram3	384	24	(	(	-LRB-
cord-029547-9ei1ram3	384	25	Vero	Vero	NNP
cord-029547-9ei1ram3	384	26	cells	cell	NNS
cord-029547-9ei1ram3	384	27	Safety	Safety	NNP
cord-029547-9ei1ram3	384	28	and	and	CC
cord-029547-9ei1ram3	384	29	Immunogenicity	Immunogenicity	NNP
cord-029547-9ei1ram3	384	30	Study	Study	NNP
cord-029547-9ei1ram3	384	31	of	of	IN
cord-029547-9ei1ram3	384	32	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	384	33	Vaccine	vaccine	NN
cord-029547-9ei1ram3	384	34	(	(	-LRB-
cord-029547-9ei1ram3	384	35	Inactivated	inactivate	VBN
cord-029547-9ei1ram3	384	36	)	)	-RRB-
cord-029547-9ei1ram3	384	37	for	for	IN
cord-029547-9ei1ram3	384	38	Prophylaxis	Prophylaxis	NNP
cord-029547-9ei1ram3	384	39	SARS	SARS	NNP
cord-029547-9ei1ram3	384	40	CoV	CoV	NNP
cord-029547-9ei1ram3	385	1	NCT04352608?term	nct04352608?term	NN
cord-029547-9ei1ram3	385	2	=	=	NFP
cord-029547-9ei1ram3	386	1	vaccine&cond	vaccine&cond	NN
cord-029547-9ei1ram3	386	2	=	=	NFP
cord-029547-9ei1ram3	387	1	COVID-19&draw	covid-19&draw	NN
cord-029547-9ei1ram3	387	2	=	=	NFP
cord-029547-9ei1ram3	388	1	2&rank	2&rank	LS
cord-029547-9ei1ram3	388	2	=	=	NFP
cord-029547-9ei1ram3	389	1	Henan	Henan	NNP
cord-029547-9ei1ram3	389	2	Provincial	Provincial	NNP
cord-029547-9ei1ram3	389	3	Center	Center	NNP
cord-029547-9ei1ram3	389	4	for	for	IN
cord-029547-9ei1ram3	389	5	Disease	Disease	NNP
cord-029547-9ei1ram3	389	6	Control	Control	NNP
cord-029547-9ei1ram3	389	7	and	and	CC
cord-029547-9ei1ram3	389	8	Prevention	Prevention	NNP
cord-029547-9ei1ram3	389	9	.	.	.
cord-029547-9ei1ram3	390	1	A	a	DT
cord-029547-9ei1ram3	390	2	phase	phase	NN
cord-029547-9ei1ram3	390	3	I	-PRON-	PRP
cord-029547-9ei1ram3	390	4	/	/	SYM
cord-029547-9ei1ram3	390	5	II	II	NNP
cord-029547-9ei1ram3	390	6	clinical	clinical	JJ
cord-029547-9ei1ram3	390	7	trial	trial	NN
cord-029547-9ei1ram3	390	8	for	for	IN
cord-029547-9ei1ram3	390	9	inactivated	inactivate	VBN
cord-029547-9ei1ram3	390	10	novel	novel	JJ
cord-029547-9ei1ram3	390	11	coronavirus	coronavirus	NN
cord-029547-9ei1ram3	390	12	(	(	-LRB-
cord-029547-9ei1ram3	390	13	2019-CoV	2019-cov	CD
cord-029547-9ei1ram3	390	14	)	)	-RRB-
cord-029547-9ei1ram3	390	15	vaccine	vaccine	NN
cord-029547-9ei1ram3	390	16	(	(	-LRB-
cord-029547-9ei1ram3	390	17	Vero	Vero	NNP
cord-029547-9ei1ram3	390	18	cells	cell	NNS
cord-029547-9ei1ram3	390	19	Study	Study	NNP
cord-029547-9ei1ram3	390	20	to	to	TO
cord-029547-9ei1ram3	390	21	Describe	describe	VB
cord-029547-9ei1ram3	390	22	the	the	DT
cord-029547-9ei1ram3	390	23	Safety	Safety	NNP
cord-029547-9ei1ram3	390	24	,	,	,
cord-029547-9ei1ram3	390	25	Tolerability	Tolerability	NNP
cord-029547-9ei1ram3	390	26	,	,	,
cord-029547-9ei1ram3	390	27	Immunogenicity	Immunogenicity	NNP
cord-029547-9ei1ram3	390	28	,	,	,
cord-029547-9ei1ram3	390	29	and	and	CC
cord-029547-9ei1ram3	390	30	Potential	Potential	NNP
cord-029547-9ei1ram3	390	31	Efficacy	Efficacy	NNP
cord-029547-9ei1ram3	390	32	of	of	IN
cord-029547-9ei1ram3	390	33	RNA	RNA	NNP
cord-029547-9ei1ram3	390	34	Vaccine	Vaccine	NNP
cord-029547-9ei1ram3	390	35	Candidates	Candidates	NNPS
cord-029547-9ei1ram3	390	36	Against	against	IN
cord-029547-9ei1ram3	390	37	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	390	38	in	in	IN
cord-029547-9ei1ram3	390	39	Healthy	Healthy	NNP
cord-029547-9ei1ram3	390	40	Adults	Adults	NNPS
cord-029547-9ei1ram3	391	1	Tolerability	Tolerability	NNP
cord-029547-9ei1ram3	391	2	and	and	CC
cord-029547-9ei1ram3	391	3	Immunogenicity	Immunogenicity	NNP
cord-029547-9ei1ram3	391	4	of	of	IN
cord-029547-9ei1ram3	391	5	INO-4800	INO-4800	NNP
cord-029547-9ei1ram3	391	6	for	for	IN
cord-029547-9ei1ram3	391	7	COVID-19	covid-19	CD
cord-029547-9ei1ram3	391	8	in	in	IN
cord-029547-9ei1ram3	391	9	Healthy	Healthy	NNP
cord-029547-9ei1ram3	391	10	Volunteers	Volunteers	NNP
cord-029547-9ei1ram3	391	11	Safety	Safety	NNP
cord-029547-9ei1ram3	391	12	and	and	CC
cord-029547-9ei1ram3	391	13	Immunogenicity	Immunogenicity	NNP
cord-029547-9ei1ram3	391	14	Study	Study	NNP
cord-029547-9ei1ram3	391	15	of	of	IN
cord-029547-9ei1ram3	391	16	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	391	17	Vaccine	vaccine	NN
cord-029547-9ei1ram3	391	18	(	(	-LRB-
cord-029547-9ei1ram3	391	19	mRNA-1273	mrna-1273	XX
cord-029547-9ei1ram3	391	20	)	)	-RRB-
cord-029547-9ei1ram3	391	21	for	for	IN
cord-029547-9ei1ram3	391	22	Prophylaxis	Prophylaxis	NNP
cord-029547-9ei1ram3	391	23	SARS	SARS	NNP
cord-029547-9ei1ram3	391	24	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	391	25	Infection	Infection	NNP
cord-029547-9ei1ram3	391	26	(	(	-LRB-
cord-029547-9ei1ram3	391	27	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	391	28	)	)	-RRB-
cord-029547-9ei1ram3	392	1	Evaluating	evaluate	VBG
cord-029547-9ei1ram3	392	2	the	the	DT
cord-029547-9ei1ram3	392	3	Safety	Safety	NNP
cord-029547-9ei1ram3	392	4	,	,	,
cord-029547-9ei1ram3	392	5	Tolerability	Tolerability	NNP
cord-029547-9ei1ram3	392	6	and	and	CC
cord-029547-9ei1ram3	392	7	Immunogenicity	Immunogenicity	NNP
cord-029547-9ei1ram3	392	8	of	of	IN
cord-029547-9ei1ram3	392	9	bacTRL	bactrl	NN
cord-029547-9ei1ram3	392	10	-	-	HYPH
cord-029547-9ei1ram3	392	11	Spike	Spike	NNP
cord-029547-9ei1ram3	392	12	Vaccine	Vaccine	NNP
cord-029547-9ei1ram3	392	13	for	for	IN
cord-029547-9ei1ram3	392	14	Prevention	Prevention	NNP
cord-029547-9ei1ram3	392	15	of	of	IN
cord-029547-9ei1ram3	392	16	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	392	17	Vaccines	Vaccines	NNPS
cord-029547-9ei1ram3	392	18	/	/	SYM
cord-029547-9ei1ram3	392	19	Vaxart	Vaxart	NNP
cord-029547-9ei1ram3	392	20	-	-	HYPH
cord-029547-9ei1ram3	392	21	Announces	Announces	NNP
cord-029547-9ei1ram3	392	22	-	-	HYPH
cord-029547-9ei1ram3	392	23	Initiation	initiation	NN
cord-029547-9ei1ram3	392	24	-	-	HYPH
cord-029547-9ei1ram3	392	25	of	of	IN
cord-029547-9ei1ram3	392	26	-	-	HYPH
cord-029547-9ei1ram3	392	27	Cor	Cor	NNP
cord-029547-9ei1ram3	392	28	onavirus-Vaccine-Program.html	onavirus-Vaccine-Program.html	NNP
cord-029547-9ei1ram3	392	29	,	,	,
cord-029547-9ei1ram3	392	30	accessed	access	VBN
cord-029547-9ei1ram3	392	31	date	date	NN
cord-029547-9ei1ram3	392	32	Evaluation	Evaluation	NNP
cord-029547-9ei1ram3	392	33	of	of	IN
cord-029547-9ei1ram3	392	34	the	the	DT
cord-029547-9ei1ram3	392	35	Safety	Safety	NNP
cord-029547-9ei1ram3	392	36	and	and	CC
cord-029547-9ei1ram3	392	37	Immunogenicity	Immunogenicity	NNP
cord-029547-9ei1ram3	392	38	of	of	IN
cord-029547-9ei1ram3	392	39	a	a	DT
cord-029547-9ei1ram3	392	40	SARS	SARS	NNP
cord-029547-9ei1ram3	392	41	-	-	HYPH
cord-029547-9ei1ram3	392	42	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	392	43	rS	rS	.
cord-029547-9ei1ram3	393	1	(	(	-LRB-
cord-029547-9ei1ram3	393	2	COVID-19	covid-19	VB
cord-029547-9ei1ram3	393	3	)	)	-RRB-
cord-029547-9ei1ram3	393	4	Nanoparticle	Nanoparticle	NNP
cord-029547-9ei1ram3	393	5	Vaccine	Vaccine	NNP
cord-029547-9ei1ram3	393	6	With	with	IN
cord-029547-9ei1ram3	393	7	/	/	,
cord-029547-9ei1ram3	393	8	Without	without	IN
cord-029547-9ei1ram3	393	9	Matrix	Matrix	NNP
cord-029547-9ei1ram3	393	10	-	-	HYPH
cord-029547-9ei1ram3	393	11	M	M	NNP
cord-029547-9ei1ram3	393	12	Adjuvant	Adjuvant	NNP
cord-029547-9ei1ram3	394	1	CT04313127?term	CT04313127?term	NNP
cord-029547-9ei1ram3	394	2	=	=	SYM
cord-029547-9ei1ram3	394	3	vaccine&cond	vaccine&cond	NN
cord-029547-9ei1ram3	394	4	=	=	SYM
cord-029547-9ei1ram3	394	5	COVID-19&draw	covid-19&draw	NN
cord-029547-9ei1ram3	394	6	=	=	NFP
cord-029547-9ei1ram3	395	1	1&r	1&r	CD
cord-029547-9ei1ram3	395	2	ank	ank	NNP
cord-029547-9ei1ram3	395	3	=	=	SYM
cord-029547-9ei1ram3	395	4	8	8	CD
cord-029547-9ei1ram3	395	5	,	,	,
cord-029547-9ei1ram3	395	6	accessed	access	VBN
cord-029547-9ei1ram3	395	7	date	date	NN
cord-029547-9ei1ram3	395	8	Academy	Academy	NNP
cord-029547-9ei1ram3	395	9	of	of	IN
cord-029547-9ei1ram3	395	10	Military	Military	NNP
cord-029547-9ei1ram3	395	11	Medical	Medical	NNP
cord-029547-9ei1ram3	395	12	Sciences	Sciences	NNPS
cord-029547-9ei1ram3	395	13	,	,	,
cord-029547-9ei1ram3	395	14	PLA	PLA	NNP
cord-029547-9ei1ram3	395	15	of	of	IN
cord-029547-9ei1ram3	395	16	China	China	NNP
cord-029547-9ei1ram3	395	17	.	.	.
cord-029547-9ei1ram3	396	1	A	a	DT
cord-029547-9ei1ram3	396	2	Phase	Phase	NNP
cord-029547-9ei1ram3	396	3	II	II	NNP
cord-029547-9ei1ram3	396	4	Clinical	Clinical	NNP
cord-029547-9ei1ram3	396	5	Trial	Trial	NNP
cord-029547-9ei1ram3	396	6	to	to	TO
cord-029547-9ei1ram3	396	7	Evaluate	evaluate	VB
cord-029547-9ei1ram3	396	8	the	the	DT
cord-029547-9ei1ram3	396	9	Recombinant	Recombinant	NNP
cord-029547-9ei1ram3	396	10	Novel	Novel	NNP
cord-029547-9ei1ram3	396	11	Coronavirus	Coronavirus	NNP
cord-029547-9ei1ram3	396	12	Vaccine	Vaccine	NNP
cord-029547-9ei1ram3	396	13	(	(	-LRB-
cord-029547-9ei1ram3	396	14	Adenovirus	Adenovirus	NNP
cord-029547-9ei1ram3	396	15	Vector	Vector	NNP
cord-029547-9ei1ram3	396	16	)	)	-RRB-
cord-029547-9ei1ram3	397	1	(	(	-LRB-
cord-029547-9ei1ram3	397	2	CTII	ctii	NN
cord-029547-9ei1ram3	397	3	-	-	HYPH
cord-029547-9ei1ram3	397	4	nCoV	nCoV	NNP
cord-029547-9ei1ram3	397	5	Immune	Immune	NNP
cord-029547-9ei1ram3	397	6	Medical	Medical	NNP
cord-029547-9ei1ram3	397	7	Institute	Institute	NNP
cord-029547-9ei1ram3	397	8	.	.	.
cord-029547-9ei1ram3	398	1	Safety	safety	NN
cord-029547-9ei1ram3	398	2	and	and	CC
cord-029547-9ei1ram3	398	3	Immunity	Immunity	NNP
cord-029547-9ei1ram3	398	4	of	of	IN
cord-029547-9ei1ram3	398	5	Covid-19	covid-19	JJ
cord-029547-9ei1ram3	398	6	aAPC	aAPC	NNP
cord-029547-9ei1ram3	398	7	Vaccine	Vaccine	NNP
cord-029547-9ei1ram3	398	8	Immunity	Immunity	NNP
cord-029547-9ei1ram3	398	9	and	and	CC
cord-029547-9ei1ram3	398	10	Safety	Safety	NNP
cord-029547-9ei1ram3	398	11	of	of	IN
cord-029547-9ei1ram3	398	12	Covid-19	Covid-19	NNP
cord-029547-9ei1ram3	398	13	Synthetic	Synthetic	NNP
cord-029547-9ei1ram3	398	14	Minigene	Minigene	NNP
cord-029547-9ei1ram3	398	15	Vaccine	Vaccine	NNP
cord-029547-9ei1ram3	398	16	Covid-19	covid-19	NN
cord-029547-9ei1ram3	398	17	:	:	:
cord-029547-9ei1ram3	398	18	four	four	CD
cord-029547-9ei1ram3	398	19	fifths	fifth	NNS
cord-029547-9ei1ram3	398	20	of	of	IN
cord-029547-9ei1ram3	398	21	cases	case	NNS
cord-029547-9ei1ram3	398	22	are	be	VBP
cord-029547-9ei1ram3	398	23	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	398	24	,	,	,
cord-029547-9ei1ram3	398	25	China	China	NNP
cord-029547-9ei1ram3	398	26	figures	figure	NNS
cord-029547-9ei1ram3	398	27	indicate	indicate	VBP
cord-029547-9ei1ram3	398	28	Presumed	presume	VBN
cord-029547-9ei1ram3	398	29	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	398	30	carrier	carrier	NN
cord-029547-9ei1ram3	398	31	transmission	transmission	NN
cord-029547-9ei1ram3	398	32	of	of	IN
cord-029547-9ei1ram3	398	33	COVID-19	COVID-19	NNP
cord-029547-9ei1ram3	398	34	Transmission	Transmission	NNP
cord-029547-9ei1ram3	398	35	of	of	IN
cord-029547-9ei1ram3	398	36	2019-nCoV	2019-ncov	CD
cord-029547-9ei1ram3	398	37	infection	infection	NN
cord-029547-9ei1ram3	398	38	from	from	IN
cord-029547-9ei1ram3	398	39	an	an	DT
cord-029547-9ei1ram3	398	40	asymptomatic	asymptomatic	JJ
cord-029547-9ei1ram3	398	41	contact	contact	NN
cord-029547-9ei1ram3	398	42	in	in	IN
cord-029547-9ei1ram3	398	43	Germany	Germany	NNP
cord-029547-9ei1ram3	398	44	Evidence	Evidence	NNP
cord-029547-9ei1ram3	398	45	of	of	IN
cord-029547-9ei1ram3	398	46	SARS	SARS	NNP
cord-029547-9ei1ram3	398	47	-	-	HYPH
cord-029547-9ei1ram3	398	48	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	398	49	infection	infection	NN
cord-029547-9ei1ram3	398	50	in	in	IN
cord-029547-9ei1ram3	398	51	returning	return	VBG
cord-029547-9ei1ram3	398	52	travelers	traveler	NNS
cord-029547-9ei1ram3	398	53	from	from	IN
cord-029547-9ei1ram3	398	54	Wuhan	Wuhan	NNP
cord-029547-9ei1ram3	398	55	,	,	,
cord-029547-9ei1ram3	398	56	China	China	NNP
cord-029547-9ei1ram3	398	57	Virological	Virological	NNP
cord-029547-9ei1ram3	398	58	assessment	assessment	NN
cord-029547-9ei1ram3	398	59	of	of	IN
cord-029547-9ei1ram3	398	60	hospitalized	hospitalize	VBN
cord-029547-9ei1ram3	398	61	patients	patient	NNS
cord-029547-9ei1ram3	398	62	with	with	IN
cord-029547-9ei1ram3	398	63	COVID-2019	COVID-2019	NNP
cord-029547-9ei1ram3	398	64	Respiratory	respiratory	JJ
cord-029547-9ei1ram3	398	65	disease	disease	NN
cord-029547-9ei1ram3	398	66	in	in	IN
cord-029547-9ei1ram3	398	67	rhesus	rhesus	NN
cord-029547-9ei1ram3	398	68	macaques	macaque	NNS
cord-029547-9ei1ram3	398	69	inoculated	inoculate	VBN
cord-029547-9ei1ram3	398	70	with	with	IN
cord-029547-9ei1ram3	398	71	SARS	SARS	NNP
cord-029547-9ei1ram3	398	72	-	-	HYPH
cord-029547-9ei1ram3	398	73	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	398	74	SARS	SARS	NNP
cord-029547-9ei1ram3	398	75	-	-	HYPH
cord-029547-9ei1ram3	398	76	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	398	77	receptor	receptor	NN
cord-029547-9ei1ram3	398	78	ACE2	ACE2	NNP
cord-029547-9ei1ram3	398	79	is	be	VBZ
cord-029547-9ei1ram3	398	80	an	an	DT
cord-029547-9ei1ram3	398	81	interferon	interferon	NN
cord-029547-9ei1ram3	398	82	-	-	HYPH
cord-029547-9ei1ram3	398	83	stimulated	stimulate	VBN
cord-029547-9ei1ram3	398	84	gene	gene	NN
cord-029547-9ei1ram3	398	85	in	in	IN
cord-029547-9ei1ram3	398	86	human	human	JJ
cord-029547-9ei1ram3	398	87	airway	airway	NN
cord-029547-9ei1ram3	398	88	epithelial	epithelial	JJ
cord-029547-9ei1ram3	398	89	cells	cell	NNS
cord-029547-9ei1ram3	398	90	and	and	CC
cord-029547-9ei1ram3	398	91	is	be	VBZ
cord-029547-9ei1ram3	398	92	detected	detect	VBN
cord-029547-9ei1ram3	398	93	in	in	IN
cord-029547-9ei1ram3	398	94	specific	specific	JJ
cord-029547-9ei1ram3	398	95	cell	cell	NN
cord-029547-9ei1ram3	398	96	subsets	subset	NNS
cord-029547-9ei1ram3	398	97	across	across	IN
cord-029547-9ei1ram3	398	98	tissues	tissue	NNS
cord-029547-9ei1ram3	399	1	The	the	DT
cord-029547-9ei1ram3	399	2	pathogenicity	pathogenicity	NN
cord-029547-9ei1ram3	399	3	of	of	IN
cord-029547-9ei1ram3	399	4	SARS	SARS	NNP
cord-029547-9ei1ram3	399	5	-	-	HYPH
cord-029547-9ei1ram3	399	6	CoV-2	CoV-2	NNP
cord-029547-9ei1ram3	399	7	in	in	IN
cord-029547-9ei1ram3	399	8	hACE2	hace2	NN
cord-029547-9ei1ram3	399	9	transgenic	transgenic	JJ
cord-029547-9ei1ram3	399	10	mice	mouse	NNS
cord-029547-9ei1ram3	400	1	This	this	DT
cord-029547-9ei1ram3	400	2	work	work	NN
cord-029547-9ei1ram3	400	3	was	be	VBD
cord-029547-9ei1ram3	400	4	supported	support	VBN
cord-029547-9ei1ram3	400	5	by	by	IN
cord-029547-9ei1ram3	400	6	the	the	DT
cord-029547-9ei1ram3	400	7	National	National	NNP
cord-029547-9ei1ram3	400	8	Natural	Natural	NNP
cord-029547-9ei1ram3	400	9	Science	Science	NNP
cord-029547-9ei1ram3	400	10	 	 	_SP
cord-029547-9ei1ram3	401	1	All	all	DT
cord-029547-9ei1ram3	401	2	authors	author	NNS
cord-029547-9ei1ram3	401	3	declared	declare	VBD
cord-029547-9ei1ram3	401	4	that	that	IN
cord-029547-9ei1ram3	401	5	they	-PRON-	PRP
cord-029547-9ei1ram3	401	6	had	have	VBD
cord-029547-9ei1ram3	401	7	no	no	DT
cord-029547-9ei1ram3	401	8	conflict	conflict	NN
cord-029547-9ei1ram3	401	9	of	of	IN
cord-029547-9ei1ram3	401	10	interest	interest	NN
cord-029547-9ei1ram3	401	11	.	.	.